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Abstract	
	
In	 the	 horse,	 there	 is	 a	 paucity	 of	 species-specific	 IVM	 optimisation	 and	 energy	
metabolism	pathways	in	COCs	during	IVM	are	undefined.	Studies	were	undertaken	
to	 characterise	 glucose,	 pyruvate	 and	 lactate	 (GPL)	 and	 oxidative	 metabolism	
(OXPHOS)	 in	 equine	 COCs	 during	 IVM	 and	 further	 investigate	 these	 parameters	
under	varying	clinical	 conditions.	Gene	expression	 in	 single	oocytes,	 cumulus	cells	
and	blastocysts	was	also	explored.	Novel	 technology	 for	 the	horse;	enzyme-linked	
metabolic	 assays,	 the	 Seahorse	 XFp	 Analyser,	 PolyA	 PCR	 and	 Primovision™	 were	
employed	 to	 generate	 data.	 Data	 demonstrated	 that	 COCs	 had	 high	 glucose	
consumption,	accounted	 for	by	 lactate	production	 (glycolytic	 index	~100%).	Up	 to	
24%	COCs	depleted	all	available	glucose	during	IVM,	which	was	not	associated	with	
a	change	in	maturation	or	cleavage	rate.	COCs	produced	and	secreted	pyruvate	into	
the	medium.	Glucose/lactate	(GL)	metabolism	was	independent	of	cumulus/meiotic	
status	but	correlated	to	COC	DNA	content.	Pyruvate	production	was	independent	of	
DNA	 content.	GPL	metabolism	displayed	 a	 temporal	 pattern;	GL	 increased	 during	
10-20	 h	 and	 GL	 decreased	 and	 pyruvate	 production	 increased	 during	 20-30	 h.	
Oxygen	 consumption	 rate	 (OCR)	 was	 high,	 demonstrating	 OXPHOS	 plays	 a	 larger	
role	 in	 equine	 COC	 energy	 metabolism	 than	 in	 other	 species.	 Examination	 of	
mitochondrial	 function	showed	that	~50%	of	OCR	was	coupled	to	ATP	production,	
~35%	was	 non-mitochondrial	 and	 17%	 due	 to	 proton	 leak	 and	 did	 not	 vary	 over	
time.	 In	 contrast,	 spare	 capacity	 fell	 from	 85%	 to	 5%	 over	 the	 course	 of	 IVM.	
Addition	of	 0.15	mM	pyruvate	 increased	glucose	 consumption	and	at	 5%	oxygen,	
0.15	mM	pyruvate	 decreased	 pyruvate	 production.	 Pyruvate	 concentration	 (0-0.5	
mM)	had	no	effect	on	OCR	or	mitochondrial	function.	Addition	of	0.5	mM	pyruvate	
to	 17	 mM	 glucose	 medium	 increased	 expression	 of	 G6PD	 in	 cumulus	 cells	 and	
resulted	in	a	switch	to	pyruvate	consumption.	Glucose	concentration	(5.6/17	mM)	
had	no	 impact	 on	 developmental,	morphokinetic,	GPL	 or	OCR	measurements	 but	
the	 proportion	 of	 OCR	 coupled	 to	 ATP	 and	 non-	 mitochondrial	 processes	 were	
decreased	 and	 increased	 respectively.	 Taken	 together,	 these	 results	 demonstrate	
the	 plasticity	 of	 the	 equine	 COC	 in	 terms	 of	 substrate	 utilisation	 but	 that	 this	
plasticity	incurs	a	change	at	the	metabolic	level	that	warrants	further	investigation.
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Chapter	1:	General	Introduction	
	
1.1	Overview	
	
Horses	 have	 been	 bred	 for	 pleasure	 and	 competition	 purposes	 for	 thousands	 of	
years.	 In	 the	 last	 century,	 breeding	 by	 artificial	 insemination	 has	 become	
commonplace	for	many	breeds	with	the	notable	exception	of	racing	thoroughbreds,	
for	which	 the	use	of	assisted	conception	 is	 specifically	excluded	by	 the	 regulatory	
authorities.	While	artificial	insemination	allows	the	wider	dissemination	of	valuable	
genetics	 traits,	 in	addition	to	many	management	benefits,	 it	 relies	on	a	 functional	
tubular	 female	 reproductive	 tract	 and	 adequate	 stallion	 fertility	 in	 order	 for	 an	
offspring	to	be	produced.	Conversely,	in	vitro	systems	bypass	the	reproductive	tract	
and	 can	 utilise	 only	 a	 single	 spermatozoon,	 thereby	 allowing	 offspring	 to	 be	
produced	from	genetic	combinations	that	would	otherwise	be	lost.		
	
Regardless	 of	 whether	 pregnancies	 are	 derived	 from	 natural	 or	 in	 vitro	 embryo	
production	 (IVP)	 systems,	 a	 good	 quality	 oocyte	 is	 a	 prerequisite	 for	 embryo	
development	and	production	of	a	healthy	offspring.	While	 intrinsic	 factors	related	
to	 the	 donor	mare	 and	donor	 follicle	 can	 directly	 influence	 oocyte	 quality	 before	
collection,	in	vitro	procedures	leading	up	to	the	fertilisation	process,	namely	in	vitro	
maturation	 (IVM)	 as	 performed	 in	 equine	 IVP,	 also	 have	 the	 capacity	 to	 affect	
oocyte	developmental	potential,	and	thus	require	optimisation.	In	the	horse,	IVP	is	
relatively	 novel.	 While	 in	 vitro	 culture	 systems	 are	 capable	 of	 producing	 viable	
offspring	in	the	hands	of	a	few	specialist	centres,	there	has	been	a	notable	paucity	
of	species-specific	optimisation	reported.	This	lack	of	detailed	study	not	only	leads	
to	a	loss	of	efficiency	in	the	IVP	process	but	also	creates	the	potential	for	undesired	
downstream	epigenetic	effects	on	the	resulting	offspring.	
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Across	the	domestic	species	and	man,	a	‘metabolic	approach’	has	proved	useful	in	
directing	 the	 optimisation	 of	 IVP	 systems.	 Studying	 metabolism	 allows	 species-
specific	 requirements	 to	 first	 be	 identified	 and	 then	 the	 culture	 system	 to	 be	
subsequently	 tailored	 to	meet	 those	 needs.	 In	 the	 horse,	 the	 energy	metabolism	
pathways	 in	 use	 by	 cumulus	 oocyte	 complexes	 (COCs)	 during	 IVM,	 and	 the	
preferred	 substrates	 for	 optimal	 and	 efficient	 ATP	 production	 and	 mitochondrial	
function,	are	unknown.		
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1.2	The	reproductive	biology	of	the	mare	
	
Several	aspects	of	 the	reproductive	biology	of	 the	mare	are	unique	to	the	species	
and	highly	relevant	to	the	clinical	application	of	assisted	reproductive	technologies	
(ARTs).	 The	 summary	 provided	 below	highlights	 these	 elements	 in	 context	 of	 the	
general	reproductive	biology	of	the	mare.	
	
1.2.1	Follicular	development	and	cyclicity	in	the	horse	
	
The	 mare	 is	 a	 long	 day,	 seasonally	 polyoestrus	 (~April-October)	 breeder	 with	 an	
oestrous	cycle	length	of	approximately	21	days	(Ginther,	1992).	Ovarian	cyclicity	in	
the	 mare	 is	 entrained	 to	 photoperiod	 and	 the	 onset	 of	 the	 breeding	 season	 is	
mediated	 by	 decreased	 durations	 of	 nocturnal	 melatonin	 secretion	 during	 the	
longer	 days	 of	 spring.	 Spring	 changes	 in	 circadian	 melatonin	 profiles	 promote	
increased	frequency	of	pulsatile	gonadotropin-releasing	hormone	(GnRH)	secretion	
from	 the	 hypothalamus.	 These	 pulsatile	 GnRH	 secretions	 directly	 stimulate	 the	
release	 of	 follicle	 stimulating	 hormone	 (FSH)	 from	 the	 anterior	 pituitary.	 Ovarian	
follicles	recruited	under	the	influence	of	this	FSH	grow	as	a	single	cohort	(known	as	
‘new	wave’	follicles)	until	the	point	of	selection	for	dominance	and	deviation,	which	
occurs	when	the	largest	ovarian	follicle	attains	a	diameter	of	21-23mm	(Ginther	et	
al.,	2004).	As	mares	are	generally	monovulatory,	this	 is	the	point	at	which	a	single	
follicle	 will	 usually	 assert	 its	 dominance	 (Ginther	 et	 al.,	 2004).	 The	 dominant	
follicle(s)	 secretes	 oestrogen	 and	 inhibin,	 which	 feedback	 negatively	 to	 decrease	
FSH	release	from	the	pituitary.	Related	to	this,	the	remainder	of	the	follicle	cohort	
undergoes	atresia.	The	dominant	 follicle	grows	 to	upwards	of	40	mm	 in	diameter	
before	ovulation,	one	of	 the	 largest	periovulatory	 follicles	 in	 the	animal	 kingdom.	
Oestrus	 is	 long	 and	 variable	 (most	 commonly	 between	 5-7	 days)	 and	 is	
characterised	 by	 a	 prolonged	 and	 gradual	 increase	 in	 peripheral	 luteinising	
hormone	(LH)	concentrations,	which	peak	1-2	days	after	ovulation	(Ginther,	1992;	
Figure	1.1).	This	prolonged	and	gradual	LH	rise	differs	from	the	sharp	LH	peak	found	
in	man	and	most	domestic	species,	but	as	for	other	species,	it	is	recognized	as	the	
trigger	event	which	brings	about	changes	within	the	oocyte	and	follicle	to	culminate	
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in	ovulation	and	luteinisation	of	follicular	cells	essential	for	the	establishment	of	the	
corpus	luteum	(CL).	
	
	
	
Figure	 1.1:	Hormonal	 profile	 of	 the	 reproductive	 cycle	of	 the	mare	 (Adaptation	of	
diagram	by	Daels	and	Hughes,	1993)	
	
The	 CL	 synthesises	 and	 secretes	 progesterone,	 which	 can	 be	 detected	 in	 the	
peripheral	 circulation	 0-2	 days	 post-ovulation	 (Hinrichs	 et	 al.,	 1988).	 Luteolysis	
occurs	 in	 the	 absence	 of	 pregnancy	 on	 days	 14-16	 of	 the	 cycle,	 due	 to	 PGF2α	
release	from	the	endometrium	(Douglas	and	Ginther,	1976)	
	
1.2.2	Reproductive	anatomy	of	the	horse	
	
The	gross	anatomy	of	the	mare’s	ovaries	is	essentially	“inverted”	in	comparison	to	
those	of	 humans	 and	other	 domestic	 species.	 The	ovary	 is	 surrounded	by	 a	 thick	
layer	 of	 connective	 tissue	 over	 all	 but	 one	 section,	 such	 that	 ovulation	 can	 only	
occur	at	a	single	point,	named	the	ovulation	fossa	(reviewed	by	Gastal,	2011).	The	
oviduct	 of	 the	mare	 is	 also	 unique	 in	 that	 the	 uterotubular	 junction	 (UTJ)	 allows	
only	 selective	 transport	 of	 viable	 embryos.	 This	 demarcation	 creates	 two	 distinct	
environments	(oviduct	and	uterus)	to	which	the	early	embryo	is	exposed.		
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1.2.3	In	vivo	fertilisation	and	early	embryo	development	in	the	horse	
	
Ovulated	 oocytes	 enter	 the	 oviduct	 surrounded	 by	 follicular	 cumulus	 cells	 and	
remain	viable	 for	a	period	of	at	 least	6-12	hours	before	 they	begin	 to	degenerate	
(Ginther,	 1992).	 Fertilisation	 takes	 place	 in	 the	 ampullary-isthmus	 junction	 of	 the	
oviduct.	Fertilisation	rates	in	vivo	are	upwards	of	90%	(Bezard	et	al.,	1989)	with	the	
first	 cleavage	 occurring	 at	 approximately	 24	 hours	 post-ovulation.	 Embryonic	
development	 to	 the	 morula	 stage	 occurs	 within	 the	 oviductal	 environment	 and	
viable	embryos	are	transported	through	the	UTJ	between	Day	5.5-6	post-ovulation	
(Freeman	 et	 al.,	 1991).	 This	 selective	 transport	 is	 attributed	 to	 the	 secretion	 of	
Prostaglandin	E2	(PGE2)	by	the	developing	embryo	(Weber	et	al.,	1991).	In	practical	
terms	 for	 research	purposes,	 this	prevents	access	 to	 the	early	embryo	until	about	
Day	6,	when	it	has	transited	to	the	uterus.	
	
Blastocyst	formation	occurs	either	during	transport	to	the	uterus	or	soon	after.	The	
blastocyst	expands	rapidly	(>	300	μm	by	Day	7	post-ovulation)	but	remains	spherical	
and	 the	 embryonic	 vesicle	 is	 highly	 mobile	 in	 the	 uterus.	 This	 mobility	 phase	 is	
essential	for	the	maternal	recognition	of	pregnancy	(McDowell	et	al.,	1988),	which	
occurs	 between	 days	 12-14,	 although	 the	 specific	 mechanism	 has	 not	 yet	 been	
identified	 in	the	horse.	At	around	day	16,	the	embryonic	vesicle	 lodges	within	the	
uterus,	 largely	 as	 a	 result	 of	 its	 increasing	 size	 and	 progesterone-induced	 tonic	
uterine	 contraction;	 however,	 it	 is	 still	 not	 attached	 to	 the	 endometrium.	
Trophoblastic	 cells	 invade	 the	maternal	endometrium	at	day	35-40,	however	 true	
attachment	 does	 not	 occur	 until	 placentation	 begins	 on	 Day	 45	 (Samuel	 et	 al.,	
1974).	
	
Another	 unique	 feature	 of	 equine	 embryology	 is	 the	 formation	 of	 an	 acellular	
glycoprotein	capsule	(review;	Stout	et	al.,	2005).	Immediately	following	entry	to	the	
uterus	 (Day	 5.5-6	 post	 ovulation),	 capsule	 glycoproteins,	 produced	 by	 the	
trophoblast	cells,	coalesce	under	the	zona	pellucida	to	encapsulate	the	developing	
embryo.	The	zona	pellucida	is	shed	within	a	day	of	entering	the	uterus,	leaving	the	
embryonic	 vesicle	 enveloped	 in	 the	 capsule.	 The	 hypothesized	 function	 of	 the	
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capsule	 is	 to	maintain	 the	 spherical	 shape	and	provide	 tensile	 strength	whilst	 the	
vesicle	 is	mobile	and	 to	 form	a	barrier	between	endometrial	and	embryonic	cells,	
preventing	adhesion	during	the	mobility	phase.	It	has	also	been	suggested	that	the	
negative	electrostatic	charge	of	the	capsule	aids	in	attracting	the	positively	charged	
histiotroph.	 The	 capsule	 is	 lost	 gradually	 around	 day	 21,	 at	 which	 point	 cell-cell	
contact	with	the	endometrium	is	established.	
	
In	order	to	appreciate	the	complex	requirements	of	an	IVP	system,	a	more	detailed	
review	of	the	intricate	and	interdependent	events	that	occur	during	 in	vivo	oocyte	
development	must	be	appreciated.		
	
1.3	Mammalian	oocyte	development		
	
At	 birth,	 the	 ovaries	 of	 female	 mammals	 already	 contain	 a	 pool	 of	 primordial	
ovarian	 follicles	 containing	 primary	 oocytes.	 On-going	 follicle	 recruitment	 then	
ensues	 throughout	 the	 female’s	 reproductive	 lifespan,	 independent	 of	
gonadotropin	 stimulation	 (Figure	 1.2).	 Gonadotropin-independent	 recruitment	
involves	 the	 early	 stages	 of	 oocyte	 development,	 whereby	 primordial	 follicles	
(single	layer	of	squamous	granulosa	cells	enclosing	an	immature	oocyte	of	~30	μm	
diameter	with	no	zona	pellucida)	develop	into	tertiary	follicles	(follicles	with	a	many	
layers	of	 cuboidal	 granulosa	 cells,	 an	oocyte	of	100-150	μm	diameter	with	a	 fully	
developed	 zona	 pellucida	 and	 an	 antrum).	 At	 this	 point,	 the	 follicle	 is	 capable	 of	
responding	 to	 gonadotropins,	 and	 gonadotropin-dependant,	 cyclic	 recruitment	 of	
ovarian	 follicles	 occurs	 (Figure	 1.2).	 FSH	 is	 the	 gonadotropin	 responsible	 for	 this	
cyclic	recruitment.	 In	monovulatory	species	(including	the	horse	and	man)	a	single	
antral	 follicle	 is	 generally	 then	 selected	 from	 the	 growing	 cohort	 of	 follicles	 and	
continues	 to	 grow	 and	 establish	 dominance.	 Attainment	 of	 dominance	 is	
accompanied	by	atresia	of	subordinate	follicles	in	the	recruited	cohort	(as	described	
in	 Section	 1.2.1;	 Figure	 1.1).	 The	 dominant	 follicle	 will	 eventually	 progress	 to	
ovulate	 under	 the	 influence	 of	 LH	 (Figure	 1.2).
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Figure	1.2:	Schematic	diagram	of	folliculogenesis	and	oocyte	development.	Initial	and	on-going	recruitment	takes	place	throughout	the	life	of	
the	female	involving	development	from	primordial	to	tertiary	follicles	which	all	contain	an	oocyte	arrested	in	Prophase	1	of	meiosis.	At	puberty,	
cyclic	 recruitment	of	antral	 follicles	begins	under	 the	 influence	of	 follicle	 stimulating	hormone	 (FSH),	 followed	by	 selection,	 establishment	of	
dominance	 and	 final	 maturation	 under	 the	 influence	 of	 luteinising	 hormone	 (LH)	 leading	 to	 ovulation	 of	 a	 mature	 Metaphase	 II	 oocyte.
	 8	
1.3.1	The	cumulus-oocyte	complex	
	
The	cumulus	cells	are	the	granulosa	cells	that	are	 in	close	proximity	to	the	oocyte	
with	 the	 innermost	 layer	 of	 cells	 (corona	 radiata)	 having	 direct	 contact	 with	 the	
oocyte	 through	 transzonal	 processes	 (Figure	 1.3).	 The	 cumulus	 cells	 arise	 from	
differentiation	of	granulosa	cells	at	the	antral	stage	of	follicular	development,	when	
two	 distinct	 sub-populations	 form;	 mural	 granulosa	 cells	 and	 cumulus	 granulosa	
cells,	 both	 with	 a	 distinct	 phenotype	 (Eppig,	 2001).	 Presence	 of	 cumulus	 cells	 is	
essential	 for	 oogenesis,	 folliculogenesis,	 meiotic	 and	 cytoplasmic	 maturation	 and	
energy	provision	to	the	oocyte	(Figure	1.3;	Ackert	et	al.,	2001;	Albertini	et	al.,	2001;	
Tripathi	 and	 Kumar,	 2010).	 While	 initially	 it	 was	 thought	 that	 the	 cumulus	 cells	
exclusively	 supported	 the	 oocyte	 in	 both	 a	 paracrine	 manner	 and	 through	 gap	
junctions,	 it	 was	 subsequently	 demonstrated	 that	 this	 communication	 was	 bi-
directional,	with	the	oocyte	also	providing	signals	to	the	cumulus	(Figure	1.3;	Eppig,	
2001;	 Kidder	 and	 Vanderhyden,	 2010).	 This	 cross	 talk	 is	 clearly	 essential	 to	
maximise	the	oocyte’s	development	potential.	Data	from	other	species	indicate	that	
IVF	 rates	 are	 low	 if	 the	 cumulus	 cells	 are	 first	 removed	 (Vanderhyden	 and	
Armstrong,	1989;	Zhang	et	al.,	1995).	Additionally,	maintaining	this	cross-talk	is	key	
to	 processes	 essential	 to	 in	 vivo	 fertility	 such	 as	 folliculogenesis,	 ovulation	 and	
follicle	luteinisation	(Ackert	et	al.,	2001;	Eppig,	2001;	Nekola	and	Nalbandov,	1971).	
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Figure	1.3:	Schematic	diagram	illustrating	bidirectional	communication	between	the	
oocyte	and	cumulus	cells.	Transzonal	processes	project	 into	the	cytoplasm	through	
the	 zona	 pellucida	 (ZP)	 and	 end	 in	 gap	 junctions	 (G)	 on	 the	 oocyte	 plasma	
membrane	and	deliver	metabolites,	cAMP,	cGMP	 (Tripathi	et	al.,	2010)	and	mRNA	
(Macaulay	 et	 al.,	 2016)	 from	 the	 cumulus	 cells	 to	 the	 oocyte.	 The	 oocyte	 also	
communicates	 with	 the	 cumulus	 cells	 in	 a	 paracrine	 regulatory	 manner	 by	
production	of	 growth	differentiation	 factor	9	 (GDF9),	 bone	morphogenetic	 protein	
15	(BMP	15)	and	cumulus	expansion	enabling	factor	(CEEF)	(Eppig,	2001).	
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1.3.2	Meiotic	maturation	and	competence	
	
In	female	mammals,	all	oocytes	arrest	at	the	prophase	of	the	first	meiotic	division	
as	 the	 primordial	 follicles	 form,	 around	 the	 time	 of	 birth.	 	 Meiotic	 arrest	 in	 the	
oocyte	 is	 an	 active	 process.	 C-type	 natriuretic	 peptide	 (CNP)	 from	 the	 mural	
granulosa	 cells	 causes	 cumulus	 cells	 to	 produce	 cyclic	 guanosine	monophosphate	
(cGMP),	which	 enters	 the	 oocyte	 and	 inhibits	 phosphodiesterase-3A	 (PDE3A)	 and	
hence	cyclic	adenosine	monophosphate	(cAMP)	 levels	are	maintained	keeping	the	
oocyte	in	meiotic	arrest	(Tripathi	et	al.,	2010;	Zhang	et	al.,	2010).	In	Prophase	1,	the	
chromosomes	 in	 the	 primary	 oocyte	 have	 already	 duplicated	 (4n;	 Note:	 the	
chromosome	terminology	used	here	 refers	 to	each	sister	chromatid	as	a	 separate	
chromosome).	The	oocyte	nucleus	 is	termed	the	“germinal	vesicle”	and	an	oocyte	
with	 an	 intact	 nucleus	 (thus	 in	 prophase	 of	meiosis)	 is	 described	 as	 being	 in	 the	
germinal-vesicle	 stage.	 Even	 if	 removed	 from	 the	 suppressive	environment	of	 the	
follicle,	 oocytes	 are	 unable	 to	 progress	 through	meiosis	 until	 the	 antral	 stage	 of	
follicular	development,	when	 the	 first	 stage	of	 acquisition	of	meiotic	 competence	
occurs.	 At	 the	 antral	 follicle	 stage,	 oocytes	 first	 acquire	 the	 ability	 to	 undergo	
germinal	vesicle	breakdown	(GVBD),	then	as	the	follicle	develops	they	acquire	the	
ability	to	reach	metaphase	II	(the	stage	at	which	they	are	ovulated;	Eppig,	2001).	A	
metaphase	 II	 oocyte	 is	 one	 that	has	extruded	 its	 first	polar	body	 (Figure	1.2)	 and	
contains	 2n	 chromosomes	 in	 the	 oocyte	 and	 2n	 in	 the	 polar	 body).	 The	 2n	
chromosomes	 in	 the	oocyte	must	 separate,	and	a	 second,	1n	polar	body	must	be	
extruded,	 in	order	 to	create	a	haploid	cell	 (n).	Meiosis	 in	 the	 female	gamete	 (one	
egg	[n]	produced	from	each	primary	oocyte	[4n])	 is	 in	contrast	to	that	in	the	male	
where	4	spermatozoa	(n)	are	produced	from	each	primary	spermatocyte	(4n).	
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1.3.3	Cytoplasmic	maturation	
	
During	follicular	development	from	primordial	to	antral	follicle,	and	through	to	the	
preovulatory	 oocyte,	 the	 cytoplasm	 of	 the	 oocyte	 also	 matures.	 Cytoplasmic	
maturation	is	essential	to	support	fertilisation	and	early	embryo	development	until	
embryonic	genome	activation	(EGA;	2-8	cell	stage	 in	most	species	studied;	Telford	
et	al.,	1990,	considered	to	be	4-8	cell	in	the	horse;	Brinsko	et	al.,	1995).	The	process	
of	cytoplasmic	maturation	 is	 relatively	undefined.	However,	essential	 components	
of	cytoplasmic	maturation	include	formation	of	cortical	granules	and	microtubules,	
and	the	elongation	of	mitochondria	and	an	 increase	 in	size	of	the	Golgi	apparatus	
(Ferreira	 et	 al.,	 2009).	Maternal	mRNA	must	 be	 transcribed	 and	 exported	 to	 the	
cytoplasm.	While	in	most	cells	mRNA	has	a	very	short	lifespan,	the	oocyte	is	unique	
in	being	able	to	store	cytoplasmic	mRNA	in	a	stable	state	by	shortening	the	polyA	
tail	 (20-40bp).	 The	 subsequent	 translation	 of	 mRNA	 is	 then	 regulated	 by	 either	
temporal	 polyadenylation	 (lengthening	 to	 80-250bp)	 or	 deadenylation	 (Rodriguez	
and	 Farin,	 2004)	 and	 timely	 availability	 of	 specific	 mRNAs	 is	 crucial	 for	 meiotic	
resumption,	fertilization	and	support	of	the	early	embryo	through	to	EGA	(Mamo	et	
al.,	2011).	
	
1.3.4	Final	maturation	under	the	influence	of	LH	
	
Cumulus	 cells	 are	 normally	 tightly	 packed	 and	 in	 close	 communication	 via	 tight	
junctions	during	the	growth	phase	of	the	follicle,	 forming	a	compact	(Cp)	cumulus	
mass.	The	final	pre-ovulatory	maturation	phase	of	the	follicle,	under	the	influence	
of	LH,	 is	 characterised	by	cumulus	expansion	and	oocyte	meiotic	 resumption.	The	
tight	 junctions	 between	 cumulus	 cells	 detach,	 and	 the	 cumulus	 cells	 produce	 an	
intercellular	 matrix	 rich	 in	 hyaluronic	 acid,	 which	 results	 in	 a	 mucified	 matrix	
forming	between	adjacent	 cells,	 thus	pushing	 them	apart	 (expanded	cumulus;	Ex;	
Eppig,	1979).	Simultaneously,	disruption	of	gap	junctions	between	the	cumulus	cells	
and	the	oocyte	reduces	input	of	cAMP	and	cGMP	to	the	oocyte.	All	of	these	actions	
appear	 to	be	tied	to	activation	of	mitogen	activated	protein	kinase	 (MAPK)	 family	
members	and	results	in	net	reduction	of	intracellular	cAMP	in	the	oocyte,	leading	to	
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activation	of	maturation-promoting	factor	(MPF),	GVBD	and	resumption	of	meiosis	
(Tripathi	 et	 al.,	 2010).	 There	 is	 also	 considerable	 cytoplasmic	 reorganisation	 of	
organelles	 like	 mitochondria	 and	 cortical	 granules,	 in	 addition	 to	 changing	
microtubule	and	actin	microfilament	distribution	(Ferreira	et	al.,	2009)	
	
This	sequence	of	events	results	in	a	secondary	oocyte,	which	has	extruded	the	first	
polar	 body,	 is	 arrested	 in	 the	 metaphase	 of	 the	 second	 meiotic	 division	 and	 is	
contained	within	 an	expanded	gelatinous	 cumulus	mass.	 This	 is	 the	oocyte	which	
will	be	ovulated	and	potentially	fertilised.	
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1.4	In	vitro	embryo	production	in	the	horse		
	
In	 vitro	 embryo	 production	 (IVP)	 in	 the	 horse	 can	 improve	 our	 understanding	 of	
early	embryo	development	and	has	clinical	applications	 in	 the	 salvage	of	valuable	
equine	genetics	(Galli	et	al.,	2007;	Hinrichs	et	al.,	2012;	Li	et	al.,	2001).	Horses	are	
long-lived	 animals	 and	 at	 advanced	 ages	 may	 have	 accumulated	 a	 range	 of	
reproductive	pathologies	that	preclude	routine	breeding	success.	Natural	breeding	
and	 artificial	 insemination	 rely	 on	 the	 mare	 ovulating	 normally	 and	 having	 a	
functional	tubular	reproductive	tract,	and	the	fertility	of	the	stallion’s	semen	being	
adequate.	 In	 vitro	 embryo	 production	 can	 circumvent	 many	 reproductive	
pathologies,	 as	 oocytes	 are	 retrieved	 before	 ovulation	 and	 the	 integrity	 of	 the	
tubular	 reproductive	 tract	 is	 not	 essential	 for	 success.	 Additionally,	 minimal	
numbers	 of	 spermatozoa	 are	 required,	 for	 which	 good	 motility	 is	 not	 essential,	
thereby	 offering	 a	 mechanism	 to	 produce	 embryos	 and	 foals	 when	 only	 limited	
reserves	of	semen	are	available	(Choi	et	al.,	2006a).		
	
Despite	 concerted	 efforts,	 standard	 in	 vitro	 fertilization	 (IVF)	 protocols	 have	 not	
been	successfully	applied	to	the	horse	in	a	repeatable	manner	(review;	Leemans	et	
al.,	 2016).	 For	 this	 reason,	 successful	 equine	 IVP	 has	 thus	 far	 relied	 on	
intracytoplasmic	 sperm	 injection	 (ICSI).	 The	 first	 equine	 pregnancy	 established	
following	 ICSI	 was	 reported	 in	 1996	 by	 Squires	 et	 al.	 	 Application	 of	 in	 vitro	
technologies	 such	 as	 ICSI	 first	 require	 the	 retrieval	 of	 oocytes,	 which	 in	 the	 live	
mare	 is	most	 commonly	 performed	 via	 ultrasound-guided	 transvaginal	 aspiration	
(TVA;	Jacobson	et	al.,	2010).	The	procedure,	performed	under	standing	sedation,	is	
well	tolerated	and	carries	little	risk	to	health	and	future	fertility	(Velez	et	al.,	2012).	
For	 research	purposes	 or	 in	 the	 case	of	 genetic	 salvage,	 should	 a	mare	die	 or	 be	
euthanised,	 oocytes	 can	 also	 be	 retrieved	post	mortem	 directly	 from	 the	 ovaries	
(Hinrichs	et	al.,	2012).	Retrieved	immature	equine	oocytes	are	then	matured	in	vitro	
before	being	subjected	to	ICSI.	Briefly,	the	ICSI	technique	involves	the	injection	of	a	
single	 spermatozoon	 into	 the	 cytoplasm	of	 a	mature	metaphase	 II	 oocyte	using	a	
micromanipulator	(Figure	1.4).		
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Injected	 oocytes	 are	 cultured	 in	 vitro	 for	 7-10	 days	 until	 blastocyst	 development	
occurs,	at	which	time	they	can	be	transferred	transcervically	to	a	recipient	mare	or	
cryopreserved	for	transfer	at	a	later	date	(Hinrichs,	2010).	
	
	
	
	
Figure	1.4:	 Intracytoplasmic	sperm	injection	in	an	equine	metaphase	II	oocyte.	The	
holding	pipette	 (left)	 secures	 the	oocyte	 for	 injection	by	 the	needle	 containing	 the	
spermatozoa	(right).	The	polar	body	can	be	seen	at	6	o’clock	(white	arrow).	
	
Development	of	a	successful	equine	ICSI	programme	remains	elusive	for	many.	The	
production	 of	 viable	 blastocysts	 in	 vitro	 encompasses	 many	 complex	 and	
interdependent	 procedures	 and	 extensive	 financial,	 technical	 and	 intellectual	
investment.	 Reported	 blastocyst	 rates	 per	 injected	 oocyte	 are	 typically	 <	 10	 %	
(Alonso	et	al.,	2014;	Smits	et	al.,	2012;	Zaniboni	et	al.,	2013).	Few	laboratories	have	
published	rates	higher	than	this	(Foss	et	al.,	2013;	Galli	et	al.,	2014a;	Jacobson	et	al.,	
2010;	Matsukawa	et	al.,	2007)	and	only	two	ICSI	laboratories	have	published	clinical	
success	in	a	commercial	programme	(Galli	et	al.,	2016;	Hinrichs	et	al.,	2014).	Despite	
recent	brief	reports	of	good	(>	20%)	blastocyst	rates	achieved	by	various	research	
groups,	none	have	yet	appeared	in	the	peer-reviewed	literature.	
	
In	other	domestic	species	and	man,	controlled	comparative	studies	to	optimise	the	
procedural	 steps	 involved	 in	 IVP,	 coupled	with	 intense	 investigation	of	 the	 in	vivo	
environment,	 have	 supported	 the	 rapid	 improvement	of	 IVP	 systems.	 In	 contrast,	
there	has	been	relatively	little	work	reported	in	either	of	these	areas	for	the	horse.		
50μm	
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This	 is	 due	 in	 part	 to	 pressures	 arising	 from	 clinical	 demand	 and	 private	 industry	
funding,	which	can	over-ride	the	necessity	for	strict	scientific	rigour	and	evidence-
based	progress.	Further,	legal	constraints	on	the	availability	of	research	animals	and	
/	or	 limited	availability	of	post	mortem-derived	oocytes	 in	some	geographic	areas,	
represents	another	barrier	to	a	structured	approach.	Given	the	clinical/commercial	
application	 of	 this	 technique	 in	 producing	 foals	 used	 for	 performance,	 and	 with	
growing	knowledge	of	potential	downstream	effects	on	offspring	as	a	result	of	an	
inadequate	 in	 vitro	 environment	 during	 IVP	 (El	 Hajj	 and	 Haaf,	 2013;	 Fernandez-
Gonzalez,	 Ramirez	 et	 al.,	 2007;	Watkins	 et	 al.,	 2007),	 it	 is	 a	 priority	 to	 develop	 a	
species-tailored	system	for	equine	IVP.	
	
1.4.1	Oocyte	developmental	competence	
	
For	all	IVP	systems,	maximising	the	quality	of	the	oocyte	presented	for	fertilisation	
is	 central	 to	 success.	 The	 concept	 of	 oocyte	 quality,	 however,	 is	 complex	 and	 ill	
defined;	the	only	true	measure	being	the	ability	of	the	oocyte	to	produce	a	viable	
embryo,	establish	an	on-going	pregnancy,	and	result	in	a	full	term	healthy	offspring.	
Thus,	 the	 term	 often	 used	 for	 oocyte	 quality,	 which	 reflects	 adequate	 oocyte	
cytoplasmic	 maturation,	 is	 ‘oocyte	 developmental	 competence’.	 In	 a	 research	
setting,	 studies	 rarely	 have	 the	 scope	 or	 funding	 to	 allow	 the	 production	 of	
offspring,	 therefore	 the	 developmental	 potential	 of	 the	 oocytes	 must	 often	 be	
extrapolated	 and	 predicted	 from	 either	 fertilisation,	 cleavage	 or	 blastocyst	
production	data.		
	
In	 many	 species,	 including	 humans,	 oocyte	 developmental	 competence	 is	
maximised	 by	 stimulating	 the	 donor	 female	 to	 produce	multiple	 in	 vivo-matured	
oocytes	through	follicle	super	stimulation	and	administration	of	an	LH-like	stimulus	
to	 induce	 final	 follicle	 maturation.	 However,	 attempts	 at	 superovulation	 have	
largely	been	unsuccessful	in	the	horse,	due	to	the	lack	of	availability	of	equine	FSH,	
the	variable	and	relatively	poor	response	(average	of	3	follicles	ovulating;	Meyers-
Brown	et	al.,	2010;	Niswender	et	al.,	2003)	and	the	large	size	of	the	pre-ovulatory	
follicles,	 making	 manual	 manipulation	 of	 the	 ovary	 technically	 difficult	 if	 follicle	
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aspiration	is	performed	(Maclellan	et	al.,	2002).	For	this	reason,	equine	IVP	relies	on	
aspiration	of	either	the	one	dominant	preovulatory	follicle	(Carnevale,	et.	al.,	2013;	
Maclellan	 et	 al.,	 2010)	 or	 of	 immature	 follicles	 to	 recover	 germinal	 vesicle-stage	
oocytes,	which	must	subsequently	undergo	IVM.		In	the	single	study	reporting	rates	
achieved	with	both	of	these	techniques,	the	blastocyst	rate	per	aspiration	obtained	
when	 all	 immature	 follicles	 were	 aspirated	 (one	 blastocyst	 per	 aspiration)	 was	
greater	 than	 that	 obtained	 when	 the	 dominant	 stimulated	 preovulatory	 follicle	
alone	was	aspirated	(0.33	blastocysts	per	aspiration;	Jacobson	et	al.,	2010).	
	
Thus	 when	 producing	 equine	 embryos	 or	 foals	 via	 in	 vitro	 methods,	 both	
understanding	the	factors	related	to	oocyte	developmental	potential	intrinsic	to	the	
immature	oocyte	before	collection,	and	maximising	the	developmental	competence	
of	 the	 immature	 oocytes	 during	 the	 IVP	 process	 leading	 to	 ICSI,	 are	 central	 to	
success.	
	
1.4.2	Intrinsic	factors	affecting	oocyte	developmental	competence	
	
Mare	factors:	Age,	breed,	reproductive	disease	and	fitness	
The	 phenotype	 of	 the	 donor	 female	 is	 known	 to	 affect	 oocyte	 developmental	
potential	 in	many	 species,	with	 age	 being	 the	most	 relevant	 factor	 in	 the	 human	
(Navot	 et	 al.,	 1991).	 In	 the	mare,	 several	 authors	 have	 investigated	mare	 factors	
affecting	clinical	outcomes	of	 IVP,	often	reporting	conflicting	results.	 Interestingly,	
while	 a	 negative	 correlation	 has	 been	 demonstrated	 between	 increased	 age	 in	
donor	mares	 and	 oocyte	 recovery	 rate	 (Claes	 et	 al.,	 2016;	 Hinrichs	 et	 al.,	 2014),	
mare	 age	 did	 not	 impact	 either	 maturation	 or	 blastocyst	 rates1	in	 either	 of	 the	
studies.		
	
Mare	athletic	fitness	(mare	actively	participating	in	a	performance	discipline),	mare	
breed	and	reproductive	disease	have	all	been	negatively	correlated	with	outcome.		
Colleoni	 et	 al.,	 (2007)	 reported	 a	 decreased	 blastocyst	 rate	 for	mares	 engaged	 in																																																									1	Blastocyst	 and	 cleavage	 rates	 are	 given	 as	 number	 of	 blastocysts/cleaved	 embryos	 obtained	 per	
number	of	metaphase	II	oocytes	subjected	to	ICSI	unless	otherwise	stated.		
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athletic	 performance	 activities	 vs.	 those	 that	 were	 not	 (3.9%	 vs.	 15.25%	
respectively)	while	 Claes	 et	 al.,	 (2016)	 reported	mares	with	 subfertility	 related	 to	
uterine	abnormalities	to	be	13	times	less	likely	to	produce	and	embryo	than	fertile	
mares	 when	 evaluating	 blastocyst	 production	 per	 aspiration	 session.	 Galli	 et	 al.,	
(2014b),	 reported	 a	 decrease	 in	 maturation,	 cleavage	 and	 blastocyst	 rates	 in	
Arabians	 compared	 to	 both	 Warmbloods	 and	 Quarter	 horses.	 However,	 both	
athletic	performance	and	reproductive	disease	have	been	found	to	be	independent	
of	 outcome	 in	 other	 studies	 (athletic	 fitness;	 Claes	 et	 al.,	 2016;	 reproductive	
disease;	Colleoni	et	al.,	2007)		
	
Season	and	cycle	stage		
It	 has	 been	 reported	 that	while	 season	 (breeding	 vs.	 non-breeding	 season	 of	 the	
mare)	 exerts	 an	 effect	 on	 follicle	 diameter	 (increased	 diameter	 during	 breeding	
season;	Hinrichs	and	Schmidt,	2000),	follicle	number	(increased	number	during	non-
breeding	season;	Choi	et	al.,	2016b)	and	oocyte	recovery	rate	(higher	recovery	rate	
during	spring	transition	than	fall;	Claes	et	al.,	2016)	it	does	not	impact	maturation,	
cleavage	 or	 blastocyst	 rates	 of	 recovered	 oocytes	 (Choi	 et	 al.,	 2016b;	 Colleoni,	
2007;).		
	
The	stage	of	the	mare’s	oestrus	cycle	has	also	been	demonstrated	to	affect	oocyte	
characteristics.	Two	successive	studies	demonstrated	that	aspiration	at	the	end	of	
the	 follicular	 phase	 (34	 hours	 after	 induction	 of	 ovulation	 with	 Crude	 Equine	
Gonadotropins;	CEG)	 resulted	 in	 the	greatest	 IVM	rates	compared	with	aspiration	
during	 the	 luteal	 phase	 (34	 hours	 after	 largest	 follicle	 reached	 18mm	 in	 the	
presence	 of	 a	 corpus	 luteum;	 Goudet	 et	 al.,	 1997	 and	 1998).	 For	 these	 reasons,	
oocytes	collected	during	 the	 luteal	phase	may	not	perform	well	 in	an	 IVP	system,	
due	 to	 the	 increased	 proportion	 of	 COCs	 with	 compact	 cumulus	 and	 higher	
prevalence	of	juvenile	chromatin	compared	to	collection	at	the	end	of	the	follicular	
wave.	 	 However,	 none	 of	 these	 studies	 evaluated	 developmental	 potential,	
therefore	the	optimal	time	to	collect	immature	oocytes	during	the	oestrous	cycle	is	
still	unknown.	
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Cumulus	classification	
Across	 species,	 the	 morphology	 of	 the	 cumulus	 of	 the	 recovered	 oocytes	 is	
considered	 an	 important	 factor	 in	 grading	 oocytes	 as	 a	 predictor	 of	 meiotic	 and	
developmental	 competence.	 In	 the	 horse,	 this	 is	 complicated	 by	 the	 discrepancy	
among	 laboratories	 as	 to	 classification	 of	 cumulus	 morphology,	 making	
comparisons	of	 results	 among	 laboratories	difficult.	As	described	 in	 Section	1.3.4,	
cumulus	and	mural	granulosa	cells	are	tightly	arranged	in	close	proximity	(compact;	
Cp)	during	the	growth	stages	of	 the	 follicle	and	become	expanded	(Ex)	during	the	
final	maturation	stage	under	the	influence	of	LH.	Follicular	atresia	is	another	reason	
that	cumulus	and	granulosa	cells	become	expanded	in	appearance,	in	this	instance	
due	to	apoptosis	and	loss	of	cell-	cell	communication	(Hinrichs	and	Williams,	1997).	
When	performing	 TVA	 for	 clinical	 purposes	 in	 the	 live	mare,	 all	 visible	 follicles	 (≥	
5mm	 diameter	 on	 transrectal	 ultrasound-generated	 images)	 are	 aspirated	 and	
immature	oocytes	are	typically	recovered	with	the	majority	of	the	cumulus	absent	
due	to	the	close	attachment	of	the	cumulus	to	the	follicle	wall	(Hawley	et	al.,	1995)	
and	 present	 as	 corona	 radiata-only	 (Figure	 1.5A).	 By	 contrast,	 immature	 oocytes	
recovered	 post-mortem,	 by	 scraping	 of	 the	 follicular	 walls	 with	 a	 bone	 curette	
(Hinrichs	and	DiGiorgio,	1991),	are	generally	retrieved	with	a	greater	proportion	of	
the	 granulosa	 cells	 intact	 and	 can	 be	 accurately	 classified	 (Figure	 1.5B-D).	 The	
scraping	technique	maximises	recovery	rates	(up	to	85%	vs.	40-60%	for	aspiration;	
Dell’Aquila	 et	 al.,	 2001).	 This	 thesis	 centres	 on	 oocytes	 obtained	post-mortem.	 In	
accordance	with	this,	the	following	descriptions	focus	on	the	collection	of	oocytes	
from	post-mortem	ovaries.	
	
In	the	horse,	the	viable	follicle	prevents	even	the	acquisition	of	meiotic	competence	
by	the	enclosed	oocyte	until	the	follicle	is		>	20	mm	diameter;	Hinrichs	and	Schmidt,	
2000),	 which	 for	 the	 follicle	 destined	 to	 ovulate	 is	 approximately	 a	 week	 before	
ovulation.	 However,	 oocytes	 within	 atretic	 follicles	 rapidly	 acquire	 meiotic	
competence	 (Hinrichs	 and	 Williams,	 1997),	 presumably	 due	 to	 breakdown	 of	
granulosa/oocyte	 communications	 and	 reduction	 in	 cAMP	 levels	 (Section	 1.3.4).	
When	 placed	 in	 culture	 in	 vitro,	 those	 oocytes	 that	 have	 acquired	 meiotic	
competence	 spontaneously	mature	 when	 removed	 from	 the	 follicle.	 By	 contrast,	
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those	that	have	not	acquired	meiotic	competence	will	fail	to	mature	when	placed	in	
culture	and	 instead	degenerate.	These	 findings	support	 the	 fact	 that	 in	 the	horse,	
the	highest	maturation	rates	are	from	oocytes	derived	from	either	large	(>	20	mm	
diameter)	 viable	 growing	 follicles	 (with	 compact	 cumulus,	 Cp)	 or	 from	 atretic	
follicles	of	 any	 size	>	5	mm.	 (with	expanded	 cumulus	 Ex;	 Figure	1.5;	Hinrichs	 and	
Schmidt,	2000;	Hinrichs	and	Williams,	1997)		
	
	
Figure	 1.5:	 Bright	 field	 photomicrographs	 of	 immature	 cumulus	 oocyte	 complexes	
(COCs).	A:	Corona	radiata-only	COCs	obtained	via	transvaginal	aspiration	(TVA).	B:	
Compact	 intact-cumulus	COCs	 (Cp)	obtained	via	 follicular	 scraping	of	post-mortem	
ovaries.	C	and	D:	Expanded	intact-cumulus	COCs	(Ex)	obtained	via	follicular	scraping	
of	post-mortem	ovaries.	
	
Unfortunately,	of	antral	follicles	found	in	horse	ovaries,	few	(<	5%)	follicles	are	>20	
mm	diameter	(Hinrichs	and	Schmidt,	2000).	 	Thus,	the	majority	of	the	meiotically-
competent	oocytes	recovered	are	those	from	follicles	in	atresia.			
	
300μm	300μm	
300μm	 300μm	
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Overall,	 if	 cumulus	morphology	 is	 rigorously	 evaluated,	 it	 is	 a	 useful	 predictor	 of	
meiotic	 competency.	 If	 all	 complexes	 showing	 any	 sign	 of	 cumulus	 expansion	 are	
classified	as	Ex,	Ex	oocytes	have	a	higher	maturation	rate	than	do	Cp	oocytes	(>	60%	
vs.	20-30%;	Hinrichs	et	al.,	1993).	Cumulus	classification	(Ex	or	Cp)	did	not	have	any	
effect	on	blastocyst	development	 rates	after	 ICSI	 (Hinrichs	et	al.,	 2005);	however,	
little	is	known	about	the	further	developmental	competence	of	these	oocyte	types.	
		
1.4.3	Factors	related	to	the	IVP	process	
	
In	addition	to	the	intrinsic	factors	discussed	above,	the	elements	of	the	IVP	process	
preceding	 ICSI	 (transport,	 handling,	 and	 IVM)	 also	 have	 the	 potential	 to	 affect	
developmental	 competence.	 These	 factors	 are	 discussed	 below	 as	 they	 relate	 to	
immature	oocytes	retrieved	from	ovaries	post	mortem.	
	
Ovary	transport	factors:	Temperature	and	duration	of	transport	
Due	to	the	sparsity	of	horse	abattoirs	in	many	geographic	areas,	slaughter	generally	
occurs	at	a	 location	remote	 to	 the	 laboratory	where	 the	 IVP	takes	place.	As	such,	
transport	 factors	 must	 be	 considered	 for	 each	 individual	 laboratory,	 in	 order	 to	
maximise	viability	of	the	oocytes	on	arrival	at	the	laboratory.	The	temperature	and	
duration	of	ovarian	transport	are	two	major	factors	that	can	affect	success.	
	
While	 some	 studies	 have	 found	 no	 difference	 in	 maturation	 rates	 according	 to	
transport	 time	 (1.5-4	 vs.	 6-8	 hours;[Guignot	 et	 al.,	 1999]),	 Hinrichs	 et	 al.,	 (2005)	
reported	that	a	delay	of	<	1	hour	between	slaughter	and	onset	of	 IVM	resulted	 in	
greater	 oocyte	maturation	 rates	 than	 following	 a	 5-9	 hour	 delay.	 Conversely,	 the	
delay	 in	 transport	 time	was	 associated	with	 an	 increased	blastocyst	 development	
rate	(29%	vs.	13%).		
	
The	effect	of	ovarian	transport	time	on	blastocyst	development	has	been	evaluated	
in	 other	 studies,	 however	 the	 confounder	 of	 temperature	 is	 often	 problematic.	
Ribeiro	et	al.,	(2008)	found	that	holding	ovaries	for	7	hours	(at	either	24°C,	or	at	a	
temperature	slowly	descending	from	35	°C)	had	no	impact	on	maturation	rate	when	
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compared	 to	 ovaries	 slowly	 cooled	 to	 27o	 C	 over	 4-6	 hours	 but	 did	 decrease	
blastocyst	development	(16.2-18.2%	vs.	34%).	However,	a	total	holding	time	of	20	
hours	decreased	both	oocyte	maturation	(29-38%	vs.	57%)	and	blastocyst	rate	(12-
14.8	 vs.	 34%)	 compared	 to	 those	 cooled	 to	 27o	C	 over	 4-6	 hours.	 Another	 study	
reported	a	blastocyst	rate	of	up	to	25.5%	after	24	hours	of	ovary	storage	at	15-20°C	
(Matsukawa	 et	 al.,	 2007).	 When	 pregnancy	 rates	 after	 surgical	 transfer	 of	 IVM	
oocytes	to	the	oviducts	of	recipient	mares	were	used	as	a	metric,	similar	outcomes	
were	achieved	for	oocytes	derived	from	ovaries	transported	at	either	12	or	22	°C	for	
18-24	hours	 (15%	vs.	 18%	 respectively;	 Preis	 et	 al.,	 2004).	 Clinically,	 healthy	 foals	
have	been	produced	from	mares	that	died	up	to	9	hours	before	oocyte	collection	
(Hinrichs	et	al.,	2012).		
	
In	 summary,	 data	 suggest	 that	 ovarian	 transport	 of	 up	 to	 5-9	 hours	 at	 ambient	
temperature,	 thereby	 allowing	 a	 slow	 cooling	 curve,	 allows	 for	 the	 greatest	
blastocyst	rates.	However,	these	studies	are	by	no	means	exhaustive,	therefore	the	
optimal	conditions	are	still	unknown.	
	
In	vitro	maturation	
The	first	successful	equine	 IVM	was	reported	by	Fulka	and	Okolski,	(1981)	and	the	
first	embryo	from	an	 IVM		oocyte	 in	1989	by	Zhang	et	al.,	after	oviductal	 transfer	
into	an	inseminated	mare	and	uterine	flushing	7	days	later.	Today,	the	majority	of	
equine	 laboratories	engaged	 in	 IVM	use	commercially	available	cell	 culture	media	
with	or	without	modifications,	and	protocols	vary	widely.	The	two	most	commonly	
used	 media	 for	 equine	 IVM	 are	 TCM-199,	 originally	 designed	 for	 chick	 embryo	
fibroblasts	 and	 first	 reported	 by	 Zhang	 et	 al.,	 (1989)	 and	 DMEM-F12,	 also	 a	
complete	tissue	culture	medium,	first	described	for	use	in	equine	IVM	by	Galli	et	al.,	
(2007).		
	
Logic	suggests	 that	when	considering	 the	optimal	media	 for	 IVM,	 it	 should	be	 the	
one	that	most	resembles	the	follicular	environment	 in	which	maturation	occurs	 in	
vivo.	However,	interpretation	of	data	on	the	composition	of	follicular	fluid	aspirates	
is	 problematic.	 Given	 its	 dynamic	 nature,	 it	 is	 difficult	 to	 ascertain	 whether	 the	
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concentrations	of	components	measured	in	follicular	fluid	are	those	that	should	be	
provided,	those	that	are	surplus	to	requirements,	or	those	that	represent	metabolic	
by-products	of	granulosa	cell	metabolism.		
	
In	 contrast	 to	other	 species,	 there	has	been	 relatively	 little	work	 reported	on	 the	
composition	 of	 equine	 follicular	 fluid,	 with	 the	 exception	 of	 quantitative	 studies	
characterising	steroid	hormones.	Collins	et	al.,	(1997)	described	both	follicular	fluid	
and	 serum	 at	 different	 time	 points	 in	 the	 oestrous	 cycle.	 They	 found	 that	
concentrations	 of	 glucose,	 the	 major	 carbohydrate	 substrate,	 were	 decreased	 in	
follicular	 fluid	 compared	 to	 serum,	 and	 that	 glucose	 concentrations	 further	
decreased	as	ovulation	approached	(4.72	±	0.29mM	24	hours	after	dominant	follicle	
selection	[20-25mm]	vs.	3.24	±	0.09mM	33	hours	after	induction	of	ovulation	with	
CEG).	 A	 brief	 report,	 by	 Gerard	 et	 al.,	 (2000)	 also	 stated	 that	 glucose	 tended	 to	
decrease	 as	 ovulation	 approached	 and	 this	 was	 confirmed	 by	 the	 same	 group	 in	
2002	using	qualitative	nuclear	magnetic	resonance	(NMR)	spectroscopy	(Gérard	et	
al.,	 2002).	 It	 is	 tempting	 to	 speculate	 this	 is	 due	 to	 increased	 consumption	 of	
glucose	by	the	COC	and	mural	granulosa	cells.	
	
Follicular	 fluid	 was	 first	 investigated	 as	 a	 medium	 for	 maturation	 in	 situ.			
Maturation	was	attempted	via	intra-follicular	transfer	of	immature	oocytes	into	the	
preovulatory	follicle	(Hinrichs	and	DiGiorgio,	1991).	These	authors	showed	that	the	
preovulatory	 follicle	 was	 capable	 of	 inducing	 cumulus	 expansion	 in	 immature	
oocytes	 after	 24	 hours,	 and	 also	 that	 the	 follicular	 environment	 was	 capable	 of	
supporting	 complete	 nuclear	 and	 cytoplasmic	 maturation	 of	 the	 transferred	
oocytes.	In	this	study,	the	number	of	embryos	recovered	on	days	7-11	exceeded	the	
number	 of	 ovulations	 in	 4/15	mares	 that	 had	 intra-follicular	 transfer	 performed.	
Goudet	 et	 al.,	 (1997)	 also	 performed	 intra-follicular	 transfer	 and	 compared	 the	
nuclear	maturation	rates	of	oocytes	transferred	to	and	recovered	from	the	follicle,	
to	 those	 of	 IVM	 oocytes.	 They	 found	 increased	 cumulus	 expansion	 in	 the	
transferred	 oocytes	 but	 no	 difference	 in	 maturation	 rates,	 however	 50%	 of	
transferred	oocytes	were	lost.	
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Following	 on	 from	 these	 findings,	 follicular	 fluid	 received	 attention	 as	 both	 a	
complete	 IVM	 media	 and	 as	 a	 supplement	 to	 IVM	 media.	 Bogh	 et	 al.,	 (2002)	
performed	 IVM	 in	 pure	 follicular	 fluid	 and	 found	 that	 while	 it	 did	 not	 increase	
maturation	 rates	 it	 supported	 cumulus	 expansion	 equal	 to	 that	 of	 M199	
supplemented	 with	 gonadotropins,	 but	 only	 when	 collected	 35	 hours	 after	 CEG	
stimulation.	 Dell’Aquila	et	 al.,	 (1997)	 found	 that	 as	 a	 20%	 supplement,	 it	 did	 not	
increase	maturation	or	fertilisation	rates	after	conventional	IVF,	but	it	did	increase	
normal	fertilisation	post	ICSI.	Unfortunately,	the	use	of	follicular	fluid,	either	pure	or	
as	 a	 supplement,	 has	 not	 been	 experimentally	 re-evaluated	 since	 blastocyst	
production	has	been	possible	via	ICSI	but	its	use	has	been	reported	(supplemented	
at	9%	of	total	volume	and	blastocyst	rates	up	to	37%;	Foss	et	al.,	2013).	
	
In	considering	the	commercial	media	used	in	equine	IVM	and	more	specifically	their	
glucose	concentrations,	M199	(at	5.6	mM)	supplies	glucose	near	the	range	found	in	
the	 follicular	 fluid	and	 in	equine	 serum	 (4.9-	6.mM),	 and	DMEM/F12	 (at	17	mM),	
supplies	supraphysiological	concentrations.	However,	both	systems	have	produced	
viable	 embryos	 and	 healthy	 offspring	 after	 ICSI	 and	 embryo	 culture	 (Galli	 et	 al.,	
2007;	 Hinrichs	 et	 al.,	 2014;	 Smits	 et	 al.,	 2010).	 Galli	 et	 al.,	 (2007)	 reported	 that	
DMEM/F12	was	superior	to	M199-based	IVM	media	when	considering	subsequent	
blastocyst	 development	 (26.4%	 [37/140]	 for	 DMEM-F12	 vs.	 12%	 [23/191]	 for	
M199).	 Other	 laboratories	 have	 found	 the	 opposite	 (K.	 Hinrichs,	 personal	
communication).	 	 Notably,	 the	 report	 of	 Galli	 et	 al.	 (2007)	 has	 encouraged	many	
new	laboratories	to	use	DMEM/F12	as	a	base	for	maturation	media;	however,	there	
is	 a	 significant	 variation	 in	 the	 composition	 of	 DMEM/F12-based	 IVM	 media	
between	 groups.	 This	 variation	 is	 in	 part	 a	 result	 of	 differences	 in	 composition	
between	 suppliers	 and	 is	 compounded	 by	 the	 inclusion	 of	 often	 undisclosed	
laboratory-specific	 modifications.	 Media	 additives	 are	 often	 included	 at	 varying	
concentrations,	 such	 as	 pyruvate,	 somatotropin,	 FSH,	 LH,	 insulin-transferrin-
selenium	(ITS),	epidermal	growth	factor	(EGF)	and	insulin-like	growth	factor	1	(IGF-
1)	(Foss	et	al.,	2013;	Galli	et	al.,	2002).	The	evidence-base	for	these	modifications	is	
rarely	 presented.	 The	 few	 that	 have	 been	 critically	 evaluated	 with	 respect	 to	
meiotic	and	developmental	competence	are	discussed	below.	
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Equine	 IVM	is	generally	performed	in	the	presence	of	either	mare	serum	or	foetal	
bovine	 serum	 (FBS).	 Zhang	 et	 al.,	 (1989)	 reported	 that	 the	 inclusion	 of	 FBS	 and	
gonadotropins	 (FSH/	 LH/	 somatotropin)	 increased	 the	 rate	 of	 cumulus	 expansion	
compared	to	mare	serum	(89	vs.	13%)	but	did	not	change	the	maturation	rate	(63-
64%).	Willis	 et	 al.,	 (1991)	 reported	 similar	 findings	 for	 addition	 of	 FSH	 to	 media	
containing	mare	serum	(increased	cumulus	expansion	but	no	change	in	maturation	
rate).	 Interestingly,	 in	 that	 study,	 when	 FBS	 was	 used	 instead	 of	 mare	 serum,	 it	
independently	 increased	 the	 rate	 of	 cumulus	 expansion	 (80	 to	 100%).	 More	
recently,	 Dell’Aquila	 et	 al.,	 (2004)	 examined	 the	 effect	 of	 FSH	 in	 a	 semi-defined	
medium	containing	bovine	 serum	albumin	 (BSA)	 instead	of	 serum	and	 found	 that	
addition	of	FSH	(1	μg/ml)	increased	rate	of	cumulus	expansion	but	not	as	much	as	
did	addition	of	20%	FBS.	These	authors	also	reported	no	effect	on	maturation	rate.		
		
Growth	factors	have	been	studied	as	potential	additives	to	equine	IVM	media	due	
to	their	regulatory	role	in	ovarian	function	and	positive	impact	on	IVM	outcomes	in	
other	species.	 	Both	EGF	and	IGF1	have	been	shown	to	 increase	maturation	rates,	
but	only	when	used	in	the	absence	of	serum	(Lorenzo	et	al.,	2002	and	Carneiro	et	
al.,	2001	respectively).	Carneiro	et	al.	(2001)	while	not	observing	a	positive	effect	of	
IGF1	on	maturation	rate	 (in	 the	presence	of	serum	and	gonadotropins)	did	 report	
an	 increase	 in	 cleavage	 rate	 after	 parthenogenetic	 activation,	 potentially	
demonstrating	 a	 positive	 effect	 on	 cytoplasmic	 maturation.	 While	 some	 groups	
include	 growth	 factors	 routinely	 (Lagutina	 et	 al.,	 2005),	 there	 are	 no	 studies	
demonstrating	a	positive	effect	on	embryo	development	in	an	ICSI	system.		
	
Interleukins	 (paracrine	 factors	 involved	 in	 ovulation)	 specifically	 interleukin	 1	 β	
(IL1β)	 have	 also	 received	 attention.	 Martoriati	 et	 al.,	 (2002)	 were	 the	 first	 to	
demonstrate	 that	 equine	 oocytes	 and	 cumulus	 cells	 expressed	 IL1β	 and	 that	
expression	 was	 lower	 in	 IVM	 oocytes	 compared	 to	 immature	 or	 in	 vivo-matured	
oocytes.	 Addition	 of	 IL1β	 to	 IVM	 media	 however,	 decreased	 maturation	 rates	
(Martoriati	et	al.,	2003,	2002);	this	was	confirmed	in	a	later	study	by	Caillaud	et	al.,	
(2008).		
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Compounds	 to	 protect	 the	 oocyte	 from	 oxidative	 damage	 have	 also	 been	
investigated,	with	the	aim	being	to	increase	intracellular	glutathione	levels,	shown	
to	be	beneficial	in	other	species.	However,	neither	cystamine	(Deleuze	et	al.,	2010;	
Luciano	 et	 al.,	 2006)	 nor	 β-	 mercaptoethanol	 (Merlo	 et	 al.,	 2016)	 had	 a	 positive	
effect	on	maturation	rate	 (Luciano	et	al.,	2006),	cleavage	rate	after	 ICSI	 (Merlo	et	
al.,	2016)	or	embryo	development	rate	after	oocyte	transfer	(Deleuze	et	al.,	2010).	
	
Of	interest,	an	M199-based	IVM	medium	containing	only	10%	FBS	and	5	mU/ml	of	
FSH	 has	 produced	 the	 highest	 reported	 blastocyst	 rates	 (≥	 40%	 in	 numerous	
reports;	Hinrichs	et	al.,	 2005;	 Jacobson	et	al.,	 2010;	Ribeiro	et	al.,	 2008).	 There	 is	
still	clearly	insufficient	information	from	controlled	comparative	studies	as	to	what	
constitutes	 an	 ideal	 equine	 IVM	 medium	 in	 terms	 of	 both	 maximising	 embryo	
development	and	physiological	suitability	for	the	horse.	
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1.5	A	metabolic	approach	to	define	optimal	requirements	for	oocyte	maturation2.	
	
Studying	energy	metabolism	has	been	used	as	an	approach	to	define	and	maximise	
oocyte	 developmental	 potential	 during	 IVM.	 Improving	 our	 understanding	 of	 the	
basic	 physiology	 and	 metabolism	 of	 the	 oocyte	 informs	 the	 design	 of	 a	 species-
specific	 maturation	 medium	 tailored	 to	 the	 substrates	 required	 by	 the	 relevant,	
active	 pathways.	 A	 further	 driver	 to	 study	 metabolism	 is	 the	 desire	 to	 identify	
biomarkers	 of	 viability	 and	 to	 subsequently	 design	 non-invasive	 methods	 for	
determination	 of	 individual	 oocyte	 developmental	 competence.	 Defining	 the	
‘normal’	 resting	 state	 of	 oocyte	 metabolism	 also	 allows	 the	 identification	 and	
description	of	any	metabolic	perturbations	when	they	occur.	
	
While	in	this	thesis,	metabolism,	in	its	function	to	generate	metabolic	energy	in	the	
form	 of	 adenosine	 triphosphate	 (ATP)	 is	 focused	 on,	 the	 term	 ‘metabolism’	 of	
course	encompasses	a	significantly	wider	range	of	functions	and	this	is	particularly	
true	 for	 the	 oocyte	 and	 developing	 embryo.	 For	 example,	 oocyte	 metabolism	
includes	DNA	synthesis,	protein	synthesis,	cell	 signalling	mechanisms	(Manser	and	
Houghton,	 2006),	 generation	 of	 Reactive	 Oxygen	 Species	 (ROS)	 (Agarwal	 et	 al.,	
2005),	redox	balance	(Sutton-McDowall	et	al.,	2010)	and	gene	expression	in	terms	
of	 establishment	 of	 epigenetic	 marks	 such	 as	 methylation	 and	 acetylation	
(DeBerardinis	and	Thompson,	2012).			
	
For	 the	horse,	essentially	all	of	 the	above	aspects	of	oocyte	and	COC	metabolism	
remain	 to	 be	 defined.	 The	 first	 step,	 as	 in	 all	 species	 studied	 to	 date,	 is	 to	
characterise	the	mechanisms	and	substrates	involved	in	ATP	production	by	the	COC	
during	 culture.	 Detailed	 consideration	 of	 these	 processes	 in	 eukaryotic	 cells	 is	
central	 to	 improving	 our	 understanding	 of	 metabolic	 function	 in	 the	 oocyte	 and	
COC.	
	
	
																																																									
2	Elements	of	the	following	section	have	been	published.	(Lewis	and	Sturmey	2015;	See	Appendix	1)	
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1.5.1	The	generation	of	ATP	
	
In	all	cells,	ATP	is	generated	as	a	result	of	two	processes;	glycolysis	and/or	oxidative	
phosphorylation	 (OXPHOS).	At	 the	 intracellular	 level,	 glucose	 is	 the	 substrate	 that	
enters	 the	 glycolytic	 pathway.	 The	 glucose	 molecule	 is	 broken	 down	 to	 two	
pyruvate	molecules	(Figure	1.6),	which	in	turn	can	either	be	converted	to	lactate,	or	
to	 acetyl-CoA,	 and	 enter	 the	 tricarboxylic	 acid	 (TCA)	 cycle.	 Fatty	 acids	 and	 amino	
acids	can	also	be	converted	 to	acetyl-CoA	and	enter	 the	TCA	cycle.	The	TCA	cycle	
generates	 reduced	 nicotinamide	 adenine	 dinucleotide	 (NADH)	 molecules	 (Figure	
1.7),	which	act	as	electron	carriers	in	the	electron	transport	chain	during	oxidative	
phosphorylation,	with	the	end	result	being	ATP	production	(Figure	1.8).		
	
Glycolysis	
Glycolysis	 is	 a	 cytosolic	 process	 by	 which	 glucose	 (C6H12O6)	 is	 metabolised	 to	
pyruvate	 (C3H4O3)	 to	 provide	 a	 net	 of	 2	 molecules	 of	 ATP	 per	 glucose	 molecule	
(Figure	1.6).	Briefly,	glucose	first	enters	the	cell	via	glucose	transporters	and	is	then	
immediately	 phosphorylated	 by	 the	 enzyme	 hexokinase	 (HK)	 into	 glucose-6	
phosphate.	 	The	rate-limiting	step	of	glycolysis	 is	the	reaction	in	which	fructose	6-
biphopshate	 is	 produced	 from	 fructose	 6-phosphate	 by	 the	 enzyme	
phosphofructokinase	(PFK).	A	series	of	reactions	then	proceed	in	parallel,	resulting	
in	the	production	of	two	pyruvate	molecules	and	a	net	of	two	molecules	of	ATP.	
	
Pyruvate	can	either	be	converted	directly	to	lactate	or	to	Acetyl-CoA.	Conversion	to	
lactate,	as	in	anaerobic	glycolysis,	occurs	when	oxygen	supply	is	limited	or	there	is	
an	urgent	ATP	requirement.	Preferentially	metabolising	glucose	via	glycolysis	in	the	
presence	of	plentiful	oxygen	is	known	as	the	‘Warburg	effect’	and	is	characteristic	
of	 cancerous	 tumour	cells	 (Warburg,	1925).	Conversion	of	pyruvate	 to	Acetyl-CoA	
allows	 for	 transport	 to	 the	mitochondria	 for	 further	 ATP	 production	 via	 the	 TCA	
cycle	and	oxidative	phosphorylation.	The	rate	of	glycolysis	is	controlled	by	two	main	
mechanisms.	The	first	is	ATP	abundance,	whereby	high	intracellular	concentrations	
can	 inhibit	 PFK	 through	 negative	 feedback	 causing	 glycolysis	 to	 proceed	 more	
slowly.	 The	 second	 is	 the	NAD+:NADH	 ratio.	 	 The	 conversion	of	 glyceraldehyde	3-
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phosphate	to	1,3-biphophoglycerate	has	an	absolute	requirement	for	NAD+		(Berg	et	
al.,	 2002).	 As	 the	 production	 of	 lactate	 from	 pyruvate	 yields	NAD+,	 the	 pyruvate:	
lactate	ratio	is	tightly	controlled.		
	
	
	
	
	
Figure	 1.6:	 Schematic	 diagram	 illustrating	 the	 sequential	 reactions	 involved	 in	
glycolysis	 by	 which	 two	 pyruvate	 molecules	 are	 generated	 from	 one	 glucose	
molecule.	 Abbreviations	 are	 as	 follows;	 HK	 =	 hexokinase	 enzyme,	 PFK	 =	
Phosphofructokinase	 enzyme,	 ATP	 =	 Adenosine	 triphosphate,	 ADP	 =	 adenosine	
diphosphate,	NAD	=	nicotinamide	adenine	dinucleotide,	NADH	=	reduced	NAD.	
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Tricarboxylic	acid	cycle	
The	 TCA	 cycle	 occurs	 within	 the	matrix	 of	 the	mitochondria	 and	 is	 the	 series	 of	
chemical	 reactions	 by	 which	 Flavin	 adenine	 dinucleotide	 (FADH2)	 and	 NADH	 are	
produced	 from	 a	 series	 of	 oxidation	 reactions	 beginning	with	 Acetyl-	 CoA	 (Figure	
1.7).	Acetyl-CoA	can	be	derived	from	either	pyruvate	as	described	above,	fatty	acids	
(through	β-oxidation)	or	amino	acids	 (through	oxidative	deamination)	 (Berg	et	al.,	
2002)	
	
	
Figure	1.7:	Schematic	diagram	illustrating	the	sequential	reactions	involved	in	in	the	
tricarboxylic	acid	(TCA)	cycle	by	which	a	series	of	oxidation	reactions	beginning	with	
Acetyl-	 CoA	 produces	 NADH	 and	 FADH2.	 Abbreviations	 are	 as	 follows;	 ATP	 =	
Adenosine	triphosphate,	ADP	=	adenosine	diphosphate,	NAD	=	nicotinamide	adenine	
dinucleotide,	 NADH	 =	 reduced	 NAD,	 FAD	 =	 Flavin	 adenine	 dinucleotide,	 FADH2	 =	
reduced	form	FAD,	GDP	=	Guanosine	diphosphate,	GTP	=	guanosine	triphosphate.	 	
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Oxidative	Phosphorylation	
Oxidative	phosphorylation	(OXPHOS)	 involves	the	transfer	of	electrons	 in	series	of	
redox	 reactions	 through	 four	 successive	 proteins	 (the	 electron	 transport	 chain)	
located	on	the	 inner	mitochondrial	membrane.	 	Hydrogen	ions	are	simultaneously	
pumped	 into	 the	 intermembrane	 space,	 creating	 a	 proton	 gradient.	 This	 proton	
gradient	is	ultimately	used	to	create	ATP	from	Adenosine	diphosphate	(ADP)	due	to	
the	passive	flow	of	protons	(H+)	through	the	enzyme	ATP	synthase	(Figure	1.8).	Up	
to	 fifteen	 ATP	molecules	 can	 be	 generated	 from	 each	 Acetyl-	 CoA	molecule	 that	
enters	 the	 TCA	 cycle	 (a	 theoretical	 maximum	 of	 30	 from	 each	 initial	 glucose	
molecule).	As	oxygen	is	the	terminal	electron	acceptor,	combining	with	hydrogen	to	
form	water,	oxygen	consumption	rate	(OCR)	can	be	used	as	an	overall	measure	of	
OXPHOS	 (Mookerjee	et	 al.,	 2017).	However,	 there	are	 several	 reasons	why	 this	 is	
not	the	case	in	all	cells	for	all	species.	These	will	be	discussed	below	with	respect	to	
mitochondrial	function.	
	
	
Figure	 1.8:	 Schematic	 diagram	 illustrating	 the	 electron	 transport	 chain	 during	
oxidative	 phosphorylation.	 Abbreviations	 are	 as	 follows;	 ATP	 =	 Adenosine	
triphosphate,	 ADP	 =	 adenosine	 diphosphate,	 NAD	 =	 nicotinamide	 adenine	
dinucleotide,	 FADH2	 	=	 Flavin	 adenine	 dinucleotide,	 NADH	 =	 reduced	 NAD,	 IMM	 =	
inner	mitochondrial	membrane,	OMM	=	outer	mitochondrial	membrane.	
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1.5.2	Mitochondrial	function	
	
Oxidative	 phosphorylation	 in	 the	 mitochondria	 is	 responsible	 for	 the	 majority	 of	
cellular	 oxygen	 consumption.	However	 some	of	 the	oxygen	 consumption	 in	 a	 cell	
can	 be	 attributed	 to	 production	 of	 reactive	 oxygen	 species	 (ROS)	 and	 to	 oxygen-
consuming	enzymes	such	as	NADPH	oxidase,	xanthine	oxidase	and	squalene	mono-
oxygenase.	Of	the	oxygen	consumption	attributable	to	OXPHOS,	60-80%	is	coupled	
to	 ATP	 production	 in	 the	 majority	 of	 mammalian	 cells	 studied	 (Divakaruni	 and	
Brand,	2011).	Oxygen	consumed	but	not	coupled	to	ATP	production	 is	either	non-
mitochondrial,	 as	 noted	 above,	 or	 is	 the	 result	 of	 proton	 leakage	 across	 the	
mitochondrial	 membrane,	 bypassing	 ATP	 synthase.	 Mitochondrial	 function	 and	
integrity	are	crucial	to	the	developmental	potential	of	the	oocyte.	All	mitochondria	
in	 the	embryo	are	maternal	 in	origin	and	there	 is	no	replication	possible	until	 the	
blastocyst	 stage	 in	 the	 horse	 (Hendriks	 et	 al.,	 2018),	 therefore	 damage	 incurred	
during	oocyte	maturation	will	 impair	 oocyte	 competency,	 and	will	 transfer	 to	 the	
next	generation	(Smeets,	2013).	
	
Reactive	oxygen	species	
Under	normal	conditions,	electrons	flow	through	the	electron	transport	chain	until	
the	final	step	of	water	formation	from	oxygen.	However,	up	to	2%	of	electrons	may	
leak	 from	complex	 I	 and	 III	 and	 result	 in	 single	electron	 transfer	 to	oxygen	which	
produces	 superoxide	 instead	 of	 water	 (Starkov,	 2008).	 Superoxide	 is	 ultimately	
converted	 to	 hydrogen	 peroxide	 by	 the	 enzyme	 superoxide	 dismutase,	 in	 which	
form	it	can	leave	the	mitochondria.	While	ROS	have	a	physiological	role	 in	normal	
cell	 function	 (Agarwal	 et	 al.,	 2005),	 they	 are	 considered	 highly	 reactive	 when	
produced	 in	 excess	 of	 a	 cell’s	 antioxidant	 defence	 capacity.	When	 this	 imbalance	
occurs,	 the	 cell	 is	 said	 to	be	 in	oxidative	 stress	 and	 the	ROS	 can	 cause	 significant	
damage	 to	 mitochondrial	 and	 nuclear	 DNA,	 organelles	 and	 phospholipid	
membranes	(Agarwal	et	al.,	2005).		
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The	level	of	ROS	production	is	dependent	upon	environmental	oxygen	(greater	ROS	
production	 at	 higher	 O2	 tension;	 Legge	 and	 Sellens,	 1991)	 but	 can	 also	 be	 self-
regulated	by	ATP	demand/production.	 If	 ATP	demand	 is	 low,	 the	proton	 gradient	
(membrane	potential)	is	high,	which	can	result	in	excess	electron	leakage	and	thus	
increased	 ROS	 production.	 However,	 when	 there	 is	 active	 ATP	 production	 in	
situations	of	high	demand,	the	membrane	potential	 is	reduced	therefore	reducing	
electron	leakage	and	ROS	production	(Starkov,	2008).	
	
Proton	Leak	
A	certain	degree	of	proton	leak,	defined	as	hydrogen	ions	‘leaking’	back	to	into	the	
matrix	through	the	inner	mitochondrial	membrane	but	not	through	ATP	synthase,	is	
physiological	 in	most	cell	types.	 In	some	organisms	such	as	the	rat,	 it	accounts	for	
up	to	25%	of	basal	metabolic	rate	(Rolfe	et	al.,	1999).	Brand,	(2000)	introduced	the	
hypothesis	of	“uncoupling	to	survive”,	by	which	proton	leak	presents	a	method	of	
regulating	 the	 mitochondrial	 membrane	 potential	 and	 therefore	 regulating	 ROS	
production.	 As	 proton	 leak	 can	 also	 be	 induced	 or	 increased	 via	 uncoupling	
proteins,	 the	 extent	 of	 leakage	 is	 under	 transcriptional	 control	 (Divakaruni	 and	
Brand,	2011).	
	
1.5.3	Studying	metabolism		
	
The	measurement	of	oocyte	and	COC	energy	metabolism	is	technically	challenging.	
Data	available	inform	us	of	substrate	depletion	and	appearance	in	a	given	milieu.		In	
vitro,	this	milieu	is	constrained	by	the	addition	of	a	limited	number	of	substrates	at	
static	 levels;	 supply	 and	 ratio	 of	 substrates	 varies	 only	 in	 response	 to	 an	
oocyte/COC’s	own	activity.		This	is	in	stark	contrast	to	the	situation	in	vivo,	which	is	
dynamic	 and	 responsive	 (Leese	 et	 al.,	 2008)	 and	 still	 largely	 unknown	 for	 most	
species.		
	
Given	the	heterogeneity	in	developmental	potential	among	oocytes	recovered	from	
immature	follicles,	measures	pertaining	to	single	oocytes	and/or	COCs	are	key	and	
thus	 highly	 sensitive	 assays	 are	 needed.	 Both	 the	 use	 of	 radiolabelled	 substrates	
(Rieger	 et	 al.,	 1992)	 and	 enzyme-linked	 fluorescence	 assays	 to	 detect	 the	
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appearance	 and	 disappearance	 of	 a	 substrate	 from	 culture	 media	 have	 been	
described	 (Leese	 and	 Barton,	 1984;	 Guerif	 et	 al.,	 2013).	 The	 relative	 metabolic	
quiescence	of	single	oocytes	and	COCs	means	that		‘analysis	media’	is	often	used	in	
order	to	permit	detection	of	changes	in	substrate	concentration	(Hardy	et	al.,	1989;	
Sturmey	and	Leese,	2003).	This	‘analysis	media’	 is	often	different	from	the	 in	vitro	
culture	 media	 known	 to	 support	 development	 for	 most	 species,	 which,	 in	 turn	
differs	vastly	from	the	in	vivo	environment.	Of	course,	it	also	must	be	realized	that	
there	are	many	complex	pathways	involved,	and	influx	and	efflux	leads	us	to	make	
what	are	essentially	informed	conclusions	about	what	occurs	in	the	interim.	Despite	
these	 limitations,	 these	assays	have	greatly	advanced	our	knowledge	of	metabolic	
pathways	 and	 have	 yielded	 repeatable	 results	 across	 different	 laboratories.	 New	
promising	studies	using	nuclear	NMR	metabolomic	 technology,	 in	which	substrate	
flux	 can	 be	measured	 in	 situ,	 have	 been	 recently	 described	 (Krisher	et	 al.,	 2015),	
however	the	subsequent	 interpretation	and	analysis	of	the	complex	data	acquired	
presents	further	challenges.	
	
Inferences	 about	 the	 extent	 of	 oxidative	 metabolism	 are	 usually	 derived	 from	
measuring	oxygen	consumption.	Methods	vary,	the	most	widely	used	being	pyrine	
fluorescence	 (Harris	et	al.,	2009;	Houghton	et	al.,	1996),	nanorespirometry	 (Lopes	
et	al.,	2010)	and	scanning	electronmicroscopy	(Sugimura	et	al.,	2012).	Again	while	
allowing	 accurate	 measurement	 of	 oxygen	 depletion,	 the	 methods	 represent	 a	
significant	‘alien’	environment	for	the	oocyte	or	COC.		
	
Studies	involving	metabolic	inhibitors	and	enzymatic	co-factors	have	also	added	to	
our	knowledge	of	oocyte	metabolism	and	in	some	cases	provided	the	initial	proof	of	
certain	 pathways	 existing	 and	 either	 being	 essential	 or	 non-essential	 for	
development.	Among	these	is	fatty	acid	β-oxidation,	the	breakdown	of	fatty	acids	to	
yield	 ATP.	 Etomoxir	 and	 methyl	 palmoxirate,	 both	 inhibitors	 of	 carnitine	
palmitoyltransferase-1	(CPT1)	the	rate-limiting	step	in	β-oxidation,	have	successfully	
been	used	during	 IVM	 to	demonstrate	 the	 critical	 role	of	 this	pathway	 in	optimal	
development.	 Specifically,	 blastocyst	 development	 in	 the	 mouse	 and	 cow	 is	
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decreased	while	nuclear	maturation	in	the	mouse,	pig	and	cow	is	inhibited	(Dunning	
et	al.,	2010;	Ferguson	and	Leese,	2006;	Paczkowski	et	al.,	2013).	
	
Another	 approach	 often	 used	 to	 explore	 COC	metabolism	 is	 to	 evaluate	 relative	
gene	expression.	This	can	involve	evaluating	metabolic	enzyme	genes,	such	as	PFK,	
in	 order	 to	 infer	 activity	 of	 different	 pathways,	 or	 evaluating	 genes	 involved	 in	
defense	 mechanisms	 such	 as	 glutathione	 peroxidases,	 which	 are	 upregulated	 in	
states	 of	 oxidative	 stress	 (Van	 Hoeck	 et	 al.,	 2013).	 Gene	 expression	 of	
developmental	 markers	 in	 blastocysts	 has	 also	 been	 used	 to	 determine	 viability	
and/or	impact	of	metabolic	perturbations	during	in	vitro	culture	(Choi	et	al.,	2015).	
	
When	we	are	measuring	oocyte	and/or	COC	metabolism	are	we	 just	measuring	a	
stress	response?	This	question	must	be	considered	given	the	extremely	adaptable	
nature	of	oocytes	of	all	species.	Metabolism	is	necessarily	dynamic,	enabling	rapid	
changes	 in	 response	 to	maintain	 development.	 	 However,	 such	 dynamism	means	
that	 the	metabolic	profile	 can	 change	quickly	 in	 response	 to	a	 change	 in	external	
environment,	 shown	 clearly	 in	 mouse	 and	 rat	 embryos,	 where	 metabolic	
perturbations	 such	 as	 elevated	 glycolysis	 and	 decreased	 pyruvate	 oxidation	
occurred	after	only	three	hours	of	in	vitro	culture	in	flushed	in	vivo	blastocysts	(Lane	
and	 Gardner,	 1998).	 Both	 the	 presence	 and	 relative	 quantities	 of	 metabolic	
substrates	in	the	environment	in	which	experiments	are	conducted	will	significantly	
affect	the	results.	In	addition	to	the	oocyte	adapting	to	its	environment,	the	culture	
environment	 itself	 is	not	static.	Depletion	of	substrates	and	buildup	and	excretion	
of	metabolites	such	as	 lactate	and	amino	acids	will	change	the	 local	environment.	
Spontaneous	 deamination	 of	 certain	 amino	 acids	 will	 occur	 at	 37°C,	 resulting	 in	
ammonium	accumulation	(Gardner	and	Lane,	1993).	Lactate	build-up	in	the	media	
may	overwhelm	the	pH-buffering	system	of	the	media.	Depletion	of	specific	energy	
substrates	 can	 promote	 the	 use	 of	 alternative	 ATP-generating	 pathways	 (Kane,	
1987).	 It	 is	 thus	 essential	 to	 consider	 that	 studies	 on	 embryo	 metabolism	 only	
provide	a	‘snapshot’	of	physiology	in	a	given	set	of	conditions.		Whilst	such	data	is	
of	fundamental	importance,	care	must	be	taken	when	extrapolating	and	comparing	
such	information.			
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Choosing	a	target-	oocyte	or	COC?	
In	the	case	of	the	oocyte,	it	must	first	be	decided	whether	to	study	the	metabolism	
of	 the	oocyte	alone	or	 that	of	 the	COC,	as	 it	 co-exists	 in	 vivo.	While	 studying	 the	
COC	as	a	whole	creates	difficulties	in	analysing	and	assigning	metabolic	data	to	one	
of	the	two	cell	 types,	 it	 is	substantially	more	physiological	to	study	them	together	
due	 to	 the	 interdependent	 nature	 in	 which	 they	 co-exist	 as	 described	 in	 Section	
1.3.3.	In	this	regard,	a	brief	summary	of	COC	metabolism	follows.	Individual	aspects	
will	be	covered	in	more	detail	in	subsequent	chapters.	
	
1.5.4.Metabolism	of	the	cumulus-oocyte	complex		
	
Metabolic	 regulation	 between	 the	 oocyte	 and	 cumulus	 is	 a	 finely	 controlled	
partnership.	 This	 relationship	 was	 first	 highlighted	 by	 Biggers	 et	 al.,	 (1967)	 who	
demonstrated	that	the	oocyte	was	not	capable	of	metabolising	glucose	but	rather	
the	 cumulus	 cells	 provided	 the	 oocyte	 with	 the	 pyruvate	 for	 subsequent	 ATP	
production.	It	was	later	discovered	that	the	reasons	for	this	were	the	relatively	low	
expression	of	glucose	transporters	and	absence	of	PFK	in	the	oocyte	(Cetica	et	al.,	
2002).	 The	 now-accepted	 mechanism	 (summarised	 in	 Figure	 1.9)	 is	 that	 the	
cumulus	cells	metabolise	glucose	via	glycolysis	 for	both	 their	own	ATP	production	
and	 for	 providing	 pyruvate	 to	 the	 oocyte	 (Harris	 et	 al.,	 2009)	 and	 the	 oocyte	
subsequently	utilises	 this	 pyruvate	 for	ATP	production	 through	 the	TCA	 cycle	 and	
OXPHOS	(Steeves	and	Gardner,	1999).		
	
Intracellular	 glucose	 in	 the	 COC	 can	 be	 used	 in	 pathways	 other	 than	 those	
generating	 ATP.	 These	 are	 the	 pentose	 phosphate	 pathway	 (PPP),	 hexosamine	
biosynthesis	 pathway	 (HBP)	 and	 the	 polyol	 pathway	 (Figure	 1.9).	 The	 PPP,	 while	
representing	 a	 small	 proportion	 of	 glucose	 consumption,	 is	 essential	 to	 oocyte	
maturation	(Downs	and	Utecht,	1999;	Xie	et	al.,	2016).	 It	provides	both	NADPH	to	
maintain	 redox	 balance	 and	 phosphoribosyl	 pyrophosphate	 (PRPP),	 an	 essential	
substrate	 for	de	novo	 purine	 synthesis	 (Horecker	 et	 al.,	 1951)	 The	HBP	generates	
products	 for	 extra	 cellular	 matrix	 production	 and	 also	 acts	 as	 a	 fuel-sensing	
pathway.	While	 it	 represents	 a	 small	 percentage	of	 total	 glucose	 consumption	by	
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the	COC,	the	requirement	for	hyaluronic	acid,	which	is	formed	as	an	end	product	of	
the	 HBP,	 during	 cumulus	 expansion	 ensures	 it	 holds	 a	 central	 role	 in	 oocyte	
maturation	 (Sutton-McDowall	 et	 al.,	 2010).	 The	 role	 of	 the	 Polyol	 pathway,	
(conversion	on	glucose	to	sorbitol	and	fructose),	has	received	little	attention	in	the	
COC.	
	
Amino	acid	metabolism	
Amino	 acids	 such	 as	 glutamine	 can	 also	 act	 as	 an	 energy	 source	 in	 the	 COC.	
Glutamine	 is	metabolised	 to	 α-ketoglutarate	which	 can	 then	 enter	 the	 TCA	 cycle	
and	undergo	 subsequent	oxidation	 to	 form	ATP	 (Figure	1.9;	Rose-Hellekant	et	al.,	
1998).	 Amino	 acids	 are	 also	 required	 for	 other	 metabolic,	 non-	 ATP	 producing	
functions	 such	 as	 maintaining	 glutathione	 levels	 (GSH).	 Glutathione	 is	 a	 potent	
reducing	 agent	 and	 ROS	 scavenger,	 the	 levels	 of	 which	 in	 the	 oocyte	 are	 closely	
correlated	to	developmental	competence,	due	to	its	role	in	sperm	decondensation	
and	male	pronucleus	formation	(de	Matos	and	Furnus,	2000).	It	is	a	thiol-tripeptide	
constructed	 of	 cysteine,	 proline	 and	 glutamine	 therefore	 these	 precursors	 are	
necessary	for	adequate	glutathione	levels	(de	Matos	and	Furnus,	2000).	
	
Lipid	metabolism	
Lipid	 content	 of	 oocytes	 varies	 widely	 between	 species,	 however	 triglycerides	
consistently	 account	 for	 the	majority	 of	 lipid	 reserves	 (Sturmey	 et	 al.,	 2009).	 The	
role	 of	 this	 lipid	 in	 ATP	 provision	 via	 β-oxidation	 in	 COCs	 has	 been	 definitively	
demonstrated	 in	many	 species	 including	 the	pig,	 cow	and	mouse	 (Dunning	 et	 al.,	
2010;	Ferguson	and	Leese,	2006;	Sturmey	and	Leese,	2003).	Even	in	species	such	as	
the	 mouse	 with	 relatively	 little	 lipid	 (oocytes	 appear	 clear,	 unlike	 large	 animal	
oocytes	 in	 which	 lipid	 droplets	 confer	 an	 opaque	 appearance)	 β-oxidation	 is	
essential	to	developmental	competence	(Dunning	et	al.,	2014b).	
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Figure	 1.9:	 Schematic	 diagram	 depicting	 metabolism	 in	 the	 cumulus	 oocyte	
complex.	 (Adapted	from	Sutton-McDowall	et	al.,	2010).	Glucose	 is	metabolised	via	
three	 main	 pathways;	 glycolysis,	 pentose	 phosphate	 pathway	 (PPP)	 and	 the	
hexosamine	 biosynthesis	 pathway	 (HBP).	 Glycolysis	 yields	 pyruvate,	 which	 is	
transferred	 to	 the	 oocyte	 for	 ATP	 production	 via	 the	 tricarboxylic	 cycle	 (TCA)	 and	
oxidative	 phosphorylation	 (OXPHOS).	 The	 PPP	 yields	 NADPH	 (involved	 in	 redox	
balance)	 and	 phosphoribosyl	 pyrophosphate	 (PRPP;	 involved	 in	 nucleotide	
synthesis).	 The	 hexosamine	 biosynthesis	 pathway	 (HBP)	 produces	 hyaluronic	 acid,	
which	 contributes	 to	 extra	 cellular	matrix	 (ECM)	 expansion.	 Intracellular	 lipids	 are	
metabolised	 via	 βoxidation	 and	 feed	 into	 the	 TCA	 cycle	 and	 amino	 acids	 such	 as	
glutamine	are	both	oxidised	after	conversion	α-ketoglutarate	via	the	TCA	cycle	and	
also	used	for	redox	balance	via	incorporation	into	glutathione.	
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While	 this	 general	 understanding	 of	 energy	 metabolism	 is	 true	 for	 the	 species	
studied	 to	date,	 the	 relative	contribution	of	each	pathway	 to	ATP	production	and	
importance	 of	 each	 pathway	 to	 developmental	 competence	 is	 species-specific.	
Furthermore,	as	highlighted	previously,	the	metabolism	of	the	COC	will	adapt	to	its	
environment,	 which	 if	 suboptimal	 can	 disrupt	 the	 delicate	 balance	 between	
pathways,	 potentially	 creating	 a	 state	 of	 oxidative	 damage,	 cell	 dysfunction	 and	
decrease	in	developmental	competence.	
	
For	the	equine	COC,	the	above	pathways	and	their	relative	contributions	to	overall	
energy	metabolism	remain	uncharacterised.	
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1.6	Conclusions	
	
In	 species	 such	 as	 the	 horse,	 in	which	 IVP	 is	 rapidly	 gaining	 commercial	 interest,	
there	is	an	urgent	need	to	understand	the	basic	metabolic	energy	requirements	of	
the	 COC,	 especially	 given	 the	 clear	 links	 between	 a	 suboptimal	 periconceptual	
environment	 and	 negative	 health	 outcomes	 (Harrison	 and	 Langley-Evans,	 2009,	
Barker	 et	 al.,	 2002).	 Not	 only	 does	 this	 understanding	 add	 to	 our	 knowledge	 of	
species-specific	physiology,	but	 it	 also	permits	 identification	of	aberrations,	which	
subsequently	 creates	 the	 potential	 to	 mitigate	 negative	 downstream	 effects.	
Ultimately,	 this	 understanding	 can	 underpin	 the	 development	 of	 optimal	 species-
specific	culture	media.		
	
Whilst	acceptable	blastocyst	 rates	 (41%)	and	pregnancy	 rates	after	 transfer	 (66%)	
can	be	achieved	by	some	in	the	horse,	(Hinrichs	et	al.,	2014;	Jacobson	et	al.,	2010)		
the	more	subtle	effects	of	potentially	inappropriate	culture	conditions	remain	to	be	
seen.	Crucially,	while	there	is	a	single	study	reporting	no	difference	in	placental	and	
foal	 morphometry	 attributable	 to	 IVP	 (Valenzuela	 et	 al.,	 2017),	 there	 is	 no	
information	on	the	long-term	outcomes	of	the	foals	produced	by	IVP.	In	studies	that	
have	compared	in	vivo	derived	and	in	vitro	derived	embryos,	consistent	differences	
have	 been	 found	 such	 as	 differing	 morphology,	 delayed	 kinetics,	 decreased	 cell	
number,	 lack	 of	 trophectoderm	 differentiation,	 increased	 DNA	 fragmentation,	
increased	 prevalence	 of	 chromosomal	 abnormalities	 and	 differential	 gene	
expression	(Choi	et	al.,	2009;	Hendriks	et	al.,	2015;	Pomar	et	al.,	2005;	Rambags	et	
al.,	2005;	Smits	et	al.,	2011;	Tremoleda	et	al.,	2003).	While	these	differences	could	
stem	 from	 inadequacies	 at	 any	 point	 in	 the	 IVP	 system,	 a	 step-wise	 optimization	
beginning	with	 IVM	 is	prudent,	 for	which	metabolic	 studies	 can	 form	 the	 starting	
blocks.	
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1.7	Aims	and	objectives	of	thesis	
	
Crucial	knowledge	gaps	identified	in	performing	this	literature	review	are	the	lack	of	
any	 information	 on	 the	 basic	 metabolic	 energy	 requirements	 of	 the	 equine	 COC	
during	IVM	and	the	fact	that	the	suitability	of	the	current	clinical	IVM	protocol	has	
not	 been	 ascertained	 with	 many	 different	 protocols	 exist	 among	 laboratories.	
Further	knowledge	gaps	pertain	 to	 the	origin	of	measured	differences	between	 in	
vivo	derived	and	IVP	blastocysts.	As	such,	the	general	aim	of	this	thesis	is	to	address	
these	knowledge	gaps	by	characterising	carbohydrate	metabolism	 in	equine	COCs	
during	IVM	and	subsequently	use	this	as	a	platform	from	which	to	evaluate	specific	
medium	 components	 and	 environmental	 factors.	 As	 carbohydrates	 are	 the	major	
contributor	 to	 energy	metabolism	 in	 all	 species	 studied	 to	date,	 the	 investigation	
begins	 by	 describing	 glucose,	 pyruvate	 and	 lactate	 (GPL)	 metabolism,	 oxidative	
metabolism	 and	 mitochondrial	 efficiency	 under	 the	 current	 clinical	 conditions	
(CHAPTER	3).	The	following	questions	will	then	be	addressed:	
	
• Are	 metabolic	 indices	 associated	 with	 markers	 of	 meiotic	 and	
developmental	 competence,	 such	 as	 nuclear	 maturation,	 cleavage,	
blastocyst	development	and	embryo	morphokinetics?	(CHAPTER	3)	
• Does	 varying	 oxygen	 tension	 or	 pyruvate	 concentration	 during	 IVM	 affect	
GPL	and	oxidative	metabolism	of	COCs?	(CHAPTER	4)	
• Does	 glucose	 concentration	 during	 IVM,	 a	 component	 that	 significantly	
varies	 in	 concentration	 between	 laboratories,	 affect	 GPL	 and	 oxidative	
metabolism	of	COCs,	oocyte	developmental	competence	or	morphokinetics	
of	early	embryo	development?	(CHAPTER	5)	
• Additionally,	 does	 glucose	 concentration	 during	 IVM	 affect	 relative	
expression	of	genes	related	to	metabolic	enzyme	activity	and	redox	status	in	
single	oocytes	and	cumulus	and	developmental	marker	genes	in	blastocysts?	
(CHAPTERS	5	and	6)	
		 	
	 41	
Chapter	2:	Materials,	Methods	and	Method	Development	
	
Five	key	methodologies	were	used	to	meet	the	aims	and	objectives	of	this	thesis;	1)	
In	 vitro	 embryo	 production,	 2)	 DNA	 quantification	 assays,	 3)	 Enzyme-linked	
metabolic	 assays,	 4)	 Oxygen	 consumption	 rate	 (OCR)	 measurements	 using	 the	
Seahorse	XFp	analyser	and	5)	Gene	expression	analyses.		
	
As	 highlighted	 in	 Chapter	 1,	 protocols	 used	 by	 different	 laboratories	 can	 vary	
widely.	This	is	especially	relevant	when	considering	in	vitro	embryo	production	and	
characterisation	of	metabolism.	Where	applicable,	sections	are	preceded	by	a	brief	
summary	 of	 the	 evidence-based	 rationale	 that	 underpinned	 selection	 of	 the	
protocols	used.	
	
2.1	In	vitro	embryo	production	
	
As	 a	 prerequisite	 to	 the	 reliable	 interpretation	 of	 oocyte	 and	 cumulus-oocyte	
complex	(COC)	metabolic	data	generated	in	these	studies,	it	was	essential	to	use	an	
efficient	 in	 vitro	 embryo	 production	 (IVP)	 system	 from	 which	 developmentally	
competent	oocytes,	capable	of	producing	viable	blastocysts,	pregnancies	and	foals	
could	 be	 derived.	 	 The	 steps	 involved	 in	 the	 IVP	 process	 will	 be	 discussed	 in	
sequence	(oocyte	collection	and	holding,	 in	vitro	maturation,	denuding	of	cumulus	
cells	and	classification,	intracytoplasmic	sperm	injection	[ICSI],	and	embryo	culture).		
	
All	procedures	were	conducted	in	agreement	with	the	principles	of	the	University	of	
Liverpool	Veterinary	Ethics	Committee	and	with	the	approval	of	the	Royal	College	of	
Veterinary	Surgeons.	
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2.1.1.Oocyte	recovery		
	
Oocytes	for	all	studies	were	obtained	from	abattoir-derived	ovaries.	As	discussed	in	
Section	1.4.3,	several	variables	related	to	ovarian	transport	and	method	of	oocyte	
collection	 have	 the	 potential	 to	 impact	 developmental	 competence.	 These	 are	
briefly	summarised	below.	
	
Evidence	for	consideration	
Immature	 oocytes	 can	 be	 recovered	 from	 post-mortem	 ovaries	 by	 using	 either	
follicular	 scraping	 or	 needle	 aspiration	 techniques	 (Section	 1.4.2).	 Needle	
aspiration,	 as	 performed	 in	 cattle	 IVP,	 is	 more	 rapid	 and	 less	 labour	 intensive	
compared	 with	 follicle	 scraping	 (Galli	 et	 al.,	 2007).	 However,	 scraping	 individual	
follicles	 using	 a	 bone	 curette	 (Hinrichs	 and	 DiGiorgio,	 1991)	 yields	 increased	
recovery	rates	(up	to	85%	c.f.	40-60%	when	using	the	needle	technique;	Dell’Aquila	
et	al.,	2001).	Additionally,	due	to	the	close	attachment	of	the	cumulus	to	the	follicle	
wall	 (Hawley	 et	 al.,	 1995),	 oocytes	 collected	 by	 follicular	 scraping	 are	 recovered	
with	a	greater	proportion	of	their	associated	granulosa	cells.	This	method	therefore	
permits	 a	more	 accurate	 classification	of	 the	 associated	 cumulus	 cell	morphology	
when	compared	 to	aspirated	COCs,	which	generally	present	with	only	 the	 corona	
radiata	intact	(Dell’Aquila	et	al.,	2001).	
	
The	 evidence	 for	 an	 optimal	 ovarian	 transport	 protocol	was	 inconclusive	 (Section	
1.4.3).	To	summarise,	the	consensus	opinion	was	that	ovarian	transport	of	up	to	5-9	
hours	post-mortem	at	 ambient	 temperature	 (slow	 cooling	 curve),	 allowed	 for	 the	
greatest	blastocyst	rates	(Hinrichs	et	al.,	2012;	Ribeiro	et	al.,	2008).	
	
Implemented	protocol	
Ovaries	were	harvested	within	15	minutes	of	slaughter	from	mares	of	unrecorded	
age	and	breed.	Animals	were	slaughtered	during	the	natural	breeding	season	(April-
October)	at	a	UK	abattoir	in	compliance	with	EU	legislations	EC	852/2004,	853/2004	
and	 854/2004,	 for	 purposes	 unrelated	 to	 the	 study.	 On	 collection,	 ovaries	 were	
transferred	to	a	polythene	bag	within	a	Styrofoam	container	and	the	container	was	
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maintained	at	18-20°C	(ambient	temperature).	At	the	end	of	the	collection	period	
(~2	hours),	the	container	was	transported	to	the	laboratory	within	four	hours,	again	
at	18-20°C.	On	arrival	at	the	laboratory,	all	visible	ovarian	follicles	were	individually	
incised	and	the	granulosa	 layer	scraped	using	a	bone	curette.	Cells	collected	were	
rinsed	 into	 a	 Petri	 dish	 with	 Flush	 Medium	 (M199	 with	 Hanks	 salts	 [Life	
Technologies	 Ltd,	 Paisley,	 UK],	 0.4%	 Fetal	 Bovine	 Serum	 [FBS;	 Life	 Technologies	
Ltd.],	 25	 μg/ml	 gentamicin,	 8	 IU/ml	 heparin	 [both	 Sigma-Aldrich	 Ltd,	 Gillingham,	
Dorset,	 UK]).	 Cumulus-oocyte	 complexes	 (COCs)	were	 identified	 in	 the	 recovered	
tissue	under	a	dissection	microscope	 (60-120x	magnification)	and	transferred	to	a	
separate	dish	containing	Manipulation	Medium	 (M199	with	Hanks	 salts,	10%	FBS,	
25	 μg/ml	 gentamicin).	 Cumulus-oocyte	 complexes	 were	 classified	 as	 corona	 only	
(COR),	 compact	 (Cp)	 or	 expanded	 (Ex)	 on	 the	 basis	 of	 gross	 cumulus	morphology	
(Section	1.4.2).	COCs	were	classified	as	Ex	if	any	expansion	of	the	cumulus	cells	was	
evident	 (Hinrichs,	 2010).	 All	 manipulations	 were	 conducted	 at	 20-24°C	 and	 all	
ovaries	were	processed	within	nine	hours	of	mare	death.	
	
2.1.2	Oocyte	holding	
	
Due	to	procedural	logistics	involving	transport	time	from	abattoirs	and	the	necessity	
for	a	30-hour	maturation	period,	it	is	desirable	to	be	able	to	hold	oocytes	in	meiotic	
arrest	 overnight.	 This	 allows	maturation	 to	 be	 initiated	 in	 the	morning	 and	 thus	
subsequent	procedures	to	be	scheduled	during	daytime	working	hours.	
	
Evidence	for	consideration	
Overnight	holding	of	 immature	oocytes	was	 first	described	by	Choi	et	al.	 in	2006.	
These	authors	demonstrated	that	oocytes	could	be	maintained	in	meiotic	arrest	in	
the	absence	of	meiotic	inhibitors	by	simply	holding	them	at	room	temperature	in	an	
M199-based	medium	containing	both	Earle’s	and	Hanks’	 salts	 (EH	media).	Several	
authors	have	since	validated	overnight	holding	using	a	variety	of	media	and	holding	
times	 (range	15-39	hours)	without	any	effect	on	maturation,	blastocyst	or	 foaling	
rates	(Choi	et	al.,	2015;	Diaw	et	al.,	2018;	Dini	et	al.,	2016;	Foss	et	al.,	2013;	Galli	et	
al.,	2014a;	Hinrichs	et	al.,	2014).		
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Selected	protocol	
Recovered	COCs	of	 the	 same	 cumulus	 classification	were	 collected	 into	 groups	of	
ten	and	placed	in	individual	1-ml	glass	vials	(Thermoscientific	Inc.,	Waltham,	MA)	in	
EH	 Medium	 (40%	 M199	 with	 Hanks	 salts,	 40%	 M199	 with	 Earle’s	 salts	 [Life	
technologies	Ltd.],	20%	foetal	bovine	serum	(FBS)	and	25	μg/ml	gentamicin;	Choi	et	
al.,	 2006).	 Vials	 were	 sealed,	 wrapped	 in	 tinfoil	 to	 protect	 from	 light	 and	 held	
overnight	(12-18	hours)	at	20-24°C.	
	
2.1.3	In	vitro	maturation	
	
The	in	vitro	maturation	period	is	the	focus	of	this	thesis	as	it	is	central	to	producing	
a	developmentally	competent	oocyte	for	fertilisation.	The	 ideal	protocol	considers	
the	media	in	which	the	COCs	will	be	cultured	but	also	the	environmental	conditions	
(gaseous	 tensions,	 temperature	 and	 humidity),	 duration	 of	 culture	 and	 technical	
elements	 such	 as	 group	 size.	 The	 different	 protocols	 in	 current	 use	 have	 been	
discussed	in	depth	in	Section	1.4.3.	Below	is	a	brief	synopsis	to	clarify	selection	of	
the	protocol	used	herein.	
	
Evidence	for	consideration	
Media	selection:	The	two	most	commonly	used	media	for	equine	IVM	are	TCM-199	
and	DMEM/F12.	Both	of	 these	media	have	produced	 viable	 embryos	 and	healthy	
offspring	after	ICSI	and	embryo	culture	(Galli	et	al.,	2007;	Hinrichs	et	al.,	2014;	Smits	
et	al.,	2010).	 	Galli	et	al.,	 (2007)	 reported	 that	DMEM/F12	was	superior	 to	M199-
based	 IVM	 media	 when	 considering	 subsequent	 blastocyst	 development	 (26.4%	
[37/140]	for	DMEM/F12	vs.	12%	[23/191]	for	M199).	However,	an	M199-based	IVM	
medium	containing	only	10%	FBS	and	5mU/ml	of	follicle	stimulating	hormone	(FSH)	
has	produced	the	highest	reported	blastocyst	rates	(up	to	42%)	in	numerous	reports	
(Hinrichs	 et	 al.,	 2005;	 Jacobson	 et	 al.,	 2010;	 Ribeiro	 et	 al.,	 2008;	 Salgado	 et	 al.,	
2018).	
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Environmental	conditions:	These	are	dictated	largely	by	the	medium	used.		Medium	
containing	25	mM	bicarbonate	 is	typically	used	under	5%	CO2	to	maintain	a	pH	of	
about	7.4.	M199	with	Earle’s	 salts	 contains	25	mM	bicarbonate.	 	 There	are	many	
formulations	of	DMEM/F-12	available,	with	different	concentrations	of	bicarbonate,	
and	 this	 is	 not	 typically	 specified	 in	 reports.	 	 The	 atmosphere	 used	 for	 IVM	 is	
typically	5%	CO2	in	air,	which	is	hyperoxic	compared	to	the	follicular	environment.	
	
Technical	considerations:	Small	droplets	of	media	are	used	to	maximise	the	benefit	
of	oocyte-secreted	factors	and	thus	there	is	a	requirement	for	a	mineral	oil	overlay	
to	 allow	 formation	 of	 the	 droplets.	 The	 oil	 overlay	 also	minimises	 environmental	
fluctuations,	 such	 as	 changes	 in	 osmolality	 due	 to	 evaporation	 and	 changes	 in	
temperature	when	the	dish	is	handled.	Droplet	and	group	size	during	IVM	have	not	
been	 critically	 evaluated	 for	 the	 horse.	 The	 majority	 of	 laboratories	 reporting	
success	 in	 equine	 ICSI	 programmes	 report	 ~10	 μl/COC,	 with	 oocytes	 being	
maintained	in	groups	of	up	to	50	in	500-μl	droplets.		
	
Duration	of	maturation:	This	requires	careful	consideration	as	cumulus	morphology	
and	ovarian	 transport	 time	 can	both	 affect	 the	maturation	 kinetics.	Oocytes	with	
compact	 cumulus	 (Cp)	 are	 reported	 to	 have	 greater	 maturation	 rates	 after	
immediate	processing	(recovery	from	ovaries	and	placement	in	culture)	than	after	a	
delay	 in	processing	of	 5-9	hours	 (up	 to	66%	MII	 if	within	45	minutes	 vs.	 32%	MII	
after	 a	 delay).	 However,	 time	 of	 processing	 did	 not	 affect	 maturation	 rate	 of	
oocytes	with	expanded	(Ex)	cumulus	(Hinrichs	et	al.,	2005).	The	highest	blastocyst	
rates	 in	 that	 study	 were	 achieved	 after	 a	 delay	 in	 processing	 for	 both	 cumulus	
classifications;	 Ex	 oocytes	 (27-32%;	 after	 24-36	 hours	maturation	 culture)	 and	 Cp	
oocytes	 (35-38%;	 after	 30-36	 hours	maturation	 culture).	 The	maturation	 duration	
reported	 by	 different	 laboratories	 is	 typically	 26-30	 hours	 thought	 to	 maximise	
developmental	competence	of	all	oocytes	(Galli	et	al.,	2016;	Hinrichs	et	al.,	2014).		
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Selected	protocol	
Maturation	dishes,	pre-prepared	with	10-μl	droplets	of	media	covered	with	an	oil	
overlay	 [OVOIL™,	 Vitrolife,	Goteburg,	 Sweden)	were	 pre-equilibrated	 in	 a	 5%	CO2	
incubator	(21%	oxygen)	at	38.3	°C	for	12	hours	before	use.	Classified	COCs	(COR,	Cp,	
Ex)	 were	 washed	 in	 Maturation	 Medium	 (M199	 with	 Earle’s	 salts,	 10%	 FBS,	 25	
μg/ml	gentamicin	with	5	mU/ml	FSH	[Sioux	Biochemical	 Inc.,	Sioux	centre,	 IA]	and	
placed	in	the	pre-prepared	droplets	of	Maturation	Medium.	When	individual	study	
objectives	 required	modification	of	 this	 standard	protocol,	 details	 are	provided	 in	
the	relevant	chapters.	
	
2.1.4	Denuding	and	classification	
	
Following	 the	 IVM	 period,	 oocytes	 are	 denuded	 of	 cumulus	 cells	 to	 permit	
visualisation	 of	 the	 oolemma	 and	 perivitelline	 space.	 For	 all	 species,	 cumulus	
removal	 is	 typically	 performed	 with	 the	 aid	 of	 hyaluronidase,	 an	 enzyme	 which	
dissolves	 the	 hyaluronic	 acid	matrix.	 As	 the	 cumulus	 cells	 have	 already	 detached	
from	one	another	and	the	oocyte	during	cumulus	expansion,	this	allows	mechanical	
removal	of	the	cells.		
	
Selected	protocol	
Oocytes	 were	 denuded	 of	 cumulus	 by	 repeated	 pipetting	 in	 a	 50-μl	 droplet	 of	
Manipulation	Medium	containing	80	 IU/ml	hyaluronidase	 (HYASE-10X™,	Vitrolife).	
Denuded	oocytes	were	evaluated	with	 the	aid	of	a	dissection	microscope	at	500x	
magnification.	 Oocytes	 with	 a	 visible	 polar	 body	 were	 classified	 as	 Metaphase	 II	
(MII),	oocytes	with	an	intact	oolemma	but	without	a	polar	body	were	classified	as	
intact	 and	 those	 with	 an	 irregular	 oolemma	were	 classed	 as	 degenerated	 (DEG).	
(Figure	2.1)	
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Figure	 2.1:	 Photomicrographs	 of	 equine	 oocytes	 after	 cumulus	 cells	 have	 been	
denuded.	 Panels	 A	 and	 B	 are	 degenerated	 oocytes	 (DEG)	 highlighted	 by	 the	
irregularity	 of	 the	 oolemma	 (red	 arrow).	 The	 oocyte	 in	 panel	 C	 is	 classified	 as	
INTACT,	 due	 to	 its	 smooth	 oolemma	 but	 lack	 of	 polar	 body.	 Panel	 D	 depicts	 a	
Metaphase	 II	 oocyte	 (MII),	 with	 the	 polar	 body	 clearly	 visible	 at	 6’oclock	 (white	
arrow).	
	
2.1.5	ICSI	procedure	
	
All	metaphase	II	oocytes	are	considered	suitable	for	fertilisation	by	ICSI.	
	
Evidence	for	consideration	
ICSI	 involves	 the	 introduction	 of	 a	 single	 spermatozoon	 into	 the	 cytoplasm	 of	 an	
oocyte.	 In	human	laboratories	this	 is	routinely	accomplished	by	direct	penetration	
using	 a	 sharp	 micro	 needle	 (conventional	 ICSI).	 However,	 equine	 ICSI	 outcomes	
were	 variable	 and	 inconsistent	 using	 conventional	 ICSI,	 until	 reports	 from	
laboratories	 using	 the	piezo	drill	 to	 facilitate	 sperm	 injection	 in	 2002	 (Choi	 et	 al.,	
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2002;	 Galli	 et	 al.,	 2002).	 The	 piezo	 drill	 involves	 the	 use	 of	 a	 blunt	micropipette,	
which	delivers	precise	micro-electric	oscillations	in	order	to	both	damage	the	sperm	
plasma	membrane	(essential	for	fertilisation)	and	penetrate	the	oolemma,	however	
mercury	 or	 other	 heavy	 liquid	 ballast	 is	 required	 to	 dampen	 the	 oscillations	 and	
improve	precision.	Use	of	 the	piezo	drill	greatly	enhanced	rates	of	oocyte	survival	
and	fertilisation	rates	in	murine	ICSI	due	to	the	ease	of	oolemma	penetration,	thus	
minimising	mechanical	distortion	and	decreasing	lysis	(Yoshida	and	Perry,	2007).		
	
Many	 equine	 laboratories	 now	 perform	 piezo-assisted	 ICSI	 routinely.	 It	 has	 been	
questioned	whether	the	piezo	drill	is	an	essential	component	for	success	in	equine	
ICSI.	 One	 study	 compared	 laser-assisted	 conventional	 and	 piezo-assisted	 ICSI	 and	
found	no	significant	differences	between	methods,	however	blastocyst	rates	were	
low	 for	 both	 (4.8%	 and	 5.1%;	 Smits	 et	 al.,	 2012).	 Prior	 to	work	 contained	 in	 this	
thesis,	only	a	single	 report	documented	the	birth	of	a	 live	 foal	using	conventional	
ICSI;	 although	again,	 this	 followed	 low	overall	 blastocyst	 rates	 (7.4%;	 Smits	 et	 al.,	
2010).	 More	 recently,	 several	 brief	 communications	 have	 reported	 improved	
blastocyst	 rates	 (>	20%)	using	conventional	 ICSI	 (Leisinger	et	al.,	2016;	Martino	et	
al.,	2016;	Schnauffer	et	al.,	2016).	Very	recently	(after	the	completion	of	the	studies	
involved	in	this	thesis)	a	prospective	controlled	study	that	compared	equine	embryo	
production	 via	 conventional	 vs.	 piezo-	 assisted	 ICSI	 was	 reported	 (Salgado	 et	 al.,	
2018).	 These	 authors	 found	 no	 difference	 in	 blastocyst	 rates	 between	 the	 two	
techniques	 (39%	 and	 40%,	 respectively)	 but	 found	 that	 blastocysts	 produced	 by	
conventional	ICSI	had	lower	numbers	of	nuclei	and	a	higher	nuclear	fragmentation	
rate	than	did	those	produced	by	piezo-assisted	ICSI.			
	
It	 remains	 to	 be	 determined	 whether	 piezo-assisted	 ICSI	 offers	 a	 significant	
advantage	over	conventional	ICSI	in	terms	of	embryo	viability	(foal	production	after	
embryo	 transfer).	 Added	 to	 this,	 the	 inclusion	 of	 the	 piezo	 drill	 represents	 a	
significant	 additional	 investment,	 introduces	 an	 additional	 requirement	 for	
technical	 expertise	 and	 presents	 risks	 for	 the	 user	 associated	 with	 the	 use	 of	
mercury	(the	most	common	ballast	used).	For	these	reasons,	conventional	ICSI	was	
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used	in	the	research	involved	in	this	thesis,	as	the	technical	expertise	was	already	in	
place	and	therefore	introduction	of	a	learning	curve	was	avoided.		
	
Selected	protocol	
For	 all	 ICSI	 sessions,	 straws	 of	 frozen	 semen	were	 from	a	 single	 ejaculate	 from	a	
stallion	of	proven	fertility.	A	small	section	of	one	0.5-ml	straw	of	frozen	semen	was	
used	 for	 each	 session	 and	 the	 section	 was	 placed	 directly	 into	 3	 ml	 of	 warmed	
EMCARE™	 Holding	 media	 (ICPbio	 Reproduction,	 Auckland,	 NZ)	 and	 incubated	 at	
room	 temperature	 (20-24°C	 for	 15	minutes	 (Foss	 et	 al.,	 2013).	 Sperm	 suspension	
from	the	top	of	the	3-ml	tube	was	used	for	ICSI.		
	
Conventional	 ICSI	 was	 performed	 using	 an	 Integra	 micromanipulator	 (Research	
Instruments,	 Falmouth,	UK)	by	Karen	Schnauffer,	 a	 senior	human	embryologist.	A	
standard	sharpened	 ICSI	needle	 (5-μm	 inner	diameter;	Research	 Instruments)	was	
used.	 Denuded	 MII	 oocytes	 were	 placed	 into	 individual	 10-μl	 droplets	 of	
Manipulation	 Medium	 with	 addition	 of	 0.27	 mM	 pyruvate,	 and	 1-2	 μl	 of	 sperm	
suspension	was	placed	on	 the	 left	 of	 a	 separate	5-μl	 droplet	 of	 a	 commercial	 9%	
PVP	solution	 (ICSITM;	Vitrolife).	Motile	 spermatozoa	 that	had	swum	to	 the	 right	of	
the	PVP	drop	were	 immobilized	by	 crushing	of	 the	 flagellum	with	 the	 ICSI	needle	
until	kinking	was	observed.	The	selected	spermatozoon	was	aspirated	into	the	ICSI	
needle,	flagellum	first.	The	oocyte	was	positioned	with	the	polar	body	at	6	o’clock	
and	the	ICSI	needle	was	advanced	through	the	zona	pellucida	and	 into	the	oocyte	
cytoplasm.	Puncture	of	the	oolemma	was	confirmed	by	visualisation	of	cytoplasmic	
contents	in	the	ICSI	needle	after	suction	and	the	spermatozoon	was	then	deposited	
in	the	cytoplasm	with	a	minimum	of	medium.	The	micromanipulator	platform	was	
maintained	at	37	°C.	
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2.1.6	Embryo	culture		
	
Injected	 oocytes	 are	 cultured	 in	 vitro,	 ideally,	 to	 the	 blastocyst	 stage	 if	 they	 are	
destined	 for	 cryopreservation	 or	 transcervical	 embryo	 transfer.	 Culture	 to	 the	
blastocyst	 stage	 is	 also	 beneficial	 for	 research	 studies	 in	 order	 to	 determine	
developmental	 potential.	 Once	 more,	 many	 variations	 in	 culture	 protocols	 are	
practiced	and	choices	are	required	for	each	of	the	independent	factors.	
	
Evidence	for	consideration	
Progress	 in	 this	 area	was	 slow;	 embryo	 development	 in	 vitro	 essentially	 stopped	
after	 4	 days	 (8-16	 cell	 stage),	 and	 culture	 was	 performed	 either	 in	 the	 mare	 or	
sheep	 oviduct	 after	 ICSI	 in	 order	 to	 achieve	 blastocyst	 development	 (Choi	 et	 al.,	
2004;	Cochran,	1998;	Lazzari	et	al.,	2010;	Li	et	al.,	2001).	Early	attempts	at	 in	vitro	
culture	 involved	 co-culture	with	 a	 variety	 of	 somatic	 cells	 such	 as	 oviductal,	 Vero	
and	cumulus	cells,	or	trophoblast-conditioned	media	(Choi	et	al.,	1994;	Dell’Aquila	
et	al.,	1997;	Guignot	et	al.,	1998;	Li	et	al.,	2001).	Efforts	were	then	made	to	move	to	
a	 semi-defined	media	 using	 synthetic	 oviduct	 fluid	 (SOF)	 supplemented	with	 BSA	
and	amino	acids	 (Galli	 et	 al.,	 2002),	G1/G2	without	 serum	 (Choi	 et	 al.,	 2003)	 and	
CZB	without	serum	(Choi	et	al.,	2004),	however	blastocyst	rates	continued	to	be	low	
(<	 10%).	 DMEM/F12,	 a	 medium	 developed	 for	 somatic	 cell	 culture,	 was	
inadvertently	discovered	to	support	high	blastocyst	rates,	when	it	was	used	alone	as	
a	 control	 in	 a	 study	 intended	 to	 evaluate	 the	 effect	 of	 embryo	 co-culture	 with	
oviductal	 cells	 (18-20%	 blastocyst	 rate;	 Choi	 et	 al.,	 2004).	 This	 finding	 led	 to	 the	
widespread	 adoption	 of	 DMEM/F12-based	media	 for	 embryo	 culture	 (Galli	 et	 al.,	
2007;	Jacobson	et	al.,	2010;	Smits	et	al.,	2010).	
	
Despite	 the	potential	 significance	within	 the	 IVP	process	 in	 the	horse	and	defined	
significance	 in	 other	 domestic	 species	 (Wale	 and	 Gardner,	 2016),	 the	 volume	 of	
culture	media	 droplets	 used	 and/or	 the	 numbers	 of	 zygotes	 cultured	within	 each	
droplet	are	 rarely	defined	 in	 reports	of	equine	 IVP.	 	Droplet	 sizes	 reported	 in	 the	
equine	literature	range	from	5-100	μl	with	1	to	10	 injected	oocytes	per	droplet.	A	
single	controlled	study	evaluated	the	effect	of	DMEM/F12	droplet	size	(Choi	et	al.,	
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2007).	These	authors	evaluated	individual	culture	of	injected	oocytes	in	2.5,	5,	10	or	
50-μl	 droplets	 and	 no	 difference	 was	 reported	 in	 blastocyst	 rate	 (21-29%).	 The	
highest	 blastocyst	 rate	 in	 that	 study	 (39%)	 was	 achieved	 in	 oocytes	 cultured	 in	
groups	of	2-7	(average	3.2)	in	a	fixed-size	5-µl	droplet.			
	
Selected	protocol	
Injected	 oocytes	 were	 washed	 twice	 through	 pre-equilibrated	 Culture	 Medium	
(DMEM/F12	with	10%	FBS	and	25	μg/ml	gentamicin;	Hinrichs	et	al.,	2005)	and	were	
placed	in	individual	wells	(approx.	2-μl	volume)	of	a	Primovision™	“well	of	the	well”	
system	dish	(individual	microwells	under	a	50-μl	overlay	droplet;	Vitrolife)	under	oil	
at	 38.3°C	 in	 5%	 CO2,	 5%	 O2	 and	 90%	 N2.	 	Dishes	 with	media	 and	 oil	 overlay	 had	
previously	been	pre-equilibrated	 for	a	minimum	of	 six	hours.	On	Day	4	after	 ICSI,	
medium	 in	 the	 original	 droplet	 was	 refreshed	 by	 adding	 20	 μl	 of	 fresh	 Culture	
Medium	and	 then	 removing	20	μl.	 Injected	oocytes	were	 continuously	monitored	
using	 the	 Primovision™	 Time-Lapse	 System.	 Embryo	 developmental	 stage	 was	
determined	on	review	of	the	time-lapse	images.		Cleavage	was	defined	as	occurring	
at	 the	 time	of	 the	 first	 visually	 identifiable	 indentation	of	 the	oolemma.	 Embryos	
were	classified	as	blastocysts	on	first	appearance	of	apparent	formation	of	a	central	
fluid-filled	cavity	(blastulation).		
	
2.1.7	Proof	of	concept		
	
In	 separate	 studies	 (by	 the	 same	 author	 but	 unrelated	 to	 this	 thesis),	 individual	
aspects	 of	 the	 IVP	 process	 were	 evaluated	 and	 validated	 (Lewis	 et	 al.,	 2016;	
Appendix	 2).	 Blastocyst	 rate,	 using	 the	 selected	 protocols	 listed	 above,	was	 7.2%	
and	the	 first	of	several	 live	 foals	was	produced	before	 the	studies	outlined	 in	 this	
thesis	 were	 initiated	 (https://www.bbc.co.uk/news/av/science-environment-
34576685/could-ivf-save-rare-british-breeds).	 While	 a	 blastocyst	 rate	 of	 7.2%	 is	
lower	than	those	reported	by	the	limited	number	of	 leading	 laboratories	(20-40%;	
Foss	 et	 al.,	 2013;	 Galli	 et	 al.,	 2007;	 Hinrichs	 et	 al.,	 2014),	 it	 is	 similar	 to	 those	
reported	by	other	established	groups	(Galli	et	al.,	2014a;	Smits	et	al.,	2010).		
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Key	 to	 this	 thesis	 is	 that	 the	 culture	 protocols	 used	 to	 generate	 data	 have	 been	
validated	 in	 terms	of	 their	 ability	 to	produce	developmentally	 competent	oocytes	
and	embryos.	
	
2.2	Enzyme-Linked	metabolic	assays	
	
In	 the	 course	 of	 these	 studies	metabolic	 consumption	 and	 release	 assays	 (CoRe;	
Guerif	et	al.,	2013)	were	carried	out	to	detect	depletion	and/or	appearance	of	key	
substrates	 (glucose,	 lactate,	 pyruvate)	 in	 spent	media.	 Assays	were	 based	 on	 the	
ultra-fluorometric	enzyme-linked	assays	first	described	by	Leese	and	Barton,	(1984).	
All	measurements	were	carried	out	on	a	FLUOstar	Omega	spectrophotometer	(BMG	
Labtech;	Buckinghamshire,	UK)	set	to	excite	samples	at	340	nm	and	collect	emission	
spectra	at	460	nm	using	V-bottom,	clear	96-well	plates	(Star	lab,	UK).		
	
Whole	 IVM	culture	dishes	containing	both	reference	droplets	(droplets	of	medium	
without	 COCs)	 and	 empty	maturation	 droplets,	 which	 had	 been	 stored	 at	 -80	 °C	
following	removal	of	COCs	under	 investigation,	were	thawed	 immediately	prior	 to	
the	assay.	The	enzyme	reaction	mixture	(prepared	prior	to	the	assays	and	stored	at	
-20	°C	for	up	to	3	months)	was	added	to	the	96-well	assay	plate	first	(mixture	and	
volume	detailed	below	for	each	substrate	assay)	and	background	fluorescence	was	
measured.	 Several	 sample	 dilutions	 (diluted	with	molecular	 grade	water;	 18.2	 Ω)	
were	 tested	 for	 each	 substrate	 assay	 in	 order	 to	 identify	 the	 optimum	 dilution	
factor	that	gave	the	lowest	co-efficient	of	variation	(CV	<	10%),	while	conserving	the	
initial	sample	volume.	The	diluted	sample	medium	was	then	added	to	the	enzyme	
reaction	mixture	 and	 incubated	 for	 the	 period	 of	 time	 dictated	 by	 the	 substrate-
specific	 assay	 being	 performed	 (see	 sections	 2.2.1-3),	 after	 which	 the	 change	 in	
fluorescence	was	 recorded.	 This	 change	 in	 fluorescence	was	 based	 on	 enzymatic	
reduction	 of	 NADP+	 (glucose),	 NAD+	 (lactate)	 or	 enzymatic	 oxidation	 of	 NADH	
(pyruvate;	see	equations	below).	All	measurements	were	performed	in	triplicate	(3	
wells	per	sample),	corrected	for	the	initial	background	fluorescence	and	calibrated	
against	 a	 6-point	 standard	 curve	 of	 known	 standards,	 prepared	 before	 each	
individual	assay.		
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Any	 standard	 curve	 giving	 an	 r2	 value	 of	 less	 than	 0.99	 was	 rejected,	 and	 the	
standard	 curve	 repeated	 before	 any	 samples	 were	 analysed.	 The	 mean	 of	 the	
empty	 reference	 droplet	 readings	was	 subtracted	 from	 each	 sample	 reading	 and	
the	mean	of	the	triplicate	measures	(3	measures	of	same	sample)	calculated.	Values	
were	only	retained	if	the	technical	triplicate	CV	was	<	10%.	Data	were	expressed	as	
substrate	 consumed/produced	 in	 pmol/COC/hour.	 Later	 this	 was	 adapted	 to	
account	for	cumulus	cell	number	(see	Section	2.3).	
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2.2.1	Glucose	Assay	
Background	 fluorescence	 measurements	 were	 taken	 by	 adding	 9	 μl	 of	 enzyme	
reaction	mixture	 to	 the	 assay	 plate	 (Table	 2.1).	 Sample	maturation	medium	was	
prepared	 as	 a	 1:6	 dilution	 with	 molecular	 grade	 H2O	 and	 reference	 maturation	
medium	1:10	to	ensure	values	obtained	were	within	 the	range	of	 the	0-	 to	1-mM	
standard	curve.	Then,	1	μl	of	diluted	sample/reference	medium	was	added	to	the	
enzyme	reaction	mixture	and	the	assay	plate	incubated	for	10	minutes	at	37°C	prior	
to	reading.	
	
Glucose	concentrations	were	determined	by	the	reduction	of	NADP+	,	which	results	
in	an	increase	in	fluorescence	as	shown	below:	
The	reaction	mixture	was	prepared	prior	to	the	assays	and	stored	at	-20	°C	for	up	to	
3	 months	 as	 follows:	 15	 ml	 EPPS	 buffer	 at	 pH	 8	 (Table	 2.1),	 1	 ml	 hexokinase	
(HK)/glucose	-6-	phosphate	dehydrogenase	(G6PDH)	[final	concentration	20IU/ml],	
2	ml	Dithiothreitol	stock,	2	ml	Magnesium	Sulphate	stock,	3	ml	NADP	stock	and	1	ml	
ATP	stock.		
	 Chemical	 Weight	
(mg)	
H2O	 added	
(ml)	
Final	
concentration	
Manufacturer	
EPPS	
buffer	
EPPS	 2520	 150	 	 Sigma	
Penicillin	G	 10	 	 50	μg/ml	 Sigma	
Streptomycin	 10	 	 50	μg/ml	 Sigma	
Sodium	
hydroxide	
To		
effect	
	 	 Fisher	
Stock	
solutions	
Dithiothreitol	 7.715	 10	 0.4	mM	 Sigma	
Magnesium	
sulphate		
91.2	 10	 3.07	mM	 Sigma	
NADP	 39.37	 5	 1.25	mM	 Roche	
ATP	 30.26	 5	 0.42	mM	 Sigma	
	
Table	2.1:	Chemical	composition	of	the	glucose	assay	enzyme	reaction	mixture.	
Glucose	+	ATP	+	NADP+		 Gluconate-6-Phosphate	+	NADPH	+H+		HK	+	G6PDH	
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2.2.2	Lactate	assay	
Background	 fluorescence	 measurements	 were	 taken	 by	 adding	 9	 μl	 of	 reaction	
mixture	to	the	plate	(Table	2.2).	Sample	maturation	medium	was	prepared	as	a	1:6	
dilution	 with	 distilled	 H2O	 and	 reference	maturation	medium	 1:10	 to	 ensure	 the	
values	obtained	were	within	the	range	of	the	0	to	1-mM	standard	curve,	then	1	μl	
diluted	sample/reference	medium	was	added	to	the	enzyme	reaction	mixture	and	
the	plate	incubated	for	30	minutes	at	37°C.	
	
Lactate	 concentrations	 were	 determined	 by	 the	 reduction	 of	 NAD+	 by	 lactate	
dehydrogenase	(LDH)	resulting	in	an	increase	in	fluorescence	as	shown	below:	
	
	
	
The	reaction	mixture	was	prepared	prior	to	the	assays	and	stored	at	-20	°C	for	up	to	
3	months	as	follows:	9	ml	Glycine	buffer	at	pH	9.4-(Table	2.2),	8	ml	dH2O,	1.5	ml	of	
NAD	 stock	 (final	 concentration	 4.8	 mM)	 and	 0.5	 ml	 LDH	 (final	 concentration	 40	
IU/ml).	
	
	 Chemical	 Weight	
(g)	
H2O	 added	
(ml)	
Manufacturer	
Glycine	
buffer	
Glycine	 7.5	 100	 Sigma	
Hydrazine	sulphate	 5.2	 	 Sigma	
EDTA	 0.2	 	 Sigma	
Sodium	Hydroxide	 To	effect	 	 Fisher	
Stock	
solutions	
NAD	 0.4	 10	 Roche	
	
Table	2.2:	Chemical	composition	of	the	lactate	assay	enzyme	reaction	mixture.	
	
	
	
Lactate	+	NAD+					 Pyruvate	+	NADH	+H+					LDH					
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2.2.3	Pyruvate	assay	
Background	 fluorescence	 measurements	 were	 taken	 by	 adding	 18	 μl	 of	 reaction	
mixture	 to	 the	 plate	 (Table	 2.3).	 Sample	 maturation	 medium	 and	 reference	
maturation	medium	samples	were	undiluted	to	ensure	values	obtained	were	within	
the	 range	 of	 the	 0	 to	 0.45-mM	 standard	 curve,	 then	 2	 μl	 of	 sample/reference	
medium	was	added	to	the	enzyme	reaction	mixture	and	the	plate	 incubated	for	3	
minutes	at	37°C.	
	
Pyruvate	 concentrations	 were	 determined	 by	 the	 oxidation	 of	 NADH	 using	 the	
enzyme	LDH,	which	results	in	a	decrease	in	fluorescence	as	shown	below.	
	
	
																																								
The	reaction	mixture	was	prepared	prior	to	the	assays	and	stored	at	-20	°C	for	up	to	
3	months	as	follows:	14	ml	EPPS	buffer	at	pH	8	(as	per	Table	2.1),	0.3	ml	of	NADH	
stock	(final	concentration	0.1	mM)	and	0.4	ml	LDH	(final	concentration	40	IU/ml).	
	
	 Chemical	 Weight	
(mg)	
H2O	 added	
(ml)	
Manufacturer	
EPPS	buffer	 As	 for	 glucose	
reaction	
	 	 	
Stock	
solutions	
NADH	Di	sodium	salt	 17.74	 5	 Roche	
	
Table	2.3:	Chemical	composition	of	the	pyruvate	assay	enzyme	reaction	mixture.	
	
	 	
Pyruvate	+	NADH	+H+					 Lactate	+	NAD+					LDH					
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2.2.4	Final	selected	protocols		
	
It	 was	 necessary	 to	 establish	 a	 protocol	 by	 which	 glucose	 consumption,	 lactate	
production	and	pyruvate	production	by	single	equine	COCs	could	be	evaluated	over	
the	 entire	 course	 of	 IVM	 (30	 hours).	 In	 addition,	 it	 was	 desirable	 to	 perform	
sequential	 incubations	 for	 shorter	 periods	 in	 order	 to	 evaluate	 the	 temporal	
changes	 in	metabolism	during	 the	 30	 hours	 of	 IVM.	 Evaluating	 temporal	 changes	
would	allow	 insight	 into	 the	pathways	used	by	 the	COC	 for	each	phase	of	oocyte	
maturation,	such	as	resumption	of	meiosis	and	cumulus	expansion.		
	
The	majority	of	equine	systems	use	group	culture	for	 IVM,	however	this	approach	
was	 inappropriate	 for	 meeting	 the	 study	 aims	 of	 assessing	 substrate	
depletion/accumulation	 of	 single	 COCs.	 	 A	 priority	was	 therefore	 to	 evaluate	 the	
impact	of	single	as	opposed	to	group	culture	of	COCs	on	the	meiotic	competence	of	
the	 oocytes.	 In	 a	 preliminary	 study,	 rates	 of	 progression	 to	 metaphase	 II	 were	
compared	 between	 COCs	 incubated	 in	 conventional	 group	 culture	 (n	 =	 80,	 10	
COCs/100-μl	 droplet)	 and	 in	 individual	 culture	 (n	 =	 36,	 1	 COC/10-μl	 droplet.	
Metaphase	 II	 (MII)	 rates	 did	 not	 differ	 between	 the	 two	 groups	 (53%	 [42/80]	 for	
group	culture	and	47%	[17/36]	for	individual	culture;	p	>	0.05),	thus	validating	the	
use	of	individual	culture.	
	
	
	
	
	
	
	
	
	
	
	
	
	 58	
Protocol	1-	Continuous	incubation	
COCs	 collected	 by	 follicular	 scraping	 were	 incubated	 continuously	 for	 30	 hours	
individually	 in	10-μl	media	droplets.	Twelve	9-μl	droplets	of	media	were	arranged	
on	each	culture	dish	(35-mm	Falcon™;	Hunter	Scientific,	Essex,	UK)	with	a	3.5-ml	oil	
overlay	 (OVOIL™;	 Vitrolife)	 as	 per	 the	 schematic	 below	 (Figure	 2.2).	 COCs	 were	
washed	 in	maturation	medium.	 In	each	dish,	 a	 single	COC	 in	1-μl	of	medium	was	
introduced	into	each	of	nine	droplets.	The	remaining	three	droplets	per	plate	had	1-
μl	 blank	 maturation	 medium	 introduced	 only.	 These	 droplets	 acted	 as	 internal	
reference	control	droplets.	At	the	end	of	the	 incubation,	COCs	were	removed	in	a	
minimum	of	medium	and	dishes	stored	at	 -80	°C	until	 spent	media	analyses	were	
carried	out.	
	
	
	
Figure	2.2:	Schematic	depicting	the	standard	layout	of	the	IVM	culture	dish.	Single	
COCs	 occupied	 nine	 of	 the	 droplets	 and	 three	 droplets	 remained	 empty	 to	 act	 as	
internal	reference	droplets.	All	droplets	had	a	final	volume	of	10	μl	and	the	dish	had	
a	3.5-ml	oil	overlay.	
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Protocol	2-	Discontinuous	sequential	incubation	
COCs	collected	by	follicular	scraping	were	incubated	for	three	consecutive	10-hour	
periods.	 Dish	 set	 up	 was	 identical	 to	 Protocol	 1,	 however	 after	 each	 10-hour	
incubation	 period,	 COCs	 were	 moved,	 in	 1	 μl	 of	 medium,	 to	 the	 same	 droplet	
location	 in	 the	 next	 dish	 (Figure	 2.3).	 At	 the	 end	 of	 the	 incubation,	 COCs	 were	
removed	 in	 a	minimum	of	medium	and	dishes	 stored	at	 -80	 °C	until	 spent	media	
analyses	were	carried	out.	
	
	
	
	
	
	
	
	
Figure	 2.3:	 Schematic	 depicting	 the	 standard	 layout	 of	 IVM	 culture	 dishes	 for	
sequential	 incubation.	 Single	 COCs	occupied	nine	 of	 the	 droplets	 and	were	moved	
every	10	hours	to	the	same	location	in	the	next	dish.	Three	droplets	remained	empty	
on	each	dish	to	act	as	internal	reference	droplets.	All	droplets	had	a	final	volume	of	
10	μl	and	the	dishes	had	a	3.5-ml	oil	overlay.	
	
10-20	hours	 20-30	hours	0-10	hours	
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2.3	DNA	quantification	of	cumulus	and	granulosa	cells	
	
A	pronounced	variation	in	amount	of	cumulus	cells	was	noted	between	COCs,	which	
could	greatly	affect	the	perceived	metabolic	rate	of	the	COCs.		Different	degrees	of	
expansion	rendered	visual	appraisal	or	morphometry	inaccurate,	thus	a	quantitative	
DNA	 assay	 was	 used	 as	 a	 proxy	 for	 the	 number	 of	 cumulus	 cells	 per	 COC.	 This	
permitted	 the	normalisation	of	 substrate	and	oxygen	consumption	 rates	between	
COCs.		
	
On	 completion	 of	 incubations,	 COCs	 were	 individually	 denuded,	 and	 recovered	
cumulus	 cells	 from	 each	 COC	were	 placed	 directly	 into	 a	 single	well	 of	 a	 96-well	
plate	(VWR	International,	Leics,	UK)	and	stored	at	-20	°C	pending	analysis.	DNA	was	
subsequently	 extracted	 from	 thawed	 cells	 using	 the	 method	 described	 by	 (M	 L	
Sutton	et	al.,	2003).	Briefly,	this	entailed	the	addition	of	50	μl/well	of	lysis	buffer	(50	
mM	 Tris-	 HCL,	 1mM	 EDTA,	 500μg/ml	 Proteinase	 K;	 all	 Sigma).	 Plates	 were	 then	
incubated	 for	180	minutes	at	50	 °C,	 followed	by	a	 further	10	minutes	at	80	 °C	 to	
deactivate	Proteinase	K.	To	eliminate	background	fluorescence	associated	with	the	
presence	of	RNA,	50	μl	of	DNAse	free	RNAse	(20	μl/ml;	Roche	Diagnostics	Ltd,	West	
Sussex,	 UK)	 was	 added	 to	 each	 well	 and	 plates	 were	 further	 incubated	 for	 30	
minutes	 at	 40°C.	 Excess	 supernatant	 was	 removed	 by	 evaporation	 at	 room	
temperature	overnight.	
	
The	 following	 day,	 100	 μl	 of	 Tris-	 EDTA	 buffer	 (Quant-	 IT™,	 Picogreene®,	 Life	
Technologies)	was	added	 to	each	well,	 and	a	 standard	curve	 (0-200	ng	DNA/well)	
was	prepared	on	the	same	plate	with	ds-lambda	DNA	standard	diluted	in	Tris-	EDTA	
buffer	 (Quant-	 IT™,	 Picogreene®,	 Life	 Technologies).	 An	 initial	 background	
fluorescence	 reading	 was	 recorded	 (excitation	 480	 nm	 and	 emission	 520	 nm;	
Glomax®	Multi	detection	system,	Promega,	Suffolk,	UK)	before	100	μl	of	Picogreene	
solution	(200-fold	dilution,	Quant-	 IT™,	Picogreene®,	Life	Technologies)	was	added	
to	 all	wells.	 The	 plate	was	 incubated	while	 protected	 from	 light	 for	 3	minutes	 at	
room	temperature	before	final	fluorescence	was	recorded.	The	background	reading	
was	 subtracted	 and	 the	 final	 fluorescence	 plotted	 against	 the	 standard	 curve	 to	
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ascertain	the	quantity	of	DNA	per	well	 in	nanograms	(ng).	All	standard	curves	had	
an	r2	of	≥0.99.	
	
2.4	Oxygen	consumption	rate	measurement	
	
Oxygen	 consumption	 rate	 (OCR)	 and	 contribution	 of	 oxidative	 phosphorylation	
(OXPHOS)	 to	 ATP	 production	 have	 not	 previously	 been	 evaluated	 for	 equine	
oocytes,	 COCs	 or	 embryos.	 Oxygen	 consumption	 was	 first	 described	 in	 rabbit	
oocytes	by	 Fridhandler	 et	 al.,	 (1957)	who	used	a	Cartesian	diver	 technique.	 Since	
then,	 several	 methods	 have	 been	 reported,	 all	 with	 various	 shortcomings.	
Spectrophotometry	 was	 described	 in	 1986	 by	 Magnusson	 et	 al.,	 however	 this	
method	 lacked	 sensitivity.	 Pyrene	 has	 also	 been	 used	 as	 a	 fluorescence	 marker	
(Houghton	et	al.,	1996;	Sturmey	and	Leese,	2003;	Thompson	et	al.,	1996),	however	
this	method	is	a	closed	system	and	relies	on	prolonged	measurements	on	groups	of	
oocytes.	More	 recently,	 Lopes	 et	 al.,	 (2005)	 used	nanorespirometry	 for	 individual	
bovine	 embryos.	 This	 technique,	 which	 while	 very	 sensitive,	 requires	 extensive	
handling,	 and	 analysis	 in	 a	 separate	 environment	 that	 differs	 from	 that	 in	 which	
they	are	cultured.	
	
The	 Seahorse	 XFp	 analyser	 (Agilent	 technologies	 LDA	 UK	 Limited,	 Cheshire,	 UK)	
allows	the	precise	and	non-invasive	measurement	of	OCR	by	measuring	changes	in	
oxygen	tension	(mmHg)	over	time	(Figure	2.4B).	It	does	this	by	creating	a	transient	
microchamber	 of	 approximately	 2	 μl	 around	 cells	 placed	 in	 a	 monolayer	 at	 the	
bottom	 of	 each	 individual	 well	 (Figure	 2.4A).	 The	 change	 in	 oxygen	 tension	 over	
time	 is	 then	 converted	 to	 OCR	 as	 pmol/well/min	 using	 a	 proprietary	 algorithm	
(Gerencser	et	al.,	2009).		While	its	application	has	not	yet	been	reported	for	oocytes	
or	COCs,	its	non-invasive	and	sensitive	nature	renders	it	 ideal	for	the	objectives	of	
this	 research.	 Additionally,	 the	 Seahorse	 XFp	 analyser	 has	 the	 ability	 to	
automatically	 introduce	 up	 to	 four	 respiratory	 inhibitors	 sequentially	 during	
undisturbed	culture.	
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Figure	 2.4:	 Schematic	 diagrams	 depicting	 the	 method	 used	 by	 the	 Seahorse	 XFp	
analyser	 to	 evaluate	 oxygen	 consumption	 rate.	 Panel	 A	 shows	 an	 individual	
Seahorse	 well	 during	 three-minute	 measurement	 phase	 (sensor	 cartridge	 probe	
down;	1)	and	during	one-minute	rest	phase	(sensor	cartridge	probe	up;	REST).	Wells	
are	 filled	 with	 medium	 and	 cells	 are	 placed	 at	 the	 bottom	 of	 the	 well	 (brown).	
Oxygen	 tension	 (mmHg)	 is	 read	by	 the	 fluorophore	probe	 sensors	 (red)	 located	at	
the	bottom	of	 the	probe.	 Injection	ports	are	 located	 in	 the	 sensor	cartridge	of	 the	
plate,	which	fits	as	a	lid	during	experiments	and	these	can	be	filled	with	respiratory	
inhibitors	 if	required	(purple).	Panel	B	depicts	oxygen	tension	decreasing	over	time	
during	 three-minute	 measurement	 phase	 (1)	 and	 the	 one-minute	 rest	 phase	
allowing	 oxygen	 tension	 to	 return	 to	 atmospheric	 152	 ±	 10	mmHg.	 A	 technique-
specific	algorithm	then	converts	the	change	in	oxygen	tension	over	time	into	oxygen	
consumption	rate	in	pmol/well/minute.	
A	
B	
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2.4.1	Approach	to	determining	mitochondrial	function	
	
As	 described	 in	 Chapter	 1	 (Section	 1.5.2),	 evaluating	 separate	 aspects	 of	
mitochondrial	function	gives	greater	insight	into	mitochondrial	efficiency	than	does	
basal	OCR	alone.	To	do	this,	OCR	coupled	to	ATP	production,	that	associated	with	
non-mitochondrial	processes,	proton	 leakage,	 and	maximal	OCR	are	 calculated	by	
the	 sequential	 use	 of	 respiratory	 inhibitor	 compounds	 (Figure	 2.5	 and	 2.6).	
Oligomycin,	an	inhibitor	of	ATP	synthase,	 is	added	first	and	decreases	OCR	to	that	
not	 linked	 to	 ATP	 synthesis	 by	 oxidative	 phosphorylation.	 FFCP	 is	 a	 proton	
ionophore	 which	 acts	 to	 uncouple	 the	 flow	 of	 protons	 across	 the	 mitochondrial	
membrane	 from	 the	 normally	 restrictive	 rate	 of	 passage	 though	 Complex	 V	 (ATP	
synthase)	 of	 the	 electron	 transport	 chain.	 	 In	 essence,	 this	 indicates	 the	maximal	
rate	 of	 OCR;	 the	 difference	 between	 this	 value	 and	 resting	 OCR	 is	 the	 “spare	
capacity”	–	the	bioenergetic	‘top	speed’	that	the	system	can	operate	at.		Antimycin	
and	 Rotenone	 are	 added	 in	 combination	 at	 the	 end.	 They	 inhibit	 the	 quinone	
reduction	 (Qi)	 site	 in	 Complex	 III	 and	 Complex	 I	 of	 the	 electron	 transport	 chain,	
respectively,	 thereby	 blocking	 all	 OXPHOS	 from	 taking	 place	 in	 the	mitochondria.	
The	proportion	of	OCR	that	is	insensitive	to	the	addition	of	antimycin	and	rotenone	
is	that	consumed	by	non-mitochondrial	processes.		
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Figure	2.5:	Schematic	diagram	of	electron	transport	chain	showing	site	of	action	of	
each	 respiratory	 inhibitor	 (Rotenone	 inhibits	 Complex	 1	 [RED];	 Antimycin	 inhibits	
Complex	3	[BLUE];	Oligomycin	blocks	ATP	synthase	[GREEN]	and	FFCP	damages	the	
inner	mitochondrial	membrane	[IMM;	PURPLE]).	Abbreviations	are	as	follows;	ATP	=	
Adenosine	triphosphate,	ADP	=	adenosine	diphosphate,	NAD	=	nicotinamide	adenine	
dinucleotide,	NADH	=	reduced	NAD,	OMM	=outer	mitochondrial	membrane.	
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The	 following	 equations	 are	 used	 to	 calculate	 the	 individual	 measures	 of	
mitochondrial	function	and	highlighted	in	the	same	colour	scheme	in	the	schematic	
below	(Figure	2.6).	
	
(1)	Basal	OCR	–	OCR	after	Oligomycin	=	OCR	coupled	to	ATP	production	 	
	
(2)	OCR	after	FCCP	=	Maximal	respiration	 	 	 	 	 	
	
(3)	Maximal	respiration-	basal	OCR	=	Spare	respiratory	capacity		 	 	
	
(4)	OCR	after	Antimycin/Rotenone	=	Non	mitochondrial	respiration	 	 	
	
(5)	OCR	after	Oligomycin	-	non	mitochondrial	OCR	=	Proton	leak		 	 	
	
	
	
	
Figure	 2.6:	 Schematic	 diagram	 to	 clarify	 how	 each	 measure	 of	 mitochondrial	
function	is	calculated	using	respiratory	inhibitors.	(Adapted	from	agilent.com)		
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2.4.2	Optimisation	required	for	OCR	measurement	in	COCs	
	
In	order	to	establish	whether	the	Seahorse	XFp	analyser	could	be	used	to	measure	
OCR	 in	 COCs,	 the	 following	 variables	 were	 evaluated	 and	 optimised;	 Group	 size,	
inhibitor	 concentration	 and	 incubation	 media.	 Preliminary	 investigations	 were	
carried	 out	 by	myself	 and	 Bethany	Muller	 using	 bovine	 COCs,	 due	 to	 the	 limited	
availability	of	equine	tissue	
	
COC	group	size	
OCR	was	measured	 in	wells	 containing	COCs,	 either	 singly	 or	 in	 groups	of	 two	or	
groups	of	three.	Single	COCs	did	not	consistently	yield	reliable	values	for	OCR,	while	
groups	of	three	COCs	resulted	in	the	most	consistent	rates	with	the	least	variation.	
Oocytes	with	a	corona	radiata	 layer	only	were	evaluated	in	groups	of	three	or	six;	
groups	of	six	resulted	in	the	most	consistent	OCR.	
	
Inhibitor	concentration	selection	
Respiratory	inhibitors	must	be	diluted	in	ethanol	to	ensure	stability.	As	ethanol	can	
be	 toxic	 to	cells,	 it	was	 first	necessary	 to	ascertain	 that	 the	 final	 concentration	of	
ethanol	 in	 each	 well	 did	 not	 damage	 cell	 function.	 In	 preliminary	 studies,	 it	 was	
found	 that	 concentrations	 of	 analytical-grade	 ethanol	 up	 to	 1%	 v/v	 in	 individual	
wells	 had	 no	 measurable	 impact	 on	 OCR	 in	 bovine	 COCs.	 As	 maximum	 ethanol	
concentrations	 during	 any	 study	 in	 the	 current	 thesis	 were	 0.064%	 v/v,	 this	
established	the	lack	of	effect	of	the	concentration	of	ethanol	used.	
	
A	series	of	titration	experiments,	using	bovine	COCs,	were	performed	to	determine	
the	optimum	concentrations	of	each	of	the	metabolic	inhibitors	(optimal	defined	as	
that	which	 elicited	maximal	 response	while	 allowing	 the	 subsequent	 inhibitors	 to	
have	an	effect).	As	a	result,	the	following	concentrations	were	selected:	Oligomycin	
1	μM;	 FCCP	5	μM;	Antimycin/Rotenone	2.5	μM	 (All	 Sigma).	When	 these	 selected	
concentrations	were	added	to	equine	COCs,	the	response	was	within	the	observed	
range	for	bovine	COCs.		
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Incubation	medium	
Conventional	 assays	 using	 the	 Seahorse	 XFp	 analyser	 use	 unbuffered	medium	 to	
allow	the	simultaneous	measurement	of	extracellular	acidification.		However,	since	
this	 was	 not	 an	 endpoint	 under	 investigation	 in	 these	 studies,	 an	 IVM	 medium	
known	 to	 support	 developmental	 competence	 was	 chosen	 (bicarbonate-buffered	
M199	with	Earle's	salts	and	10%	FBS).		The	use	of	this	bicarbonate-buffered	medium	
resulted	 in	 the	 pH	 rising	 to	 7.9	 during	 a	 40-minute	 analysis	 period,	 therefore	 in	
complimentary	experiments	on	bovine	COCs,	 phosphate	+	HEPES-buffered	 (stable	
pH)	 and	 bicarbonate	 buffered	medium	were	 compared.	 Bovine	 COC	OCR	 did	 not	
vary	 between	 the	 two	 media	 (data	 not	 presented).	 Additionally,	 bicarbonate	
buffered	M199	medium	 allowed	OCR	 to	 be	measured	 in	 situ	 during	 IVM	without	
excessive	handling	of	the	COCs.	When	tested	the	increase	in	pH	during	the	analysis	
period	did	not	appear	to	impact	OCR	over	time	or	MII	(40%)	rate	in	equine	COCs	(n	
=	12;	Figure	2.7).		
	
	
	
Figure	2.7:	Oxygen	consumption	rate	(OCR)	measurements	over	time	of	equine	COCs	
incubated	in	M199	with	Earle's	salts.	Each	line	represents	the	average	OCR	per	COC	
in	each	well.	Measurements	were	taken	at	two	times	during	maturation;	four	hours	
(A)	and	28	hours	(B)	after	initiating	in	vitro	maturation.	Each	colour	represents	the	
same	well	at	the	two	time	points.	Readings	were	begun	after	a	12-min	equilibration	
phase.		
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2.4.3	Final	protocol	selected	
	
Oocyte	 collection	 and	 holding	 was	 performed	 as	 described	 in	 Sections	 2.1.1	 and	
2.1.2.	On	the	morning	maturation	culture	was	due	to	begin,	each	well	of	an	8-well	
Seahorse	 assay	 plate	was	 filled	with	 170	μl	 of	 pre-equilibrated	Maturation	media	
(M199	with	Earle’s	salts,	10%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml	FSH)	unless	
otherwise	stated	in	individual	experiments.	External	wells	were	filled	with	400	μl	of	
distilled	water	to	provide	humidity	and	the	plate	was	placed	in	a	5%	CO2	incubator	
at	38	°C	for	a	minimum	of	two	hours.	Three	COCs	 in	10	μl	of	Maturation	medium	
were	 loaded	 into	 each	of	 six	 individual	wells,	 and	10	μl	Maturation	medium	only	
was	placed	in	the	remaining	two	wells	(final	volume	of	each	well	180	μl).	The	loaded	
plate	 was	 then	 placed	 back	 in	 the	 incubator	 with	 the	 lid	 on.	 Seahorse	 sensor	
cartridges	were	hydrated	for	a	minimum	of	12	hours	before	use	at	37	°C	by	placing	
200	μl	of	calibrant	solution	in	each	well	and	400	μl	of	distilled	water	in	each	external	
well.		
	
Basal	OCR	measurements	
To	 measure	 OCR	 of	 COCs	 the	 sensor	 cartridge	 was	 placed	 in	 the	 Seahorse	 XFp	
analyser,	then	the	culture	plate	was	removed	from	the	incubator	and	also	placed	in	
the	 Seahorse	 XFp	 analyser	 [preheated	 to	 37°C].	 After	 an	 initial	 12-minute	
equilibration	phase,	measurements	were	taken	over	three	minutes	(15	readings	per	
measurements	with	a	90	 second	 rest	period	between	measurements	 (Figure	2.4).	
Basal	reading	experiments	were	performed	in	less	than	30	minutes,	after	which	the	
culture	plate	was	placed	back	in	the	incubator.	
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Mitochondrial	function	testing	
All	 inhibitors	 were	 prepared	 with	 the	 same	 medium	 contained	 in	 the	 well	 into	
which	they	were	to	be	injected.	The	sensor	cartridge	compound	injection	ports	for	
all	eight	wells	were	first	loaded	with	the	following;	Port	A:	20-μl	10	μM	Oligomycin;	
Port	B:	22-μl	50	μM	FCCP;	Port	C:	25	-μl	25	μM	Antimycin/Rotenone.	The	volumes	
injected	 resulted	 in	 a	 dilution	 factor	 of	 10	 in	 the	 well	 medium.	 Therefore,	 final	
concentrations	of	each	inhibitor	in	the	well	were:	1	μM	Oligomycin;	5	μM	FCCP;	2.5	
μM	Antimycin/Rotenone.	
	
The	 sensor	 cartridge	 and	 culture	 plate	 were	 then	 placed	 in	 the	 Seahorse	 XFp	
Analyser	 and	 after	 an	 initial	 12-minute	 equilibration	 phase,	 three	 basal	
measurements	 were	 taken	 (as	 above)	 before	 each	 inhibitor	 was	 injected	
sequentially.	Three	further	measurements	were	recorded	after	each	injection.	The	
total	analysis	 time	was	 less	than	90	minutes,	after	which	the	COCs	were	removed	
for	DNA	analysis	and	the	culture	plate	discarded.	
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2.5	Gene	expression	analysis	
	
Throughout	 investigations	 for	 this	 thesis,	 the	 emphasis	 was	 on	 tracking	
development	 and	 metabolism	 of	 single	 COCs.	 As	 such,	 a	 method	 for	 analyzing	
transcript	abundance	in	single	oocytes	was	required.	Methods	that	have	been	used	
for	 RNA	 amplification	 from	 small	 samples	 of	 oocytes	 and/or	 single	
oocytes/blastocysts	 include	 linear	 amplification,	 which	 is	 an	 in	 vitro	 transcription	
based	 protocol	 (Shaw	 et	 al.,	 2013;	 Smits	 et	 al.,	 2009)	 or	 exponential	 PCR	 based	
protocols,	 with	 linear	 amplification	 being	 less	 prone	 to	 amplification	 artifacts	
(Patrizio	et	al.,	2007).	PolyA	PCR	is	a	transcription-based	method,	in	which	an	Oligo-	
DT	primer	is	annealed	to	the	mRNA	polyA	tail	and	reverse	transcriptase	is	added	to	
generate	 the	 cDNA.	 A	 polyA	 tail	 is	 then	 added	 and	 the	 PolyA-tailed	 cDNA	 is	
amplified	 through	 serial	 linear	 amplifications.	 The	 initial	 Oligo-	 DT	 has	 24	 ‘A’	
nucleotides	therefore	would	detect	and	anneal	to	most	if	not	all	of	the	stored	and	
polyadenylated	oocyte	mRNA	(range	18-250	‘A’	nucleotides).	
	
PolyA	PCR	preserves	the	relative	abundance	of	transcripts	within	each	sample	and	
avoids	biased	amplification	due	 to	using	a	 very	 limited	 reverse	 transcription	 step,	
thereby	ensuring	all	products	are	between	300-600	bp	in	length	and	at	the	3’	UTR.	
This	 method	 also	 optimizes	 the	 amount	 of	 sample	 available	 as	 it	 avoids	 the	
requirement	 for	RNA	purification	step	 (Bloor	et	al.,	2002;	Brady	and	 Iscove,	1993;	
Núnêz	et	al.,	2000).	However,	limitations	include	not	being	able	to	access	any	splice	
variants	in	the	gene,	which	would	be	at	the	5’	UTR	and	also	primers	for	both	genes	
of	interest	and	reference	genes	need	to	be	3’	end	directed.	PolyA	PCR	has	thus	far	
not	 been	 reported	 for	 equine	 samples	 and	 therefore	 required	 development	 and	
validation	for	single	equine	oocytes,	cumulus/granulosa	cells	and	single	blastocysts.	
Additionally,	 stable	 3’	 end	 directed	 gene	 primers	 required	 identification	 and	
validation	 for	 use	 in	 the	 cDNA	 samples.	 Despite	 the	 equine	 genome	 being	
sequenced,	 very	 few	 genes	 are	 annotated	 the	 entire	 way	 to	 the	 3’end.	 As	 such	
primer	design	presented	a	challenge.	
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Furthermore,	 given	 the	 existing	 challenges	 and	 the	 heterogeneity	 of	 the	 oocyte	
population,	 identifying	 stable	 reference	 genes	 to	which	data	 could	be	normalized	
against	was	essential.	As	there	has	been	a	lack	of	robust	reference	gene	validation	
in	 the	 equine	 literature	 for	 oocytes	 or	 cumulus	 cells,	 this	 was	 a	 priority.	 For	
blastocysts,	 there	 have	 been	 two	 studies	 carried	 out	 to	 identify	 stable	 reference	
genes,	 one	 in	 a	 range	 of	 early	 developmental	 stages	 (morula	 to	 expanded	
blastocyst;	 Paris	 et	 al.,	 2011)	 and	 one	 in	 in	 vivo	 vs.	 in	 vitro	 produced	 blastocysts	
(Smits	 et	 al.,	 2009).	 However,	 as	 each	 culture	 system	 varies	 and	 the	 PolyA	 PCR	
amplification	 technique	 was	 unique,	 it	 was	 prudent	 to	 also	 validate	 blastocyst	
reference	genes	in	our	own	experimental	system.	
	
2.5.1	PolyA	PCR	protocol	
	
Lysis	and	cDNA	amplification	
The	PolyA	PCR	 technique	was	used	as	previously	described	by	Bloor	et	al.,	 (2002)	
and	 Brady	 and	 Iscove,	 (1993)	 .	 Briefly,	 the	 sample	 oocyte,	 cumulus	 cells	 or	
blastocyst	were	first	placed	in	individual	tubes	containing	10-μl	lysis	buffer	(2-μl	RT	
enzyme	 buffer	 [ThermoFisher	 Scientific],	 40	 μg/ml	 BSA,	 0.5%	 NP40,	 9.7	 pmol/l	
dNTPs,	23	pmol/l	Not1	oligo	dT24	 [all	Roche]	and	0.8	units/μl	RNAsin	ribonuclease	
inhibitor	[Promega]).	The	tubes	were	then	heated	to	65°C	for	1	minute	followed	by	
cooling	 at	 25°C	 for	 3	minutes	 then	placed	on	 ice,	which	 allowed	unfolding	of	 the	
mRNA	and	subsequent	annealing	of	the	Not	1	oligo	dT24	to	the	polyA	tail.	Reverse	
transcriptase	 (25u;	M-MLV;	Thermofisher	Scientific)	was	 then	added	 to	each	 tube	
and	the	tubes	placed	in	a	thermal	cycler	first	at	37°C	for	15	minutes	followed	by	65	
°C	 for	 10	minutes,	 then	 again	 cooled	 on	 ice.	 This	 restricted	 cycle	 length	 ensured	
extension	of	the	first	strand	to	between	300-600	base	pairs.	
	
Tailing	buffer	(10	μl;	3.5	μl	TdT	enzyme	buffer	[ThermoFisher	Scientific],	0.16mmol/l	
dATP	[Roche]	and	0.45	units/μl	rTdT	[Invitrogen])	was	added	to	each	tube	of	newly	
synthesized	1st	strand	cDNA,	heated	to	37°C	for	15	minutes	followed	by	65	°C	for	10	
minutes,	 then	 again	 cooled	 on	 ice.	 This	 step	 added	 a	 polyA	 tail	 to	 the	 1st	 strand	
cDNA,	which	then	allowed	subsequent	amplification.	
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Primary	amplification	took	place	by	the	addition	of	5-μl	tailed	first	strand	synthesis	
cDNA	 product	 to	 10-μl	 primary	 amplification	 mastermix	 (2.6	 μl	 10x	 PCR	 buffer	
[Roche],	2mmol/l	dNTPs,	0.04mg/ml	BSA,	0.2%	Triton	X-100,	6.3mmol/l	MgCl2	[both	
Sigma	 Aldrich],	 8.5μmol/l	 Not1	 oligo	 dT24	 and	 0.16IU/μl	 Taq	 DNA	 Polymerase	
[Roche]).	The	following	cycle	profile	was	then	used;	29	cycles	of	1	minute	at	94	°C,	2	
minutes	at	42	°C	and	6	minutes	at	72	°C	followed	by	a	further	29	cycles	of	1	minute	
at	94	°C,	2	minutes	at	42	°C	and	2	minutes	at	72	°C.		
	
Secondary	 amplification	 was	 then	 performed	 using	 1-μl	 primary	 amplified	 cDNA	
product	 added	 to	 49-μl	 secondary	 amplification	 mastermix	 (5μl	 PCR	 buffer,	 0.2	
mmol/l	dNTPs,	2	μmol/l	Not1	oligo	dT24				and	0.025	IU/μl	Taq	DNA	Polymerase.	The	
following	 cycle	 profile	 was	 then	 used;	 initial	 denaturation	 at	 94	 °C	 for	 1	 minute	
followed	by	70	cycles	of	30	seconds	at	94	°C,	30	seconds	at	54	°C	and	30	seconds	at	
72	°C.	Holding	was	carried	out	at	4	°C	and	then	samples	were	stored	at	-20	°C	until	
gene	specific	PCR	was	carried	out.	
	
Picogreene	cDNA	quantification	
Secondary	 amplification	 samples	 were	 thawed	 and	 5-μl	 diluted	 1:200	 using	 Tris-	
EDTA	buffer	(Quant-	IT™,	Picogreene®,	Life	Technologies).	A	standard	curve	(0-1000	
ng/ml)	 was	 also	 prepared	 with	 ds-lambda	 DNA	 standard	 and	 Tris-	 EDTA	 buffer	
(Quant-	IT™,	Picogreene®,	Life	Technologies).	Samples	and	standards	(100	μl)	were	
added	to	the	plate	in	triplicate	and	an	initial	background	fluorescence	reading	was	
taken	 (excitation	 480nm	 and	 emission	 520nm;	 Glomax®	 Multi	 detection	 system,	
Promega).	 After	 addition	 of	 100-μl	 Picogreene	 solution	 to	 each	 well	 (200	 fold	
dilution,	 Quant-	 IT™,	 Picogreene®,	 Life	 Technologies),	 the	 plate	 was	 incubated	
protected	 from	 light	 for	 3	minutes	 at	 room	 temperature.	 	 Fluorescence	was	 then	
measured	again.	The	background	reading	was	subtracted	and	the	final	fluorescence	
plotted	 against	 the	 standard	 curve	 to	 ascertain	 cDNA	 concentration.	 Standard	
curves	were	only	used	if	r2	>	0.99.	Each	secondary	amplification	product	was	then	
diluted	to	1ng/	μl	concentration	using	PCR	grade	water	and	stored	again	at	-20	°C.	
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2.5.2	Reference	gene	selection	
A	 total	 of	 six	 reference	 genes	 were	 selected	 for	 stability	 testing	 based	 on	 either	
their	validated	use	in	other	equine	tissues	or	as	validated	on	a	wide	range	of	tissues	
in	other	species	(de	Jonge	et	al.,	2007;	Paris	et	al.,	2011;	Smits	et	al.,	2009).	SYBR®	
primers	were	designed	within	the	300bp	immediately	upstream	from	the	polyA	tail	
at	 the	 3’	 UTR	 (Primerdesign	 LTD;	 Table	 2.4).	 All	 primers	 were	 bio-informatically	
validated	and	QC	tested	by	Primerdesign	LTD.	
	
	
Table	 2.4:	 Genes	 and	 SYBR®	 primer	 sequences	 used	 for	 reference	 gene	 stability	
testing.	
	
Reference	 gene	 selection	 was	 performed	 using	 cDNA	 from	 six	 oocyte	 and	 six	
cumulus	cell	 samples	 (chosen	at	 random;	one	 from	each	experimental	group	post	
IVM	and	 two	pre-IVM	See	 Section	 6.3.1).	 For	 blastocysts,	 cDNA	 from	all	 five	 that	
were	 produced	 (See	 Section	 5.4.1)	 were	 used.	 qPCR	 reactions	 were	 made	 up	 as	
follows	 and	 plated	 in	 duplicate;	 5	 μl	 cDNA	 (5ng),	 1	 μl	 primer,	 10	 μl	 PrecisionPlus	
mastermix	(Primerdesign	LTD)	and	4	μl	PCR	water.	Amplification	was	performed	on	
a	Roche	Lightcycler	480	using	the	following	protocol;	initial	enzyme	denaturation	of	
2	minutes	at	95	 °C	 then	40	cycles	of	10	 seconds	at	95°C	and	60	 seconds	at	60°C.	
Post	 PCR	 melt	 curves	 were	 run	 for	 each	 gene	 to	 test	 specificity	 and	 the	 gene	
excluded	 from	analysis	 if	more	 than	one	peak	 existed	 (Figure	 2.8).	 The	 two	most	
Name	 Accession	
number	
Sense	primer	 Antisense	primer	
RPL32	 XM_001492042.5	 CGGAAGTTCCTGGTCCACAA	 GTGAGCAATCTCAGCACAGTAC	
UBC	 NM_0010818621	 CGACCAGCAGAGGCTCATC	 TGGACATTACAAAGACAAGACT
GAA	
SRP14	 XM_001503583.4	 AGCTAGGTTTCTGGTTCTCCT
AC	
AACTGGCTTCTTACAACTCCT	
HPRT
1	
XM_014729196.1	 ACATATCAGTGACAGCATCT
AAGAG	
TGAACAAGTGGGAAAATACAGT
TAAT	
ACTB	 NM_001081838.1	 CGACAGGATGCAGAAGGAG
AT	
GTGGACAATGAGGCCAGAATG	
SDHA	 XM_014734954.1	 ATGTGTCCTGGAGTATTCAA
GTAAC	
TTGATTGGATTCTACAGAAGCG	
	 74	
stable	 genes	 were	 then	 chosen	 (and	 redesigned	 in	 Taqman®	 probe	 format	 by	
Primerdesign	 LTD)	 to	 run	 alongside	 the	 target	 gene	 qPCR	 for	 further	 stability	
testing.	
	
	
	
	
Figure	2.8:	Example	of	adequate	melt	curve	with	single	peak	(A)	and	an	unspecific	
melt	 curve	 with	 multiple	 peaks	 indicating	 failure	 of	 primer	 and	 exclusion	 of	 that	
gene	in	analysis	(B).	
	
	
For	 stability	 testing,	 Ct	 values	 for	 all	 samples	were	 determined	 and	 entered	 into	
previously	validated	software	packages	geNorm	™	(Vandesompele	et	al.,	2002)	and	
Ref	 Keeper	 (Xie	 et	 al.,	 2012).	 RefKeeper	 is	 an	 online	 tool	 using	 a	 combination	 of	
BestKeeper	 (Pfaffl	 et	 al.,	 2004),	 ΔCt	 method	 (Silver	 et	 al.,	 2006),	 NormFinder	
(Andersen	 et	 al.,	 2004)	 and	 geNorm™.	 All	 packages	 result	 in	 a	 method	 specific	
stability	 value	based	on	a	unique	algorithm	where	 lower	numbers	 indicate	higher	
stability	and	thus	suitability	as	a	reference	gene.	
	
	
	
	
A	
B	
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Cumulus	cells	
One	 of	 the	 six	 samples	 selected	 for	 reference	 gene	 stability	 testing	 showed	 no	
expression	for	two	of	six	genes	tested	and	therefore	was	excluded	from	analysis.	Ct	
values	were	 first	entered	 into	geNorm™	alone	showing	 that	UBC	 and	RPL32	were	
the	 most	 stable	 of	 the	 genes	 tested.	 However	 geNorm	 M	 values	 were	 >	 1	 as	
determined	by	the	average	pairwise	variation	of	each	gene	against	all	other	genes	
(<	 0.5	 indicates	 adequate	 stability,	 0.5-1	 indicates	 moderate	 stability	 and	 >	 1	
indicates	 low	stability;	 [Vandesompele	et	al.,	2002];	Figure	2.9).	Additionally,	 they	
showed	 high	 variability,	 as	 all	 combinations	 of	 genes	 yielded	 geNorm	 V	 values	 >	
0.15	(as	determined	by	calculating	the	variability	of	sequential	normalisation	factors	
[Vn/n+1];	Vandesompele	et	al.,	2002;	Figure	2.10),	this	software	“could	not	determine	
an	 optimum	 number	 of	 reference	 genes	 to	 use”	 and	 showed	 no	 benefit	 of	
combining	multiple	genes	to	accurately	normalise	the	subsequent	data.	
	
	
	
	
	
Figure	 2.9:	Average	expression	 stability	 (geNorm	M)	 for	 reference	genes	 tested	 in	
cumulus	cells.	Genes	increase	in	stability	from	left	to	right.		
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Figure	 2.10:	 Determination	 of	 the	 optimal	 number	 of	 reference	 genes	 in	 cumulus	
cells.	 Each	 bar	 represents	 the	 stability	 measure	 	 (geNorm	 V	 value)	 of	 combining	
either	 2/3,	 3/4,	 4/5,	 or	 5/6	 reference	 genes.	 Green	 line	 depicts	 geNorm	V	 cut	 off	
(0.15).	
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As	geNorm	did	not	determine	a	suitable	combination	of	reference	genes,	Ct	values	
were	 then	entered	 into	 the	online	 combination	 software	RefKeeper	 to	determine	
the	 stability	 across	 four	 different	 validated	 reference	 gene	 selection	 platforms	
(Table	 2.5).	 RPL32	 came	 out	 repeatedly	 as	 the	 most	 stable,	 with	 UBC	 in	 second	
place.	Both	were	chosen	for	further	testing	during	target	gene	qPCR.	
	
	
Rank	 RefKeeper	 ΔCt	method	 BestKeeper	 NormFinder	 geNorm	
1	 RPL32	
1	
RPL32	
1.95	
RPL32	
1.95	
RPL32	
0.62	
RPL32/UBC	
1.95	
2	 UBC	
2	
UBC	
2.62	
SRP14	
2.14	
UBC	
1.56	
ACTB	
1.95	
3	 SRP14	
3.13	
SRP14	
2.65	
ACTB	
2.38	
ACTB	
1.56	
SRP14	
2.18	
	
Table	 2.5:	 RefKeeper	 results	 for	 cumulus	 cells.	 Chosen	 genes	 depicted	 in	 bold.		
RefKeeper	 stability	 measure	 derived	 from	 combining	 stability	 measures	 from	 the	
other	four	methods	(ΔCt	method,	Bestkeeper,	Normfinder,	geNorm).	The	 lower	the	
value	the	more	stable	the	gene.	
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Oocytes	
Two	of	six	gene	primers	tested	(SDHA	and	ACTB)	showed	non-	specific	melt	curves	
so	were	excluded	 from	analysis.	Ct	values	were	 first	entered	 into	geNorm™	alone	
showing	 that	UBC	and	RPL32	were	 the	most	 stable	of	 the	 genes	 tested,	however	
with	geNorm	M	values	>	0.5	(Figure	2.11)	they	showed	medium	stability	and	as	all	
combinations	of	genes	yielded	geNorm	V	values	>	0.15	(Figure	2.12),	this	software	
“could	not	determine	an	optimum	number	of	reference	genes	to	use”	and	showed	
no	benefit	of	combining	any	of	 the	genes	 to	accurately	normalise	 the	subsequent	
data.	
	
	
	
	
Figure	2.11:	Average	expression	stability	(geNorm	M)	for	reference	genes	tested	in	
single	oocytes.	Genes	increase	in	stability	from	left	to	right.	
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Figure	 2.12:	 Determination	 of	 the	 optimal	 number	 of	 reference	 genes	 in	 single	
oocytes.	Each	bar	represents	the	stability	measure		(geNorm	V	value)	of	combining	
either	2/3	or	3/4	reference	genes	Green	line	depicts	geNorm	V	cut	off	(0.15).	
	
As	 for	 the	 cumulus	 samples,	 Ct	 values	 were	 then	 entered	 into	 the	 online	
combination	software	RefKeeper	(Table	2.6).	RPL32	and	UBC	again	came	out	as	the	
most	stable	and	were	chosen	for	further	testing	during	target	gene	qPCR.	
	
Table	 2.6:	 RefKeeper	 results	 for	 oocyte	 samples.	 Chosen	 genes	 depicted	 in	 bold.		
RefKeeper	 stability	 measure	 derived	 from	 combining	 stability	 measures	 from	 the	
other	four	methods	(ΔCt	method,	Bestkeeper,	Normfinder,	geNorm).	The	 lower	the	
number	the	more	stable	the	gene.	
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Rank	 Refkeeper	 Delta	ct	 Best	keeper	 Norm	
finder	
geNorm	
1	 RPL32	
1.32	
RPL32	
0.96	
UBC		
0.75	
RPL32	
0.43	
UBC/RPL32	
0.79	
2	 UBC	
1.73	
SRP14	
1.02	
SRP14	
1.02	
SRP14	
0.56	
SRP14	
0.89	
3	 SRP14	
2.2	
UBC	
1.1	
RPL32	
1.16	
UBC	
0.85	
HPRT1	
1.10	
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Blastocysts	
The	 same	 two	 gene	 primers	 that	 failed	 in	 the	 oocyte	 samples	 also	 failed	 in	 the	
blastocysts	 (ACTB	 and	 SDHA)	 therefore	 they	 were	 not	 further	 considered	 as	
reference	genes.	Additionally	one	sample	did	not	show	normal	amplification	for	any	
of	the	reference	genes	tested	and	was	therefore	excluded	from	analysis.	Ct	values	
were	 first	 entered	 into	 geNorm™	 showing	 that	RPL32	 and	 SRP14	 were	 the	most	
stable	of	the	genes	tested,	however	with	geNorm	M	values	>	0.5	(Figure	2.13)	they	
showed	medium	stability	and	as	all	combinations	of	genes	yielded	geNorm	V	values	
>	 0.15	 (Figure	 2.14),	 this	 software	 did	 not	 give	 an	 optimum	number	 of	 reference	
genes	to	use.	
	
	
	
	
Figure	2.13:	Average	expression	stability	(geNorm	M)	for	reference	genes	tested	in	
blastocysts.	Genes	increase	in	stability	from	left	to	right		
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Figure	2.14:	Determination	of	the	optimal	number	of	reference	genes	in	blastocysts.	
Each	bar	represents	the	stability	measure		(geNorm	V	value)	of	combining	either	2/3	
or	3/4	reference	genes	Green	line	depicts	geNorm	V	cut	off	(0.15).	
	
Ct	 values	 were	 then	 entered	 into	 the	 online	 combination	 software	 RefKeeper	 to	
determine	 the	 stability	 across	 four	 different	 validated	 reference	 gene	 selection	
platforms	(Table	2.7).	RPL32	came	out	repeatedly	as	the	most	stable,	with	SRP14	in	
second	place.	Both	were	chosen	for	further	testing	during	target	gene	qPCR.	
	
Rank	 RefKeeper	 ΔCt	method	 BestKeeper	 NormFinder	 geNorm	
1	 RPL	32		
1.19	
RPL32	
0.94	
HPRT1	
1.56	
RPL32	
0.13	
RPL32/SRP14	
0.48	
2	 SRP14		
2.45	
UBC	
0.99	
RPL32	
1.83	
UBC	
0.37	
UBC	
0.78	
3	 UBC	
2.45	
SRP14	
1.21	
UBC	
1.93	
SRP14	
1.07	
HPRT1		
1.8	
	
Table	2.7:	RefKeeper	results	for	blastocyst	samples.	Chosen	genes	depicted	in	bold.	
RefKeeper	 stability	 measure	 derived	 from	 combining	 stability	 measures	 from	 the	
other	four	methods	(ΔCt	method,	Bestkeeper,	Normfinder,	geNorm).	The	 lower	the	
number	the	more	stable	the	gene.	
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2.6	Data	analysis	
	
Enzyme	linked	assays	
The	 primary	 outcome	 variables	 were	 glucose	 consumption,	 lactate	 and	 pyruvate	
production	 (expressed	 as	 pmol/ngDNA/hour).	 Ratio	 of	 Lactate	 :	 Glucose	 was	
calculated	by	dividing	 lactate	production	by	glucose	consumption.	Glycolytic	 index	
was	 calculated	as	 the	percentage	of	 glucose	accounted	 for	by	 lactate	production;	
where	two	molecules	of	lactate	are	produced	for	every	one	molecule	of	glucose	is	
100%.	 Data	 were	 scrutinised	 for	 erroneous	 values	 and	 outliers	 excluded	 from	
subsequent	analyses	if	deemed	biologically	improbable,	most	likely	due	to	technical	
error	in	on	one	of	the	assays.	Criteria	used	for	cleaning	and	exclusion	of	data	were	
as	 follows;	 Ratio	 lactate	 :	 glucose	 >	 10	 and	 >	 100	 pmol/ng	 DNA/hour	 for	 either	
glucose	consumption	or	lactate	production.	If	this	occurred	in	any	COC	at	any	time	
point	all	data	for	that	COC	were	excluded	from	statistical	analyses.	Significance	was	
set	at	p	<	0.05.	
	
Oxygen	consumption	rate	measurement	
	The	third	reading	was	taken	for	all	basal	OCR	readings	and	the	reading	representing	
maximal	response	was	used	for	all	inhibitor	OCR	readings.	Data	were	expressed	as	
pmolO2/	COC/	hour	or	pmolO2/ngDNA/hour.	Data	were	excluded	from	subsequent	
analyses	if	the	Seahorse	instrument	produced	a	biologically	improbable	value.	Spare	
capacity	and	proton	 leak	were	corrected	to	zero	 if	a	negative	value	was	obtained.	
Percentage	data	were	first	arcsine	transformed	before	performing	statistical	tests.	
	
The	word	‘replicate’	was	used	in	all	studies	to	describe	all	COCs	collected	from	the	
abattoir	on	a	 single	day.	The	average	 recovery	 rate	was	3	COCs/ovary	 i.e.	6	COCs	
per	 mare.	 	 The	 range	 of	 number	 of	 mares	 represented	 in	 each	 replicate	 was	
therefore	6-13.	N	numbers	pertain	to	number	of	COCs	(n	=	1	=	COC).		 	
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Chapter	 3:	 Characterising	 equine	 carbohydrate	 metabolism	 and	 oxygen	
consumption	of	equine	cumulus-oocyte	complexes	during	in	vitro	maturation.	
	
3.1	Introduction	
	
Production	of	offspring	using	in	vitro	technologies	remains	inefficient	in	all	species.	
In	 the	 horse,	 collection	 of	 immature	 oocytes	 and	 subsequent	 in	 vitro	maturation	
(IVM)	is	relied	upon	to	produce	offspring	via	intracytoplasmic	sperm	injection	(ICSI).	
As	outlined	in	Section	1.4.3,	little	work	has	been	done	to	optimize	the	IVM	process	
in	 the	 horse	 and	 there	 are	major	 knowledge	 gaps	 concerning	 the	 species-specific	
requirements	 of	 the	 cumulus	 oocyte	 complex	 (COC)	 during	 IVM.	With	 increasing	
knowledge	 of	 potential	 downstream	 effects	 on	 offspring	 as	 a	 result	 of	 an	
inadequate	 in	 vitro	 environment	 during	 in	 vitro	 embryo	 production	 (IVP)	 	 (El	Hajj	
and	 Haaf,	 2013;	 Fernandez-Gonzalez	 et	 al.,	 2007;	 Watkins	 et	 al.,	 2007),	 it	 is	 a	
priority	to	develop	a	species-tailored	system	that	is	as	physiological	as	possible.		
	
One	 approach	used	widely	 to	 optimise	 IVP	 in	 other	 species	 is	 to	 characterise	 the	
energy	metabolism	of	 the	COC.	This	approach	can	 inform	the	design	of	a	species-
specific	 maturation	 medium	 by	 defining	 the	 major	 nutrients	 required	 by	 the	
relevant	metabolic	pathways	and	the	appropriate	concentrations	of	these	nutrients.	
This	 has	 already	 been	 carried	 out	 for	 oocytes	 of	 the	 pig,	 mouse,	 human,	 cow,	
monkey,	 cat,	 sheep	 and	 rabbit	 (For	 review;	 Krisher	 et	 al.,	 2007).	 	While	many	 of	
these	 characterisations	 have	 been	 performed	 on	 the	 denuded	 oocyte,	 for	 the	
purpose	 of	 the	 studies	 in	 this	 thesis,	 the	 intact	 COC	 was	 examined	 given	 the	
interdependent	nature	in	which	the	oocyte	and	cumulus	cells	co-exist,	as	described	
in	Section	1.3.1.	
	
The	 measurement	 of	 COC	 metabolism	 in	 a	 meaningful	 way	 is	 technically	
challenging,	 as	 the	 heterogeneity	 in	 developmental	 potential	 of	 COCs	 ideally	
necessitates	 assessment	 of	 individual	 complexes,	 to	 define	 the	 metabolism	
corresponding	 to	 optimum	 oocyte	 competence.	 	 This	 requires	 highly	 sensitive	
assays.	 The	 relative	metabolic	 quiescence	of	 single	oocytes	 and	COCs	means	 that	
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‘analysis	media’	with	lower	substrate	concentrations	have	often	been	used	in	order	
to	permit	detection	of	consumption/accumulation	of	substrates	(Hardy	et	al.,	1989;	
Sturmey	 and	 Leese,	 2003).	 As	 the	 in	 vitro	 environment	 is	 an	 already	 ‘imperfect	
model’	 in	which	 to	 study	metabolism	 (Section	 1.5.3),	 attempts	were	made	 in	 the	
current	 studies	 to	 minimise	 analysis-related	 changes	 by	 using	 only	 maturation	
media	 proven	 to	 be	 capable	 of	 producing	 developmentally	 competent	 oocytes	
(M199	with	Earle’s	salts,	10%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml	FSH;	Hinrichs	
et	 al.,	 2014,	 2005).	However,	 using	 this	medium	presented	 challenges	due	 to	 the	
glucose	 concentration	 (5.6	mM)	 and	 presence	 of	 serum,	 both	 of	 which	 have	 the	
potential	to	confound	the	use	of	standard	substrate	assay	systems	by	not	allowing	
small	changes	in	substrate	depletion	to	be	detected.	To	overcome	these	challenges,	
the	selected	protocol	had	to	enable	reliable	and	repeatable	detection	of	differences	
in	 substrate	 concentrations	between	media	 samples	 and	 reference	droplets	 post-
incubation.		
	
Information	about	oxidative	metabolism	is	best	acquired	by	measuring	the	oxygen	
consumption	rate	 (OCR)	 (Brand	and	Nicholls,	2011).	Mitochondrial	 integrity	of	 the	
oocyte	is	crucial	to	successful	fertilisation	and	embryo	development	(Dumollard	et	
al.,	2007).	All	mitochondria	in	the	embryo	are	maternally	inherited	and	there	is	little	
or	no	further	replication	of	mitochondria	until	the	blastocyst	stage	(recently	defined	
in	 the	 horse;	 Hendriks	 et	 al.,	 2018),	 such	 that	 damage	 incurred	 during	 oocyte	
maturation	has	the	potential	to	impair	not	only	their	function	but	also	the	transfer	
of	 healthy	 mtDNA	 to	 the	 next	 generation	 (Smeets,	 2013).	 Mitochondrial	 DNA	
(mtDNA)	is	especially	susceptible	to	damage,	given	the	local	production	of	reactive	
oxygen	species	(ROS)	and	limited	mtDNA	repair	mechanisms	(Van	Blerkom,	2011).		
	
Most	 studies	 evaluating	 mitochondrial	 function	 in	 the	 oocyte	 have	 thus	 far	
measured	 mitochondrial	 potential	 by	 relative	 fluorescence	 staining,	 assessing	 mt	
copy	 number,	 mitochondrial	 localisation	 and	 cellular	 ATP	 content	 (Van	 Blerkom,	
2011).	 In	the	horse,	the	use	of	MitoTracker	staining	has	shown	that	mitochondrial	
membrane	 potential	 increases	 throughout	 maturation,	 and	 that	 the	 aggregation	
pattern	becomes	more	granular	and	heterogeneous	(Ambruosi	et	al.,	2009;	Caillaud	
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et	 al.,	 2005;	 Torner	 et	 al.,	 2007).	 Additionally,	 when	 mtDNA	 copy	 number	 was	
analysed	before	and	after	 IVM,	it	was	found	to	decrease	only	 in	aged	mares	(>	12	
years)	and	not	in	young	(Rambags	et	al.,	2014,	2006).		
	
While	the	above	methods	provide	valuable	information	on	mitochondrial	function,	
more	recent	technology	based	on	measurement	of	OCR	before	and	after	the	use	of	
respiratory	 inhibitors	 allows	 detailed	 assessment	 of	 individual	 elements	 of	 the	
electron	 transport	 chain	 and	 thus	 mitochondrial	 efficiency.	 There	 are	 numerous	
reports	 in	 somatic	 cells,	 including	 cancer	 cells,	 and	 more	 recently	 in	 embryos	
(Houghton	 et	 al.,	 1996;	 Manes	 and	 Lai,	 1995;	 Trimarchi	 et	 al.,	 2000);	 however,		
there	are	only	 two	studies	 to	date	utilising	 these	methods	 in	mammalian	oocytes	
(Obeidat	et	al.,	2018;	Sugimura	et	al.,	2012).	The	use	of	respiratory	inhibitors	such	
as	oligomycin	(ATP	synthase	inhibitor),	FCCP	(uncoupler	of	the	inner	mitochondrial	
membrane)	 and	 rotenone	 and	 antimycin	 (inhibitors	 of	 complex	 I	 and	 III	
respectively)	 allow	 estimation	 of	 respiration	 coupled	 to	 ATP	 production,	 OCR	
attributable	 to	 proton	 leak,	 non-mitochondrial	 respiration,	 and	 spare	 respiratory	
capacity.	These	measures	can	build	a	detailed	picture	of	mitochondrial	health	and	
also	aid	in	estimating	relative	contribution	of	OXPHOS	and	glycolysis	to	overall	ATP	
production	(for	detailed	explanation	of	these	elements,	see	Section	1.5.2).	
	
In	addition	to	informing	and	optimising	IVM	protocols,	a	further	driver	to	study	and	
characterise	 the	 metabolism	 of	 the	 COC	 is	 the	 desire	 to	 identify	 biomarkers	 of	
viability	 and	 to	 subsequently	 design	 non-invasive	 methods	 for	 determination	 of	
individual	 oocyte	 developmental	 competence.	 While	 this	 has	 been	 attempted	 in	
various	species	with	promising	results,	a	reliable	predictive	marker	remains	elusive.	
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Summary	
The	 aim	 of	 these	 studies	 was	 to	 characterise	 the	 glycolytic	 and	 oxidative	
metabolism	of	 the	equine	COC	during	 in	 vitro	maturation,	describe	mitochondrial	
function	and	efficiency	throughout	maturation	and	discover	whether	differences	in	
metabolism	 were	 associated	 with	 factors	 known	 to	 influence	 development	
including	meiotic	status	and	cumulus	classification.	The	final	aim	was	to	discover	if	
glucose	 metabolism	 during	 IVM	 had	 predictive	 value	 for	 developmental	
competence.	
	
	
	
3.2	Objectives	
	
1. Determine	glucose	consumption	and	lactate	production	of	equine	COCs	during	
IVM	and	explore	potential	relationships	between	these	nutritional	markers	and:	
a) Cumulus	classification	and	oocyte	maturation	status	(Pilot	study	1).	
b) Markers	 of	 developmental	 competence	 including	 subsequent	 embryo	
cleavage	and	blastocyst	development	(Study	3.1).	
2. Quantify	 the	 temporal	 changes	 in	 glucose/lactate	metabolism	during	different	
phases	of	IVM,	(0-10	hours,	10-20	hours,	20-30	hours)	(Pilot	study	2).	
3. Evaluate	 OCR	 in	 intact	 COCs	 over	 the	 time	 course	 of	 IVM	 and	 explore	
associations	between	OCR	and	glucose/lactate	metabolism	(Study	3.2).	
4. Evaluate	mitochondrial	function	over	the	time	course	of	IVM	(Study	3.3).	
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3.3	Materials	and	methods	
	
The	 study	 design	 is	 outlined	 in	 Figure	 3.1	 and	 individual	 elements	 are	 discussed	
below	when	they	differ	from	descriptions	in	Chapter	2.	
	
	
	
	
Figure	 3.1:	 Schematic	 flow	 diagram	 of	 study	 design.	 Abbreviations	 used	 are	 as	
follows:	COCs	=	cumulus	oocyte	complexes,	IVM	=	in	vitro	maturation,	OCR	=	oxygen	
consumption	rates,	ICSI	=	intra	cytoplasmic	sperm	injection.		
	
General	methods	
To	meet	the	study	objectives,	COCs	were	recovered	from	abattoir-derived	ovaries,	
classified	as	compact	(Cp),	expanded	(Ex)	or	corona	radiata-only,	and	held	overnight	
as	 previously	 described	 in	 Section	 2.1.	Maturation	 was	 performed	 in	Maturation	
medium	(M199	with	Earle’s	salts,	10%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml	FSH)	
at	5%	CO2	in	air.	IVM	conditions	varied	slightly	between	studies	as	outlined	below.	
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Pilot	Study	1		
Maturation	was	carried	out	in	individual	10-μl	droplets	under	oil,	with	nine	droplets	
per	dish.	Only	Ex	and	Cp	COCs	were	used.	Three	additional	medium	droplets	in	each	
dish	 remained	 empty	 and	 were	 used	 as	 reference	 droplets.	 Dishes	 were	
continuously	incubated	for	the	entire	IVM	period	(30	hours;	Figure	3.1;	See	Section	
2.2.4	 for	 full	description).	After	the	maturation	period	was	completed,	COCs	were	
denuded	 and	 classified	 as	 Metaphase	 II,	 intact	 or	 degenerated	 as	 previously	
described	in	Section	2.1.4.	All	denuded	cumulus	cells	from	each	COC	were	placed	in	
a	 labelled	 96-well	 plate	 and	 kept	 at	 -20°	 C	 for	 later	 DNA	 quantification	 analysis.	
Spent	media	samples	were	frozen	at	-80°	C	and	analyses	of	thawed	samples	carried	
out	using	the	Consumption	and	release	method	(CoRe)	as	described	in	Section	2.2	
	
Study	3.1	
COCs	were	 individually	cultured	and	denuded,	and	cumulus	cells	and	spent	media	
analysed,	 as	 described	 for	 Pilot	 Study	 1.	 	 After	 denuding,	 metaphase	 II	 oocytes	
underwent	ICSI	and	subsequent	embryo	culture	as	described	in	Section	2.1.6.	
	
Pilot	Study	2	
COCs	 were	 individually	 cultured	 and	 dishes	 were	 prepared	 as	 described	 above	
however	each	individual	COC,	was	moved	every	ten	hours	from	one	dish	to	another	
therefore	three	dishes	were	prepared	per	nine	COCs	(Figure	3.1;	See	Section	2.2.4	
for	 full	 description).	 The	 oocytes	were	 denuded	 and	 classified,	 and	 cumulus	 cells	
and	spent	media	were	analysed,	as	described	for	Pilot	Study	1.			
	
Study	3.2	
Culture	 for	 IVM	 was	 carried	 out	 in	 the	 conditions	 described	 above,	 with	 COCs	
cultured	 in	Seahorse	plates	 in	180	μl	of	maturation	medium	(see	Section	2.4.3	for	
full	description).	To	optimize	the	measurement	of	changes	in	oxygen	tension	across	
the	study	period,	COCs	were	cultured	in	groups	of	three	of	the	same	cumulus	type	
(Cp	or	Ex),	whereas	corona	radiata-only	oocytes	were	cultured	in	groups	of	six.	The	
Seahorse	 plate	was	 removed	 from	 the	 incubator	 and	 placed	 in	 the	 Seahorse	 XFp	
analyser	 at	 three	different	 time	points	 (four,	 twelve	and	 twenty-eight	hours	 after	
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the	start	of	 IVM;	 IVM	+	4hours,	 IVM	+	12	hours	and	 IVM	+	28	hours).	Three	basal	
OCR	readings	were	obtained	(pmolO2/well/min)	at	each	time	point.	After	each	set	
of	readings	was	complete	the	plate	was	replaced	in	the	incubator.	After	30	hours,	
COCs	 were	 placed	 directly	 in	 a	 plate	 without	 stripping	 and	 frozen	 for	 later	 DNA	
analysis.	 Spent	 medium	 was	 collected	 directly	 from	 the	 Seahorse	 plate	 well	 and	
media	analyses	were	carried	out	as	for	the	previous	studies.	
	
Study	3.3	
Culture	 for	 IVM	 was	 carried	 out	 directly	 in	 Seahorse	 plates	 as	 for	 Study	 3.2.	
Separate	plates	were	prepared	 for	 the	 two	analysis	 time	points	 to	be	performed.	
Mitochondrial	function	was	evaluated	at	either	IVM	+	4	hours	or	IVM	+	28	hours.	To	
do	 this,	 after	 calibration,	 three	 basal	 oxygen	 consumption	 rate	 readings	
(pmolO2/well/min),	 were	 recorded	 before	 a	 series	 of	 respiratory	 inhibitors	 were	
sequentially	 added	 to	 each	 well;	 1)	 Oligomycin	 [1	 μM]	 2)	 FCCP	 [5	 μM]	 3)	
Antimycin/Rotenone	 [2.5	 μM].	 *See	 Section	 2.4.3	 for	 full	 description	 of	 method.	
After	the	readings	were	obtained,	COCs	were	placed	into	a	plate	and	frozen	for	DNA	
quantification.	Spent	media	analysis	was	not	performed.	
	
Statistical	analysis	
In	 Pilot	 Studies	 and	 Study	 3.1,	 the	 primary	 outcome	 variables	 were	 glucose	
consumption,	 lactate	 and	 pyruvate	 production	 (expressed	 as	 pmol/ngDNA/hour).	
Univariable	 analyses	 using	 the	 Student’s	 t-test	 test	 were	 performed	 to	 explore	
associations	 between	 substrate	 consumption	 and	maturation	 status	 and	between	
substrate	 consumption	 and	 cumulus	 classification.	 Linear	 regression	models	were	
used	 to	 explore	 associations	 between	 substrates	 and	 between	 substrate	
consumption/production	and	DNA	content.	Significance	was	set	at	p	<	0.05.	
	
In	 Studies	 3.2	 and	 3.3,	 the	 third	 basal	 OCR	 measurement	 obtained	 was	 used	 to	
represent	 basal	 OCR,	 and	 the	 measurement	 representing	 maximal	 response	 was	
used	as	 the	 inhibitor-specific	OCR	reading.	Data	were	expressed	as	pmolO2/	COC/	
hour	 or	 pmolO2/ngDNA/hour.	 One-way	 ANOVA	was	 used	 to	 explore	 associations	
between	OCR	and	time	points	and	between	OCR	and	cumulus	classification,	while	
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linear	 regression	 was	 used	 to	 explore	 associations	 between	 OCR	 and	
glucose/lactate	 measurements.	 For	 full	 details	 on	 statistical	 analyses	 including	
criteria	for	data	cleaning	and	replicates	see	Section	2.5.	
	
	
3.4	Results	
	
3.4.1	Pilot	study	1:	Glucose	consumption	and	lactate	production	over	the	30	hours	
of	IVM	
	
Twenty-nine	 COCs,	 obtained	 and	 processed	 in	 a	 single	 replicate,	were	 evaluated.	
Glucose	consumption	rate	(mean	1223	and	range,	300-	1965	pmol/COC/hour)	and	
lactate	production	rate	(mean	1851	and	range,	732-	2909.5	pmol/COC/hour)	were	
positively	 correlated	 to	 each	other	 (p<0.01)	 and	 to	 the	DNA	 content	 of	 the	 COCs	
(p<0.01;	Figure	3.2).	Almost	25%	of	COCs	(7/29)	depleted	all	available	glucose	from	
the	10-μl	droplets	of	5.6	mM	glucose,	M199-based	media	over	the	30	hours	of	IVM		
(total	consumption	~55980	pmol).	Those	COCs	which	depleted	all	available	glucose	
had	 a	 reduced	 glycolytic	 index	 (100%	 is	 the	 formation	 of	 2	 lactate	molecules	 for	
each	 glucose	 consumed);	 only	 60%	 of	 glucose	 was	 accounted	 for	 by	 lactate	
production	vs.	95%	of	glucose	being	accounted	 for	by	 lactate	production	 in	 those	
COCs	for	which	glucose	did	not	become	limiting	(p	=	0.02).	There	was	no	difference	
in	glucose	and	lactate	metabolism	between	COCs	containing	a	MII	oocyte	and	those	
containing	a	degenerated	oocyte	at	 the	end	of	 IVM.	COCs	with	compact	 (Cp)	and	
expanded	 (Ex)	 cumulus	 differed	 in	 DNA	 content	 (125	 ng/COC	 vs.	 79	 ng/COC	
respectively,	 p	 <	 0.001;	 overall	mean	 107.26	 ng/COC).	 Numerically,	 Cp	 COCs	 had	
higher	glucose	consumption	and	lactate	production,	however	when	normalised	for	
DNA	content	this	difference	disappeared	(Figure	3.3).	
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Figure	 3.2:	 Data	 describing	 glucose	 consumption	 (BLUE)	 and	 lactate	 production	
rates	(RED)	in	equine	COCs	during	in	vitro	maturation	(n	=	29).	Panels	A	&	C	denote	
the	mean	(±	SEM)	rates	for	individual	COC	and	are	presented	per	COC/Hour	(A)	and	
per	ng	DNA/hour	(C).	Panel	B	shows	linear	correlation	between	glucose	consumption	
and	lactate	production	rates	(r2	=	0.59;	p	<	0.001).	Panel	D	shows	correlation	of	both	
glucose	consumption	and	lactate	production	with	DNA	content	(r2	=	0.3;	P	=	0.01).	
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Figure	3.3:	Glucose	consumption	and	lactate	production	rates	by	maturation	status	
of	 the	 oocyte	 at	 the	 end	 of	 the	 culture	 period	 (A;	 metaphase	 II	 [MII]	 and	
degenerated	 [DEG]	 oocytes)	 and	 by	 cumulus	 classification	 (B;	 compact	 [Cp]	 and	
expanded	 [Ex]).	 Bars	 represent	mean	 ±	 SEM.	 (n	 =	 29).	 There	were	 no	 statistically	
significant	 differences	 in	 metabolic	 indices	 between	 either	 maturation	 status	 or	
cumulus	classification.	
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3.4.2	 Study	 3.1:	 Association	 of	 Glucose/Lactate/Pyruvate	 metabolism	 and	
developmental	markers	after	ICSI.	
	
Eighty-eight	 COCs	 were	 analysed	 over	 five	 replicates.3	Fifty-five	 oocytes	 reached	
metaphase	II	(63%	maturation	rate).	Forty-nine	of	the	55	MII	oocytes	subsequently	
underwent	ICSI	and	embryo	culture;	6	oocytes	were	either	used	for	other	studies	or	
were	lost	due	to	technical	issues.	The	cleavage	rate	at	48	hours	was	75.5%	(37/49),	
and	4	blastocysts	were	produced	(8.2%).		
	
Mean	glucose	consumption	and	lactate	production	rates	were	only	evaluated	in	MII	
oocytes	 (n	=	50)	and	 the	 resulting	data	were	similar	 to	 those	obtained	during	 the	
pilot	 study	 (glucose	 consumption	 rates	 173.4	 to	 1866	 pmol/COC/hour;	 lactate	
production	 rates,	272.9	 to	2683.5	pmol/COC/hour).	Pyruvate	concentrations	were	
also	measured	and	found	to	increase	over	the	course	of	IVM,	indicating	production	
and	secretion	of	pyruvate	by	the	COCs	(0-	117	pmol/COC/hour,	Table	3.1).		
	
Eighteen	 per	 cent	 (9/50)	 of	 MII	 COCs	 depleted	 all	 available	 glucose	 from	 the	
droplet.	 As	 in	 Pilot	 Study	 3.1,	 these	 oocytes	 had	 a	 decreased	 glycolytic	 index	
compared	 to	 those	 for	 which	 glucose	 did	 not	 become	 limiting,	 and	 they	 also	
produced	 less	 pyruvate	 (0.23	 vs.	 0.73	 pmol/ng	DNA/hour;	 p	 =	 0.01;	 Table	 3.1).	 It	
was	 noteworthy	 that	 while	 numbers	 were	 small,	 depletion	 of	 available	 glucose	
during	 IVM	did	not	appear	to	affect	either	cleavage	rate	or	blastocyst	rate	(66.7%	
cleavage	and	11%	blastocysts,	vs.	77.5%	and	7.5%,	respectively,	for	oocytes	that	did	
not	deplete	glucose	during	IVM).		
	
	
	
	
	
	
																																																								3	Data	derived	from	control	group	in	Experiment	5.1	(Chapter	5).	
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	 Depleted		
(n	=	9)	
Undepleted		
(n	=	41)	
P	
Glucose	 consumption	 rate	
(pmol/ng	DNA/hour)	
12.67	±	0.97	 9.99	±	1.11	 0.3	
Lactate	 production	 rate	
(pmol/ng	DNA/hour)	
	15.	06		±	1.56	 18.39	±	1.82	 0.4	
Pyruvate	 production	 rate	
(pmol/ng	DNA/hour)	
0.23	±	0.08	 0.73	±	0.09	 0.01*	
Lactate:	glucose	ratio	 1.17	±	0.07	 2.12	±	0.17	 0.01*	
Cleavage	rate	 66.7%	(6/9)	 77.5%	(31/40)	 0.5	
Blastocyst	rate	 11.1%	(1/9)	 7.5%	(3/40)	 0.6	
	
Table	 3.1:	 Mean	 (±SEM)	 substrate	 consumption	 and	 production	 rates	 and	
developmental	markers	 (cleavage	and	blastocyst	 rate)	 for	Metaphase	 II	COCs	 that	
depleted	 all	 available	 glucose	 during	 IVM	 and	 those	 that	 did	 not.	 *	 denotes	
significance.	
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In	 those	 MII	 COCs	 for	 which	 glucose	 was	 not	 limiting,	 there	 was	 no	 association	
between	 glucose	 consumption,	 lactate	 production,	 pyruvate	 production	 rates	 or	
lactate	:	glucose	ratio	during	IVM	and	cleavage	rate	or	blastocyst	rate	after	ICSI	(p	>	
0.05;	Figure	3.4).		
	
	
	
	
Figure	3.4:	Individual	COC	values	for	glucose	consumption	rates	(BLUES;	Panel	A	and	
C)	and	 lactate	production	rates	(REDS;	Panels	B	and	D)	during	 IVM	plotted	around	
the	mean	 ±	 SEM	 (n	 =	 49	 injected	 oocytes).	 Cleaved	 vs.	 un-cleaved	 oocytes	 at	 48	
hours	 are	 compared	 (A-B)	 and	 blastocysts	 vs.	 non-blastocyst	 compared	 (C-D).	 No	
statistically	significant	differences	were	found	between	groups.	
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3.4.3	 Pilot	 study	 2:	 Temporal	 changes	 in	 glucose	 consumption	 and	 lactate	
production	rates	during	IVM	
	
Eighteen	COCs	were	evaluated,	of	which	three	were	excluded	during	data	cleaning	
leaving	 15	 COCs	 for	 statistical	 analyses.	 Glucose	 consumption	 and	 lactate	
production	rates	decreased	significantly	during	the	final	period	of	IVM	(20-30	hours)	
compared	to	0-10	and	10-20	hours	(Figure	3.5).	The	lactate	:	glucose	ratio	did	not	
vary	with	time	(mean	2.37	±	0.3).	No	COCs	depleted	all	available	glucose	during	any	
of	the	ten-hour	analysis	segments.	
	
	
Figure	3.5:	Temporal	changes	in	glucose	consumption	(BLUE)	and	lactate	production	
(RED)	 rates	 during	 IVM	 (n	 =	 15).	 Data	 are	 presented	 as	 mean	 ±	 SEM.	 *	 denotes	
significant	difference	at	20-30	hours	for	both	substrates		(p	<	0.01).	
	
	
	
	
	
*	
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3.4.4	 Study	3.2:	Basal	 oxygen	 consumption	 rate	over	 the	 time	 course	of	 IVM	and	
associations	with	glucose	and	lactate	metabolism.	
	
Fifty-one	 COCs	 were	 used	 for	 this	 experiment	 across	 three	 replicates.	 Data	 from	
nine	COCs	were	excluded	from	subsequent	analysis	due	to	biologically	 implausible	
OCR	values	from	the	Seahorse	instrument,	and	in	five	of	the	wells	(n	=	3	COCs	per	
well),	 one	 COC	was	 not	 located	 at	 the	 end	 of	 the	 experiment	 and	 accurate	 DNA	
quantification	could	not	therefore	be	performed.	
	
Oxygen	 consumption	 rates	 (OCR)	 varied	 widely	 (IVM	 +	 4	 hours;	 range	 370-4875	
pmol/COC/hour;	IVM	+	12	hours;	range	259-6176	pmol/COC/hour;	IVM	+	28	hours;	
range	303-5805	pmol/COC/	hour).	There	were	differences	between	values	derived	
for	 COCs	 within	 different	 cumulus	 categories	 (Figure	 3.6),	 however,	 these	
differences	 were	 not	 statistically	 significant,	 and	 were	 lost	 when	 individual	 COC	
OCRs	were	 standardised	 to	 account	 for	 differences	 in	 COC	 DNA	 content.	 On	 this	
basis,	 DNA-corrected	 COC	 OCR	 data	 were	 pooled	 across	 morphological	
classifications	 before	 carrying	 out	 further	 analyses.	 DNA	 content	 tended	 to	 be	
positively	correlated	with	OCR	at	all	three	time	points	(r2	≥	0.3;	p	=	0.2;	Figure	3.6C).	
Basal	OCR	did	not	vary	with	time	(IVM	+	4hours,	IVM	+	12hours	and	IVM	+	28hours;	
Figure	3.6)	
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Figure	3.6:	Panel	A	and	B:	Mean	(±	SEM)	Basal	COC	oxygen	consumption	rates	(OCR)	
measured	 at	 4,	 12	 and	 28	 hours	 after	 the	 initiation	 of	 the	 30	 hour	 in	 vitro	
maturation	period	(IVM	+	4,	+	12,	+	28)	for	corona-only	COCs	(n	=12),	compact	COCs	
(n	=	27	Panel	A,	n	=	12	Panel	B)	and	expanded	COCs	 (n	=	3).	Panel	C:	Association	
between	COC	DNA	 content	and	OCR	 (all	 associations	 r2	 ≥	 0.3;	 p	 =	0.2).	 Each	data	
point	represents	one	Seahorse	well	(n	=	3	COCs).		
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Glucose	 consumption	 rates	 (r2	 =	0.83,	p	<	0.01;	 r2	 =	0.78,	p	=	0.01;	 r2	 =	0.48,	p	=	
0.08)	at	IVM	+	4	hours,	12	hours	and	28	hours	respectively;	Figure	3.7A)	and	lactate	
production	rates	(r2	=	0.76,	p	=	0.01;	r2	=	0.73,	p	=	0.02;	r2	=	0.5,	p	=	0.06)	at	IVM+	4	
hours,	12	hours	and	28	hours	respectively;	Figure	3.7B)	were	positively	correlated	
with	OCR	at	all	 time	points	measured	during	 IVM.	Lactate	 :	 glucose	 ratio	was	not	
correlated	to	OCR	at	any	time	point	(p	>	0.5	for	all	time	points;	Figure	3.7C).	
	
	
	
Figure	 3.7:	 Associations	 between	 substrate	 analyses	 of	 spent	 media	 and	 oxygen	
consumption	rates	(OCR)	at	4,	12	and	28	hours	after	the	initiation	of	IVM	(each	data	
point	represents	one	well;	n	=	27).	Panel	A:		Glucose	consumption	rate	and	OCR	(r2	=	
0.83,	p	<	0.01;	r2	=	0.78,	p	=	0.01;	r2	=	0.48,	p	=	0.08	at	IVM	+	4	hours,	12	hours	and	
28	hours	respectively).	Panel	B:	Lactate	production	rate	and	OCR	(r2	=	0.76,	p	=	0.01;	
r2	 =	 0.73,	 p	 =	 0.02;	 r2	 =	 0.5,	 p	 =	 0.06	 at	 IVM	 +	 4	 hours,	 12	 hours	 and	 28	 hours	
respectively).	Panel	C:	Lactate	:	Glucose	ratio	and	OCR		(association	not	statistically	
significant	at	any	time	point	p	>	0.5).		
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3.4.5	Study	3.3:	Mitochondrial	function	over	the	IVM	period.	
	
Sixty-nine	COCs	were	used	across	three	replicates.	Data	for	12	COCs	were	excluded	
from	subsequent	analysis	due	to	OCR	readings	from	the	Seahorse	 instrument	that	
lacked	biological	plausibility.	
	
Oxygen	consumption	rate	coupled	to	ATP	production	(47	±	10%	and	58	±	4%	at	IVM	
+	4	and	28	hours	 respectively),	non-mitochondrial	OCR	 (38	±	10%	and	31	±	5%	at	
IVM	+	4	and	28	hours	respectively)	and	OCR	attributed	to	proton	leak	(17	±	6%	and	
17	 ±	 2%)	 did	 not	 vary	 between	 the	 outset	 and	 end	 of	 IVM	 (Figure	 3.9).	 Spare	
capacity	however,	changed	significantly	during	IVM	(85	±	31%	and	5	±	3%	at	IVM	+	4	
and	28	hours	respectively;	p	<	0.01).	In	evaluating	data	from	individual	wells,	100%	
responded	to	FCCP	at	 IVM	+	4	hours,	demonstrating	spare	respiratory	capacity,	as	
opposed	to	only	50%	of	wells	responding	at	IVM	+	28	hours	(Figure	3.8).	
	
	
	
	
	
Figure	 3.8:	 Oxygen	 consumption	 rates	 after	 addition	 of	 respiratory	 inhibitors	 to	
evaluate	mitochondrial	function	at	IVM	+	4	hours	(outset)	and	IVM	+	28	hours	(end).	
Panels	A	and	B;	Data	are	presented	as	OCR	normalised	for	COC	DNA	content,	each	
data	point	represents	one	well,	with	mean	±	SEM	(n	=	57).	
A	 B	
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Figure	3.9:	Mitochondrial	function	at	IVM	+	4	(outset)	and	IVM	+	28	hours	(end)	as	
determined	from	respiratory	inhibitor	studies	(Panel	A;	n	=	57).	Oxygen	consumption	
rates	 (OCR)	 coupled	 to	 ATP	 production	 (BLUE),	 OCR	 associated	 with	 proton	 leak	
(RED),	non-mitochondrial	OCR	(GREEN)	and	spare	respiratory	capacity	(PURPLE)	are	
expressed	as	%	basal	OCR.	Mean	±	SEM	are	presented	in	Panel	A	and	mean	values	
are	 stacked	 in	 Panel	 B.	 Asterisks	 represent	 significance	 difference	 between	 spare	
capacity	at	time	IVM	+	4	and	IVM	+	28	hours;	P	<	0.01.	
	
	
	
	
	
	
	
	
A	
B	
*	
*	
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3.5	Discussion	
	
This	 is	 the	 first	 report	 describing	 carbohydrate	metabolism,	 oxygen	 consumption	
and	mitochondrial	efficiency	in	equine	COCs.	In	addition,	it	is	the	first	time	the	use	
of	the	Seahorse	XFp	analyser	has	been	reported	for	COCs	in	any	species.	The	data	
demonstrate	that	glycolysis	was	the	major	active	pathway	of	glucose	metabolism	in	
equine	COCs	during	IVM,	as	95%	of	glucose	consumed	was	accounted	for	by	lactate	
production	 in	 COCs	 for	which	 glucose	was	 not	 limiting.	While	 glycolysis	what	 the	
main	 pathway	 for	 glucose	 utilisation	 however,	 the	 high	 concurrent	 OCR	
demonstrates	 that	 equine	 COCs	 are	 not	 “mainly	 glycolytic”	 as	 other	 species	 but	
rather	OXPHOS	plays	a	significant	role	in	energy	metabolism.	Glycolysis	is	the	main	
pathway	reported	in	previous	studies	on	equine	COCs,	as	well	as	in	those	of	other	
species	 studied	 to	 date	 (Biggers	 et	 al.,	 1967,	 Gonzalez-Fernandez	 et	 al.,	 2018,	
Sutton	et	al.,	2003).	While	OCR	was	measured	in	the	bovine	study	confirming	that	
glycolysis	was	the	main	pathway	in	energy	provision	(Sutton	et	al.,	2003),	OCR	was	
not	measured	in	either	the	murine	(Biggers	et	al.,	1967)	or	equine	study	(	Gonzalez-
Fernandez	et	al.,	2018).	
	
Most	 studies	 of	 this	 nature	 have	 been	 carried	 out	 on	 the	 denuded	 oocyte	 and	
demonstrated	 an	 uptake	 of	 pyruvate	 (Harris	 et	 al.,	 2009),	 a	 net	 production	 of	
pyruvate	 was	 found	 in	 the	 present	 study.	 This	 has	 been	 reported	 previously	 in	
equine	and	murine	COCs	during	IVM	(Downs	et	al.,	2002,	Gonzalez-Fernandez	et	al.,	
2018,	Harris	et	al.,	2007).	It	was	demonstrated	as	early	as	1985	by	Leese	and	Barton	
that	 isolated	murine	cumulus	cells	were	capable	of	producing	pyruvate	 from	both	
glucose	 and	 lactate.	 It	 was	 further	 shown	 in	 the	 mouse	 that	 the	 pyruvate	
concentration	was	higher	in	the	oviduct	containing	the	ovulated	COC/cumulus	cells	
than	the	oviduct	without	(Gardner	and	Leese,	1990;	Harris	et	al.,	2005).	Given	that	
pyruvate	is	an	important	energy	source	for	oocytes	and	embryos	immediately	post-
fertilisation,	 this	observation	was	unexpected.	 	However,	 formation	and	 secretion	
of	 pyruvate	 could	 have	 two	 explanations;	 the	 cumulus	 cells	 produce	 pyruvate	 in	
excess	 of	 that	 needed	 by	 the	 oocyte,	 perhaps	 as	 a	 result	 of	 some	 metabolic	
decoupling	 occurring	 in	 the	 in	 vitro	 conditions,	 or	 more	 likely	 as	 a	 defence	
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mechanism	 against	 Reactive	 Oxygen	 Species	 (ROS)	 to	 aid	 in	 redox	 balance,	 since	
pyruvate	 can	 act	 as	 a	 ROS	 scavenger	 (Pyruvate	 +	 H2O2	èAcetate	 +	 CO2	 +	 H2O;	
O’Donnell-	Tormey	et	al.,	1987).	For	example,	in	somatic	cells,	pyruvate	production	
and	secretion	to	the	culture	media	is	prioritised	over	intracellular	ATP	production	in	
order	 to	 protect	 against	 ROS	 in	 the	 scavenging	 of	 H2O2	(O'Donnell-Tormey	 et	 al.,	
1987).	 Interestingly,	 Downs	 and	 Hudson,	 (2000)	 showed	 that	 in	 a	 microdrop	
environment	 (8	 μl)	 secreted	 pyruvate	 build-up	 meant	 that	 glucose	 alone	 as	 a	
substrate	was	sufficient	to	support	meiotic	maturation	in	murine	COCs		where	as	in	
larger	 volumes	 (1	 ml)	 pyruvate	 addition	 was	 required	 for	 optimal	 meiotic	
maturation	 rates.	 For	 this	 reason,	 culture	 media	 for	 somatic	 cells	 often	 includes	
pyruvate;	something	that	will	be	explored	for	equine	IVM	media	in	Chapter	4.		
	
Up	to	24%	of	COCs	depleted	all	the	available	glucose	from	a	10-μl	droplet	of	M199	
based	maturation	media	 (5.6	mM	glucose)	and	the	glucose	consumption	rate	was	
positively	 correlated	 to	 the	 DNA	 content	 of	 the	 COC.	 This	 depletion	 of	 available	
glucose	 has	 not	 been	 previously	 reported	 and	 suggests	 that	 the	 current	 IVM	
environment,	as	often	reported	(10	µL	medium	per	COC;	Choi	et	al.,	2016)	may	be	
inadequate	in	terms	of	glucose	supply.	In	other	species	such	as	the	mouse,	human	
and	 cow,	 immature	 oocyte	 retrieval	 is	 performed	 via	 follicular	 aspiration	 and	
therefore	 COCs	 are	 typically	 collected	 with	 only	 a	 few	 layers	 of	 cumulus,	 which	
could	account	for	the	lack	of	depletion.	In	two	reports,	the	number	of	cumulus	cells	
in	 murine	 COCs	 were	 counted	 and	 averaged	 2060	 per	 cumulus	mass	 (Leese	 and	
Barton,	1985)	and	1200	(Preis	et	al.,	2005).	Although	not	counted	in	this	study,	as	
an	 estimate	 using	 DNA	 content	measured	 in	 single	 bovine	 cumulus	 cells	 (6.45pg;	
Mirsky	and	Osawa,	1961)	the	average	number	of	cumulus	cells	in	the	current	study	
would	be	16,629	per	COC.	As	reported	by	Sutton	et	al.	(2003)	in	cattle,	normalising	
results	 for	 DNA	 content	 allowed	 for	 more	 accurate	 comparison	 of	 metabolic	
measurements	 between	 COCs,	 given	 the	 wide	 range	 of	 COC	 size	 both	 due	 to	
number	 of	 cells	 and	 expansion.	 	 When	 adjusted	 for	 DNA	 content,	 the	 glucose	
consumption	 and	 lactate	 production	 rates	 during	 IVM	 by	 equine	 COCs	 were	
approximately	half	of	those	reported	by	Sutton	et	al.,	 (2003)	by	bovine	COCs	(~30	
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pmol	 glucose	 produced/ng	 DNA/hour	 and	 ~	 70	 pmol	 lactate	 produced/ng	 DNA	
hour).		
	
In	 the	 single	 previous	 report	 available	 on	 glucose	 metabolism	 by	 equine	 COCs,	
nuclear	 magnetic	 resonance	 (NMR)	 spectroscopy	 was	 used	 as	 the	 measurement	
method	 and	 results	 were	 reported	 in	 nmol/COC/entire	 IVM	 period	 (Gonzalez-
Fernandez	 et	 al.,	 2018).	 The	 COC-to-medium	 ratio	 also	 varied,	 as	 COCs	 were	
cultured	 in	 groups	 of	 1-25	 in	 250-μl	 droplets.	 Despite	 these	 differences	 in	
experimental	design	and	analysis,	it	is	interesting	that	metabolic	rates	measured	in	
that	 study	 were	 within	 the	 range	 reported	 herein	 (~	 495	 pmol/COC/hr	 glucose	
consumption	 and	 ~1,	 145	 pmol/COC/hr	 lactate	 production	 vs.	 300	 to	 1965	 pmol	
glucose/COC/hour	and	732	to	2909.5	pmol	lactate/COC/hour	in	the	current	study).	
As	most	studies	in	other	species	have	examined	metabolism	in	denuded	oocytes,	it	
is	inappropriate	to	compare	these	data	with	those	obtained	here.	Furthermore,	the	
method	 of	 collection	 and	 number	 of	 cumulus	 cells	 differ,	 making	 comparison	 of	
COC	data	in	other	species	difficult	unless	also	corrected	for	DNA	content.	
	
The	depletion	of	 glucose	and	 thus	 lack	of	 glucose	 towards	 the	end	of	maturation	
suggests	that	COC	physiology	might	be	compromised,	however	developmental	data	
in	the	present	study	suggested	otherwise.	While	numbers	were	small,	one	oocyte	of	
nine	 that	 had	 depleted	 all	 the	 available	 glucose	 during	 IVM	 was	 able	 to	 form	 a	
blastocyst	after	 ICSI.	 	 This	either	 suggests	 that	 the	COC	was	able	 to	use	alternate	
substrates	 for	 ATP	 production	 such	 as	 reusing	 excreted	 lactate	 or	 pyruvate	 or	
alternatively	 had	 completed	 the	 necessary	 glucose-requiring	 processes	 before	
glucose	availability	was	limiting.	In	support	of	this,	glucose	consumption	decreased	
during	20-30	hours	of	IVM.	Of	course	it	is	not	possible	to	determine	when	the	COC	
effectively	ran	out	of	glucose	during	 IVM,	therefore	either	explanation	 is	possible.	
The	 finding	 that	 COCs	 that	 had	 depleted	 all	 available	 glucose	 also	 had	 a	 reduced	
glycolytic	 index	 (60%	 vs.	 95%)	 however,	 suggests	 a	 sensing	 mechanism	 enabling	
glucose	to	be	diverted	to	pathways	other	than	glycolysis,	with	ATP	demand	satisfied	
from	other	 substrates.	 Additionally,	 the	 decrease	 in	 net	 pyruvate	 production	 also	
suggests	 that	 the	 COC	 and/or	 oocyte	 was	 able	 to	 either	 consume	 some	 of	 the	
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secreted	 pyruvate	 after	 glucose	 was	 depleted	 or	 secreted	 less	 in	 favour	 of	
conserving	glucose.	Increased	β-oxidation	of	 intracellular	fatty	acids	as	a	source	of	
ATP	can	also	not	be	ruled	out	in	these	COCs	that	had	depleted	available	glucose.		
	
Maturation	 status	 did	 not	 impact	 either	 glucose	 or	 lactate	 (GL)	metabolism.	 This	
suggests	that	the	oocyte	had	a	negligible	effect	on	the	overall	COC	metabolism	as	
suggested	by	 	 Sutton	et	 al.	 (2003),	who	did	not	 find	 the	oocyte	 to	 influence	COC	
metabolism.	This	will	be	explored	 in	Chapter	4.	Additionally,	cumulus	morphology	
did	not	influence	COC	metabolism.	Given	the	physiological	differences	in	follicle	of	
origin	 between	Cp	 and	 Ex	 COCs	 this	 result	was	 unexpected.	 	While	 compact	 (Cp)	
COCs	 had	 an	 increased	GL	metabolism	when	 evaluated	 by	 individual	 complex,	 as	
also	 reported	 by	Gonzalez-Fernandez	 et	 al.,	 (2018),	 this	 difference	was	 no	 longer	
present	when	values	were	normalised	for	DNA	content,	as	the	Cp	cumuli	contained	
many	more	cumulus	cell	than	did	expanded	(Ex)	COCs.	This	was	perhaps	a	limitation	
of	 the	 equine	 study	 by	 Gonzalez-Fernandez	 et	 al.,	 (2018)	 who	 reported	 that	 Cp	
COCs	consumed	significantly	more	glucose	as	results	were	not	normalised	for	DNA	
content,	which	may	 have	 diminished	 the	 reported	 difference	 between	 Cp	 and	 Ex	
metabolism.		
	
There	 were	 no	 differences	 in	 COC	 glucose	 or	 lactate	 metabolism	 during	 IVM	
between	those	oocytes	that	subsequently	cleaved	after	ICSI	and	those	that	did	not	
cleave;	or	between	those	that	reached	the	blastocyst	stage	and	those	that	did	not.	
The	 association	 between	 COC	metabolism	 during	 IVM	 and	 oocyte	 developmental	
competence	has	been	evaluated	in	the	cat,	mouse	and	cow,	and	in	all	three	species,	
increased	 glucose	 consumption	 during	 IVM	 was	 associated	 with	 increased	
developmental	competence	(Spindler	et	al.,	2000,	Preis	et	al.,	2005	and	Krisher	and	
Bavister,	 1999).	 The	 lack	 of	 association	 in	 this	 study	 could	 be	 due	 to	 species	
differences,	the	 increased	number	of	cumulus	cells	dampening	the	effect,	or	most	
likely	 the	 small	 number	 of	 blastocysts	 available	 for	 comparison.	 Further	 study	 is	
required	to	discover	if	COC	glucose	metabolism	during	IVM	has	predictive	value	in	
determining	blastocyst	development	for	the	horse.		
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Temporal	differences	were	observed	in	metabolism	over	the	course	of	IVM,	in	that	
COCs	 consumed	glucose	 and	produced	 lactate	 at	 a	 lower	 rate	during	 the	 final	 10	
hours	 of	 IVM.	 The	 glycolytic	 index	 remained	 constant	 however	 (119%;	 lactate	 :	
glucose	ratio	2.37)	suggesting	that	the	change	at	the	end	of	maturation	represented	
an	 overall	 decrease	 in	 metabolism	 rather	 than	 a	 change	 of	 pathway.	 This	 is	 in	
contrast	 to	 studies	 in	 the	mouse	 and	 the	 cow,	 which	 have	 found	 an	 increase	 in	
glucose	consumption	rates	at	the	end	of	maturation	but	no	corresponding	increase	
in	lactate	production	(Preis	et	al.,	2005;	Sutton	et	al.,	2003).	This	increased	glucose	
consumption	 suggests	 that	 additional	 pathways	 are	 utilised	 towards	 the	 end	 of	
maturation	 in	 these	 species	 other	 than	 glycolysis	 alone.	 	 The	 constant	 rate	 of	
glycolysis	 found	 in	 the	 present	 study	 supports	 the	 findings	 of	 Cetica	 et	 al.	 (2002)	
who	reported	that	the	activity	of	phosphofructokinase	(PFK;	a	regulatory	enzyme	of	
glycolysis)	did	not	change	over	the	course	of	bovine	IVM.	In	contrast,	Harris	et	al.,	
(2007)	observed	an	 increase	 in	both	glucose	and	 lactate	production	 in	MII	murine	
COCs	 compared	 to	 those	 at	 the	 GV	 stage,	 representing	 an	 overall	 increase	 in	
metabolism	towards	the	end	of	maturation.	Again,	it	is	difficult	to	compare	studies	
reliably,	 even	 in	 the	 same	 species,	 due	 to	 differences	 in	 culture	 and	 analytical	
methods.	 For	example,	 the	data	 from	 the	Harris,	 2007	 study	was	derived	 from	 in	
vivo	matured	COCs	or	those	originating	from	in	vitro	cultured	follicles.	
	
As	 considered	 in	 Section	 1.3.2,	 a	 key	 component	 of	 meiosis	 is	 germinal	 vesicle	
breakdown	 (GVBD)	 which	 is	 known	 to	 be	 associated	 with	 an	 increase	 in	 glucose	
consumption	via	both	glycolysis	and	the	Pentose	Phosphate	Pathway	(PPP)	(Downs	
and	Utecht,	1999,	Herrick	et	al.,	2006).	There	is	wide	species	variation	in	the	time	of	
GVBD	 after	 onset	 of	 IVM;	 this	 occurs	 after	 2	 hours	 of	 a	 12-14-hour	 IVM	 in	 the	
mouse,	after	6-9	hours	of	a	24-hour	IVM	in	the	cow	and	after	16-20	hours	of	a	44-
hour	IVM	in	the	pig	(Donahue,	1968;	Motlik	and	Fulka,	1976;	Sirard	and	First,	1988).	
In	 a	 study	 examining	 maturation	 kinetics	 in	 the	 horse,	 GVBD	 occurred	 at	
approximately	12	hours	after	onset	of	 IVM	and	progression	 to	MII	 after	16	hours	
(Alm	and	Hinrichs,	1996),	both	events	falling	within	the	10-20	hour	culture	window.	
Additionally,	 cumulus	 expansion	 occurs	 in	 the	 later	 part	 of	 IVM,	 at	 least	 in	 the	
mouse	 (Chen	 et	 al.,	 1993).	 	 Cumulus	 expansion	 increases	 glucose	 consumption	
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through	 the	 hexosamine	 biosynthesis	 pathway	 (HBP).	 It	 would	 be	 therefore	
expected	 that	 glucose	 consumption	 would	 be	 highest	 when	 both	 meiotic	
maturation	and	cumulus	expansion	are	occurring.	In	the	present	study	there	was	no	
significant	 increase	 in	 glucose	 metabolism	 during	 the	 time	 period	 that	 these	
processes	would	potentially	be	occurring	(10-20	hours),	however	numbers	of	COCs	
were	low.	This	will	be	explored	further	in	Chapter	4.	
	
This	is	the	first	study	to	examine	oxygen	consumption	and	its	components	in	equine	
COCs	 and	 only	 the	 second	 to	 examine	 OCR	 in	 COCs	 of	 any	 species.	 The	method	
used,	 proved	 to	 generate	 reliable	 and	 consistent	 data	 and	 has	 great	 potential	 to	
provide	vital	information	on	mitochondrial	function	during	IVM	and	the	subsequent	
stages	of	embryo	development.	Examining	basal	OCR	revealed	a	tendency	for	it	to	
increase	over	time	(the	opposite	pattern	to	glycolysis)	however	the	change	was	not	
statistically	 significant	 (42.48	 ±	 10.4	 at	 the	 beginning	 of	 IVM	 vs.	 60.58	 ±	 14.08	
pmol/ng	 DNA/hour	 at	 the	 end	 of	 IVM).	 	 The	 trend	 is	 in	 agreement	 with	 both	
Johnson	 et	 al.,	 (2007),	 who	 demonstrated	 an	 increase	 in	 pyruvate	 oxidation	
following	 GVBD	 in	 murine	 oocytes,	 and	 Sutton	 et	 al.	 (2003)	 who	 demonstrated	
increase	 in	OCR	over	 time	 in	 bovine	 COCs.	 Interestingly,	 basal	OCR	 in	 the	 equine	
COCs	in	the	present	study	was	~20	times	higher	than	that	reported	for	bovine	COCS	
(per	 ng	DNA;	 Sutton	 et	 al.,	 2003).	 This	 represents	 a	 significant	 species	 difference	
and	highlights	 that	unlike	at	 least	 the	bovine	COC,	 the	equine	COC	 is	not	 “mainly	
glycolytic”.	 It	 is	 interesting	 to	 note	 that	 this	 data	 is	 in	 agreement	 with	 that	 for	
denuded	oocytes.	 A	 recent	 report	 of	OCR	 in	 single	metaphase	 II	 denuded	 equine	
oocytes	using	a	novel	Clark-type	electrode	reported	an	OCR	of	10%	of	that	measure	
in	entire	COCs	in	the	present	study;	approx.	180	pmol/oocyte/hour	(Obeidat	et	al.,	
2018).	 In	 contrast,	 reported	 OCR	 for	 denuded	 bovine	 oocytes	 was	 approx.	 1.4	
pmol/oocyte/hour	 (Sugimura	 et	 al.,	 2012)	 and	 20-30	 pmol/oocyte/hour	 for	
denuded	 porcine	 oocytes	 (Sturmey	 and	 Leese,	 2003).	 The	 reason	 for	 the	 species	
differences	 could	 potentially	 be	 attributed	 to	 differences	 in	 ATP	 requirements	 or	
more	 likely,	 differences	 in	 triglyceride	 content	 and	 the	 proportion	 of	 which	 is	
subsequently	oxidised.	While	 intracellular	 lipid	 content	has	not	been	measured	 in	
equine	oocytes,	they	are	also	very	dark	in	colour,	as	in	the	pig,	and	have	numerous	
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lipid-like	vesicles	present	on	electron	microscopic	evaluation	(Grondahl	et	al.,	1995)	
thus	it	is	assumed	that	they	have	a	high	lipid	content.	
	
As	 was	 demonstrated	 for	 glucose	 and	 lactate	 metabolism,	 there	 were	 no	
differences	 in	 OCR	 attributable	 to	 cumulus	 classification.	 However,	 numbers	 of	
COCs	in	each	cumulus	category	were	small	and	this	comparison	would	need	to	be	
repeated	before	any	conclusion	can	be	drawn.	To	 the	best	of	my	knowledge	OCR	
and	GL	metabolism	have	 not	 been	 reported	 in	 the	 same	oocytes	 or	 COCs;	 in	 the	
present	 study,	 these	 measurements	 were	 made	 possible	 with	 the	 in	 situ	
assessments	of	the	Seahorse	XFp	analyser.	Interestingly,	while	glucose	consumption	
was	within	the	range	found	from	the	COCs	in	the	previous	microdrop	experiments,	
lactate	 production	 was	 much	 lower	 and	 hence	 so	 was	 the	 glycolytic	 index.	
Unfortunately,	 this	 was	 not	 explored	 further	 but	 could	 be	 due	 to	 differences	 in	
volume	(60	µl/COC	vs.	10	μl)	or	group	vs.	single	culture.	An	additional	difference	is	
the	 fact	 that	 the	media	was	mixed	 and	 reoxygenenated	 several	 times	 during	 the	
Seahorse	 experiments	 compared	 to	 the	 static	 nature	 of	 the	 microdrop	 culture.	
Reoxygenation	 could	 have	 increased	 OXPHOS	 and	 therefore	 proportionately	
decreased	glycolysis	to	explain	the	lowered	lactate	production.	Overall,	as	the	ratio	
of	 lactate	 :	 glucose	 was	 not	 correlated	 to	 OCR	 but	 the	 GL	 metabolism	 was,	 it	
suggests	an	absence	of	a	reciprocal	relationship	but	rather	that	COCs	either	had	a	
“quiet”	or	“noisy”	level	of	metabolism	overall.		
	
Mitochondrial	 function	 testing,	 by	 examining	 the	 efficiency	 of	OXPHOS,	 has	 been	
reported	widely	 for	 somatic	 cells,	but	 there	 is	only	one	 report	 for	bovine	oocytes	
(Sugimura	et	al.,	2012)	and	one	in	equine	oocytes	(Obeidat	et	al.,	2018).	The	equine	
study	by	Obeidat	et	al.,	used	oligomycin	in	isolation	and	therefore	only	coupled	OCR	
could	be	determined.	The	findings	reported	here	for	equine	COCs	are	very	similar	to	
those	 reported	previously	 for	bovine	denuded	oocytes	by	Sugimura	et	al.,	 (2012).	
While	 somatic	 cells	have	a	non-mitochondrial	OCR	of	 approximately	10%	of	basal	
(basal	OCR	=	100%)	(Wu	et	al.,	2007),	equine	COCs	in	this	study	and	bovine	oocytes	
in	the	Sugimura	study	had	a	non-mitochondrial	OCR	of	38%	and	35%	respectively.	
Non-	mitochondrial	OCR	can	be	attributed	to	the	production	of	ROS	or	to	the	action	
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of	 oxygen-consuming	 enzymes	 such	 as	 NADPH	 oxidase,	 xanthine	 oxidase	 and	
squalene	 mono-oxygenase,	 as	 demonstrated	 in	 rabbit	 embryos	 (Manes	 and	 Lai,	
1995).	 The	 efficiency	 with	 which	 OCR	 in	 equine	 COCs	 was	 coupled	 to	 ATP	
production	via	ATP	synthase	varied	between	47	–	58%	and	did	not	change	over	the	
time	 course	 of	 IVM.	 This	 is	 in	 contrast	 to	 the	 bovine	 denuded	 oocyte	 in	 which	
coupling	 efficiency	 decreased	 from	 40.9%	 in	 immature	 oocytes	 to	 25%	 in	
Metaphase	 II	 oocytes	 (Sugimura	 et	 al.,	 2012).	 The	 fall	 in	 coupling	 efficiency	 was	
attributed	to	an	increase	in	proton	leak	in	the	bovine	oocytes,	which	did	not	occur	
in	the	equine	COCs	(17%	throughout	IVM).	Interestingly,	the	previous	equine	study	
by	 Obeidat	 et	 al.,	 reported	 an	 85%	 coupling	 efficiency.	 However,	 it	 is	 difficult	 to	
compare	 this	 result,	 and	 those	 from	 the	 Sugimura	 study,	 given	 that	 both	 were	
performed	on	individual	denuded	MII	oocytes	rather	than	COCs	in	group	culture.	A	
drawback	of	 this	present	study	 is	 that	COCs	were	not	cultured	 individually	due	 to	
lack	 of	 sensitivity	 of	 the	 Seahorse	 XFp	 analyser	 and	 hence	 meiotic	 status	 was	
unknown	at	the	end	of	the	maturation	period.		
	
Surprisingly,	there	was	an	80%	reduction	in	the	spare	respiratory	capacity	of	equine	
COCs	 at	 the	 end	 of	 IVM	 (IVM	 +	 28	 hours)	 compared	 to	 initially	 (IVM	 +	 4	 hours),	
however	 the	 increase	 in	OCR	by	 the	end	of	maturation	 (<	20	pmol/ng	DNA/hour)	
cannot	account	for	all	of	this	loss	of	spare	capacity.	A	decrease	in	spare	capacity	is	a	
marker	of	mitochondrial	dysfunction	(Brand	and	Nicholls,	2011)	and	potentially	has	
detrimental	consequences	for	oocyte	developmental	competence,	especially	given	
the	requirement	for	a	high	electrical	potential	across	the	mitochondrial	membrane	
to	sustain	calcium	oscillations	at	fertilisation	(Dumollard	et	al.,	2004).	In	the	murine	
study	by	Sugimura	et	al.,	a	decreased	spare	capacity	was	found	only	in	aged	oocytes	
following	IVM.	This	is	interesting,	given	that	recent	reports	in	the	equine	literature	
suggesting	 that	 overnight	 holding	 of	 COCs	 prior	 to	 initiating	 IVM	 affects	 oocyte	
maturation	kinetics	and	may	result	in	a	significant	portion	(up	to	42.3%)	of	oocytes	
becoming	mature	 after	 only	 20-22	 hours	 in	maturation	 culture	 (Dini	 et	 al.,	 2016;	
Rodríguez	 et	 al.,	 2016).	 This	 could	 potentially	 cause	 some	 oocytes	 to	 become	
“aged”	 by	 28	 hours	 of	 IVM.	 However,	 the	 study	 by	 Dini	 et	 al.,	 performed	 with	
oocytes	 recovered	 from	slaughterhouse	 tissue,	contrasts	with	 the	 findings	of	Choi	
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et	al.	 (2015)	 in	which	oocytes	 from	 live	mares	were	held	overnight	and	only	28%	
were	 at	 MII	 after	 20	 hours	 maturation	 culture,	 vs.	 60%	 at	 24	 hours.	 Moreover,	
Jacobson	 et	 al.	 (2010)	 reported	 that	 blastocyst	 rates	 did	 not	 differ	 between	
maturation	 times	 of	 24	 vs.	 30	 hours	 for	 oocytes	 recovered	 by	 TVA	 and	 held	
overnight	before	onset	of	maturation	(33%	blastocysts	in	both	groups),	and	that	in	
vivo	 data	 suggest	 oocytes	 remain	 viable	 for	 at	 least	 6-12	 hours	 after	 ovulation	
(Ginther,	 1992;	 Woods	 et	 al.,	 1990).	 Overall,	 these	 findings	 indicate	 that	 oocyte	
aging	 is	unlikely	 to	explain	the	reduction	 in	spare	mitochondrial	capacity.	Another	
possibility	is	that	the	cumulus	cells,	nearing	the	end	of	their	physiological	role	have	
no	 further	 requirement	 to	 maintain	 ‘metabolic	 scope’	 and	 as	 an	 evolutionary	
adaptation	this	 lack	of	mitochondrial	spare	capacity	signals	their	demise	(Peterson	
et	al.,	1990)	
	
Conclusions	
The	work	presented	 in	 this	chapter	has	 for	 the	 first	 time	described	the	pattern	of	
glucose,	 lactate	 and	oxidative	metabolism	 in	 equine	COCS	during	 the	30	hours	of	
IVM	using	CoRe	methods	and	the	Seahorse	XFp	analyser.	The	findings	demonstrate	
that	 like	 other	 species,	 equine	 COCs	 utilise	 the	majority	 of	 glucose	 via	 glycolysis	
however	equine	COCs	have	a	unique	temporal	pattern	of	glucose	metabolism.		It	is	
also	 shown	 that	 unlike	 at	 least	 the	 bovine	 COC,	 the	 equine	 COC	 is	 not	 “mainly	
glycolytic”	 as	 OXPHOS	 also	 plays	 a	 major	 role	 in	 energy	 metabolism	 suggesting	
oxidation	 of	 an	 additional	 substrate(s).	 Additionally,	 as	 analysis	 was	 performed	
using	clinical	IVM	conditions,	clinically	relevant	findings	are	described:	shortcomings	
in	glucose	availability	during	IVM	culture	were	identified,	and	marked	decreases	in	
mitochondrial	efficiency	were	uncovered	at	the	completion	of	 IVM.	These	findings	
will	form	the	basis	of	further	studies	in	subsequent	chapters	to	optimise	equine	IVM	
in	terms	of	glucose	availability	and	to	explore	the	addition	of	substrates	that	would	
potentially	 prevent	 such	 a	 dramatic	 loss	 of	 spare	 mitochondrial	 capacity	 by	 the	
conclusion	of	maturation.		
		 	
	 111	
Chapter	 4:	 The	 effect	 of	 oxygen	 and	 pyruvate	 concentration	 on	 carbohydrate	
metabolism	and	oxygen	consumption	in	equine	cumulus	oocyte	complexes.	
	
4.1	Introduction	
	
Equine	 oocyte	 IVM	 conditions	 have	 not	 been	 critically	 evaluated.	 Indeed,	 in	 all	
species	 studied	 thus	 far,	 in	 vitro	 matured	 oocytes	 are	 inferior	 to	 their	 in	 vivo	
matured	 counterparts	 and	 perform	 sub-optimally	 in	 IVP	 systems.	 The	 benefits	 of	
low	oxygen	concentration	during	embryo	culture	are	widely	accepted	and	embryo	
culture	 at	 5%	 oxygen	 is	 nearly	 universal	 for	 animals	 and	 becoming	 so	 for	 human	
embryo	culture	(Wale	and	Gardner,	2016).	In	contrast,	the	ideal	oxygen	tension	for	
IVM	 is	 still	 under	 debate,	 with	 conflicting	 results	 from	 different	 studies.	 This	 is	
despite	the	fact	that	the	oxygen	concentration	 in	the	ovarian	follicle	 is	between	1	
and	5.5%	in	the	human	(VanBerkom	et	al.,	1997).	Additionally,	as	the	antrum	grows	
during	 follicular	 growth	 and	 then	 the	 cumulus	 cells	 expand	 in	 the	 large	 pre-
ovulatory	 follicle,	 the	 oxygen-consuming	 cell	 mass	 increases,	 and	 the	 oocyte	
becomes	 farther	 away	 from	 follicular	 vascular	 supply	 and	 thus	 also	 oxygen	
(Tamanini	 and	De	Ambrogi,	 2004;	 Thompson	et	 al.,	 2015).	 This	 lack	of	 apposition	
could	potentially	be	even	more	important	in	the	equine	pre-ovulatory	follicle,	which	
can	reach	upwards	of	45	mm	in	diameter	before	ovulation.	Interestingly,	it	has	been	
demonstrated	 through	 mathematical	 modelling	 that	 little	 oxygen	 is	 removed	 by	
murine	and	bovine	cumulus	cells	(<	0.5%)	as	they	are	mainly	glycolytic	(Clark	et	al.,	
2006)	as	such,	the	oxygen	gradient	between	the	follicle	wall	and	the	oocyte		will	be	
small.	 In	contrast,	results	from	Chapter	3	for	the	equine	COC	suggest	this	gradient	
may	be	larger	if	the	high	OCR	was	maintained	in	vivo.	
	
An	early	 study	by	Gwatkin	and	Haidri,	 (1974)	demonstrated	a	 clear	benefit	of	5%	
oxygen	 during	 IVM	 on	 the	 meiotic	 competence	 of	 hamster	 oocytes.	 However,	
reported	 benefits	 of	 low	 oxygen	 are	 not	 unanimous	 across	 species.	 In	 the	 pig,	
atmospheric	oxygen	 (20%)	during	 IVM	has	been	shown	to	be	superior	 in	 terms	of	
blastocyst	development	in	some	studies	(Kang	et	al.,	2011;	Park	et	al.,	2005)	yet	in	
other	 studies,	 inferior	 in	 terms	 of	 both	 blastocyst	 development	 and	 quality	
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(increased	cell	number	and	decreased	DNA	fragmentation	with	IVM	at	5%	vs.	20%;	
Iwamoto	 et	 al.,	 2005;	 Karja	 et	 al.,	 2004).	 In	 cattle,	 one	 study	 reported	 increased	
blastocyst	 numbers	 after	 IVM	 at	 20%	 vs.	 5%	 oxygen	 (Oyamada	 and	 Fukui,	 2004),	
however	others	found	a	positive	effect	of	low	oxygen	(5%)	during	IVM	on	blastocyst	
numbers	(Bermejo-Álvarez	et	al.,	2010;	Hashimoto	et	al.,	2000;	Kumar	et	al.,	2015),	
and	also	on	the	expression	of	genes	related	to	oocyte	developmental	competence	
(Bermejo-Álvarez	et	al.,	2010).	In	the	mouse,	Banwell	et	al.,	(2007)	and	Preis	et	al.,	
(2007)	reported	that	while	there	were	no	differences	in	developmental	rates	or	live	
birth	 rates	between	oocytes	matured	 in	 low	and	high	oxygen	concentration,	 total	
cell	and		trophectoderm	cell	numbers	were	increased	when	oocytes	underwent	IVM	
at	5%.	In	the	only	study	to	examine	the	effect	of	oxygen	concentration	during	IVM	
on	 post	 implantation	 development,	 murine	 foetal	 and	 placental	 weights	 were	
decreased	 with	 IVM	 at	 5%	 vs.	 20%	 (Banwell	 et	 al.,	 2007).	 There	 are	 no	 studies	
directly	 comparing	outcomes	between	different	oxygen	concentrations	 for	 IVM	 in	
the	 human,	 however	 clinical	 success	 has	 been	 reported	 at	 both	 5%	 (Child	 et	 al.,	
2001;	 Junk	 et	 al.,	 2012;	 Walls	 et	 al.,	 2015)	 and	 20%	 oxygen	 (Filali	 et	 al.,	 2008).	
Clearly,	 the	 optimal	 concentration	 of	 oxygen	 during	 IVM	 requires	 further	
investigation.	
	
If	 the	 approach	 of	 mimicking	 the	 in	 vivo	 environment	 is	 adopted,	 an	 important	
substrate	not	included	in	M199	media	but	known	to	be	present	in	follicular	fluid	is	
pyruvate	 (Gerard	 et	 al.,	 2000).	 Pyruvate	 is	 important	 in	 order	 to	 meet	 the	 ATP	
requirements	of	the	oocyte	(Gardner	and	Leese,	1990;	Harris	et	al.,	2005;	Leese	and	
Barton,	 1984)	 	 and	 for	 ROS	 scavenging	 (O’Donnel	 and	 Tormey	 et	 al.,	 1987).	 As	
detailed	in	Section	1.5.4	the	cumulus	cells	metabolise	glucose	via	glycolysis	for	both	
their	 own	ATP	production	and	 for	providing	pyruvate	 to	 the	oocyte	 (Harris	 et	 al.,	
2009)	 and	 the	 oocyte	 subsequently	 utilises	 a	 portion	 of	 this	 pyruvate	 for	 ATP	
production	through	the	TCA	cycle	and	OXPHOS	(Steeves	and	Gardner,	1999).	It	has	
also	been	shown	that	cumulus	cells	will	prioritise	pyruvate	secretion	over	meeting	
their	 own	 metabolic	 ATP	 requirements	 in	 order	 to	 maintain	 redox	 balance	
(O’Donnel	 and	 Tormey	 et	 al.,	 1987).	 Given	 the	 net	 pyruvate	 production	 in	 COCs	
reported	in	Chapter	3,	it	is	possible	that	by	adding	pyruvate	to	the	medium	before	
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IVM	 commences,	 glucose	 may	 be	 spared	 and	 used	 for	 other	 functions.	
Furthermore,	 it	 has	 been	 shown	 that	 the	 combined	 presence	 of	 glucose	 and	
pyruvate	 results	 in	 the	 highest	 maturation	 rates	 for	 mouse	 COCs	 (Downs	 and	
Hudson,	2000).	While	addition	of	pyruvate	at	varying	concentrations	(0.1	to	1	mM)	
during	equine	IVM	has	been	reported	by	some	(Foss	et	al.,	2013;	Galli	et	al.,	2002).,	
the	 effect	 on	 metabolic,	 meiotic	 or	 developmental	 parameters	 has	 not	 been	
studied.	 Follicular-fluid	 pyruvate	 concentrations	 in	 the	 mouse,	 human,	 cow	 and	
mare	are	0.38,	0.26,	0.01-0.05	and	0.03-0.13	mM	respectively	(Gerard	et	al.,	2000;	
Harris	et	al.,	2005;	Leese	and	Lenton,	1990;	Orsi	et	al.,	2005).	 Interestingly,	 in	 the	
human	 this	 is	 3	 to	 5	 times	 the	 plasma	 concentration	 (Leese	 et	 al.,	 1986)	
emphasising	its	importance	to	the	developing	oocyte.	
	
It	 is	 also	 of	 interest	 to	 consider	what	 elements	 are	 responsible	 for	 the	 temporal	
differences	 in	 glucose	 consumption	 reported	 in	 Chapter	 3.	 It	 could	 be	 postulated	
that	 ATP-requiring	 meiotic	 events	 such	 as	 GVBD	 within	 the	 oocyte	 would	 drive	
metabolism	in	the	COC	as	a	whole,	which	has	been	demonstrated	in	the	mouse	and	
pig	(Matsuno	et	al.,	2016;	Sugiura	et	al.,	2005),	however	in	the	cow	this	was	not	the	
case	as	the	presence	of	the	oocyte	did	not	alter	glucose	metabolism	compared	to	
cumulus	cells	only	(oocyte-ectomised	COCs)	(Sutton	et	al.,	2003).	Follicle	stimulating	
hormone	 (FSH)	 has	 also	 been	 shown	 to	 affect	 glucose	 metabolism	 in	 the	 COC,	
possibly	 linked	to	 its	role	 in	stimulating	cumulus	expansion.	As	cumulus	expansion	
requires	hyaluronic	acid,	an	end	product	of	 the	hexosamine	biosynthesis	pathway	
(HBP),	 FSH	 addition	 increases	 glucose	 demands	 through	 the	 HBP.	 This	 has	 been	
shown	in	cattle	where	glucosamine	addition,	an	alternative	substrate	for	the	HBP,	
decreased	glucose	consumption	(Sutton-McDowall	et	al.,	2005).	
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Summary	
The	 data	 in	 Chapter	 3	 indicated	 that	 equine	 COCs	 consume	 glucose	 avidly	 and	
export	pyruvate	into	the	medium.	In	addition,	the	spare	respiratory	capacity	of	the	
COC	 mitochondria	 was	 significantly	 decreased	 at	 the	 end	 of	 maturation.	 Taken	
together,	 these	 findings	 suggest	 that	 the	 current	 IVM	conditions	 for	 equine	COCs	
are	 suboptimal.	 Data	 is	 ambiguous	 on	 environmental	 aspects	 such	 as	 oxygen	
concentration	 and	 medium	 composition	 that	 could	 address	 these	 inadequacies	
therefore	 further	 studies	are	 required.	As	 such,	 the	effect	of	 lowering	 the	oxygen	
concentration	 and	 adding	 pyruvate	 at	 physiological	 concentrations	 on	 COC	
metabolism	 and	meiotic	 potential	was	 investigated.	 Further,	 from	a	 basic	 biology	
viewpoint,	 the	 temporal	pattern	of	glucose,	 lactate	and	pyruvate	metabolism	was	
scrutinized.
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4.2	Objectives	
1. Evaluate	 the	 effect	 of	 addition	of	 0.15	mM	pyruvate	 to	 IVM	medium,	 and	
the	 effect	 of	 decreased	 oxygen	 concentration	 (5%	 vs.	 21%),	 on	 COC	
maturation	 rate	 and	 glucose,	 pyruvate	 and	 lactate	 (GPL)	 metabolism	
(Experiment	4.1).	
2. Evaluate	effect	of	IVM	medium	pyruvate	concentration	(0	mM,	0.15	mM,	0.5	
mM)	 on	 basal	 OCR	 and	 mitochondrial	 function	 at	 the	 completion	 of	 IVM	
(Experiment	4.2).	
3. Evaluate	the	temporal	changes	in	GPL	metabolism	over	the	30-hour	duration	
of	 IVM	(0-10	hours,	10-20	hours,	20-30	hours)	 in	 the	presence	of	pyruvate	
(Experiment	4.3,	Study	1).	Using	this	model,	evaluate:	
a. The	 impact	 of	 oocyte	 presence	 within	 a	 COC	 on	 GPL	 metabolism	
(intact	COC	vs.	granulosa	only)	(Experiment	4.3,	Study	2)	
b. The	 impact	 of	 presence	 of	 FSH	 (0	 vs.	 5	 mU/ml)	 in	 the	maturation	
media	on	GPL	metabolism.	(Experiment	4.3,	Study	3)	
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4.3	Materials	and	methods	
	
General	methods	
COCs	 were	 recovered	 from	 abattoir-derived	 ovaries,	 classified	 as	 compact	 (Cp),	
expanded	 (Ex)	 or	 corona	 radiata-only	 as	 previously	 described	 in	 Section	 2.1.	
Granulosa	 was	 trimmed	 using	 a	 21-G	 needle	 (visual	 trimming	 [VT])	 or	 a	 290-μm	
pipette	 (pipette	 trimming	 [PT])	 in	 an	 attempt	 to	 minimise	 variation	 in	 cumulus	
mass.	See	results	of	each	experiment	for	details.	COCs	were	then	held	overnight	as	
previously	described	in	Section	2.1.		
	
Experiment	4.1	
When	 COCs	 were	 removed	 from	 the	 holding	 vial	 Cp	 and	 Ex	 COCs	 were	 divided	
equally	 and	 without	 any	 further	 selection	 between	 conditions,	 so	 that	 for	 each	
collection	 day,	 each	 maturation	 condition	 contained	 equal	 numbers	 of	 each	
cumulus	type.	Maturation	in	all	groups	was	carried	out	in	individual	15-μl	droplets	
(increased	 from	10-μl	 in	an	attempt	 to	prevent	glucose	depletion;	 Section	3.4.1.).	
There	were	12	droplets	 in	each	dish;	COCs	were	placed	in	nine	of	them	and	three	
remained	 empty	 and	were	 used	 as	 reference	 droplets.	 Dishes	were	 continuously	
incubated	 for	 the	 entire	 30-hour	 IVM	 period	 in	 one	 of	 four	 IVM	 conditions	 as	
follows	 (as	 indicated	 in	 Figure	 4.1):	Group	 21C:	 Control	Maturation	Medium	 (no	
pyruvate;	M199	with	Earle’s	salts,	10%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml	FSH	
[Sioux	Biochemical	Inc.,	Sioux	Center,	IA])	and	maturation	at	5%	CO2	in	air	(21%	O2).	
Group	5C:	Control	Maturation	Medium	(as	above,	no	pyruvate)	and	maturation	at	
5%	CO2,	5%	O2	and	90%	N2.	Group	21P:	Maturation	Medium	with	added	pyruvate	
(control	medium	as	above	with	the	addition	of	0.15	mM	Pyruvate)	and	incubation	
at	 5%	 CO2	 in	 air.	 Group	 5P:	 Maturation	 Medium	 with	 added	 pyruvate	 and	
incubation	 at	 5%	 CO2,	 5%	 O2	 and	 90%	 N2.	 After	 the	 maturation	 period	 was	
completed,	 COCs	 were	 denuded	 and	 classified	 as	 Metaphase	 II	 (MII),	 intact	 or	
degenerated	 (DEG)	 as	 described	 in	 Section	 2.1.4.	 All	 denuded	 cumulus	 cells	 from	
each	 COC	 were	 placed	 in	 a	 96-well	 plate	 and	 kept	 at	 -20°	 C	 for	 later	 DNA	
quantification	analysis.	Spent	media	samples	were	frozen	at	-80°	C	and	analyses	of	
thawed	samples	carried	out	as	described	in	Section	2.2	
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Figure	4.1:	Schematic	diagram	of	experimental	design	for	Experiment	4.1.	
	
Experiment	4.2	
In	vitro	maturation	was	carried	out	directly	in	a	Seahorse	plate	(180	μl	medium	per	
well)	 in	 groups	of	 3	Cp	COCs	 (see	 Section	2.4.3	 for	 full	 description)	 in	 one	of	 the	
following	three	conditions;	1)	Control	Maturation	Medium	(M199	with	Earle’s	salts,	
10%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml	FSH	and	maturation	at	5%	CO2	in	air	
(21%	O2).	As	for	Experiment	4.1,	Control	Maturation	Medium	[Group	21C-	0mM];	2)	
Control	Maturation	Medium	as	above	with	the	addition	of	0.15	mM	pyruvate	and	
incubation	at	5%	CO2	in	air	[0.15mM];	and	3)	Control	Maturation	Medium	as	above	
with	the	addition	of	0.5	mM	pyruvate	and	incubation	at	5%	CO2	in	air	[0.5mM].	The	
Seahorse	plate	was	removed	from	the	incubator	after	28	hours	of	IVM	and	placed	in	
the	Seahorse	XFp	analyser.	After	calibration,	three	basal	oxygen	consumption	rate	
readings	(pmolO2/well/min),	were	recorded	before	a	series	of	respiratory	inhibitors	
were	 added	 sequentially	 to	 each	 well	 to	 reach	 the	 following	 working	
concentrations;	1)	Oligomycin	[1	μM]	2)	FCCP	[5	μM]	3)	Antimycin/Rotenone	[2.5	μM]	
(See	Section	2.4.3	for	full	description	of	method.)	After	the	readings	were	obtained,	
COCs	were	placed	into	a	plate	and	frozen	for	DNA	quantification.		
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Experiment	4.3	
Only	 Cp	 COCs	 were	 used	 and	 all	 were	 individually	 cultured.	 A	 10-μl	 droplet	 was	
prepared	 for	each	 individual	COC	 in	each	of	 three	 separate	dishes,	 and	each	COC	
was	moved	 every	 ten	 hours	 from	 one	 dish	 to	 another	 (See	 Section	 2.2.4	 for	 full	
description).	IVM	was	carried	out	at	5%	CO2	in	air,	with	other	conditions	differing	as	
follows;	 In	Study	1,	maturation	was	carried	out	 in	pyruvate-containing	maturation	
medium	as	per	Group	21P	 in	 Experiment	1.	 	 In	Study	 2,	maturation	medium	and	
conditions	were	performed,	as	for	Study	1,	but	in	each	replicate,	half	of	the	droplets	
contained	granulosa	cells	only	that	were	visually	estimated	to	be	the	same	size	as	
the	 COC.	Mural	 granulosa	 cell	 samples	were	 obtained	 from	 dishes	 in	which	 a	 Cp	
COC	was	located	(i.e.	the	same	follicle).	In	Study	3,	COCs	were	divided	between	two	
treatments:		Maturation	medium	with	pyruvate,	incubated	in	5%	CO2	in	air,	as	per	
Group	 21P	 (+	 FSH)	 and	 identical	maturation	medium	 and	 conditions	 but	without	
FSH	(-	FSH).	The	oocytes	were	denuded	and	classified,	and	cumulus	cells	from	each	
COC	and	the	granulosa	cells	cultured	separately	and	spent	media	were	analysed,	as	
described	for	Experiment	4.1.			
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Statistical	analysis	
In	Experiments	4.1	and	4.3,	the	primary	outcome	variables	were	glucose	depletion,	
lactate	 and	 pyruvate	 accumulation	 rates	 (expressed	 as	 pmol/ngDNA/hour).	
Univariate	 analyses	 using	 the	 Chi-squared	 test	 and	 student’s	 t-test	 were	 initially	
performed	to	explore	possible	associations	between	measured	variables.	Following	
univariate	 analyses,	 multivariable	 linear	 regression	 models	 (Experiment	 4.1)	 and	
mixed	 multivariate	 linear	 regression	 models,	 with	 COC	 ID	 included	 as	 a	 random	
effect	to	account	for	repeated	measures	over	time	(Experiment	4.3)	were	fitted	to	
verify	 associations	 while	 accounting	 for	 potentially	 confounding	 variables.	 All	
potential	explanatory	variables	were	offered	to	the	 initial	model	(medium,	oxygen	
concentration,	date	of	 replicate	 (batch),	 trimming,	maturation	status	and	cumulus	
classification).	Interaction	terms	were	included	if	biologically	plausible	and	retained	
if	 they	 improved	 model	 fit.	 Final	 variable	 selection	 was	 by	 a	 backward-stepwise	
method	taking	p	<	0.25	as	the	criterion	for	retaining	the	variable	in	the	final	model.	
The	likelihood	ratio	test	was	used	for	comparison	of	competing	models.		
	
In	Experiment	4.2,	the	third	OCR	measurement	was	used	to	represent	the	basal	OCR	
and	 the	 measurement	 representing	 maximal	 response	 was	 used	 for	 all	 inhibitor	
OCR	data.	Data	were	evaluated	as	pmol	O2/	COC/	hour	and	pmol	O2/ngDNA/hour.	
One-way	ANOVA	was	used	to	explore	associations	between	groups.	
	
For	 full	 details	 on	 statistical	 analyses	 including	 criteria	 for	 data	 cleaning	 and	
replicates	see	Section	2.5.	
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4.4	Results	
	
4.4.1	Experiment	4.1-	Effect	of	pyruvate	addition	and	oxygen	concentration	during	
IVM	on	GPL	metabolism	
	
One	hundred	and	thirty	two	COCs	were	evaluated	over	four	replicates	(Table	4.1).	
Three	were	 lost	due	 to	 technical	 errors	and	a	 further	 seven	during	data	 cleaning.	
Data	for	a	total	of	122	COCs	were	available	for	statistical	analysis.		
	
	 21%	OXYGEN	 5%	OXYGEN	 	 	
REPLICATE	 +P	
Group	21P	
-P	
Group	21C	
+P	
Group	5P	
-P	
Group	5C	
TRIM	 DNA		
(mean;	ng)	
1	 10(9)	 10(9)	 10	(9)	 10	(6)	 VT	 139	a	
2	 8	(8)	 8	(8)	 8	(8)	 8	(8)	 VT	 136	a	
3	 10	(10)	 10(9)	 	 	 PT	 43	b	
4	 10	(10)	 10(9)	 10	(10)	 10(9)	 PT	 64	b	
	
Table	 4.1:	 Allocation	 of	 COCs	 to	 maturation	 conditions	 for	 Experiment	 4.1.	
Abbreviation	+P	denotes	addition	of	0.15	mM	Pyruvate,	 -P	denotes	control	media.	
TRIM	indicates	method	used	for	granulosa	trimming;	VT	=	visual	trimming	with	21-G	
needle	 and	 PT	 indicates	 pipette	 trimming	 (290-μm).	 Numbers	 in	 parenthesis	
represent	final	number	of	COCs	analysed.	Different	superscripts	 indicate	significant	
differences	within	columns	(p	<	0.05).		
	
Cumulus	 oocyte	 complexes	 with	 compact	 cumulus	 (Cp)	 accounted	 for	 54.9%	 of	
COCs	analysed	and	expanded	COCs	(Ex),	45.1	%.	Metaphase	II	rate	was	higher	in	Ex	
(60%)	 than	 Cp	 (22.4%;	 p	 =	 0.01).	 Maturation	 rate	 did	 not	 vary	 over	 the	 four	
conditions	(35-43.5%;	p	>	0.05).		
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Glucose	 consumption	 and	 lactate	 production	 were	 positively	 correlated	 to	 DNA	
content	of	the	COC	in	all	 four	IVM	conditions	(r2	=	0.3;	p	<	0.001).	However,	there	
was	 no	 association	 between	 pyruvate	 production	 and	 COC	 DNA	 content	 (Figure	
4.2).	In	the	control	standard	conditions	(Group	21C),	2.9%	(1/35)	of	COCs	depleted	
all	 available	 glucose	 from	 the	 15-μl	 drop	 compared	 to	 16.2%-26.1%	 in	 the	 other	
three	conditions.	
	
Figure	 4.2:	Glucose	 consumption	 (A)	 lactate	 (B)	and	pyruvate	production	 (C)	 rates	
regressed	on	COC	DNA	content	 for	 the	 four	 IVM	culture	conditions	as	 follows;	21C	
(blue)	=	Control	maturation	medium	and	maturation	at	5%	CO2	in	air	(21%	oxygen);	
21P	(red)	=	Pyruvate	containing	Maturation	Medium	(control	medium	as	above	with	
the	addition	of	0.15	mM	Pyruvate)	and	incubation	at	5%	CO2	in	air	(21%	oxygen);	5C	
(green)	=	Control	maturation	medium	and	maturation	at	5%	CO2,	5%	O2	and	90%	N2;	
5P	(purple)	=	Pyruvate	containing	maturation	medium	and	incubation	at	5%	CO2,	5%	
O2	and	90%	N2	.	Associations	between	glucose	consumption	rate	and	DNA	content,	
and	between	lactate	production	rate	and	DNA	content	were	statistically	significant	
(p	<	0.01).	Pyruvate	production	rates	were	independent	of	DNA	content.	
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In	COCs	for	which	glucose	was	not	limiting	(COCs	that	did	not	deplete	all	available	
glucose	during	 IVM;	n	 =	 103),	 the	 effect	 of	 oxygen	 concentration	 and	 addition	of	
pyruvate	 to	 the	media	 on	 glucose	 consumption,	 lactate	 production	 and	 pyruvate	
production	rates	could	be	evaluated.	The	addition	of	0.15	mM	pyruvate	 increased	
glucose	 consumption	at	both	5%	and	21%	oxygen	 (21P	and	5P)	but	 there	was	no	
corresponding	 increase	 in	 lactate	 production	 (Figure	 4.3).	 At	 5%	 oxygen,	 the	
addition	 of	 pyruvate	 (Group	 5P)	 decreased	 the	 lactate	 :	 glucose	 ratio	 and	 thus	
decreased	the	glycolytic	 index	 (70	vs.	100%;	p	=	0.001).	This	condition	 (Group	5P)	
also	 resulted	 in	 significantly	 decreased	 pyruvate	 production	 rates	 compared	with	
the	 other	 three	 conditions	 (0.6	 vs.	 1.6-2.1	 pmol/ng	 DNA/hour;	 p	 =	 0.02).	 These	
univariate	 findings	 were	 confirmed	 following	 multivariable	 linear	 regression	
modelling	 (See	 Table	 A3.1,	 Appendix	 3).	 Degree	 of	 trimming	was	 retained	 in	 the	
final	model.	
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Figure	4.3:	The	effect	of	0.15	mM	pyruvate	and	oxygen	concentration	(5%	vs.	21%)	
on	glucose	 consumption	 (A),	 lactate	production	 (B),	 lactate	 :	glucose	 ratio	 (C)	and	
pyruvate	 production	 (D)	 during	 IVM.	 Condition	 abbreviations	 on	 X	 axes	 are	 as	
follows;	21C	 (blue)	=	Control	maturation	medium	and	maturation	at	5%	CO2	 in	air	
(21%	oxygen);	21P	(red)	=	Pyruvate	containing	Maturation	Medium	(control	medium	
as	above	with	 the	addition	of	0.15	mM	Pyruvate)	and	 incubation	at	5%	Co2	 in	air	
(21%	oxygen);	5C	(green)	=	Control	maturation	medium	and	maturation	at	5%	CO2,	
5%	 O2	 and	 90%	 N2;	 5P	 (purple)	 =	 Pyruvate	 containing	 maturation	 medium	 and	
incubation	at	5%	CO2,	5%	O2	and	90%	N2.	Bars	represent	mean	±	SEM	and	different	
superscripts	denote	significance	differences	between	groups	(P	<	0.05).	
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4.4.2	Experiment	4.2:	 Effect	of	pyruvate	 concentration	on	OCR	and	mitochondrial	
function	
	
Forty-five	compact	COCs	(15	in	each	condition)	were	used	for	this	experiment	over	
three	replicates.	Data	from	six	COCs	in	the	0.15	mM	Pyruvate	group	were	excluded	
from	subsequent	analysis	due	to	biologically	implausible	OCR	readings.	
	
There	was	a	tendency	for	the	COCs	in	the	0.5	mM	Pyruvate	group	to	have	a	higher	
basal	 OCR	 however	 this	 was	 not	 significant	 (p	 =	 0.2;	 Figure	 4.4).	 Pyruvate	
concentration	 (0	 -	 0.5	 mM)	 had	 no	 significant	 effect	 on	 any	 measure	 of	
mitochondrial	function	(Figure	4.5).		
	
	
Figure	4.4:	Effect	of	pyruvate	concentration	during	IVM	on	oxygen	consumption	rate	
(OCR)	using	respiratory	inhibitors	to	evaluate	mitochondrial	function	(n	=	39).	Each	
bar	 represents	 the	 mean	 OCR	 after	 addition	 of	 the	 inhibitor	 stated	 (±	 SEM).	
Abbreviations	as	follows:	OLIGO:	Oligomycin;	AR:	Antimycin/rotenone.	
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Figure	 4.5:	 Effect	of	pyruvate	concentration	during	 IVM	on	mitochondrial	 function	
as	 determined	 following	 the	 sequential	 addition	 of	 respiratory	 inhibitors.	 Oxygen	
consumption	 rate	 (OCR)	 coupled	 to	 ATP	 production	 (BLUE),	 OCR	 associated	 with	
proton	 leak	 (RED),	non-mitochondrial	OCR	 (GREEN)	and	 spare	 respiratory	 capacity	
(PURPLE)	are	expressed	as	%	basal	OCR.	Mean	±	SEM	 is	presented	 in	Panel	A	and	
mean	presented	in	Panel	B.	
	 	
A	
B	
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4.4.3	Experiment	4.3-	Temporal	changes	in	GPL	metabolism	
	
One	 hundred	 and	 twenty-four	 COCs	were	 evaluated	 over	 six	 replicates.	One	 COC	
was	lost	due	to	technical	issues	and	15	were	excluded	from	further	analysis	during	
data	cleaning.	A	total	of	108	COCs	remained	for	statistical	analyses.		
	
REPLICATE	 COC+FSH	 COC		
NO	FSH	
GRAN	ONLY	
(+FSH)	
TRIM	 DNA	
(mean;	
ng)	
1	 10	(5)	 	 	 COR	 67	a	
2	 18	(15)	 10	(9)	 10	(7)	 NONE/COR	 107	b	
3	 10	(10)	 10	(8)	 	 VT	 120	b	
4	 10	(10)	 	 	 PT	 74	a	
5	 10	(9)	 10	(10)	 10	(10)	 PT	 83	a	
6	 8	(8)	 	 8	(7)	 PT	 90	a	
	
Table	 4.2:	 Cumulus	 oocyte	 complex	 allocation	 for	 Experiment	 4.3	 (Studies	 1-3).	
Abbreviations	 as	 follows;	 COC	 +	 FSH	 =	 cumulus	 oocyte	 complex	 in	 control	
Maturation	Media	containing	FSH	(5mU/ml).	GRAN	=	Granulosa	cells	only.	TRIM	=	
method	used	for	granulosa	cell	 trimming;	COR=	corona	only,	no	trimming	(NONE),	
VT	=	visual	trimming	using	21G	needle;	PT	=	pipette	trimming	(290	μm).	Numbers	in	
parenthesis	represent	final	number	of	COCs	analysed.	Different	superscripts	indicate	
significant	differences	within	columns	(p	<	0.05).	
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Study	 1:	 Temporal	 changes	 in	 GPL	 metabolism	 over	 the	 course	 of	 IVM	 in	 the	
presence	of	pyruvate.	
	
Data	for	57	COCs	over	six	replicates	were	analysed	for	this	study	(COC	+	FSH;	Table	
4.2).	 Glucose	 consumption	 increased	 during	 10-20	 hours	 of	 culture,	 with	 a	
subsequent	 decrease	 during	 20-30	 hours	 (Figure	 4.6).	 There	 was	 a	 simultaneous	
decrease	 in	 lactate	 production	 during	 20-30	 hours	 (Figure	 4.6)	 resulting	 in	 the	
lactate	:	glucose	ratio	being	unaffected	by	maturation	period.	Pyruvate	production	
remained	similar	during	0-10	and	10-20	hours	but	significantly	increased	during	the	
final	period	of	IVM	(20-30	hours;	Figure	4.6).	These	findings	remained	significant	in	
the	 mixed	 multivariate	 linear	 regression	 model	 when	 all	 potential	 confounding	
variables	were	taken	into	account	(batch	number	remained	in	the	final	model,	see	
Table	A3.2,	Appendix	3).	
	
Figure	 4.6:	 Effect	 of	 IVM	 period	 (0-10,	 10-20,	 20-30	 hours)	 on	 glucose	 (blue)	
consumption,	lactate	(red)	and	pyruvate	(green;	right	axis)	production	rates.	Mean	±	
SEM	are	depicted;	blue	asterisks	denote	significant	differences	between	time	periods	
in	 glucose	 consumption	 rate	 (10-20	 and	 20-30hours);	 red	 asterisks	 denote	 a	
significant	 decrease	 in	 lactate	 production	 rate	 (20-30hours)	 and	 green	 asterisks	 a	
significant	increase	in	pyruvate	production	rate	(20-30hours).		(All	p	<	0.05)	
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Study	 2:	 The	 impact	 of	 oocyte	 presence	 on	 GPL	 metabolism	 (intact	 COC	 vs.	
granulosa	only).		
	
Data	from	56	COCs/granulosa	samples	over	three	replicates	were	analysed	for	this	
study	 (COC	 +	 FSH	 and	 GRAN	 only;	 Table	 4.2).	 	 Glucose,	 lactate	 and	 pyruvate	
metabolism	 of	 COCs	 was	 significantly	 different	 to	 that	 of	 granulosa	 cells	 alone	
during	at	 least	one	time	period	over	the	30	hours	of	 IVM	(Figure	4.7;	yellow	line).		
As	 shown	 in	 Study	 1,	 GPL	 metabolism	 varied	 over	 time	 for	 COCs,	 however	 in	
contrast,	 when	 granulosa	 cells	 were	 cultured	 separately	 in	 maturation	 media	
without	 an	 oocyte,	 glucose	 and	 lactate	metabolism	 remained	 constant	 over	 time	
(Figure	 4.7A	 and	 4.7B).	 In	 addition,	 granulosa	 cells	 cultured	 alone	 had	 decreased	
pyruvate	production	during	20-30	hours,	which	was	the	opposite	temporal	pattern	
to	 that	 of	 intact	 COCs	 (significant	 increase	 at	 20-30	 hours;	 Figure	 4.7D).	 These	
findings	were	 confirmed	 in	 the	mixed	multivariate	 linear	 regression	model	 (Table	
A3.3;	Appendix	3).	No	other	variables	were	found	to	affect	any	of	the	parameters	
significantly	and	were	therefore	not	retained	in	the	final	model.	
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Figure	4.7:		Effect	of	oocyte	presence	(COC;	yellow)	vs.	granulosa	cells	only	(blue)	on	
glucose	consumption	(Panel	A),	lactate	production	(Panel	B),	lactate	:	glucose	ratio	
(Panel	C)	and	pyruvate	production	 (Panel	D)	over	 the	 time	course	of	 IVM.	Mean	±	
SEM	are	depicted	and	asterisks	represent	significant	difference	between	conditions	
at	that	time	point	(p	<	0.05).	
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Study	3:	Impact	of	the	presence/absence	of	FSH	on	GPL	metabolism.	
	
Data	 from	61	COCs	over	 three	replicates	were	analysed	 for	 this	 study	 (COC	+	FSH	
and	 COC	 NO	 FSH;	 Table	 4.2).	 The	 presence	 of	 FSH	 did	 not	 affect	 the	 temporal	
pattern	of	glucose	consumption	or	lactate	and	pyruvate	production,	however	there	
were	significantly	 increased	lactate	and	pyruvate	production	rates	during	both	10-
20	and	20-30	hours	of	IVM	in	the	presence	of	FSH	(Figure	4.8).	These	findings	were	
confirmed	in	the	mixed	multivariate	linear	regression	model	(Table	A3.4;	Appendix	
3).	No	other	variables	were	found	to	affect	any	of	the	parameters	significantly	and	
were	therefore	not	retained	in	the	final	model.	
	
Figure	 4.8:	 Effect	 of	 FSH	 (5mU/ml	 purple	 and	 0mU/ml	 FSH	 teal)	 on	 glucose	
consumption	(Panel	A),	lactate	production	(Panel	B),	lactate	:	glucose	ratio	(Panel	C)	
and	pyruvate	production	(Panel	D)	over	the	time	course	of	IVM.	Data	are	presented	
as	mean	±	SEM,	asterisks	represent	significant	difference	between	conditions	at	that	
time	point	(p	<	0.05).	
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4.5	Summary	findings	
	
• Provision	of	0.15	mM	pyruvate	 increased	glucose	consumption	at	both	5%	
and	21%	oxygen.	
• At	 5%	 oxygen,	 the	 addition	 of	 pyruvate	 decreased	 the	 glycolytic	 index	
compared	 to	 21%	 oxygen.	 This	 condition	 (Group	 5P)	 also	 resulted	 in	
significantly	decreased	pyruvate	production	rates	compared	with	the	other	
three	conditions.	
• Pyruvate	production	was	not	correlated	to	COC	DNA	content.	
• The	proportion	of	COCs	depleting	all	available	glucose	decreased	to	2.9%	in	
Group	21C	as	a	result	of	technical	interventions	(trimming	excess	granulosa	
and	increasing	droplet	size	to	15	μl).	
• Pyruvate	 concentration	 had	 no	 significant	 effect	 on	 basal	 OCR	 or	 on	 any	
measure	of	mitochondrial	function.	
• GPL	metabolism	 varied	 over	 time	 for	 COCs,	 however,	 glucose	 and	 lactate	
metabolism	 remained	 constant	 over	 time	 in	 granulosa	 cells	 that	 were	
cultured	separately	in	maturation	media	without	an	oocyte.	
• The	 presence	 of	 FSH	 did	 not	 affect	 the	 temporal	 pattern	 of	 glucose	
consumption	 or	 lactate	 and	 pyruvate	 production,	 however	 there	 were	
significantly	increased	lactate	and	pyruvate	production	rates	during	both	10-
20	and	20-30	hours	of	IVM	in	the	presence	of	FSH.	
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4.6	Discussion	
	
In	 this	 study	 it	 was	 shown	 that	 provision	 of	 pyruvate	 and	 lowering	 the	 oxygen	
concentration	 during	 IVM	 resulted	 in	 measurable	 changes	 in	 the	 metabolism	 of	
equine	 COCs.	 Glucose	 consumption	 was	 increased	 in	 media	 containing	 0.15	 mM	
pyruvate,	 independent	 of	 oxygen	 concentration.	 At	 5%	 oxygen	 (Group	 5P),	 there	
was	a	reduction	in	pyruvate	production.	Multivariable	analysis	confirmed	pyruvate	
concentration	 to	 be	 a	 significant	 explanatory	 variable.	 Given	 the	 known	 role	 of	
pyruvate	 production	 in	 antioxidant	 defence,	 it	 is	 interesting	 that	 there	 was	 a	
reduction	in	pyruvate	production	at	5%	oxygen	but	only	in	media	already	containing	
pyruvate	 (Group	 5P).	 Assuming	 that	 pyruvate	 secretion	 reflects	 the	 oocyte’s	
response	 to	 oxidative	 stress,	 these	data	 support	 the	notion	 that	 these	 conditions	
result	in	the	least	oxidative	stress	for	the	COC	and	hence	production	is	lowered	and	
glucose	 is	 spared	 for	 other	 pathways.	 In	 further	 support	 of	 this	 proposition,	 only	
70%	 of	 glucose	 consumed	was	 converted	 to	 lactate	 in	 Group	 5P	 vs.	 100%	 in	 the	
other	conditions.	While	an	increase	in	oxidative	stress	at	20%	oxygen	compared	to	
5%	 is	 widely	 accepted	 to	 occur	 in	 the	 early	 embryo,	 there	 is	 still	 debate	 as	 to	
whether	the	same	is	true	for	the	COC	during	IVM,	and	species-specific	differences	
might	exist.	Bermejo-Álvarez	et	 al.,	 (2010)	 reported	an	 increase	 in	developmental	
competence	in	bovine	oocytes	after	IVM	at	5%	oxygen	compared	to	20%,	however	
when	 expression	 of	 genes	 related	 to	 oxidative	 response	 (GPX1	 and	MNSOD)	was	
evaluated,	no	differences	were	found.	The	authors	did	note	however	that	this	does	
not	rule	out	a	role	of	oxidative	stress	at	atmospheric	oxygen	concentration,	as	the	
response	 could	be	post-transcriptional.	Moreover,	 gene	expression	 results	 do	not	
necessarily	indicate	changes	in	protein	content	or	enzyme	activity.	
	
A	higher	number	of	COCs	depleted	all	available	glucose	at	5%	oxygen	compared	to	
the	 same	 pyruvate	 concentration	 at	 21%	 (26%	 depleted	 in	 Group	 5C	 vs.	 2.9%	 in	
Group	 21C).	 While	 there	 are	 no	 similar	 studies	 evaluating	 glucose	 consumption	
directly,	 several	 studies	 in	 the	 cow,	 mouse,	 human	 and	 buffalo	 have	 reported	
increased	 expression	 of	 glycolytic	 pathway	 genes	 in	 COCs	matured	 at	 5%	 oxygen	
(Bermejo-Álvarez	et	al.,	2010;	Hashimoto	et	al.,	2000;	Kang	et	al.,	2011;	Kumar	et	
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al.,	2015).	It	has	been	shown	that	such	changes	in	gene	expression	are	regulated	by	
the	oxygen	sensitive	hypoxia-inducing	factors	(HIFs;	Kind	et	al.,	2015;	Thompson	et	
al.,	 2015),	 a	 pathway	 also	 utilised	 by	 cancer	 cells	 as	 a	 means	 of	 switching	 from	
oxidative	 to	 glycolytic	metabolism	 (Semenza,	 2010).	 This	 adaptation	 is	 thought	 to	
limit	 oxidative	 stress	 and	 enhance	 survival	 in	 hypoxic	 conditions.	 Interestingly,	 in	
vivo	 this	 is	 proposed	 to	 be	 further	mediated	 by	 the	 presence	 of	 haemoglobin	 in	
cumulus	 cells	 which	 acts	 to	 bind	 and	 lower	 the	 oxygen	 concentration	 thereby	
promoting	 HIF	 activation	 (Brown	 et	 al.,	 2015).	When	 the	 glucose-depleting	 COCs	
were	 removed	 from	 analysis,	 there	 was	 no	 relationship	 between	 oxygen	
consumption	and	glucose	consumption,	moreover	there	was	no	change	in	glycolytic	
index.	 A	 more	 definitive	 measure	 would	 be	 to	 record	 oxygen	 consumption	 and	
mitochondrial	function	directly	at	both	oxygen	concentrations	in	order	to	conclude	
if	 there	 was	 a	 shift	 between	 glycolysis	 and	 oxidative	 phosphorylation.	
Unfortunately,	 the	 present	method	 involving	 the	 Seahorse	 XFp	 analyser	 does	 not	
allow	measurements	at	 low	oxygen	concentrations.	There	are	no	other	 reports	of	
equine	 IVM	 at	 low	 oxygen	 concentration	 and	 as	 developmental	 competence	was	
not	 evaluated	 in	 the	 present	 study,	 this	 remains	 an	 interesting	 area	 for	 further	
research.		
	
In	this	study,	the	aim	was	to	adjust	experimental	conditions	in	light	of	the	high	rate	
of	 glucose	 depletion	 (in	 18-24%	 of	 COCs)	 reported	 in	 the	 pilot	 study;	 Chapter	 3.	
Increasing	 the	 drop	 size	 to	 15	 μl	 (from	 10	 μl	 previously)	 and	 trimming	 excess	
granulosa	cells	successfully	reduced	the	proportion	of	COCs	depleting	glucose	in	the	
standard	 conditions	 (Group	 21C)	 to	 2.9%	 (1/35).	 This	 has	 both	 clinical	 and	
experimental	 implications.	 Clinically,	 these	 modifications	 ensure	 that	 glucose	
availability	 is	 not	 an	 impediment	 to	 full	 developmental	 potential,	 and	
experimentally,	 the	analysis	of	 substrate	 flux	may	be	determined	more	accurately	
under	conditions	when	glucose	availability	is	not	a	limiting	factor.			
	
As	shown	in	Chapter	3,	glucose	consumption	and	lactate	production	were	positively	
correlated	 to	 DNA	 content	 of	 the	 COC	 (a	 proxy	 measurement	 of	 cumulus	 cell	
numbers).	 In	contrast,	pyruvate	production	was	 independent	of	DNA	content,	and	
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the	 final	 concentration	 of	 pyruvate	 in	 the	medium	was	 0.2-0.3	mM	 after	 the	 30	
hour	IVM	for	all	COCs.	This	is	interesting	as	O’Fallon	and	Wright,	(1974)	reported	an	
absolute	medium	concentration	of	0.3	mM	to	be	protective	against	ROS	in	the	early	
murine	embryo.	Leese	and	Lenton,	(1990)	proposed	an	elegant	model	of	pyruvate	
homeostasis	within	 the	human	 follicle	 in	which	 the	pyruvate	 concentration	was	a	
reflection	of	 the	 lactate	dehydrogenase	 reaction	equilibrium	between	 lactate	 and	
pyruvate	to	regulate	the	pH.	However,	as	the	culture	medium	was	already	buffered,	
the	definitive	reason	for	this	observation	remains	unclear.	
	
Addition	of	pyruvate	(0.15	mM)	increased	glucose	consumption	rather	than	acting	
to	 spare	 it.	 This	 was	 unexpected	 given	 that	 the	 COCs	 seemed	 to	 prioritise	 the	
production	of	pyruvate,	which	presumably	was	derived	directly	from	glycolysis	or	by	
conversion	from	lactate,	the	source	of	which	could	also	have	been	glucose	as	there	
was	minimal	lactate	in	the	starting	medium	(<	1mM	from	FBS).	Also	interesting	was	
that	 addition	 of	 pyruvate	 (up	 to	 0.5	 mM)	 did	 not	 alter	 oxygen	 consumption	 or	
mitochondrial	 function	 of	 COCs.	 Taken	 together,	 these	 findings	 suggest	 that	 the	
presence	 of	 pyruvate	 resulted	 in	 a	 higher	 rate	 of	 glycolysis,	 but	 at	 the	 same	
proportion	 in	 relation	 to	 other	 pathways,	 as	 lactate	 :	 glucose	 ratio	 remained	
constant,	and	these	treatments	had	a	similar	rate	of	oxidative	phosphorylation.	This	
lack	of	increase	in	OXPHOS	is	not	surprising	as	even	in	standard	conditions	(Group	
21C)	mitochondria	were	working	at	close	to	maximal	rate	as	per	the	very	low	spare	
capacity	at	the	end	of	IVM	(<	10%).		
	
As	found	in	the	pilot	study	in	Chapter	3,	temporal	differences	were	observed	over	
the	 course	 of	 IVM	 and	 with	 increased	 numbers	 and	 replicates	 these	 differences	
became	significant.	In	agreement	with	the	findings	of	Alm	and	Hinrichs	(1996)	that	
GVBD	 and	 progression	 to	 MII	 occurred	 between	 12-16	 hours,	 we	 observed	 a	
significant	 increase	 in	 glucose	 consumption	 between	 10-20	 hours	 coinciding	with	
the	 increased	 metabolic	 demands	 at	 this	 time.	 To	 confirm	 that	 the	 metabolism	
measured	 was	 a	 function	 of	 events	 related	 to	 the	 COC	 itself	 and	 driven	 by	 the	
oocyte,	 granulosa	 cells	were	 cultured	 alone	 and	 compared	 to	 intact	 COCs.	 It	was	
reassuring	 to	 find	 that	 there	was	 no	 variation	 in	 glucose	 and	 lactate	metabolism	
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over	time	in	granulosa	cells	cultured	alone,	verifying	that	the	oocyte	was	influencing	
energy	 requirements	 in	 the	 COCs.	 It	 is	 also	 possible	 that	 the	 more	 highly	
differentiated	 corona	 radiata	or	 cumulus	 cells	 (not	 included	 in	 the	granulosa	only	
samples	 in	 the	 current	 study)	 also	 influence	 temporal	 changes	 in	 glucose	
metabolism	as	when	bovine	oocyte-ectomised	COCs	were	compared	to	intact	COCs,	
no	 differences	 in	 glucose	 metabolism	 were	 observed	 (Sutton	 et	 al.,	 2003).	
Interestingly,	 the	 decreased	 pyruvate	 production	 pattern	 at	 the	 end	 of	 the	
maturation	period	when	granulosa	cells	were	cultured	alone	was	opposite	to	that	of	
COCs,	which	demonstrated	 increased	pyruvate	production	during	 this	 time	period	
of	20-30	hours.		
	
Oocytes	undergoing	meiosis	have	an	increased	requirement	for	pyruvate	(Downs	et	
al.,	 2002)	 which	 may	 explain	 the	 decreased	 production	 of	 pyruvate	 during	 0-20	
hours	and	its	subsequent	increase	in	production	when	it	was	no	longer	required	at	
the	 end	 of	 maturation,	 when	 the	 oocyte	 had	 reached	 metaphase	 II.	 Another	
possible	 explanation	 for	 increased	 pyruvate	 production	 at	 the	 end	 of	 IVM,	 could	
relate	to	its	antioxidant	capacity	given	the	decreased	mitochondrial	spare	capacity	
at	 the	 end	 of	 IVM	 reported	 in	 Chapter	 3.	 The	 oocyte	 is	 known	 to	 have	 several	
hundred	 thousand	mitochondria	 compared	 to	 only	 a	 few	 hundred	 in	 a	 granulosa	
cell	 (Collado-Fernandez	 et	 al.,	 2012).	 It	 has	 been	 hypothesized	 that	 this	 low	
individual	 activity	 minimises	 oxidative	 stress	 (Dumollard	 et	 al.,	 2007),	 but	 if	
metabolic	activity	 is	high	as	 in	 these	COCs	near	maximal	 respiration,	 it	may	mean	
that	more	ROS	 are	produced	placing	 the	COC	 in	 an	oxidative	 state	 and	 therefore	
requiring	more	pyruvate	to	limit	oxidative	damage.	
	
Gonadotropin	 addition	 to	 IVM	medium	 has	multiple	 actions,	 including	mediating	
cumulus	 expansion	 and	 driving	 meiotic	 resumption	 (reviewed	 by	 Rodriguez	 and	
Farin,	2004).	The	proposed	mechanism	is	an	increase	in	intracellular	communication	
brought	about	by	elevated	connexin	43	levels	through	activation	of	protein	kinase	A	
(PKA)	 (Sommersberg	 et	 al.,	 2000),	 events	 shown	 to	 cause	 an	 increase	 in	 glucose	
uptake	and	lactate	production	by	the	cumulus	cells	(2.7	fold	 increase	in	glycolysis;	
Downs	 and	 Utecht,	 1999).	 In	 the	 mouse	 and	 the	 cow,	 addition	 of	 FSH	 also	
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upregulated	expression	of	glucose	transport	proteins	such	as	GLUT	4	and	glycolytic	
enzymes	 in	 cumulus	 cells,	 (Roberts	 et	 al.,	 2004;	 Sutton-McDowall	 et	 al.,	 2004).		
Increased	 glucose	 consumption	 in	 response	 to	 FSH	 can	 further	 be	 attributed	 to	
increased	 HBP	 flux	 in	 order	 to	 synthesize	 hyaluronic	 acid	 essential	 for	 cumulus	
expansion	(Sutton-McDowall	et	al.,	2010).	In	the	present	study,	while	the	presence	
of	FSH	resulted	in	an	increase	in	glucose	consumption	and	lactate	production,	only	
the	increase	in	lactate	production	at	10-30	hours	was	significant	(p	<	0.05).	As	such,	
there	was	no	fall	in	glycolytic	index	attributable	to	FSH	to	account	for	the	presumed	
increase	in	HBP	activity	in	the	presence	of	FSH.	Unexpectedly,	the	presence	of	FSH	
also	 increased	 pyruvate	 production	 at	 10-30	 hours.	 This	 could	 potentially	 be	 a	
regulatory	 response	 to	 stabilise	 the	 lactate	 :	 pyruvate	 ratio	 and	 hence	 the	 pH	
however	it	is	not	easily	explained	at	this	time.	
	
Conclusions		
The	main	 findings	 that	emerged	 from	 the	experiments	 carried	out	 in	 this	 chapter	
are	as	follows	(i)	a	strategy	(reduction	of	cumulus	mass	and	increase	in	droplet	size)	
was	confirmed	to	reduce	the	proportion	of	COCs	depleting	available	glucose	during	
IVM	 in	 clinical	 conditions	 (ii)	 measures	 of	 equine	 COC	 metabolism,	 i.e.	 glucose	
consumption	 and	 lactate/	 pyruvate	 production	 are	 driven	 by	 the	 oocyte,	 as	 they	
differed	between	COC	and	 isolated	granulosa	 cells	 (iii)	 FSH	 stimulates	 lactate	and	
pyruvate	production	in	the	COC	(iv)	low	oxygen	and	presence	of	0.15	mM	pyruvate	
during	 IVM	 results	 in	 a	 decreased	 glycolytic	 index	 and	 decreased	 pyruvate	
production	 suggestive	 of	 a	 decreased	 oxidative	 state	 of	 the	 COC,	 (v)	 addition	 of	
pyruvate	 did	 not	 spare	 glucose	 consumption	 or	 ameliorate	 the	 issue	 of	 low	
mitochondrial	spare	capacity	at	the	end	of	IVM.				 	
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Chapter	 5:	 The	 effect	 of	 increased	 glucose	 concentration	 during	 IVM	on	 equine	
oocyte	developmental	markers,	glucose	metabolism	and	mitochondrial	function.			
	
5.1	Introduction	
	
The	 potential	 influence	 of	 the	 periconceptual	 environment	 on	 oocyte	 quality,	
oocyte	 developmental	 competence	 and	 future	 health	 of	 the	 offspring	 is	 well	
established	 (Fleming	 et	 al.,	 2018).	 Assisted	 conception	 technologies	 aim	 to	mimic	
the	periconceptual	environment,	so	it	is	important	to	make	sure	they	are	optimised	
to	the	best	of	our	knowledge.	In	the	horse,	there	is	a	paucity	of	species-specific	IVM	
optimisation	and	many	differences	exist	 in	protocols	between	laboratories.	 It	 is	as	
yet	 unknown	 what	 effect	 many	 of	 these	 procedural	 differences	 have	 on	 oocyte	
developmental	potential.	The	two	most	commonly	used	media	for	equine	IVM	are	
TCM-199,	 originally	 designed	 for	 chick	 embryo	 fibroblasts	 (i.e.	 somatic	 cells)	 and	
first	reported	in	the	horse	by	Zhang	et	al.,	(1989)	and	DMEM/F12,	also	a	complete	
tissue	culture	medium,	first	described	for	use	in	equine	IVM	by	Galli	et	al.,	(2007).		
M199	supplies	glucose	at	5.6	mM,	i.e.	near	the	range	found	in	equine	follicular	fluid	
and	serum	while	DMEM/F12	contains	a	supraphysiological	concentration	of	glucose	
at	 17	 mM.	 However,	 both	 systems	 have	 produced	 viable	 embryos	 and	 healthy	
offspring	after	ICSI	and	embryo	culture	(Galli	et	al.,	2007;	Hinrichs	et	al.,	2014,	2007;	
Smits	et	al.,	2010).		
	
In	the	horse,	serum	glucose	levels	are	controlled	between	4.9-6.2	mM.	Unlike	other	
species,	 insulin	 resistance	associated	with	diseases	 such	as	obesity	 and	metabolic	
syndrome	 is	 characterised	 by	 secondary	 hyperinsulinaemia	 and	 as	 such,	
hyperglycaemia	does	not	occur.	In	contrast,	pancreatic	exhaustion	occurs	in	human	
insulin	 resistance	 leading	 to	decreased	 insulin	 secretion	and	hyperglycaemia	as	 in	
Type-2	diabetes	(Morgan	et	al.,	2015).	In	fact,	clinical	hyperglycaemia	in	the	horse	is	
only	 found	 at	 the	 end	 stage	 of	 diseases	 such	 as	 sepsis	 when	 death	 is	 imminent	
(Hollis	 et	 al.,	 2007).	 Thus,	 the	 equine	 COC	 and	 embryo	 would	 never	 experience	
hyperglycaemia	 in	 vivo.	 Additionally,	 the	 follicular	 fluid	 glucose	 concentration	 is	
lower	 than	 that	 of	 serum	 and	 further	 decreases	 as	 ovulation	 approaches	 (4.72	 ±	
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0.29	mM	24	hours	after	dominant	follicle	selection	[largest	follicle	20-25	mm]	falling	
to	3.24	±	0.09	mM	33	hours	after	induction	of	ovulation;	(Collins	et	al.,	1997;	Gerard	
et	al.,	2000;	Gérard	et	al.,	2002).		
	
In	 humans,	 the	 detrimental	 effect	 of	 hyperglycaemia	 during	 pregnancy	 is	 well	
described	 and	 adverse	 clinical	 outcomes	 include	 increased	 risk	 of	 abortion,	 pre-
eclampsia,	pre-	 term	birth	and	neonatal/childhood	 illness	 (Frank	et	al.,	2014).	The	
risk	of	congenital	defects	is	also	up	to	20	times	higher	in	children	born	to	mothers	
experiencing	 hyperglycaemia	 during	 pregnancy	 than	 in	 those	 born	 to	 normo-
glycaemic	 mothers	 (Becerra	 et	 al.,	 1990;	 Bell	 et	 al.,	 2012;	 Casson	 et	 al.,	 1997;	
Eriksen	 et	 al.,	 2017).	 Notably,	 this	 risk	 is	 significantly	 lowered	 only	 if	 glycaemic	
control	 is	 instituted	before	contraception	is	discontinued,	pointing	to	the	follicular	
environment	and	 the	periconception	period	as	a	 critical	 time	window	 (Pearson	et	
al.,	2007).	 In	this	regard,	work	 in	mice	has	demonstrated	that	at	the	cellular	 level,	
hyperglycaemia	 during	 oocyte	 maturation	 results	 in	 delayed	 meiotic	 kinetics,	
increased	 apoptosis	 in	 granulosa	 cells,	 decreased	 oocyte	 ATP	 content,	 aberrant	
glucose	 metabolism,	 changes	 in	 mitochondrial	 distribution	 and	 morphology	 and	
decreased	 oocyte-cumulus	 cell	 communication	 (Chang	 et	 al.,	 2005;	 Colton	 et	 al.,	
2003;	Frank	et	al.,	2014;	Ratchford	et	al.,	2008;	Wang	et	al.,	2010)	
	
Given	 the	 range	of	 detrimental	 effects	 of	 increased	 glucose	 in	 other	 species,	 it	 is	
striking	that	good	blastocyst	rates	and	clinical	foal	production	have	been	reported	
by	 equine	 laboratories	 performing	 IVM	 in	 both	 M199	 and	 DMEM/F12	 based	
medium	(5.6	mM	and	17	mM	glucose	respectively;	Galli	et	al.,	2007;	Hinrichs	et	al.,	
2014,	2007;	Smits	et	al.,	2010).	In	the	single	study	in	which	these	media	have	been	
compared,	 it	 was	 reported	 that	 DMEM/F12	 was	 superior	 to	 M199-based	 IVM	
medium	when	considering	subsequent	blastocyst	development	(26.4%	[37/140]	for	
DMEM/F12	 vs.	 12%	 [23/191]	 for	 M199;	 Galli	 et	 al.,	 2007).	 However,	 in	 another	
laboratory,	M199-based	IVM	medium	has	produced	the	highest	reported	blastocyst	
rates	(up	to	46%)	in	numerous	reports	(Hinrichs	et	al.,	2005;	Jacobson	et	al.,	2010;	
Ribeiro	et	al.,	2008;	Salgado	et	al.,	2018).	 	Notably,	equine	 in	vitro	embryo	culture	
often	 also	 involves	 supraphysiological	 levels	 of	 glucose	 (17	 mM,	 DMEM/F12).	
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Research	to	date	suggests	that	not	only	does	this	concentration	of	glucose	not	lead	
to	embryo	developmental	arrest,	as	it	would	in	other	species	such	as	the	cow,	but	
the	 equine	 embryo	 seems	 to	 thrive,	 as	 demonstrated	 by	 46%	 blastocyst	
development	at	20	mM	glucose;	Choi	et	al.,	2015,	Choi	et	al.,	2004).		
	
The	 known	 mechanisms	 by	 which	 hyperglycaemia	 causes	 downstream	 effects	 in	
oocytes	 and	 embryos	 are	 largely	 related	 to	 carbohydrate	 metabolism	 and	 are	
similar	 to	 those	 reported	 in	 somatic	 cells.	 The	 hexosamine	 biosynthesis	 pathway	
(HBP)	 has	 received	 particular	 attention	 as	 a	 potential	 central	 mediator	 of	
glucotoxicity	 in	 COCs,	 embryos	 and	 somatic	 cells	 due	 to	 its	 end	 product	 UDP-N-
Acetylglucosamine	 resulting	 in	 excessive	 β-O	 linked	 glycosylation	 of	 proteins,	
(Figure	 5.13;	 Pantaleon	 et	 al.,	 2010;	 Sutton-McDowall	 et	 al.,	 2010;	 Wong	 et	 al.,	
2015)	 as	 has	 overproduction	 of	 reactive	 oxygen	 species	 (ROS)	 due	 to	 increased	
oxidative	 damage	 and	 aberrant	 glucose	 utilisation	 (Rolo	 and	 Palmeira,	 2006).	 To	
date,	the	consequences	of	supraphysiological	glucose	concentration	during	equine	
IVM	are	unknown.	The	establishment	of	methods,	as	reported	in	previous	chapters,	
for	investigation	of	parameters	such	as	glucose,	lactate	and	pyruvate	measurement	
in	 addition	 to	 oxygen	 consumption	 measurements	 and	 mitochondrial	 efficiency	
testing	 in	 equine	 COCs,	 allows	 the	 effect	 of	 glucose	 concentration	 on	 COC	
carbohydrate	metabolism	to	now	be	explored.	
	
A	 further	 tool	 to	 investigate	 the	 downstream	 effects	 of	 changes	 to	 the	 IVM	
environment	 is	 to	 evaluate	 developmental	 potential	 (blastocyst	 formation	 after	
ICSI)	 and	 gene	 expression	 in	 the	 resulting	 blastocysts.	 In	 other	 species,	 there	 are	
many	 studies	 demonstrating	 a	 clear	 negative	 effect	 on	 blastocyst	 development	
associated	 with	 increased	 glucose	 concentration	 during	 the	 period	 of	
preimplantation	embryo	development	(Frank	et	al.,	2014;	Fraser	et	al.,	2007;	Moley	
et	 al.,	 1998).	 However,	 fewer	 studies	 demonstrating	 a	 reduction	 in	 blastocyst	
development	 attributable	 specifically	 to	 supraphysiological	 glucose	 during	 the	
period	of	IVM	are	available;	these	have	been	carried	out	in	mice,	cattle	and	buffalo	
(Frank	 et	 al.,	 2013;	 Hashimoto	 et	 al.,	 2000;	 Kumar	 et	 al.,	 2012;	 Lea	 et	 al.,	 1996).	
When	considering	aberrations	in	blastocyst	gene	expression,	the	situation	is	similar.	
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Hyperglycaemia4	during	the	period	of	early	embryo	development	is	associated	with	
decreased	expression	of	insulin	and	IGF-1	receptors	in	rabbit	blastocysts	(Ramin	et	
al.,	 2010),	 decreased	 glucose	 transporter	 expression	 and	 increased	 expression	 of	
apoptosis	related	genes	in	mouse	embryos	(Moley	et	al.,	1998;	Moley	et	al.,	1998)	
and	 increase	 in	 expression	 of	 genes	 related	 to	 the	Warburg	 effect	 i.e.	 increased	
glycolysis	and	decreased	OXPHOS	 in	cattle	embryos	(Cagnone	et	al.,	2012).	To	the	
best	of	my	knowledge	studies	investigating	blastocyst	gene	expression	as	a	result	of	
the	isolated	effect	of	glucose	during	IVM	have	not	been	carried	out	in	any	species.	
Evaluating	 gene	 expression	 in	 blastocysts	 can	 be	 extremely	 informative;	 both	 for	
understanding	 metabolic	 pathways	 and	 the	 way	 they	 are	 regulated	 at	 the	
transcription	level	but	also	as	a	general	marker	of	developmental	competence.	
	
The	 aim	 of	 this	 study	 was	 to	 measure	 expression	 of	 genes	 for	 factors	 in	 key	
metabolic	pathways	and	related	enzymes	of	carbohydrate	metabolism	known	to	be	
affected	 by	 hyperglycaemia.	 These	 include;	 glycolysis	 (phosphofructokinase	 [PFK]	
and	 lactate	 dehydrogenase	 [LDHA]),	 pentose	 phosphate	 pathway	 (glucose-6-
phosphate	 dehydrogenase	 [G6PD])	 and	 glucose	 transport	 (solute	 carrier	 family	 2	
member	 1	 [SLC2A1;	 formerly	 GLUT1]).	 Since	 hyperglycaemia	 also	 affects	 lipid	
metabolism	via	the	glucose:	fatty	acid	cycle	(De	Bie	et	al.,	2017;	Wong	et	al.,	2015),	
the	 relative	 expression	 of	 the	 gene	 encoding	 carnitine	 palmitoyltransferase	 1A	
(CPT1A),	 a	 regulatory	 enzyme	 in	 β-oxidation	 and	 fatty	 acid	 transport,	 was	 also	
evaluated.	 As	 oxidative	 stress	 is	 known	 to	 be	 an	 additional	 regulator	 of	 the	
response	 to	 hyperglycaemia,	 relative	 expression	 of	 genes	 encoding	 glutathione	
peroxidase	 1	 (GPX1)	 and	 mitochondrial	 transcription	 factor	 A	 (TFAM)	 were	
examined.	GPX1	 is	 a	 potent	 antioxidant	 enzyme,	 central	 in	 defence	 against	H2O2,	
and	abundant	 in	oocytes	and	embryos	 (Agarwal	et	al.,	2012).	TFAM	 is	 involved	 in	
mitochondrial	 biogenesis	 and	 mtDNA	 transcription	 and	 translation	 (Itami	 et	 al.,	
2015),	and	is	known	to	be	affected	by	hyperglycaemia	in	human	somatic	cells	and	
cumulus	cells	(Palmeira	et	al.,	2007;	Suarez	et	al.,	2008;	Wang	et	al.,	2010).	
																																																								
4	For	brevity,	the	term	hyperglycaemia	is	used	throughout	this	thesis	to	connote	supraphysiological	
glucose	concentrations	both	in	vivo	and	in	media	in	vitro.	
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In	 addition	 to	 functional	 changes	 in	 carbohydrate	 metabolism,	 evaluation	 of	
expression	of	pluripotency	marker	genes	(POU5F1,	SOX2	and	NANOG)	and	genes	for	
markers	 of	 trophectoderm	differentiation	 (CDX2	 and	TEAD4)	 can	 give	 insight	 into	
blastocyst	 quality	 and	 timely	 development	 (Filliers	 et	 al.,	 2012;	 Li	 et	 al.,	 2005;	
Purpera	 et	 al.,	 2009),	 and	 were	 thus	measured.	 Successful	 embryo	 development	
requires	a	series	of	cell	lineage	differentiation	events,	the	first	being	differentiation	
of	 cells	 into	 trophectoderm	 (TE)	 and	 inner	 cell	 mass	 (ICM)	 cells	 (containing	
endoderm	 and	 future	 epiblast	 cells;	 Kuijk	 et	 al.,	 2012;	 Schrode	 et	 al.,	 2014),	
followed	by	spatial	segregation	of	 the	 latter	two	cell	 types	 into	the	hypoblast	and	
epiblast.	 	 These	 events	 are	 tightly	 controlled	 by	 temporal	 expression	 of	
developmental	genes,	the	sequence	of	which	is	partially	species	specific	(Choi	et	al.,	
2009;	Filliers	et	al.,	2012;	Kuijk	et	al.,	2008;	Paris	et	al.,	2012).		
	
POU5F1	 (OCT4),	 is	 a	 regulatory	 transcription	 factor	 essential	 in	 cell	 lineage	
differentiation	and	maintenance	of	pluripotency	(Ovitt	and	Scholer,	1998;	Wu	and	
Schöler,	2014).	POU5F1	is	both	maternally	and	zygotically	expressed	but	as	embryo	
development	 progresses	 to	 the	 blastocyst	 stage	 it	 is	 increasingly	 confined	 to	 the	
ICM	 in	 the	mouse	 and	 human,	 however	 in	 the	 pig	 and	 cow	 there	 appears	 to	 be	
expression	 in	 both	 the	 ICM	and	 TE	 until	 after	 the	 blastocyst	 stage	 (Kimber	 et	 al.,	
2008;	Kirchhof	et	al.,	2000).	SOX2,	acts	with	POU5F1	to	maintain	pluripotency	in	the	
ICM	and	to	regulate	NANOG.	NANOG	is	an	epiblast-specific	ICM	transcription	factor	
downstream	 of	 POU5F1/SOX2,	 and	 in	 the	 absence	 of	 NANOG,	 ICM	 cells	 become	
GATA-6	 positive	 primitive	 endoderm	 (Mitsui	 et	 al.,	 2003).	 	 CDX2	 is	 a	 TE	 specific	
transcription	 factor	which	 acts	 in	 a	 reciprocal	manner	with	POU5F1	 to	determine	
ICM/TE	 fate.	 In	 the	 absence	 of	 CDX2	 there	 is	 no	 downregulation	 of	 POU5F1	 and	
therefore	 no	 TE	 formation	 (Strumpf	 et	 al.,	 2005).	 As	 such,	 CDX2	 expression	
increases	 over	 the	 course	 of	 early	 embryo	 development	 as	 the	 TE	 forms	 and	 the	
number	of	 TE	 cells	 increases	 (Filliers	 et	 al.,	 2012;	 Paris	 et	 al.,	 2011).	Upstream	of	
CDX2,	TEAD4,	controls	CDX2	expression	after	the	morula	stage;	thus	in	the	absence	
of	 TEAD4	 there	 is	 no	 upregulation	 of	 CDX2	 and	 hence	 all	 blastomeres	 remain	
POU5F1	 positive	 (Nishioka	 et	 al.,	 2008).	 Given	 their	 importance	 in	 initial	
differentiation	 and	 ICM	 formation	 POU5F1	 and	 SOX2	 have	 been	 suggested	 as	
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markers	of	developmental	potential	 (Filliers	et	al.,	2012;	Kimber	et	al.,	2008;	Li	et	
al.,	2005).	
	
In	 the	 horse,	 studies	 on	 blastocyst	 gene	 expression	 are	 scarce.	 Differences	 have	
been	 reported	 in	 both	 quantitative	 and	 spatial	 expression	 of	 POU5F1	 and	 CDX2	
between	IVP	and	 in	vivo	embryos	(Choi	et	al.,	2009;	Paris	et	al.,	2012).	A	study	by	
Smits	 et	 al.,	 (2011)	 demonstrated	 downregulation	 of	 five	 developmentally	
important	 genes	 in	 Day-9	 IVP	 blastocysts	 compared	 to	 Day-7	 in	 vivo	 blastocysts,	
while	 Hendriks	 et	 al.,	 (2015)	 found	 that	 expression	 of	 mitochondrial	 replication	
gene	mtPOLB	 was	 upregulated	 and	 the	 gene	 coding	 antioxidant	 enzyme,	 GPX3	
downregulated	 in	 Day-8	 IVP	 blastocysts	 compared	 to	 Day-7	 in	 vivo	 blastocysts.	
However,	these	comparisons	may	not	be	meaningful,	as	they	were	made	between	
embryos	 at	 very	different	 stages	of	 development	 (morula/early	 blastocyst	 for	 IVP	
embryos,	 vs.	 expanded	 blastocyst	 for	 in	 vivo	 embryos).	 Using	
immunohistochemistry,	 Choi	 et	 al.,	 (2015)	 reported	 differences	 in	 cell	 lineage	
allocation	 genes	 at	 the	 protein	 level	 attributable	 to	 glucose	 concentration	 during	
early	 embryo	 culture	 while	 Desmarais	 et	 al.,	 (2011)	 demonstrated	 differences	 in	
GATA-6	 allocation	 between	 in	 vivo,	 nuclear	 transfer	 and	 parthenogenetic	 equine	
embryos.	Differential	antibody	staining	 reveals	 that	 IVP	equine	embryos	 resemble	
Day-6	 in	 vivo	 embryos,	 as	 there	 is	 no	 distinct	 formation	 of	 an	 ICM;	 rather	 the	
epiblast	 and	 endoderm	 cells	 are	 distributed	 in	 a	 network	 within	 the	 trophoblast	
cavity	 (Bruyas	 et	 al.,	 1993;	 Hinrichs	 et	 al.,	 2007;	 Tremoleda	 et	 al.,	 2003).	
Additionally,	formation	of	hypoblast	and	epiblast	does	not	appear	to	occur	in	horse	
embryos;	 rather	 the	 endodermal	 cells	 of	 a	 central	 unorganized	 cell	 network	 seed	
directly	onto	 the	 inner	surface	of	 the	 trophoblast	 (Choi	et	al.,	2015;	Enders	et	al.,	
1993).	
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Summary	
The	 combined	 approach	 of	 investigating	 COC	 carbohydrate	 metabolism	 and	
blastocyst	gene	expression	in	response	to	hyperglycaemia	during	IVM	may	provide	
insights	into	the	mechanism	by	which,	unlike	oocytes	and	embryos	of	other	species,	
the	equine	oocyte	can	tolerate	such	high	levels	of	glucose.	The	experimental	set	up	
of	individual	COC	culture	and	the	Primovision™	time-lapse	system,	uniquely	allows	
associations	 between	 COC	 carbohydrate	 metabolism	 during	 IVM,	 morphokinetics	
during	embryo	development	and	gene	expression	in	the	resulting	blastocysts	to	be	
explored.	
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5.2	Objectives	
	
1. Evaluate	the	impact	of	increased	medium	glucose	concentration	(17	mM	vs.	
5.6	mM)	during	IVM	on:	
a. Oocyte	maturation,	embryo	cleavage	and	blastocyst	 rates	after	 ICSI	
(Experiment	5.1;	Study	1)	
b. Morphokinetics	 of	 early	 embryo	 development	 using	 Primovision™	
time-lapse	imaging	(Experiment	5.1;	Study	2).	
c. Glucose,	 lactate	 and	 pyruvate	 metabolism	 of	 COCs	 during	 IVM	
(Experiment	5.1;	Study	3).	
d. Basal	oxygen	consumption	rate	and	mitochondrial	 function	of	COCs	
at	the	completion	of	IVM	(Experiment	5.2).	
e. Expression	 of	 genes	 related	 to	 metabolism,	 oxidative	 stress	 and	
developmental	competence	in	the	blastocysts.	
I. Measure	 the	 relative	 expression	 of	 genes	 for	 factors	
associated	with	glucose	metabolism	(G6PD,	PFKM	and	LDHA),	
oxidative	 stress	 (GPX1	 and	 TFAM),	 glucose	 transport	
(SLC2A1),	 fatty	 acid	 transport	 (CPT1A),	 pluripotency	 marker	
genes	 (POU5F1,	 SOX2	 and	 NANOG)	 and	 trophectoderm	
markers	(CDX2	and	TEAD4)	in	IVP	blastocysts	(Experiment	5.3;	
Study	1)	
II. Explore	 associations	 between	 the	 relative	 expression	 of	 the	
above	genes.	(Experiment	5.3;	Study	2A)	
III. Explore	 the	 association	 between	 the	 relative	 expression	 of	
the	 above	 genes	 in	 the	 blastocysts	 and	 the	 corresponding	
COC	metabolism	during	IVM.	(Experiment	5.3;	Study	2B)	
IV. Explore	 the	 association	 between	 the	 relative	 expression	 of	
the	 genes	 in	 (i)	 and	 blastocyst	 morphokinetics	 during	
development	(Experiment	5.3;	Study	2C).	
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5.3	Materials	and	Methods	
	
General	methods	
COCs	were	recovered	from	abattoir-derived	ovaries	and	classified	as	compact	(Cp),	
expanded	 (Ex)	or	 corona	 radiata-only	as	previously	described	 in	Section	2.1.1	The	
COCs	 were	 held	 overnight	 at	 room	 temperature	 (Section	 2.1.2).	 When	 removed	
from	the	holding	vial,	compact	 (Cp)	and	expanded	(Ex)	COCs	were	divided	equally	
between	the	different	conditions,	so	that	for	each	collection	day,	each	maturation	
condition	contained	equal	numbers	of	each	cumulus	type.		
	
Experiment	5.1	
Culture	 for	 IVM	 was	 carried	 out	 in	 individual	 10-μl	 droplets	 under	 oil	 of	 either	
Control	Maturation	Medium	(5.6	mM	glucose;	M199	with	Earle’s	salts,	10%	FBS,	25	
μg/ml	gentamicin	with	5	mU/ml	FSH)	or	High	glucose	Maturation	Medium	(17	mM	
Glucose;	M199	with	Earle’s	 salts	and	11.4	mM	added	glucose,	10%	FBS,	25	μg/ml	
gentamicin	 with	 5	 mU/ml	 FSH)	 and	 conducted	 at	 5%	 CO2	 in	 air.	 High	 glucose	
medium	 (17	mM)	was	 prepared	 by	 increasing	 the	 concentration	 of	 stock	 control	
media	 by	 the	 addition	 of	 1.026	 g	 embryo	 grade	 glucose	 (Sigma)	 to	 500	ml	M199	
media.	 This	 raised	 the	 osmolarity	 by	 approximately	 11.4	 mOSM,	 which	 required	
approximately	 3%	 dilution	 to	 ensure	 it	was	 iso-osmolar	with	 the	 control	medium	
(290-300	mOsm).	This	in	turn	lowered	the	final	glucose	concentration	to	16.5	mM,	
rounded	to	17	mM	throughout.	Twelve	droplets	were	placed	in	each	dish;	of	these,	
three	medium	 droplets	 remained	 empty	 and	were	 used	 as	 controls.	 Dishes	were	
continuously	 incubated	 for	 the	entire	 IVM	period	 (30	hours;	 See	Section	2.2.4	 for	
full	description).		
	
After	the	maturation	period	was	completed,	COCs	were	denuded	and	classified	as	
Metaphase	 II,	 intact	 or	 degenerated	 as	 previously	 described	 in	 Section	 2.1.4.	 All	
denuded	cumulus	cells	from	each	COC	were	placed	in	a	96-well	plate	and	kept	at	-
20°	C	until	later	DNA	quantification	analysis.	Spent	media	were	frozen	at	-80°	C	and	
analyses	of	thawed	samples	carried	out	as	previously	described	in	Section	2.2		
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Metaphase	II	oocytes	underwent	ICSI	and	subsequent	embryo	culture	as	described	
in	 Section	 2.1.6.	 Injected	 oocytes	 were	 continuously	 monitored	 using	 a	
Primovision™	 Time–Lapse	 System.	 Zona	 pellucida	 thickness	 and	 oocyte	 diameter	
were	 measured	 on	 the	 first	 frame	 by	 taking	 the	 mean	 of	 at	 least	 two	
measurements.	 Time	 of	 cytoplasmic	 extrusion,	 first	 cleavage	 and	 blastocyst	
formation	was	recorded	for	each	 injected	oocyte	where	visualisation	allowed	(this	
was	complicated	by	the	dark,	opaque	nature	of	the	horse	oocyte/embryo	cytoplasm	
and	excess	movement	due	to	adherent	cumulus	cells).	Diameter	of	the	embryo	at	
the	time	of	blastocyst	formation	was	recorded.	Cytoplasmic	extrusion	was	defined	
as	 the	 time	 cytoplasmic	 contents	 were	 first	 extruded	 from	 the	 oolema.	 Time	 of	
cleavage	was	defined	as	the	time	of	the	first	visually	identifiable	indentation	of	the	
oolema	before	a	visualized	cleavage.	Embryos	were	classified	as	blastocysts	on	first	
appearance	of	 apparent	 formation	of	 a	 central	 fluid-filled	 cavity	 (blastulation).	All	
annotations	 were	 performed	 by	 a	 single	 operator,	 blind	 as	 to	 oocyte	 treatment	
group.	
	
Experiment	5.2	
In	vitro	maturation	was	carried	out	directly	in	a	Seahorse	plate.	COCs	were	matured	
in	groups	of	3	COCs	in	180	μl	of	either	control	maturation	medium	or	high	glucose	
maturation	 medium	 at	 5%	 CO2	 in	 air.	 (As	 per	 Experiment	 1;	 full	 details	 of	
maturation	 in	 Seahorse	 plate	 in	 Section	 2.4.3).	 The	 Seahorse	 plate	 was	 removed	
from	the	incubator	and	placed	in	the	Seahorse	analyser	28	hours	after	initiation	of	
IVM	 (completion	 of	 IVM;	 IVM	 +	 28	 hours).	 After	 calibration,	 three	 basal	 oxygen	
consumption	 rate	 readings	 (pmolO2/well/min)	 were	 recorded	 before	 a	 series	 of	
respiratory	inhibitors	were	added	sequentially	to	each	well	to	achieve	the	following	
final	 concentrations;	 1)	 Oligomycin	 [1μM]	 2)	 FCCP	 [5μM]	 3)	 Antimycin/Rotenone	
[2.5μM].	*See	Section	2.4.3	for	full	description	of	method.	After	the	readings	were	
obtained,	COCs	were	placed	into	a	plate	and	frozen	for	later	DNA	quantification.		
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Experiment	5.3	
All	 blastocysts	 produced	were	used	experimentally.	 Lysis	 and	polyA	 amplification,	
cDNA	quantification	and	storage	were	carried	out	as	previously	described	in	Section	
2.5.1.	 A	 total	 of	 twelve	 genes	 of	 interest	 were	 investigated	 and	 Taqman®	 probe	
based	primers	designed	within	300	bp	of	the	polyA	tail	at	the	3’	UTR	(Primerdesign	
LTD;	Table	5.1).	All	primers	were	optimised	and	tested	using	amplified	cDNA	from	
an	equine	IVP	blastocyst	by	Primerdesign	LTD.	
	
Name	 Accession	
number	
Sense	primer	 Antisense	primer	
G6PD	 XM_001492
232	
CTTGCCACTAGGAAAGTA
GAAGC	
AGGCAGGTCTGTTTGTGG
ATT	
PFKM	 NM_001081
922	
TGGAAGCTCCTTTTAGGT
AGAATTTAT	
AATCTCGCAGTGGCACTA
GAGG	
CPT1A	 NM_001081
808	
TTCCTTCCATCCAGGGTTG
G	
GACCTGCCCAGAAGTAGT
AGG	
GPX1	 NM_001166
479	
GAACGCCTGATGTTAAGG
AGAAT	
TTATTAGTGAGAAGCCGT
GGTCT	
TFAM	 XM_001503
382.3	
ATCTTGGGAAGAACAAAT
GATTGAAG	
TGTCTATCTACTGTGAACA
TAACTCAA	
LDHA	 NM_001144
880	
GATGCGTGTTTACTCTGTG
TGAT	
TCTCAAGATGTGACTGACT
GAAGA	
SLC2A1		
	
NM_001163
971	
GAGGTCAGGCTCCATTAG
GATT	
CAACTGGTCTCAGGCAAG
GA	
POU5F1	 XM_014734
67	
	
GGATCAGGTTCTTCATTCA
CTAAGA	
AATCAAGAGCATCATTGA
ACTTCAC	
SOX	2	 XM_003363
34	
GTAGTTGTATTTTAAAGAT
TCGGCTCT	
ACCTGTTATAAGGATGGT
ATTAGTTCA	
NANOG	 XM_014740
545	
GCTGTGGAGAGGACTTCC
TG	
TTGCTGTGTTGCGTTATGG
C	
CDX-2	 XM_014731
940	
GGCTGAATGTATGTCAGT
GCTATAA	
TGGATGTTACACAGACCA
ACAAC	
TEAD4	 XM_014740
495.1	
AAGCTCATGGATGTCTAA
TATTCAATT	
GTGTGTGGCAGACTTTAC
TGAA	
	
Table	5.1:	Genes	and	primer	sequences	for	genes	of	interest	in	blastocysts.	
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The	qPCR	reactions	were	made	up	as	follows	and	plated	in	triplicate:	5	μl	cDNA	(5	
ng),	 1	 μl	 primer,	 10	 μl	 PrecisionPlus	mastermix	 (Primerdesign	 LTD)	 and	 4	 μl	 PCR	
water.	Amplification	was	performed	on	a	Biorad	CFX	using	the	following	protocol;	
initial	enzyme	denaturation	of	2	minutes	at	95	°C	then	50	cycles	of	15	seconds	at	95	
°C	and	60	seconds	at	60	 °C.	Data	were	collected	 through	 the	FAM	channel	at	 the	
final	 stage.	 Reference	 genes	 (RPL32	 and	 SRP14;	 Section	 2.5.1)	 were	 also	 run	 for	
each	 sample	 on	 each	 plate.	 All	 blastocysts	 and	 all	 genes	were	 plated	 on	 a	 single	
plate.	
	
Statistical	analysis	
For	 Experiment	 5.1,	 Study	 1,	 parameters	Metaphase	 II	 (Y/N),	 cleavage	 (Y/N)	 and	
blastocyst	(Y/N)	were	set	as	binary	outcomes	and	univariate	analyses	using	the	Chi-
square	 test	 were	 performed	 to	 explore	 associations	 related	 to	 IVM	 condition.	
Fisher’s	exact	 test	was	used	when	values	 in	a	 cell	were	 less	 than	 five.	 In	Study	2,	
morphokinetic	 parameters	 were	 noted	 for	 each	 injected	 oocyte	 and	 compared	
between	 IVM	 conditions	 using	 Student’s	 t-test.	 In	 Study	 3,	 the	 primary	 outcome	
variables	were	glucose	consumption,	lactate	and	pyruvate	production	(expressed	as	
pmol/ngDNA/hour).	Student’s	t-test	was	used	to	explore	to	associations	related	to	
IVM	condition.	
	
In	 Experiment	 5.2,	 data	 were	 expressed	 as	 pmolO2/	 COC/	 hour	 or	
pmolO2/ngDNA/hour.	 Spare	 capacity	 and	 proton	 leak	were	 corrected	 to	 zero	 if	 a	
negative	 value	 was	 obtained.	 Student’s	 t-test	 was	 used	 to	 compare	 readings	
between	 experimental	 IVM	 conditions	 after	 arcsine	 transformation	 of	 percentage	
data.	
	
Experiment	 5.3,	 Study	 1:	 The	 mean	 Ct	 value	 from	 each	 technical	 triplicate	 was	
calculated	 for	 each	 sample	 and	 retained	 if	 variation	 was	 <1	 Ct.	 Δct	 was	 then	
calculated	for	each	sample	by	subtracting	the	Ct	value	of	the	reference	gene	of	that	
sample	from	the	Ct	value	of	the	gene	of	interest.	Relative	expression	(2	-	ΔCt)	was	
then	presented	for	each	blastocyst	(Schmittgen	and	Livak,	2008).	In	Experiment	5.3,	
Study	 2A:	 Pairwise	 regression	 comparisons	 were	 performed	 for	 each	 gene	 (90	
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regression	 comparisons)	 in	 order	 to	 determine	 if	 any	 significant	 associations	
existed.	Experiment	5.3,	Study	2B	and	2C:	Relative	gene	expression	for	each	gene	in	
each	blastocyst	was	analysed	against	the	corresponding	COC	glucose	consumption,	
lactate	 and	 pyruvate	 production	 rates	 (all	 in	 pmol/ngDNA/hour)	 and	 the	 ratio	 of	
lactate	production	to	glucose	consumption	during	IVM	(30	comparisons;	Study	2B).	
Relative	 gene	 expression	 was	 also	 analysed	 against	morphokinetic	 indices	 during	
development	for	each	blastocyst	(time	of	blastulation	and	diameter	at	blastulation;	
20	comparisons;	Study	2C).	
	
For	 full	 details	 on	 statistical	 analyses	 including	 criteria	 for	 data	 cleaning	 and	
replicates	see	Section	2.5.	
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5.4	Results	
	
5.4.1	Experiment	5.1	
	
One	hundred	and	seventy	six	oocytes	were	evaluated	over	five	replicates.	Of	55	MII	
oocytes	in	the	control	(5.6	mM	glucose)	group,	six	were	not	subjected	to	ICSI	(two	
used	for	other	studies	(cDNA)	and	four	rejected	due	to	adherent	cumulus	cells).	Of	
45	MII	in	the	high	(17	mM	glucose)	group,	11	were	not	injected	(two	used	for	other	
studies	(cDNA)	and	nine	rejected	due	to	adherent	cumulus	cells;	see	Table	5.2).	
	
Study	1-	Effect	of	glucose	concentration	during	IVM	on	development	post	ICSI	
	
The	 concentration	of	 glucose	 added	 to	 the	medium	during	 IVM	did	not	 influence	
maturation,	 cleavage	 or	 blastocyst	 rate	 (Table	 5.2).	 Blastocyst	 rates	 were	 low	
overall,	however.	
	
	 IVM	
5.6	mM	Glucose	
IVM	
17	mM	Glucose	
P	
Maturation	rate	 62.5%	(55/88)	 51%	(45/88)	 0.13	
Cleavage	rate	 75.5%	(37/49)	 76.5%	(26/34)	 0.92	
Blastocyst	rate	 8.2%	(4/49)	 2.9%	(1/34)	 0.4	
	
Table	5.2:	Effect	of	glucose	concentration	during	IVM	on	maturation,	cleavage	and	
blastocyst	rate	post	ICSI.	
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Study	 2-	 Effect	 of	 glucose	 concentration	 during	 IVM	 on	 morphokinetics	 of	 early	
embryo	development	
	
All	injected	MII	oocytes	were	analysed	(n	=	83),	however	data	was	lost	for	2	COCs	in	
the	17	mM	glucose	group	due	to	technical	issues,	therefore	for	final	analysis	n	=	81.	
Cytoplasmic	 extrusion	 and	 cleavage	 determination	 was	 possible	 for	 37	 and	 48	
oocytes	 respectively.	As	 there	were	only	 five	blastocysts,	 the	effect	of	 glucose	on	
blastocyst	 morphology/morphokinetics	 could	 not	 be	 evaluated.	 There	 were	 no	
differences	 attributable	 to	 glucose	 concentration	 during	 IVM	 on	 any	 of	 the	 four	
morphokinetic	parameters	measured	(Figure	5.1).		
	
	
	
Figure	5.1:	Effect	of	glucose	concentration	(5.6	mM	[BLUE]	and	17	mM	[RED])	during	
IVM	 on	 morphokinetic	 parameters	 measured	 using	 the	 Primovision™	 Time-lapse	
system.	Bars	represent	mean	±	SEM.	
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For	 descriptive	 purposes,	 time	 of	 cytoplasmic	 extrusion,	 cleavage	 and	 blastocyst	
formation	(range	165.2-224.6	hours	[mean	183	hours	±	11	SEM)	is	shown	in	Figure	
5.2	 for	 each	blastocyst.	All	 blastocysts	were	 lysed	 for	mRNA	extraction	and	 cDNA	
synthesis	at	21.6-31.6	hours	post	blastulation	(mean	25.9	hours	±	1.7	SEM).		
	
	
Figure	5.2:	Developmental	timings	for	each	of	the	five	blastocysts.	Mean	±	SEM	are	
presented.	 Blastocysts	 from	 the	 5.6	mM	 glucose	 IVM	 group	 are	 in	 BLUE	 and	 the	
single	blastocyst	 from	the	17	mM	IVM	group	 is	 in	RED.	Detection	of	cleavage	and	
fragmentation	 timing	was	only	possible	 for	3/5	blastocysts	due	 to	 loss	of	 focus	of	
the	Primovision	camera	as	a	result	of	excess	zygote	movement.	
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Study	3-	Effect	of	glucose	concentration	during	IVM	on	COC	metabolism.	
	
Metabolic	data	were	analysed	for	all	injected	MII	oocytes	and	those	used	for	cDNA	
with	the	following	exceptions;	5.6	mM	glucose	group,	n	=	1	lost	due	to	data	cleaning	
(final	analyses	n	=	50);	17	mM	glucose	group,	n	=	2	 lost	due	to	data	cleaning	and	
n=4	 lost	due	to	 technical	 issues	 (final	analyses	n	=	30).	Of	COCs	 in	 the	control	5.6	
mM	glucose	group,	18%	(9/50)	depleted	all	available	glucose,	vs.	0/30	in	the	17	mM	
glucose.	One	of	the	nine	COCs	that	depleted	all	available	glucose	went	on	to	form	a	
blastocyst.	 When	 evaluating	 those	 that	 did	 not	 deplete	 available	 glucose	 and	
therefore	for	which	glucose	was	not	limiting,	glucose	concentration	during	IVM	did	
not	 affect	 glucose	 consumption,	 lactate/pyruvate	 production	 or	 lactate	 :	 glucose	
ratio	(Figure	5.3).		
	
	
Figure	 5.3:	 Effect	 of	 glucose	 concentration	 (5.6	 mM	 vs.	 17	 mM)	 during	 IVM	 on	
glucose	 consumption,	 lactate	 production,	 lactate	 :	 glucose	 ratio	 and	 pyruvate	
production.	Bars	represent	mean	±	SEM.	Data	points	represent	individual	COCs	
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5.4.2	 Experiment	 5.2:	 Effect	 of	 glucose	 concentration	 during	 IVM	 on	 OCR	 and	
mitochondrial	function.	
	
Fifty-four	COCs	were	used	 for	 this	 experiment	 across	 three	 replicates	 (27	 in	 each	
condition).	Thirty	COCs	had	compact	cumulus	and	24	COCs	had	expanded	cumulus.	
Data	from	three	expanded	COCs	in	each	condition	were	excluded	from	subsequent	
analysis	 due	 to	 biologically	 implausible	 OCR	 readings	 (See	 Table	 5.3	 for	 final	
numbers	available	for	analysis)	
	
	 IVM	
5.6	mM	Glucose	
IVM	
17	mM	Glucose	
Cp	 15	 15	
Ex	 9	 9	
Total	 24	 24	
	
Table	 5.3:	 Final	 numbers	 of	 COCs	 analysed	 for	 Experiment	 5.2.	 Cp	 =	 COCs	 with	
compact	cumulus	and	Ex	=	COCs	with	expanded	cumulus.	
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There	 were	 no	 differences	 attributable	 to	 cumulus	 classification	 within	
experimental	condition	(p	>	0.5)	therefore	Cp	and	Ex	were	treated	as	one	group	for	
further	analysis.	The	basal	OCR	showed	a	non-statistically	significant	trend	towards	
being	lower	in	the	17-mM	glucose	group	(Figure	5.4).	When	mitochondrial	function	
was	evaluated,	the	proportion	of	OCR	coupled	to	ATP	production	was	lower	in	the	
17-mM	glucose	group	 (42	±	5.3%	vs.	62	±	4.8%	 in	 the	5.6-mM	glucose	group;	p	=	
0.01)	and	non-mitochondrial	OCR	was	higher	 (48	±	6%	 in	17-mM	vs.	26	±	6.1%	 in	
5.6-mM;	p	=	0.02;	Figure	5.5).	
	
	
	
	
Figure	5.4:	Effect	of	glucose	concentration	during	IVM	on	oxygen	consumption	rate	
(OCR)	 after	 sequential	 addition	 of	 respiratory	 inhibitors	 to	 evaluate	mitochondrial	
function	(n	=	48).	Each	bar	represents	the	mean	OCR	after	addition	of	the	inhibitor	
stated	 (±	 SEM).	 Abbreviations	 as	 follows:	 OLIGO:	 Oligomycin;	 AR:	
Antimycin/rotenone.	
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Figure	5.5:	Effect	of	glucose	concentration	during	IVM	on	mitochondrial	function	as	
determined	 by	 sequential	 addition	 of	 respiratory	 inhibitors.	 Oxygen	 consumption	
rate	 (OCR)	 coupled	 to	 ATP	 production	 (BLUE),	 OCR	 associated	 with	 proton	 leak	
(RED),	non-mitochondrial	OCR	(GREEN)	and	spare	respiratory	capacity	(PURPLE)	are	
expressed	as	%	basal	OCR.	Mean	±	SEM	is	presented	in	Panel	A	and	mean	presented	
in	 Panel	 B.	 Asterisks	 represent	 significant	 differences	 in	 that	 parameter	 between	
glucose	 concentrations	 (BLUE*=	 Coupled;	 p	 =	 0.01	 and	 GREEN*=	 Non-	
mitochondrial;	p	=	0.02)	
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5.	4.3	Experiment	5.3.	Study	1:	Effect	of	glucose	concentration	during	IVM	on	
resulting	blastocyst	gene	expression.		
	
Five	blastocysts	were	analysed.	Blastocysts	C1-4	were	from	the	5.6-mM	glucose	IVM	
group	 and	 blastocyst	 H1	 from	 the	 17-mM	 glucose	 IVM	 group	 (Figures	 5.7-5.11).	
Blastocyst	 C1	 developed	 from	 an	 oocyte	 that	 had	 depleted	 all	 available	 glucose	
during	IVM.	Due	to	the	small	sample	size	and	large	biological	variation,	the	effect	of	
glucose	concentration	during	IVM	could	not	be	evaluated	and	a	descriptive	analysis	
of	 the	 relative	 expression	 of	 each	 of	 the	 genes	 is	 therefore	 shown	 below	 both	
overall	(Figure	5.6),	and	for	each	individual	blastocyst	(Figures	5.7-5.9).		
	
Reference	 genes	 SRP14	 (Signal	 Recognition	 Particle	 14)	 and	 RPL32	 (Ribosomal	
protein	32)	 (See	Section	2.5.2)	were	further	examined	for	suitability	alongside	the	
genes	of	interest	using	probe-based	primers.	RPL32	showed	higher	expression	than	
did	SRP14	in	all	samples	(mean	Ct	17.2,	vs.	19.6	for	SRP14)	and	was	therefore	used	
to	 calculate	 ΔCt	 values.	 GPX1,	 LDHA	 and	 POU5F1	 showed	 the	 highest	 relative	
expression	and	were	expressed	in	all	blastocysts	(Figure	5.6).	TFAM,	SLC2A1,	PFKM	
and	 CDX2	 were	 not	 universally	 expressed	 and	 CPT1A	 and	NANOG	 did	 not	 show	
expression	 in	 any	of	 the	 five	blastocysts.	 	All	 blastocysts	 showed	expression	of	 at	
least	six	genes	of	interest	in	addition	to	the	reference	genes	(Table	5.4).	
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	 BLASTOCYST	
GENE	 C1	 C2	 C3	 C4	 H1	
TFAM	 0.00921	 0	 0	 0	 0	
SLC2A1	 0	 0	 0	 0	 0.00010	
LDHA	 0.27042	 0.08322	 0.04966	 0.21525	 0.12729	
G6PD	 0.00027	 0.00532	 0.00002	 0.00475	 0.00281	
GPX1	 0.22463	 1.39289	 2.62175	 0.24190	 0.77179	
PFKM	 0.00233	 0	 0	 0	 0.00220	
CDX2	 0	 0	 0	 0.00030	 0	
TEAD4	 0.00039	 0.00012	 0.02053	 0.00205	 0.00677	
SOX2	 0.00185	 0.00061	 0.00139	 0.00343	 0.00337	
POU5F1	 0.25489	 0.69544	 1.60626	 0.24622	 0.88087	
	
Table	5.4:	Summary	of	relative	expression	(normalised	to	RPL32)	of	genes	of	interest	
in	each	of	 the	 five	blastocysts.	Blastocysts	C1-4	are	 from	COCs	matured	 in	 control	
maturation	medium	(5.6	mM	glucose)	and	blastocyst	H1	from	COC	matured	in	high	
glucose	medium	(17	mM).			
	
	
Figure	5.6:	Relative	expression	(normalised	to	RPL32)	of	the	ten	target	genes	in	the	
five	blastocysts	studied.	Mean	and	SEM	are	depicted	where	appropriate.	Only	one	
embryo	expressed	SLC2A1	and	CDX2	and	a	mean	is	therefore	not	presented.	
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Figure	 5.7:	 Relative	 expression	 levels	 (normalised	 to	 RPL32)	 of	 genes	 related	 to	
glucose	metabolism	and	oxidative	stress.	Blastocysts	C1-4	are	from	COCs	matured	in	
control	maturation	medium	(5.6	mM	glucose)	and	blastocyst	H1	from	COC	matured	
in	high	glucose	medium	(17	mM).	Empty	bars	denote	lack	of	gene	expression	in	that			
blastocyst.	
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Figure	 5.8:	 Relative	 expression	 levels	 (normalised	 to	 RPL32)	 of	 genes	 related	 to	
trophectoderm	differentiation.	 Blastocysts	 C1-4	 are	 from	COCs	matured	 in	 control	
maturation	medium	(5.6	mM	glucose)	and	blastocyst	H1	from	COC	matured	in	high	
glucose	 medium	 (17	 mM).	 Empty	 bars	 denote	 lack	 of	 gene	 expression	 in	 that	
blastocyst.	
	
	
	
Figure	 5.9:	 Relative	 expression	 levels	 (normalised	 to	 RPL32)	 of	 genes	 related	 to	
pluripotency.	 Blastocysts	 C1-4	 are	 from	 COCs	 matured	 in	 control	 maturation	
medium	 (5.6	 mM	 glucose)	 and	 blastocyst	 H1	 from	 COC	 matured	 in	 high	 glucose	
medium	(17	mM).		
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Study	2A-	Pairwise	comparison	between	relative	expression	of	genes	
	
Of	 the	 90	 pairwise	 comparisons	 performed	 (data	 not	 shown),	 five	 were	 either	
significant	 (p	 <	 0.05)	 or	 approached	 significance	 (p	 <	 0.1).	 LDHA	 and	 GPX1	
expression	were	 negatively	 correlated	 (r2	=	 0.8;	 p	 =	 0.04;	 Figure	 5.10A)	 and	 both	
were	correlated	to	POU5F1	expression	(r2	=	0.75;	p	=	0.06;	Figure	5.12D	and	r2	=	0.9;	
p	=	0.02;	Figure	5.10B	respectively).	GPX1	expression	was	also	correlated	to	TEAD4	
expression	(r2	=	0.7;	p	=	0.08;	Figure	5.10C)	and	TEAD4	expression	was	correlated	to	
POU5F1	expression	(r2	=	0.9;	p	=	0.03;	Figure	5.10E).		
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Figure	5.10:	Correlation	of	 relative	gene	expression	 levels	 in	 individual	blastocysts.	
A:	GPX1	and	LDHA	 (r2	=	0.8;	p=	0.04);	B:	GPX1	and	POU5F1	 (r2	=	0.9;	p	=	0.02);	C:	
GPX1	and	TEAD4	(r2	=	0.7;	p	=	0.08);	D:	LDHA	and	POU5F1	(r2	=	0.75;	p	=	0.06);	E:	
TEAD4	and	POU5F1	(r2	=	0.9;	p	=	0.03).	
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Study	 2B-	 Correlation	 between	 relative	 gene	 expression	 and	 corresponding	 IVM	
metabolic	parameters.	
	
Glucose	consumption,	 lactate	and	pyruvate	production	 rates	and	 lactate	 :	glucose	
ratios	 during	 IVM	 are	 shown	 below	 for	 each	 of	 the	 COCs	 from	 which	 the	 five	
blastocysts	 developed	 (Figure	 5.11;	 Pyruvate	 was	 only	 measurable	 in	 3/5	 due	 to	
technical	issues).	Blastocyst	C1	developed	from	an	oocyte	that	depleted	all	available	
glucose	during	the	30-hour	maturation	period.	
	
	
Figure	5.11:	Glucose	consumption	(A),	lactate	production	(B),	lactate:	glucose	ratio	
(C)	and	pyruvate	production	(D)	in	each	of	the	five	blastocysts.	All	bars	represent	the	
mean	 of	 a	 technical	 triplicate	 (CV<10%)	 in	 pmol/	 ng	 DNA/	 hour.	 Blastocysts	 C1-4	
were	 from	 COCs	 matured	 in	 control	 maturation	 medium	 (5.6	 mM	 glucose)	 and	
blastocyst	H1	from	COC	matured	in	high	glucose	medium	(17	mM).		
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The	 association	 between	 glucose	 consumption	 rate,	 lactate	 production	 rate	 and	
lactate	:	glucose	ratio	during	IVM	and	relative	expression	of	each	of	the	ten	genes	in	
the	 resulting	 blastocyst	 was	 explored	 (data	 not	 shown).	 Associations	were	 either	
significant	 (p	 <	 0.05)	 or	 approached	 significance	 (p	 <	 0.1)	 for	 two	 comparisons	
however	 were	 driven	 by	 a	 single	 blastocyst.	 Glucose	 consumption	 rate	 was	
positively	 correlated	 to	 SLC2A1	 expression	 (the	 only	 blastocyst	 with	 SLC2A1	
expression	 [H1]	 developed	 from	 the	 COC	 with	 the	 highest	 glucose	 consumption;					
r2	 =	 0.8;	 p	 =	 0.06).	 Lactate	 production	 rate	 was	 negatively	 correlated	 to	 TFAM	
expression	(the	only	blastocyst	with	TFAM	expression	[C1]	developed	from	the	COC	
with	the	lowest	lactate	production;	r2	=	0.7;	p	=	0.08)		
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Study	 2C-	 Correlation	 between	 relative	 gene	 expression	 and	 corresponding	
morphokinetics	during	development	
		
Time	 of	 blastocyst	 formation	 and	 blastocyst	 diameter	 at	 blastulation	 are	 shown	
below	for	each	embryo	(Figure	5.12A	and	B).	The	association	between	relative	gene	
expression	in	the	blastocyst	and	time	of	blastulation	and	diameter	was	found	to	be	
either	significant	(p	<	0.05)	or	approaching	significance	(p	<	0.2)	in	three	of	the	20	
comparisons.	 Blastulation	 time	was	 negatively	 correlated	 to	POU5F1	 (r2	=	 0.6;	 p=	
0.17;Figure	5.12C)	and	positively	correlated	to	CDX2	expression		(r2	=	0.9;	p	=	0.02)	
and	diameter	at	blastulation	was	positively	correlated	to	TEAD4	expression	(r2	=	0.6;	
p	=	0.1).	The	latter	two	associations	were	however	driven	by	a	single	blastocyst.	
	
	
Figure	5.12:	Time	of	blastulation	(A)	and	diameter	at	time	of	lysis	(B)	for	each	of	the	
five	 blastocysts.	 Blastocysts	 C1-4	 are	 from	 COCs	 matured	 in	 control	 maturation	
medium	 (5.6	 mM	 glucose)	 and	 blastocyst	 H1	 from	 COC	 matured	 in	 high	 glucose	
medium	 (17	 mM).	 Panel	 C:	 Correlation	 of	 blastulation	 time	 and	 relative	 POU5F1	
expression	in	the	blastocysts	C;	r	2	=	0.6;	p	=	0.17).	
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5.5	Discussion	
	
The	effect	of	hyperglycaemia	during	 IVM	on	oocytes,	COCs	and	embryos	of	other	
species	 is	well	described	(reviewed	by	Frank	et	al.,	2014),	however	this	 is	 the	first	
report	 to	 investigate	the	effect	of	glucose	concentration	during	the	period	of	 IVM	
on	equine	COCs	and	resulting	blastocysts.	Glucose	concentration	during	IVM	(5.6	vs.	
17	 mM)	 did	 not	 influence	 developmental	 parameters,	 morphokinetics	 of	 early	
embryo	development,	glucose	consumption,	 lactate/	pyruvate	production	or	basal	
OCR.	 However,	 IVM	 at	 17	 mM	 glucose	 resulted	 in	 changes	 in	 mitochondrial	
function:	 decreased	 ATP-coupled	 respiration	 and	 increased	 non-mitochondrial	
respiration.	Regrettably,	blastocyst	development	 rates	were	 low	and	 the	effect	of	
IVM	glucose	concentration	on	blastocyst	gene	expression	and	morphokinetics	could	
therefore	 not	 be	 determined.	 However,	 the	 expression	 of	 glucose	 metabolism	
genes	SLC2A1,	LDHA,	G6PD,	PFKM	and	the	TE	marker	TEAD4	is	reported	for	the	first	
time	in	equine	blastocysts	and	further	description	of	POU5F1,	SOX2	and	CDX2	adds	
to	our	limited	knowledge	of	dynamics	of	cell	lineage-associated	gene	expression	in	
the	horse.			
	
Hyperglycaemia	 was	 not	 associated	 with	 a	 change	 in	 measured	 markers	 of	 COC	
carbohydrate	metabolism	
Studies	in	both	mice	and	cattle	have	demonstrated	a	reduction	in	glucose	uptake	by	
COCs	and	embryos	in	hyperglycaemic	conditions	attributed	to	a	downregulation	of	
glucose	transporters	(Frank	et	al.,	2014;	Sutton-McDowall	et	al.,	2010;	Wang	et	al.,	
2012,	 2010).	 In	 contrast,	 variation	 in	 the	 medium	 glucose	 concentration	 had	 no	
effect	on	glucose	consumption	in	the	present	study.	The	degree	of	COC	and	embryo	
glucose	 tolerance	 appears	 to	 be	 species	 specific,	 although	 the	 mechanism	 is	
unknown.	 While	 hyperglycaemia	 (~	 5	 mM)	 in	 early	 development	 dramatically	
lowers	embryo	development	in	the	mouse,	hamster,	sheep	and	cow	(Chatot	et	al.,	
1989;	 Furnus	 et	 al.,	 1997;	 Seshagiri	 and	 Bavister,	 1989;	 Thompson	 et	 al.,	 1992),	
porcine	 and	 equine	 embryos	 develop	 normally	 (Choi	 et	 al.,	 2015;	 Sturmey	 and	
Leese,	2003).	In	fact,	equine	embryos	tolerate	glucose	concentrations	up	to	20	mM	
during	 this	 time	with	 no	 apparent	 effect	 on	 developmental	 potential	 (Choi	 et	 al.,	
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2015).	 In	pig	embryos,	 in	which	 lipids	 are	abundant	 as	 is	 assumed	 for	 the	equine	
oocyte,	 it	 has	 been	 proposed	 that	 high	 glucose	 levels	 are	 protective	 in	 that	 they	
prevent	the	preferential	oxidation	of	intracellular	fatty	acids	and	hence	potentially	
prevent	excess	ROS	production	(Sturmey	and	Leese,	2003).		
	
Glucose	transporters	(GLUT1-12)	are	differentially	expressed	in	different	tissues	and	
also	 vary	 in	 substrate	 affinity	 (Zhao	 and	 Keating,	 2007).	 GLUT1	 is	 a	 high	 affinity	
glucose	 transporter	 (Km	 =	 3-7	mM)	 shown	 to	 be	 present	 in	 cumulus	 cells	 and	 be	
downregulated	in	the	face	of	hyperglycaemia	(Wang	et	al.,	2010).	In	this	regard	it	is	
interesting	 to	 consider	 another	 equine	 tissue	 in	 which	 GLUT1	 activity	 has	 been	
evaluated.	A	common	clinical	problem	in	equine	medicine	is	laminitis,	in	which	the	
digital	lamellae	(structures	that	attach	the	distal	phalanx	to	the	hoof	wall)	separate	
from	 the	 hoof	 capsule	 and	 lead	 to	 extreme	 pain	 and	 lameness,	 resulting	 in	
morbidity	 and	 even	 necessitating	 eventual	 euthanasia.	 Laminitis	 is	 closely	
associated	with	 obesity,	metabolic	 syndrome	 and	 insulin	 resistance;	 however	 the	
mechanism	by	which	these	changes	 induce	the	pathology	 in	the	hoof	 is	unknown.	
One	 theory	put	 forward	was	 that	 the	digital	 lamellae	 in	 the	hoof	were	 starved	of	
glucose	 due	 to	 impaired	 GLUT4	mobilisation,	 which	 typically	 accompanies	 insulin	
resistance.	 However,	 a	 study	 examining	 the	 GLUT1	 and	 GLUT4	 (SLC2A1	 and	 4)	
expression	in	equine	lamellar	explants	discounted	that	theory,	as	glucose	transport	
in	the	hoof	was	found	to	be	mediated	by	only	the	insulin	insensitive	GLUT1	receptor	
(Asplin	et	al.,	2011).	 	Moreover,	 in	the	context	to	the	present	study,	 they	showed	
that	glucose	uptake	by	the	lamellar	explants	increased	up	to	a	concentration	of	15	
mmol/L	and	did	not	 fall	as	a	 result	of	GLUT1	downregulation	until	21	mmol/L.	 	 In	
contrast,	a	study	examining	glucose	uptake	in	human	keratinocytes	demonstrated	a	
decrease	in	glucose	uptake	at	4	mM	glucose	(Spravchikov	et	al.,	2001).	While	there	
is	 variation	 in	 glucose	 transport	 properties	 between	 tissues,	 the	 study	 by	 Asplin	
lends	weight	to	the	theory	that	higher	concentrations	of	glucose	than	used	 in	the	
present	 study	may	be	 required	 in	 the	equine	COC/embryo	 to	cause	a	decrease	 in	
glucose	uptake.	
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A	limitation	of	the	current	experimental	method,	which	measured	disappearance	of	
glucose	 and	 appearance	 of	 lactate,	 is	 that	 it	 provides	 only	 a	 global	 estimate	 of	
glycolysis	 through	 the	 glycolytic	 index	 (lactate	 :	 glucose	 ratio).	 Glucose	 can	
additionally	 be	metabolised	 via	 the	 pentose	 phosphate	 pathway	 (PPP),	 Poly-	 O-L	
pathway	 and	 HBP	 or	 directly	 oxidised	 via	 OXPHOS	 (Figure	 5.13).	 The	 change	 in	
proportional	 flux	 through	 these	 individual	 pathways	 is	 perhaps	more	 informative	
than	the	overall	consumption.	The	HBP	in	particular	has	received	attention	in	recent	
years	as	a	potential	central	mediator	of	glucotoxicity	in	COCs,	embryos	and	somatic	
cells	 (Pantaleon,	 2015;	 Rolo	 and	 Palmeira,	 2006;	 Sutton-McDowall	 et	 al.,	 2010;	
Wong	 et	 al.,	 2015).	 In	 somatic	 cells	 under	 normoglycaemic	 conditions,	 the	 HBP	
accounts	 for	 1-3%	of	 glucose	metabolised	 (Marshall	 et	 al.,	 1991).	However	 in	 the	
maturing	 COC,	 it	 has	 a	 particularly	 central	 role:	 hyaluronic	 acid,	 a	 component	
essential	 for	 cumulus	 expansion,	 is	 an	 end	 product	 of	 the	HBP	 and	 up	 to	 25%	of	
glucose	taken	up	by	 the	COC	 is	metabolised	via	 the	HBP	at	 the	end	of	 IVM	 in	 the	
cow	 (Sutton-McDowall	 et	 al.,	 2004).	Another	 fate	of	 the	end	product	of	 the	HBP,	
UDP-N-Acetylglucosamine,	is	β-O	linked	glycosylation	of	proteins	(O-	GlcNAcylation;	
Figure	5.13).	O-GlcNAcylation	acts	 in	a	 similar	way	 to	phosphorylation	 to	 regulate	
protein	 function	 (Marshall	et	al.,	1991)	and	as	such,	a	certain	 level	 is	 required	 for	
optimal	 cell	 function	 but	 excess	 may	 be	 detrimental.	 Hyperglycaemia	 has	 been	
shown	to	increase	flux	through	the	HBP	thereby	increasing	O-	GlcNAcylation,	which	
in	 the	 COC,	 may	 have	 profound	 downstream	 negative	 effects	 on	 blastocyst	
development	 (Pantaleon	 et	 al.,	 2010;	 Sutton-Mcdowall	 et	 al.,	 2006;	Wong	 et	 al.,	
2015).	 In	 murine	 and	 bovine	 studies,	 embryotoxic	 effects	 of	 hyperglycaemia	 are	
ameliorated	 if	 the	 O-	 GlcNAcylation	 is	 inhibited,	 adding	 further	 evidence	 to	 the	
proposition	that	increased	HBP	activity	is	a	major	cause	of	glucotoxicity	(Pantaleon	
et	al.,	2010;	Sutton-Mcdowall	et	al.,	2006).	Interestingly,	aberrant	O-	GlcNAcylation	
of	reproductive	tissues	has	also	been	 implicated	as	a	cause	of	negative	pregnancy	
and	birth	outcomes	secondary	to	hyperglycaemia	(Brown	et	al.,	2018).	
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In	addition	to	increased	HBP	flux,	hyperglycaemia	causes	an	increase	in	conversion	
of	glucose	to	sorbitol	 (Poly–O-L	pathway),	and	both	decrease	PPP	activity	through	
negative	 feedback	 on	 Glucose-6-phosphate	 dehydrogenase	 (G6PDH,	 Figure	 5.13)	
(Colton	et	al.,	2003;	Rolo	and	Palmeira,	2006;	Sutton-Mcdowall	et	al.,	2006;	Wong	
et	 al.,	 2015).	 As	 the	 PPP	 generates	 NADPH,	 it	 contributes	 to	 redox	 balance	 by	
ensuring	the	NADPH:	NADP	ratio	 is	maintained	 in	a	reduced	state.	A	high	NADPH:	
NADP	is	essential	 for	optimal	ROS	scavenging	via	enzymes	such	as	the	glutathione	
reductases.		
	
	
	
	
	
Figure	 5.13	 A	 simplified	 schematic	 showing	 the	 potential	 routes	 of	 glucose	
metabolism.	 Enzymes	 and	 steps	 relevant	 to	 this	 discussion	 are	 highlighted.	
Abbreviations:	 	 PFK:	 Phosphofructokinase,	 GAPDH:	 Glyceraldehyde	 3-phosphate	
dehydrogenase,	 G6PDH:	 Glucose-6-phosphate	 dehydrogenase,	 OXPHOS;	 Oxidative	
phosphorylation.	Adapted	from	(Sutton	et	al.,	2003).	
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Hyperglycaemia	 has	 also	 been	 shown	 to	 reduce	 the	 proportion	 of	 glucose	 that	 is	
directly	oxidised,	as	it	lowers	pyruvate	dehydrogenase	activity	(PDH).	PDH	converts	
pyruvate	to	acetyl-CoA	and	as	such,	low	activity	means	that	pyruvate	is	not	oxidised	
but	is	preferentially	converted	to	lactate.	This	is	a	well-recognised	phenomenon	in	
diabetic	cardiomyopathy	(DCM)	in	which	resultant	overutilisation	of	fatty	acids	for	
oxidation	 (as	 a	 source	 of	 ATP	 in	 the	 absence	 of	 pyruvate	 availability)	 is	 linked	 to	
many	of	the	negative	effects	of	DCM.	Thus,	PDH	promoters	are	currently	of	interest	
as	 potential	 drug	 targets	 for	 amelioration	 of	 DCM-related	 pathology	 (Page	 et	 al.,	
2015).	In	the	current	study,	there	were	no	differences	in	glycolytic	index	associated	
with	17	mM	vs.	5.6	mM	glucose;	however	it	would	be	interesting	to	re-evaluate	this	
at	higher	glucose	concentrations,	and	to	concurrently	evaluate	PDH	expression.		
	
Hyperglycaemia	resulted	in	mitochondrial	dysfunction	
In	the	current	study,	 there	was	a	decrease	 in	ATP-coupled	OCR	at	17	mM	glucose	
during	IVM,	compared	to	5.6	mM,	associated	with	an	increase	in	the	proportion	of	
non-mitochondrial	 respiration	 (OCR	 not	 associated	 with	 the	 electron	 transport	
chain).	Both	these	measures	suggest	compromised	mitochondria	and	an	increase	in	
ROS	 production	 in	 COCs	matured	 in	 hyperglycaemic	 conditions.	 This	 finding	 is	 in	
agreement	with	studies	in	both	oocytes	and	somatic	cells	exposed	to	high	glucose	
levels	(Hashimoto	et	al.,	2000;	Rolo	and	Palmeira,	2006;	Wang	et	al.,	2010).	Recent	
studies	 using	 the	 Seahorse	 XF	 analyser	 also	 demonstrated	 a	 decrease	 in	 ATP-
coupled	OCR	 in	 response	 to	 hyperglycaemia	 in	 both	 renal	mesengial	 and	 tubular	
cells	 (Czajka	 and	Malik,	 2016)	 and	 peripheral	 mononuclear	 cells	 (Hartman	 et	 al.,	
2014).	 A	 decrease	 in	 coupling	 has	 also	 been	 demonstrated	 in	 myocardium,	
attributed	 to	 overutilisation	 of	 fatty	 acids	 for	 oxidation	 and	 subsequent	
upregulation	 of	 uncoupling	 proteins	 (UPCs)	 (Rider	 et	 al.,	 2012).	 Interestingly,	
consistently	lower	ATP	levels	are	reported	in	oocytes	and	cumulus	cells	as	a	sequela	
to	hyperglycaemia	(Chang	and	Moley,	2004;	Colton	et	al.,	2003;	Wang	et	al.,	2012,	
2010).	While	not	directly	measured	 in	 the	 current	 study,	 it	 could	be	extrapolated	
that	as	 the	basal	OCR	did	not	differ	 significantly	between	conditions	and	 the	ATP	
linked	 proportion	was	 significantly	 decreased	 at	 17	mM,	 this	would	 also	 result	 in	
decreased	ATP	production.		
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According	 to	 Rolo	 and	 Palmeira,	 (2006)	 the	 consequences	 of	 hyperglycaemia	 in	
somatic	cells	can	be	traced	back	to	an	increase	in	ROS	production	and	impaired	ROS	
scavenging.	One	of	 the	principal	 factors	determining	ROS	production	 is	 the	 redox	
state	of	the	mitochondrial	membrane	and	in	turn,	mitochondrial	efficiency	is	central	
to	 regulating	 this	 response.	 It	 has	 been	 elegantly	 demonstrated	 by	 a	 series	 of	
experiments	 from	Kelle	Molley’s	 laboratory	 that	mitochondria	 both	 in	 the	 oocyte	
and	cumulus	cell	are	a	target	for	hyperglycaemia	(Chi	et	al.,	2000;	Ratchford	et	al.,	
2007;	Wang	et	al.,	2012,	2010,	2009).	Using	the	streptozotocin	(STZ)	injected	mouse	
model	 to	 create	 diabetes	 through	 destruction	 of	 pancreatic	 β	 cells,	 they	 have	
shown	 that	 oocytes	 from	 those	 mice	 have	 increased	 numbers	 of	 fragmented	
mitochondria,	a	more	aggregated	mitochondrial	pattern	and	morphological	changes	
in	 remaining	 individual	 mitochondria.	 	 All	 these	 findings	 combine	 to	 decrease	
mitochondrial	 efficiency.	 Further	 inefficiencies	 stem	 from	 aberrations	 in	 glucose	
pathways	 mentioned	 above.	 Firstly,	 decreased	 PPP	 activity	 leads	 to	 decreased	
NADPH	levels	and	a	subsequent	increase	in	the	electron	donor	NADH.	This	results	in	
an	elevated	mitochondrial	membrane	potential	due	to	 increased	electron	transfer	
chain	activity,	and	also	in	increased	ATP/ADP	ratio.	Consequently,	there	is	negative	
feedback	 on	 Complex	 III,	 due	 to	 the	 high	 electrochemical	 gradient,	 and	
subsequently	a	resultant	accumulation	of	electrons	within	the	chain	which	leads	to	
partial	 reduction	of	oxygen	(O2	+	e−		*O−2)	and	thus	 increased	super	oxide	 (SO)	
formation	(Rolo	and	Palmeira,	2006).	This	mechanism	has	been	confirmed	in	bovine	
aortic	endothelium	exposed	to	hyperglycaemia	whereby	ROS	production	is	lowered	
in	response	to	treatment	with	FCCP,	which	lowers	membrane	potential	by	allowing	
free	passage	of	protons	out	of	 the	 intermembrane	space	 (Nishikawa	et	al.,	2000).	
An	 increase	 in	 ROS	 in	 response	 to	 hyperglycaemia	 (20mM)	 has	 also	 been	
demonstrated	 in	 bovine	 oocytes	 Hashimoto	 et	 al.,	 (2000).	 Excess	 superoxide	 can	
inhibit	the	glycolytic	enzyme	Glyceraldehyde-3	phosphate	dehydrogenase	(GAPDH,	
Figure	5.13),	which	prevents	completion	of	glycolysis	and	thus	the	excess	glucose	in	
hyperglycaemia	 is	shunted	through	the	HBP	(Rolo	and	Palmeira,	2006).	Consistent	
with	 these	 findings,	 addition	 of	 antioxidants	 improves	 bovine	 IVF	 outcome	 in	 the	
face	of	hyperglycaemia	during	embryo	culture	(Iwata	et	al.,	1998).	
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Hyperglycaemia	had	no	effect	on	developmental	parameters	or	morphokinetics	
Much	of	the	research	investigating	the	effects	of	hyperglycaemia	on	oocytes,	COCs	
and	 embryos	 has	 utilised	 the	 Akita	 mouse	 model	 which	 has	 a	 mutation	 in	 the	
insulin-2	 gene	 (Ins2)	 leading	 to	 insulin-dependent	 diabetes	 (Wang	 et	 al.,	 1999).	
Using	this	mouse	model,	it	has	been	demonstrated	that	oocytes	from	diabetic	mice	
exhibit	 slower	 progression	 to	 MII	 in	 response	 to	 gonadotropins,	 and	 also	 show	
meiotic	 spindle	 defects	 (Chang	 et	 al.,	 2005).	 These	 authors	 have	 attributed	 the	
delay	 in	 meiotic	 progression	 to	 loss	 of	 oocyte-cumulus	 cell	 communication	 as	 a	
result	 of	 two	 separate	 processes;	 increased	 extrinsic	 apoptosis	 and	 decreased	
connexin	 expression.	 The	 connexin	 proteins	 are	 vital	 for	 gap	 junction	 formation	
between	the	oocyte	and	cumulus	cells	and	progression	to	Metaphase	II	is	reliant	in	
particular	 on	 connexin	 43	 (Ackert	 et	 al.,	 2001).	 Ratchford	 et	 al.,	 (2008)	
demonstrated	that	there	was	a	60%	decrease	in	cumulus	cell	connexin	expression	in	
response	to	hyperglycaemia	in	the	Akita	mouse.	In	the	present	study,	there	was	no	
difference	 in	maturation	rate	associated	with	hyperglycaemic	conditions,	however	
meiotic	status	was	evaluated	at	30	hours	only,	so	it	is	unknown	whether	the	kinetics	
differed	between	the	two	groups.		
	
The	 assessment	 of	morphokinetics	 is	 an	 emerging	 field,	 especially	 in	 human	ART,	
and	most	research	to	date	has	concentrated	on	developing	algorithms	for	selection	
of	high	quality	embryos	(meta-analysis	by	Chen	et	al.,	2017).	Notably,	there	are	no	
data	 on	 the	 effect	 of	 glucose	 concentration	 on	 embryo	morphokinetics.	 Oocytes	
from	 the	 diabetic	 Akita	 mouse	 model	 are	 reportedly	 smaller	 than	 those	 from	
normoglycaemic	 mice	 (Chang	 et	 al.,	 2005).	 Not	 unexpectedly,	 unlike	 prolonged	
exposure	during	folliculogenesis	in	vivo,	short	exposure	to	increased	glucose	during	
IVM	in	the	present	study	did	not	influence	oocyte	size.	With	higher	numbers	and	a	
system	 with	 higher	 blastocyst	 development	 rates,	 it	 would	 be	 interesting	 to	
evaluate	the	kinetics	of	blastocyst	development,	since	there	is	evidence	to	suggest	
retardation	 in	murine	embryo	development	 in	 response	to	hyperglycaemia.	When	
murine	embryos	were	exposed	to	increased	glucose	concentrations	(25.56	mM)	at	
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the	 2-cell	 stage,	 decreased	 hatching	 and	 lower	 blastocyst	 cell	 numbers	 were	
observed	on	Day	5	(Fraser	et	al.,	2007).		
	
Hyperglycaemia	and	blastocyst	gene	expression	
Blastocyst	rates	were	too	low	in	this	study	to	satisfy	the	original	experimental	aim	
of	 identifying	 an	 effect	 of	 glucose	 concentration	 on	 developmental	 potential	 or	
blastocyst	 gene	 expression.	 Large	 animal	 studies	 performed	 in	 buffalo	 and	 cattle	
have	 demonstrated	 a	 consistent	 decrease	 in	 blastocyst	 rate	 attributable	 to	 high	
glucose	during	IVM	(10	and	20	mM,	compared	to	5.6	mM)	(Hashimoto	et	al.,	2000;	
Kumar	et	al.,	2012).	While	DMEM/F12	(17	mM	glucose)	has	been	successfully	used	
for	 IVM	 in	 the	 horse	 (blastocyst	 rates	 up	 to	 17%;	Galli	 et	 al.,	 2016)	 the	 effect	 of	
glucose	has	not	been	independently	evaluated.	In	the	current	study,	due	to	the	low	
overall	rate	of	blastocyst	development,	differences	in	blastocyst	development	could	
not	be	tested.	However,	 it	 is	 interesting	to	comment	on	the	relative	expression	of	
the	genes	measured	in	this	study	since	most	have	not	previously	been	described	in	
the	 equine	 blastocyst.	 There	was	 universal	 expression	 of	GPX1,	 LDHA	 and	 G6PD.	
Only	one	blastocyst	(the	5.6	mM	COC	that	exhausted	glucose	during	IVM)	expressed	
TFAM	and	one	(17	mM	group)	expressed	SLC2A1.	 	Two	expressed	PFKM	and	none	
CPT1A.	Carnitine	palmitoyl	 transferase	1	 (CPT1)	 is	 the	enzyme	 responsible	 for	 the	
transfer	 of	 fatty	 acids	 across	 the	 outer	mitochondrial	membrane	 and	 is	 the	 rate-
limiting	step	of	β-oxidation.	CPT1	has	 three	 isoforms	1A,	1B	and	1C.	While	CPT1A	
has	 been	 detected	 in	 bovine	 blastocysts,	 it	 is	 possible	 that	 one	 of	 the	 other	 two	
isoforms	 is	 of	 more	 importance	 in	 the	 equine	 blastocyst.	 In	 two	 bovine	 studies	
investigating	 the	 effect	 of	 varying	 IVM	 conditions	 (the	 first	 investigating	 oxygen	
tension	[5%/20%]	and	the	second,	glucose	concentration	in	the	face	of	lipolysis-like	
conditions)	 on	 blastocyst	 gene	 expression,	 no	 differences	were	 identified	 in	 gene	
expression	attributable	to	IVM	condition	(Bermejo-Álvarez	et	al.,	2010	and	De	Bie	et	
al.,	2017	respectively)	however,	there	was	universal	expression	of	TFAM,	CPT1A	and	
SLC2A1.		
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Expression	of	TFAM,	which	codes	for	a	key	activator	of	mitochondrial	transcription,	
has	been	described	 in	equine	blastocysts	 in	two	studies	from	the	same	laboratory	
(Hendriks	et	al.,	2015,	2018).	They	first	examined	TFAM	and	other	genes	related	to	
mitochondrial	 replication	between	 in	 vivo-derived	blastocysts	 from	young	and	old	
mares	and	IVP	blastocysts	and	reported	no	differences	in	TFAM	expression.	In	that	
study,	 only	GPX3,	 a	 glutathione	 peroxidase,	was	 differentially	 expressed;	 namely,	
lower	expression	in	IVP	compared	to	in	vivo	derived	blastocysts	from	young	mares.	
In	the	2018	study,	the	temporal	expression	of	TFAM	was	evaluated	in	relation	to	re-
initiation	of	mtDNA	replication.	The	increase	in	mtDNA	at	the	blastocyst	stage	was	
preceded	by	an	increase	in	TFAM	expression	on	Day	4	after	ICSI.	It	is	not	clear	why	
only	 one	 blastocyst	 in	 the	 present	 study	 expressed	 TFAM	 and	 one	 the	 glucose	
transporter	 gene	 SLC2A1.	 However,	 it	 is	 noteworthy	 that	 Blastocyst	 H1,	 the	 only	
embryo	 to	express	SLC2A1,	was	 the	only	blastocyst	 to	develop	 from	a	COC	 in	 the	
17-mM	IVM	group.		
	
Information	on	 the	 temporal	dynamics	 and	 regulation	of	 cell	 lineage	allocation	 in	
the	equine	embryo	is	limited.	Choi	et	al.	first	described	POU5F1,	SOX2,	NANOG	and	
CDX2	 in	 equine	 blastocysts	 in	 2009	 and	 showed	 that	 there	 was	 indiscriminate	
presence	of	POU5F1	protein	across	the	entire	IVP	blastocyst	(Day	7-11)	whereas	it	
was	confined	to	the	ICM	in	in	vivo	derived	blastocysts	(Day	7-10).	They	then	showed	
that	TE	levels	of	POU5F1	fell	when	the	IVP	embryos	were	transferred	to	the	uteri	of	
mares	 for	 2	 to	 3	 days	 (IVP-ET).	 To	 confirm	 these	 immunohistochemistry	 findings,	
isolated	 TE	 and	 ICM	 cells	 from	 IVP-ET	 blastocysts	 were	 evaluated	 for	 mRNA	
expression,	 which	 revealed	 higher	 expression	 of	 pluripotency	 markers	 POU5F1,	
SOX2	 and	 NANOG	 in	 the	 ICM	 compared	 to	 the	 TE	 cells,	 verifying	 the	
immunohistochemistry	 results.	 A	 second	 study,	 published	 as	 a	 short	
communication,	compared	the	overall	expression	of	POU5F1,	NANOG,	SOX2,	GATA6	
and	 CDX2	 between	 in	 vivo	 and	 IVP	 embryos	 of	 different	 developmental	 stages	
(morula,	early	blastocyst	and	expanded	blastocyst)	and	found	that	in	in	vivo	derived	
embryos	 POU5F1,	 NANOG	 and	 SOX2	 expression	 decreased	 between	 the	 early	
blastocyst	and	blastocyst	stage	and	CDX2	increased	between	morula	and	expanded	
blastocyst	 (Paris	et	al.,	 2012).	 In	 contrast,	 they	did	not	detect	CDX2	mRNA	at	any	
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stage	in	IVP	embryos	and	reported	a	decrease	in	POU5F1	expression	overall	(Paris	
et	 al.,	 2012).	 A	 third	 study,	 by	 Iqbal	 et	 al.,	 (2014),	 reported	 next	 generation	
sequencing	 data	 of	 isolated	 ICM	 and	 TE	 cells	 from	 in	 vivo	 derived	 Day-8	 equine	
blastocysts.	These	authors	also	found	POU5F1	to	be	expressed	in	both	the	ICM	and	
TE,	but	reported	a	two	to	four	fold	increase	in	the	ICM.	Human	and	bovine	embryos	
also	display	delayed	loss	of	POU5F1	in	the	TE	compared	to	the	mouse	(Berg	et	al.,	
2011;	Niakan	and	Eggan,	2013).	
	
In	the	present	study,	the	five	blastocysts	had	high	universal	expression	of	POU5F1,	
perhaps	the	most	widely	studied	developmental	marker	given	its	important	role	in	
in	 regulating	and	maintaining	pluripotency.	 	With	 increased	 interest	 in	embryonic	
stem	 (ES)	 cells	 for	 clinical	 use	 in	 horses,	 several	 studies	 have	 reported	 POU5F1	
expression	in	isolated	equine	ICM	cells	and	ICM	outgrowths	after	several	passages	
to	 demonstrate	 pluripotency	 (Desmarais	 et	 al.,	 2011;	 Guest	 and	 Allen,	 2007).	
POU5F1	protein	was	detected	in	all	cells	 in	equine	IVP	blastocysts	 in	two	separate	
studies	 (Choi	 et	 al.,	 2015;	 Choi	 et	 al.,	 2009).	 In	 the	 present	 study	 there	was	 also	
universal	 expression	 of	 SOX2	 while	 significantly,	 none	 of	 the	 five	 blastocysts	
expressed	NANOG.	There	 is	known	species	variation	 in	NANOG	expression	and	 its	
temporal	 role	 in	 epiblast	 formation.	 For	 example	 it	 is	 not	 detected	 in	 the	 pig	
embryo	(Kuijk	et	al.,	2008)	while	in	the	cat	it	is	only	detectable	at	low	levels	(Filliers	
et	 al.,	 2012).	 Heterogeneity	 also	 exists	 within	 the	 same	 species	 as	 reported	 by	
Kimber	 et	 al.,	 (2008)	 who	 found	 non-universal	 expression	 of	 SOX2,	 NANOG	 	 and	
POU5F1	 in	human	blastocysts	 (5/13,	12/13	and	12/13	 respectively).	When	equine	
IVP	 embryo	 culture	 systems	 were	 being	 developed,	 a	 high	 incidence	 of	 an-
embryonic,	 trophoblast-only	 pregnancies	 after	 transfer	 was	 reported	 (Hinrichs	 et	
al.,	2007).	Given	the	role	of	NANOG	in	establishing	the	epiblast	which	later	gives	rise	
the	 embryo	 proper,	 it	 would	 have	 been	 interesting	 to	 know	 the	 NANOG	 mRNA	
status	 of	 those	 failed	pregnancies.	 As	 it	was	 detected	 in	 all	 three	 equine	 embryo	
studies	to	date,	the	reason	for	the	 lack	of	expression	 in	the	five	blastocysts	 in	the	
current	 study	 is	 unknown.	 It	 is	 unlikely	 to	be	a	primer	 fault	 as	 it	was	detected	 in	
cumulus	 cells	 (Chapter	 6)	 but	 could	 be	 due	 to	 differences	 in	 culture	 conditions,	
embryo	stage	or	possibly	individual	animal	variation.	
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Considering	 the	 TE	 marker	 genes,	 only	 one	 embryo	 expressed	 the	 trophoblast-
specific	transcription	factor	CDX2	while	expression	of	TEAD4,	a	transcription	factor	
upstream	of	CDX2	(Yagi	et	al.,	2007)	was	universal	but	at	varying	levels.	Choi	et	al.	
(2009)	 found	high	CDX2	expression	 in	 IVP-ET	blastocysts,	but	did	not	evaluate	 IVP	
blastocysts.	Paris	et	al.,	(2012)	failed	to	detect	CDX2	in	equine	IVP	blastocysts	while	
in	a	separate	study	they	reported	a	clear	increase	in	mRNA	expression	between	the	
morula	 and	 blastocyst	 stage	 in	 in	 vivo	 derived	 equine	 embryos	 in	 line	 with	 an	
increase	 in	 number	 of	 TE	 cells	 (Paris	 et	 al.,	 2011).	 Given	 this	 strong	 temporal	
relationship	in	expression,	it	is	worthwhile	noting	that	all	blastocysts	in	the	present	
study	 were	 lysed	 within	 a	 similar	 time	 frame	 (25.9	 ±	 1.7	 hours	 post	 start	 of	
blastulation),	 and	 as	 such	 it	 is	 possible	 that	 all	 the	 blastocysts	were	 lysed	 before	
sufficient	TE	cells	were	present	and	hence	detectable	amounts	of	CDX2	mRNA.	As	
TEAD4	acts	upstream	of	CDX2,	the	presence	of	TEAD4	in	all	blastocysts	supports	this	
idea.	 Notably,	 expression	 of	 CDX2	 protein	 was	 found	 universally	 in	 IVP	 equine	
blastocysts	 cultured	 for	 24	 hours	 after	 recognition	 of	 blastulation,	 similar	 to	 the	
current	 study	 (Choi	 et	 al.,	 2015).	 It	 was	 interesting	 that	 the	 single	 blastocyst	
expressing	CDX2	(Blastocyst	C4)	also	had	the	lowest	POU5F1	expression,	suggesting	
a	reciprocal	relationship	between	these	transcription	factors,	in	agreement	with	the	
literature	 in	 other	 species	 (Filliers	 et	 al.,	 2012;	 Kuijk	 et	 al.,	 2008;	 Strumpf	 et	 al.,	
2005).		
	
Due	to	the	low	number	of	blastocysts	obtained,	the	effect	of	glucose	during	IVM	on	
the	expression	of	pluripotency	or	TE	marker	genes	in	the	equine	embryo	could	not	
be	determined.	 In	other	 species,	 hyperglycaemia	affects	 cell	 lineage	allocation.	 In	
both	the	mouse	and	rat,	in	vivo	diabetic	models	have	generated	data	demonstrating	
that	 blastocysts	 recovered	 from	 diabetic	 mice	 have	 a	 decreased	 number	 of	 ICM	
cells	 resulting	 in	 a	 decreased	 ICM	 :TE	 ratio	 (Lea	 et	 al.,	 1996;	 Leunda-	 Casi	 et	 al.,	
2002;	Pampfer	et	al.,	1990).	The	mechanism	behind	this	decreased	ICM	:TE	ratio	is	
likely	mediated	by	increased	apoptosis	via	upregulation	of	BAX	leading	to	increased	
DNA	fragmentation	(Chi	et	al.,	2000;	Moley	et	al.,	1998),	however	the	reason	for	the	
increased	 sensitivity	 of	 the	 ICM	 cells	 is	 unclear.	 There	 is	 one	 study	 on	 equine	
embryos	by	Choi	et	al.,	(2015)	performed	during	early	embryo	development	in	vitro	
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(Days	 0-7	 after	 ICSI)	 which	 also	 demonstrated	 that	 the	 medium	 glucose	
concentration	during	Days	0-5	of	 culture	 influenced	 cell	 allocation.	 These	authors	
reported	that	while	the	blastocyst	rate	remained	constant,	there	was	a	decrease	in	
total	cell	number	and	presumptive	epiblast	cell	number	when	injected	oocytes	were	
cultured	 at	 5	mM	 glucose	 compared	 to	 0	mM.	While	 expression	 of	 pluripotency	
genes	was	 not	measured	 in	 any	 of	 the	 above	 studies	 it	 could	 be	 postulated	 that	
those	 embryos	 with	 decreased	 number	 of	 ICM	 cells	 would	 also	 have	 decreased	
POU5F1	expression	given	the	preferential	 ICM	expression	 in	the	mouse	and	rat.	 It	
would	be	interesting	to	discover	if	the	same	was	true	for	the	horse	given	the	lack	of	
POU5F1	localisation	to	the	ICM.	
	
While	 the	 ambitious	 aim	 of	 identifying	 associations	 between	 blastocyst	 gene	
expression,	COC	metabolism	and	morphokinetics	of	embryo	development	could	not	
be	addressed	due	to	low	embryo	numbers,	this	study	served	as	proof	of	principle	of	
the	value	of	this	experimental	design.	It	is	possible	to	speculate	on	some	interesting	
observations.	 Blastocyst	 C1	 developed	 from	 a	 COC	 that	 depleted	 all	 available	
glucose	during	IVM,	and	of	the	five	embryos,	it	had	the	highest	relative	expression	
of	PFKM	and	LDHA,	was	the	only	embryo	to	express	TFAM	and	had	the	lowest	GPX1	
expression.	It	is	possible	that	high	rates	of	COC	glucose	metabolism	programmed	a	
high	 rate	of	 glycolysis	 in	 the	blastocyst	 as	demonstrated	by	high	PFKM	and	 LDHA	
expression.	The	effect	of	the	complete	depletion	of	glucose	during	IVM	could	also	
not	 be	 investigated,	 however	 the	 low	 expression	 of	 GPX1,	 is	 of	 interest	 given	 its	
association	with	developmental	potential	in	other	species.	GPX1	has	been	shown	to	
be	upregulated	both	in	higher	quality	bovine	embryos	(Cebrian-Serrano	et	al.,	2013)	
and	in	porcine	embryos	with	enhanced	survival	after	cryopreservation	and	thawing	
(Castillo-martín	 et	 al.,	 2014).	 An	 equine	 study	 also	 reported	 a	 decrease	 in	GPX3	
expression	 in	 IVP	 compared	 to	 in	 vivo	 derived	blastocysts,	 further	pointing	 to	 the	
potential	 association	 of	 glutathione	 peroxidase	 expression	 with	 developmental	
competence.	In	line	with	GPX1	potentially	being	a	marker	for	blastocyst	quality,	it	is	
interesting	 that	 Blastocyst	 C3,	 which	 had	 the	 highest	 GPX1	 expression,	 had	 the	
highest	POU5F1	expression	in	addition	to	being	the	largest	and	fastest	to	develop.	
POU5F1	 expression	 was	 also	 positively	 correlated	 to	 the	 time	 of	 blastocyst	
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development	overall.	Equine	clinical	ICSI	data	have	recently	shown	that	likelihood	of	
foal	production	 is	higher	for	blastocysts	that	form	on	Day	7	(52%)	than	those	that	
form	on	Day	8	(38%)	(Claes	et	al.,	2018).	The	slowest	embryo	to	develop	(Blastocyst	
C4)	began	blastulating	at	224	hours	(Day	9)	and	had	the	lowest	POU5F1	expression	
and	 very	 low	 GPX1	 expression,	 further	 suggesting	 that	 POU5F1	 and	 GPX1	 are	
potential	developmental	markers.	It	was	also	notable	that	this	embryo	was	the	only	
one	to	express	CDX2.	
	
Conclusions	
The	 results	 of	 this	 study	 demonstrate	 that	 a	 change	 in	metabolism	occurs	 at	 the	
level	 of	 the	mitochondria	when	 equine	 COCs	 undergo	 IVM	 in	 the	 presence	 of	 17	
mM	vs.	5.6	mM	glucose,	however	further	work	is	needed	to	unravel	the	differences	
in	pathway	allocation	and	 their	 consequences,	 if	any,	 to	developmental	potential.	
The	 role	 of	 the	 HBP	 and	 direct	 measurement	 of	 ROS	 would	 be	 particularly	
interesting	 areas	 for	 future	 research	 in	 the	 horse.	 Currently,	 it	 appears	 that	 the	
equine	 COC	 can	 adapt	 to	 differing	 glucose	 concentrations,	 however	 it	 is	 not	
established	whether	the	imbalance	of	glucose	pathways	and	altered	mitochondrial	
function	have	negative	downstream	effects	on	pregnancy	outcome	or	the	offspring.		
	
The	 novel	 experimental	 design	 and	 blastocyst	 gene	 expression	 data	 represent	
exciting	avenues	for	future	study,	in	both	the	horse	and	other	species.	
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Chapter	6:	The	use	of	transcript	profiling	of	single	COCs	to	understand	the	impact	
of	glucose	concentration	during	IVM.			
	
6.1	Introduction	
	
Interpretation	of	data	 in	Chapter	5	 indicated	that	 increased	glucose	concentration	
during	 IVM	 resulted	 in	 altered	 mitochondrial	 function	 in	 the	 COC.	 However,	 no	
effect	 on	 gene	 expression	 in	 the	 blastocyst	 was	 observed.	 In	 the	 experiments	
reported	in	this	chapter,	the	immediate	effects	of	hyperglycaemia	on	the	cumulus	
cell	 and	 oocyte	 transcriptome	 were	 examined	 in	 an	 attempt	 to	 identify	 the	
mechanisms	 and	 consequences	 of	 the	 observed	 alteration	 in	 mitochondrial	
function.	 However,	 this	 approach	 presented	 challenges	 in	 interpretation	 and	 as	
such	a	brief	 literature	 review	on	aspects	of	 transcriptomic	analysis	 specific	 to	 this	
chapter	is	given	below.	
	
Interpreting	the	oocyte	transcriptome	given	the	dynamic	nature	of	maternal	mRNA	
While	 it	 is	 accepted	 that	 the	 majority	 of	 mRNA	 within	 the	 mature	 oocyte	 is	
synthesized	 in	 the	 growth	 phase,	 continuing	 up	 to	 the	 point	 of	 chromatin	
condensation,	 there	 is	 controversy	 (a)	 on	 whether	 or	 not	 transcription	 occurs	
during	 meiotic	 resumption	 (i.e.	 final	 maturation	 of	 the	 oocyte)	 and	 (b)	 the	
interpretation	 of	 differentially	 expressed	 genes	 in	 oocytes	 between	 different	
conditions.		
	
Maternal	mRNA	 is	produced	 in	 the	nucleus	and	exported	to	 the	cytoplasm	during	
the	growth	phase	of	the	oocyte.	While	in	most	cells	mRNA	has	a	very	short	lifespan,	
the	oocyte	 is	unique	 in	being	able	to	store	cytoplasmic	mRNA	 in	a	stable	state	by	
shortening	 the	polyA	 tail	 (20-40	bp).	 The	 subsequent	 translation	of	mRNA	 is	 then	
regulated	by	temporal	polyadenylation	(lengthening	to	80-250	bp)	or	deadenylation	
(Rodriguez	and	Farin,	2004)	and	 timely	availability	of	 specific	mRNAs	 is	 crucial	 for	
meiotic	resumption,	fertilization	and	early	cleavage	divisions	through	to	embryonic	
genome	 activation	 [EGA]	 (Mamo	 et	 al.,	 2011).	 Polyadenylation	 involves	 the	
phosphorylation	 of	 CPE	 (cytoplasmic	 polyadenylation	 element)-binding	 proteins	
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(CPEs	 are	 uridine-rich	 sequences	 at	 the	 3’UTR).	 In	Xenopus	 oocytes,	 in	 the	 stable	
(inactive)	 state,	 these	 proteins	 are	 associated	 via	 a	 closed-loop	 structure	 with	
maskin	proteins	 at	 the	5’	 end,	 however	when	phosphorylated	 they	 are	no	 longer	
associated	and	other	proteins	 such	as	Poly-A	binding	proteins	act	 to	elongate	 the	
PolyA	tail	(Lin,	2010).	This	mechanism	is	fairly	well	conserved	in	mammalian	species	
(Reyes	and	Ross,	2016).	
	
The	mechanisms	by	which	temporal	translation	of	maternal	mRNAs	is	controlled	are	
still	 unclear.	 Recently	 Cakmak	 et	 al.,	 (2016),	 using	 IL-7	 as	 an	 example	 (an	 oocyte	
specific	 cytokine,	 secretion	 of	 which	 increases	 during	 final	 oocyte	 maturation),	
showed	 that	 translation	 in	 the	oocyte	was	promoted	by	 the	presence	of	 cumulus	
cells.	 They	 measured	 polysome-associated	 mRNA,	 an	 indicator	 of	 translation,	 in	
response	 to	 AREG	 (an	 epidermal-like	 growth	 factor)	 in	 cumulus-surrounded	
oocytes.	 	 In	 comparison	 to	 denuded	 oocytes,	 they	 reported	 increased	 polysome	
bound	 IL-7	mRNA	 in	 cumulus-surrounded	oocytes	 in	 the	presence	of	AREG,	while	
total	 mRNA	 remained	 the	 same.	 As	 such,	 the	 changes	 in	 measured	 polysome-
associated	transcript	levels	were	due	to	cumulus	cell	regulated	transfer	of	mRNA	to	
the	polysome	for	translation	and	not	due	to	increased	transcription.		
	
At	least	in	the	mouse,	oocyte	maturation	initiates	a	transition	from	mRNA	stability	
to	 instability,	 largely	attributable	to	phosphorylation	of	the	oocyte	specific	protein	
MSY2	(Medvedev	et	al.,	2008).	This	subsequently	triggers	degradation	of	maternal	
mRNA	both	by	3’	end	deadenylation	and	5’	end	decapping.	 It	has	been	proposed	
that	these	processes	occur	in	a	regulated	manner	to	decrease	total	mRNA	load	and	
time	 the	 oocyte	 to	 zygote	 transition	 (Ma	 et	 al.,	 2015,	 2013).	 The	 rate	 at	 which	
mRNA	 degradation	 occurs	 at	 the	 5’	 end	 may	 be	 regulated	 by	 the	 maternally	
imprinted	genes	DCP1A	and	DCP2	(Ma	et	al.,	2013),	while	3’	deadenylation	may	be	
regulated	 by	 CNOT7	 (Ma	 et	 al.,	 2015).	 These	 authors	 showed	 that	 by	 inhibiting	
accumulation	 of	 DCP1/2	 proteins,	 there	 was	 less	 degradation	 of	 mRNA	 and	 the	
progression	 to	 EGA	 was	 subsequently	 slowed	 while	 inhibition	 of	 CNOT7	 protein	
resulted	in	a	70%	decrease	in	transcription	at	the	2-cell	embryo	stage.	
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Given	 the	 above,	 detected	 oocyte	 mRNA	 at	 any	 given	 time	 point	 potentially	
represents	either	 those	 transcripts	 remaining	after	 translation	and	degradation	or	
those	 being	 stored	 for	 use	 during	 subsequent	 developmental	 stages	 such	 as	
fertilization	and	transition	though	EGA.	However,	several	authors	have	shown	that	
there	 are	 differentially	 expressed	 transcripts	 between	 IVM	 and	 in	 vivo	 matured	
oocytes	 (Katz-jaffe	 et	 al.,	 2009),	 GV	 and	 MII	 oocytes	 (Mamo	 et	 al.,	 2011)	 and	
oocytes	matured	in	vitro	in	different	conditions	(Kumar	et	al.,	2013;	Ma	et	al.,	2012;	
Van	Hoeck	et	 al.,	 2013;	Watson	et	 al.,	 2000).	 	While	 some	 report	 this	differential	
expression	 to	be	due	 to	differences	 in	 cytoplasmic	polyadenylation	 (CP)	 (Reyes	et	
al.,	2015)	and	not	transcription,	others	disagree.	Mamo	et	al.	(2011)	found	25%	of	
9500	 bovine	 transcripts	 to	 be	 differentially	 expressed	 between	 GV	 and	 MII	 IVM	
oocytes	and	that	25%	of	these	(approx.	600)	were	upregulated	in	MII	oocytes.	They	
discussed	that	this	25%	upregulation	defies	the	commonly	held	understanding	that	
maturing	oocytes	are	transcriptionally	silent.	They	went	on	to	show	that	these	were	
in	fact	newly	transcribed	by	culturing	in	the	presence	of	α-amanatin	(a	transcription	
inhibitor)	 and	 finding	 that	 the	 transcripts	were	 no	 longer	 upregulated.	 There	 are	
clearly	divergent	views	on	the	regulation	of	the	oocyte	transcriptome.		
	
Effects	of	glucose	concentration	on	the	oocyte	and	cumulus	cell	transcriptome		
Hyperglycaemia,	secondary	to	either	Type	I	or	II	diabetes	is	a	major	clinical	concern	
in	 women	 due	 to	 the	 increased	 prevalence	 of	 pregnancy	 complications,	 birth	
defects	and	ill	health	in	the	offspring.	Many	mechanisms	have	been	put	forward	but	
the	 precise	 physiology	 mediating	 the	 downstream	 pregnancy-related	 effects	 of	
diabetes	 remains	 elusive.	 In	 attempts	 to	 uncover	 these	mechanisms,	 researchers	
have	 investigated	 the	 oocyte	 and	 cumulus	 cell	 transcriptome	 in	 streptozotocin	
(STZ)-injected	mice	 (in	which	pancreatic	β	cells	have	been	destroyed)	or	 the	Akita	
mouse	(which	have	genetic	mutation	 in	 Ins2	gene)	both	of	which	result	 in	 insulin-
dependent	diabetes.	Several	changes	due	to	hyperglycaemia	have	been	reported	in	
cumulus	 cells	 from	 diabetic	 mice	 such	 as	 upregulation	 of	 apoptotic	 genes	 and	
downregulation	of	connexin	expression	and	glucose	 transport	 (Chang	et	al.,	2005;	
Colton	et	al.,	2003;	Ratchford	et	al.,	2008;	Wang	et	al.,	2010).	 	 In	2012,	Ma	et	al.	
carried	out	whole	transcriptome	analysis	on	oocytes	from	normal,	STZ	injected	and	
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non-obese	 diabetic	 (NOD)	mice.	 They	 reported	 that	 535	 genes	were	 upregulated	
and	 83	 genes	 downregulated	 in	 both	 the	 STZ	 and	 NOD	 mice	 compared	 to	 the	
normal	mice.	During	 IVM,	 genes	 related	 to	 the	hexosamine	biosynthesis	 pathway	
(HBP)	and	endoplasmic	reticulum	stress	are	also	upregulated	in	murine	COCs	in	the	
face	of	hyperglycaemia	(30	mM	glucose),	some	after	only	8	hours	in	culture	(Wong	
et	 al.,	 2015).	 A	 single	 study	 in	 the	 buffalo	 reported	 differential	 expression	 of	
carbohydrate	 metabolism	 genes	 in	 oocytes	 after	 IVM	 attributable	 to	 medium	
glucose	concentrations	(0,	1.5,	5.6	and	10	mM	glucose;	Kumar	et	al.,	2013).		
	
The	equine	oocyte	and	cumulus	cell	transcriptome-	what	is	known?	
There	 have	 been	 several	 gene	 expression	 studies	 in	 equine	 oocytes	 and	 cumulus	
cells.	Thus	far,	they	have	been	limited	to	comparing	in	vivo	maturation	and	IVM,	the	
effect	of	mare	age	and	the	influence	of	maturation	status	and	cumulus	morphology	
(Summarised	 in	Table	6.1).	Of	 interest	 to	 this	 study,	TFAM	has	been	shown	 to	be	
differentially	expressed	in	oocytes,	and	GPX1	and	SLC2A1	differentially	expressed	in	
cumulus	cells	in	COCs	from	different	sources	or	treatments.	
	
There	 are	 no	 studies	 on	 the	 effect	 of	 culture	 conditions	 on	 the	 equine	 COC	
transcriptome.	In	previous	chapters	the	independent	effect	of	glucose	(5.6	mM	and	
17	 mM)	 and	 pyruvate	 (0	 mM,	 0.15	 mM	 and	 0.5	 mM)	 on	 COC	 meiotic	 and	
developmental	 competence,	 glucose	metabolism	 and	mitochondrial	 function	 was	
evaluated;	 while	 there	 was	 an	 effect	 of	 glucose	 concentration	 on	 mitochondrial	
function,	 this	was	not	 associated	with	 a	 significant	 effect	 on	measured	metabolic	
parameters	or	on	meiotic	or	developmental	competence.	The	mechanism	by	which	
the	 equine	 COC	 can	 tolerate	 and	 thrive	 in	 high	 glucose	 media	 remains	 unclear.	
DMEM/F12,	one	of	 the	media	used	 clinically	 for	 IVM	 in	 the	horse,	 combines	high	
glucose	 (17	mM	glucose)	 and	pyruvate	 (0.5	mM).	 It	 is	 possible	 that	 the	 supply	of	
pyruvate	in	DMEM/F12	is	protective	or	ameliorates	the	effect	of	the	high	glucose.	In	
this	 regard,	 two	 further	media	 are	 introduced	 to	 the	 experimental	 design	 in	 the	
current	 study;	 DMEM/F12	 itself	 and	M199	medium	with	 added	 glucose	 (17	mM)	
and	pyruvate	(0.5	mM)	to	account	for	this	difference	in	composition.	
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Genes	 for	 key	 factors	 in	 metabolic	 pathways,	 and	 enzymes	 of	 carbohydrate	
metabolism,	known	 to	be	affected	by	hyperglycaemia	 (measured	 in	blastocysts	 in	
Chapter	5)	were	measured	 in	oocytes/cumulus	cells	 in	the	present	chapter.	These	
are	 glycolysis	 (phosphofructokinase	 [PFK]	 and	 lactate	 dehydrogenase	 [LDHA]),	
pentose	 phosphate	 pathway	 (Glucose-6-phosphate	 dehydrogenase	 [G6PD]),	
glucose	transporter	solute	carrier	family	2	member	1	(SLC2A1;	formerly	GLUT	1)	and	
fatty	acid	transporter	carnitine	palmitoyltransferase	1A	(CPT1A).	Finally,	markers	of	
oxidative	stress	and	mitochondrial	replication;	glutathione	peroxidase	1	(GPX1)	and	
mitochondrial	 transcription	 factor	 A	 (TFAM)	 were	 also	 evaluated.
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Table	6.1:	Summary	of	the	literature	on	equine	oocyte	and	cumulus	gene	expression.	Genes	relative	to	this	chapter	are	highlighted	in	yellow
Area	of	Study	 Oocyte		 Cumulus	 Type	of	pathway	 Author	
Pre	and	post	IVM	 	 êGPX	MII	 Oxidative	stress	 Luciano	et	al.,	2006	
	 çèConnexin	43,	COX2,	FSHr	 Cumulus	expansion	 Dell’Aquila	et	al.,	2004	
ê	IL1β	MII	
çè	ILIR2	
	 Inflammation	 Martoriati	et	al.,	2002	
êTFAM,	mtPLOB,	ATP-synthF6	
MII	
çèSSB,	GPX3	
	 Mitochondrial	replication,	
oxidative	stress	and	
energy	production	
Hendriks	et	al.,	2015	
çèKAT8,	HAT,	SIRT,	HDAC1	 	 Histone	deacetylation	 Franciosi	et	al.,	2015	
In	vivo	vs.	IVM	 ê	IL1β	IVM	  Inflammation	 Martoriati	et	al.,	2002	
êHK16	acetylation	IVM  Histone	deacetylation	 Franciosi	et	al.,	2015	
çèKAT8,	HAT,	SIRT,	HDAC1  	 	
Mare	age	 êGDF9,	BMP15	in	old	mares	
çèLHR,	AREG,	EREG,	PDE,	
GPR3 
çèLHR,	AREG,	EREG,	PDE,	GPR3,	GDF9,	
BMP15 
Oocyte-	cumulus	
communication	
Campos-chillon	et	al.,	2015	
çè	TFAM,	GPX3,	mtPLOB,	ATP-
synthF6,	SSB 
 Mitochondrial	replication,	
oxidative	stress	and	
energy	production	
Hendriks	et	al.,	2015	
êIF3,	HSF5,	YBX2	in	old	mares é	ARL6IP6,	BAX,	HYOU1	in	old	mares Apoptosis,	oxidative	stress	 Cox	et	al.,	2015	
 é	INSR,	ADIPOR2,	PPARG,	IL6,	IL6S,	STAR,	
TXN2	in	old	mares	
ê	TNF	old	mares 
Metabolism,	inflammation	
(*Mural	granulosa	only)	
Sessions-Bresnahan	and	
Carnevale,	2015	
Obesity	  êPLIN2,	EIF2AK3,	IGFR1/2	in	obese	mares	
 
Lipid	homeostatis,	
oxidative	and	
mitochondrial	stress	
Sessions-Bresnahan	et	al.,	
2016	
Metabolic	Syndrome		  êEREG	in	EMS	mares	
 
Oocyte	maturation	
(*Mural	granulosa	only)	
Sessions-Bresnahan	et	al.,	
2014	
Cumulus	morphology	 é	TNFAIP6	in	intact	EX	COC	
çè	SLC2A1,	PFKP,	LDHA,	GDF9,	
BMP15,	FAS,	BAX,	BCL2L1,	
SLC2A3,	PDK3	 
é	SLC2A1,	TNFAIP6	in	EX	
êFAS,	BAX	in	EX	
çè	PFKP,	LDHA,	FASLG,	BCL2L1,	SLC2A3,	
PDK3	
Cumulus	expansion,	
glucose	transport	and	
metabolism	(*intact	COC	
vs.	mural	granulosa	only)	
Gonzalez-fernandez	et	al.,	
2018	
é	TFAM,	STAT3,	CKS2	in	EX	
êCOX1,	ATPV6E,	DNMT1	in	EX	
 
 Oxidative	stress,	
mitochondria,	cell	cycle	
Mohammadi-Sangcheshmeh	
et	al.,	2014		
çèBAX,	p53,	SURVIVIN	 êBAX	in	EX	
çè	p53,	SURVIVIN	 
	 Leon	et	al.,	2013	
	 185	
Summary	
By	evaluating	relative	gene	expression	in	oocytes	and	cumulus	cells	 in	response	to	
hyperglycaemia	during	IVM,	the	aim	was	to	shed	light	on	the	mechanism	by	which	
mitochondrial	 efficiency	 is	 altered	 but	 developmental	 potential	 and	 glucose	
metabolism	 are	 not.	 Uniquely,	 gene	 expression	 analysis	 allows	 associations	
between	oocyte/cumulus	cell	relative	gene	expression	and	COC	glucose,	lactate	and	
pyruvate	metabolism	to	be	explored	in	detail.		
	
	
6.2	Objectives	
	
1. Evaluate	 the	 impact	 of	 increased	 glucose	 (17	mM	 vs.	 5.6	mM),	 increased	
pyruvate	 concentration	 (0.5	 vs.	 0	 mM),	 and	 an	 established	 medium	
containing	17	mM	glucose	and	0.5	mM	pyruvate,	during	IVM	on:	
a. Relative	 expression	 of	 genes	 associated	 with	 glucose	 metabolism	
(G6PD,	PFKM	and	LDHA),	oxidative	stress	(GPX1	and	TFAM),	glucose	
transport	(SLC2A1)	and	fatty	acid	transport	(CPT1A)	in	single	oocytes	
and	corresponding	cumulus	cells	(Experiment	6.1,	Study	1).		
g. Glucose	 consumption	 and	 lactate	 and	pyruvate	production	 rates	 of	
COCs	during	IVM	(Experiment	6.1,	Study	2).	
2. Explore	associations	between	the	relative	expression	of	the	above	genes	in	
oocytes	and	their	corresponding	cumulus	cells	(Experiment	6.1,	Study	3A).	
3. Explore	associations	between	the	relative	expression	of	 individual	genes	 in	
the	same	oocyte	and	cumulus	cell	sample	(Experiment	6.1,	Study	3B).	4. Explore	 the	 association	 between	 the	 relative	 expression	 of	 the	 above	
metabolic	genes	in	the	oocyte	and	cumulus	cells	and	the	corresponding	COC	
metabolism	during	IVM	(Experiment	6.1,	Study	3C).		
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6.3	Materials	and	Methods	
	
COCs	were	recovered	from	abattoir-derived	ovaries,	classified	and	held	overnight	as	
previously	described	 in	Sections	2.1.1	and	2.1.2.	Compact	 (Cp)	and	expanded	 (Ex)	
COCs	 were	 divided	 equally	 and	 randomly	 between	 conditions,	 so	 that	 for	 each	
collection	 day,	 each	 maturation	 condition	 contained	 equal	 numbers	 of	 each	
cumulus	type.		
	
In	vitro	maturation	
Maturation	was	carried	out	in	individual	10-μl	droplets	at	5%	CO2	in	air.	There	were	
12	droplets	 in	each	dish;	COCs	were	placed	 in	nine	of	 them	while	 three	remained	
empty	 and	were	 used	 as	 reference	 droplets.	 Dishes	were	 continuously	 incubated	
for	 the	 entire	 30-hour	 IVM	 period	 in	 one	 of	 four	 IVM	 conditions	 as	 follows:	 1)	
Control	Maturation	Medium	(5.6	mM	glucose;	M199	with	Earle’s	salts,	10	%	FBS,	25	
μg/ml	 gentamicin	 with	 5	 mU/ml	 FSH;	 0	 mM	 pyruvate)	 [Group	 C];	 High	 glucose	
Maturation	Medium	 (17	mM	 glucose;	 As	 above	with	 addition	 of	 glucose)	 [Group	
HG];	 DMEM/F12	 Maturation	 medium	 (17	 mM	 glucose	 and	 0.5mM	 Pyruvate;	
DMEM/F12	[Sigma],	10	%	FBS,	25	μg/ml	gentamicin	with	5	mU/ml)	[Group	DMEM];	
High	glucose,	high	pyruvate	Maturation	Medium	(high	glucose	[17mM]	maturation	
medium	 as	 above	 with	 the	 addition	 of	 0.5	 mM	 pyruvate)	 [Group	 HG-HP].	 This	
medium	 was	 chosen	 due	 to	 the	 many	 differences	 in	 composition	 between	 the	
DMEM/F12	and	M199	media	other	than	the	glucose/pyruvate	concentrations.	
	
After	 the	maturation	 period	was	 complete,	 COCs	were	 denuded	 and	 classified	 as	
Metaphase	 II,	 intact	 or	 degenerated	 as	 previously	 described	 in	 Section	 2.1.4.	
Denuded	cumulus	cells	 from	each	MII	COC	were	placed	 in	a	 labelled	96-well	plate	
and	kept	at	-20	°C	until	later	DNA	quantification	analysis.	Some	denuded	cells	were	
saved	 for	extraction	of	mRNA.	Spent	media	were	 frozen	at	 -80°	C	and	analyses	of	
thawed	samples	carried	out	as	previously	described	in	Section	2.2.		
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Gene	expression	analysis		
In	each	of	the	three	replicates,	cDNA	was	prepared	from	mRNA	extracted	from	two	
immature	 oocytes	 with	 compact	 cumulus	 (Cp)	 and	 two	 immature	 oocytes	 with	
expanded	cumulus	(Ex).		After	maturation,	cDNA	was	prepared	from	all	MII	oocytes	
and	from	a	sample	of	each	oocyte’s	corresponding	cumulus	cells	(those	associated	
with	 the	oocyte	during	 IVM	and	 removed	by	denuding).	 Lysis,	 cDNA	amplification	
and	picogreene	quantification	were	carried	out	as	detailed	in	Section	2.5.1.	
	
Seven	 genes	 of	 interest	 were	 investigated	 and	 Taqman®	 probe	 based	 primers	
designed	within	300	bp	of	the	polyA	tail	at	the	3’	UTR	(Primerdesign	LTD;	Table	6.2).	
All	 primers	 were	 the	 same	 as	 those	 used	 for	 the	 blastocysts	 in	 Chapter	 5	 and	
optimised	 and	 tested	 using	 amplified	 cDNA	of	 each	 sample	 type	 by	 Primerdesign	
LTD.		
	
Name	 Accession	
number	
Sense	primer	 Antisense	primer	
G6PD	 XM_001492232	 CTTGCCACTAGGAAAGTA
GAAGC	
AGGCAGGTCTGTTTGTGGA
TT	
PFKM	 NM_001081922	 TGGAAGCTCCTTTTAGGT
AGAATTTAT	
AATCTCGCAGTGGCACTAG
AGG	
Cpt1A	 NM_001081808	 TTCCTTCCATCCAGGGTTG
G	
GACCTGCCCAGAAGTAGTA
GG	
GPX1	 NM_001166479	 GAACGCCTGATGTTAAGG
AGAAT	
TTATTAGTGAGAAGCCGTG
GTCT	
TFAM	 XM_001503382.3	 ATCTTGGGAAGAACAAAT
GATTGAAG	
TGTCTATCTACTGTGAACAT
AACTCAA	
LDHA	 NM_001144880	 GATGCGTGTTTACTCTGT
GTGAT	
TCTCAAGATGTGACTGACT
GAAGA	
SLC2A1		
	
NM_001163971	 GAGGTCAGGCTCCATTAG
GATT	
CAACTGGTCTCAGGCAAGG
A	
	
Table	6.2:	Genes	and	primer	sequences	for	genes	of	interest	used	in	Study	1.	
	
qPCR	reactions	were	made	up	as	follows	and	plated	in	triplicate;	5	μl	cDNA	(5ng),	1	
μl	 primer,	 10	 μl	 PrecisionPlus	mastermix	 (Primerdesign	 LTD)	 and	 4	 μl	 PCR	water.	
Amplification	was	 performed	on	 a	 Biorad	CFX	using	 the	 following	 protocol;	 initial	
enzyme	denaturation	of	2	minutes	at	95	°C	 then	50	cycles	of	15	seconds	at	95	°C	
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and	60	seconds	at	60	°C.	Data	was	collected	through	the	FAM	channel	at	the	final	
stage.	Reference	genes	RPL32	and	UBC	were	also	run	for	each	sample	on	each	plate	
for	further	stability	testing	(See	Section	2.5.2).	
	
Statistical	analysis	
	
Study	1	
The	 rate	 of	 maturation	 to	 MII	 was	 compared	 among	 treatments	 using	 the	 Chi-	
square	 test.	 The	mean	 Ct	 value	 from	 each	 technical	 triplicate	 was	 calculated	 for	
each	 sample	 and	 retained	 if	 variation	 was	 <	 1	 Ct.	 Ct	 values	 over	 36	 with	 high	
technical	variation	were	assumed	to	be	not	expressed.	ΔCt	was	then	calculated	for	
each	sample	by	subtracting	the	Ct	value	of	the	reference	gene	of	that	sample	(from	
that	 plate)	 from	 the	 Ct	 value	 of	 the	 gene	 of	 interest.	 Relative	 expression	 (2-ΔCt;	
Schmittgen	and	Livak,	2008)	was	then	compared	across	experimental	groups	using	
either	Student’s	t-test	(immature	vs.	MII)	or	One-way	ANOVA	using	the	Bonferroni	
statistic.	
	
Study	2	
The	 primary	 outcome	 variables	 were	 glucose	 consumption,	 lactate	 and	 pyruvate	
production	 rates	 (expressed	 as	 pmol/ngDNA/hour).	 One-way	 ANOVA	 using	 the	
Bonferroni	statistic	was	used	to	explore	differences	related	to	IVM	condition.	
	
Study	3		
Relative	gene	expression	between	oocytes	and	corresponding	cumulus	cells	(Study	
3A)	 and	 between	 individual	 genes	 (Study	 3B)	were	 analysed	 by	 linear	 regression.	
Relative	gene	expression	for	both	oocytes	and	cumulus	cells	was	analysed	by	linear	
regression	 against	 the	 corresponding	 COC	 glucose	 consumption,	 lactate,	 and	
pyruvate	 production	 rates	 (all	 expressed	 as	 pmol/ngDNA/hour)	 and	 the	 ratio	 of	
lactate	production	to	glucose	consumption	during	IVM	(Study	3C).	 	
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6.4	Results	
	
Twelve	immature	oocytes	and	61	IVM	oocytes	were	evaluated	over	three	replicates.	
Of	 the	 IVM	 oocytes,	 26	 (42.6%)	 reached	 Metaphase	 II.	 There	 was	 no	 significant	
difference	 in	maturation	rate	among	 IVM	treatments	 (P	>	0.1).	For	5/26	MII	COCs	
there	were	 insufficient	numbers	of	cumulus	cells	 for	both	DNA	quantification	and	
mRNA	extraction,	in	these	cases	(where	there	were	enough	cells)	mRNA	extraction	
was	 prioritised	 and	 spent	 media	 analyses	 were	 not	 performed	 for	 those	 COCs.	
Where	 there	were	 insufficient	cells	 for	either	evaluation,	only	 the	MII	oocyte	was	
used	for	mRNA	extraction	(see	Table	6.3).		
	
	 Immature	 Control	
(5.6	mM	G/	
0	mM	P)	
High	Glucose	
(17	mM	G/		
0	mM	P)	
High	Glucose	
High	Pyruvate	
(17mM	G/	
0.5mM	P)	
DMEM	
(17	mM	G/	
0.5	mM	P)	
Total	
n	 12	 14	 14	 15	 18	 73	
MII	%	 N/A	 43%		
(6/14)	
50%		
(7/14)	
27%		
(4/15)	
50%		
(9/18)	
26	
GPL	 N/A	 4		 7	 3	 7	 21	
cDNA	
oocytes	
11	 6	 7	 4	 9	 37	
cDNA	
cumulus	
10	 5	 7	 4	 7	 33	
	
Table	 6.3:	Number	 of	 COCs	 assigned	 to	 each	 experimental	 group	 (n).	Maturation	
rate	for	each	experimental	condition	and	number	of	samples	subsequently	available	
for	 each	 study	 is	 also	 shown	 (GPL;	 glucose	 pyruvate	 lactate	 metabolic	
measurements).	
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6.4.1	 Experiment	 6.1,	 Study	 1:	 Effect	 of	 increased	 glucose	 and	 pyruvate	
concentration	during	IVM	on	gene	expression	
	
Cumulus	cells	
Thirty-three	 cumulus	 cell	 samples	were	 analysed	 in	 total	 across	 the	 experimental	
groups	and	all	data	were	included	in	the	analysis	(Table	6.3).	As	each	housekeeping	
gene	was	plated	for	each	sample	on	each	plate,	 the	 inter-plate	variation	could	be	
calculated.	This	was	≤	1%.	Reference	genes	UBC	and	RPL32	were	further	examined	
for	 suitability	 for	 normalisation,	 and	 as	 RPL32	 showed	 higher	 expression	 in	 all	
samples	(mean	Ct	19.5	vs.	23.4	for	UBC)	and	also	less	variation	(SD	2.9	and	CV	15%	
vs.	4.8	and	20%	for	UBC),	RPL32	was	used	to	calculate	ΔCt	values.	
	
Across	 all	 groups,	GPX1,	 LDHA	 and	 G6PD	 showed	 the	 highest	 relative	 expression	
and	were	detected	 in	all	 samples	 (Figure	6.1).	One	gene,	PFKM,	was	differentially	
expressed,	being	significantly	higher	 in	cumulus	from	MII	oocytes	than	 in	cumulus	
from	immature	oocytes	(p	<	0.05).	
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Figure	6.1:	Summary	of	relative	expression	(normalised	against	RPL32)	of	each	gene	
in	cumulus	cells	across	all	experimental	groups.	N	=	33.	Mean	±	SEM	are	presented.	
Asterisk	represents	significant	difference	(p	<	0.05).	
	
As	each	group	contained	a	similar	number	of	oocytes	with	Ex	and	Cp	cumulus	cells,	
relative	 gene	 expression	 data	 for	 each	 gene	 of	 interest	 were	 first	 compared	
between	 Ex	 and	 Cp	 within	 each	 condition	 (Immature	 [IMM],	 control	 maturation	
media	 [C],	 high	 glucose	 maturation	 media	 [HG],	 high	 glucose	 high	 pyruvate	
maturation	media	[HG-HP]	and	DMEM	media).	In	Group	DMEM,	Ex	showed	higher	
G6PD	 expression	 than	 did	 Cp	 (p	 <	 0.01).	 In	 group	 HG-HP,	 LDHA	 showed	 higher	
expression	in	Ex	compared	to	Cp	(p	<	0.01).	Of	the	thirty	comparisons,	there	were	
no	other	differences	attributable	to	Ex/Cp	cumulus	classification	and,	notably,	none	
existed	 within	 the	 immature	 (pre-maturation)	 samples	 or	 when	 conditions	 were	
merged	and	so	for	further	analysis	Ex	and	Cp	were	treated	as	one	group.	
	
	
*	
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When	differences	among	IVM	treatments	were	evaluated,	expression	of	G6PD	was	
found	to	be	significantly	higher	 in	Group	HG-HP	compared	to	HG	(p	<	0.05;	Figure	
6.2).	 Biological	 variation	 was	 large	 within	 experimental	 groups	 and	 no	 other	
significant	 differences	were	 detected	 in	 relative	 gene	 expression	 (Figure	 6.2,	 6.3,	
6.4).	Two	of	the	four	COCs	in	the	control	group	depleted	all	available	glucose	during	
IVM	and	are	highlighted	separately.	
	
	
Figure	6.2:	Relative	gene	expression	(normalised	against	RPL32)	of	genes	related	to	
glucose	metabolism	 in	 the	cumulus	cell	 samples.	Experimental	groups	abbreviated	
as	 follows;	 control	 maturation	 media	 [C;	 BLUE,	 COCs	 that	 depleted	 all	 available	
glucose	 during	 IVM	 are	 highlighted	 in	 light	 blue],	 high	 glucose	maturation	media	
[HG;	 RED],	 high	 glucose	 high	 pyruvate	 maturation	 media	 [HG-HP;	 GREEN]	 and	
DMEM	 media;	 PINK.	 Mean	 ±	 SEM	 are	 presented	 with	 significance	 differences	
between	groups	indicated	by	different	superscripts	for	G6PD	(p	<	0.05).	
	
b	
ab	
a	
ab	
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Figure	6.3:	Relative	gene	expression	(normalised	against	RPL32)	of	genes	related	to	
oxidative	 stress	 in	 the	 cumulus	 cell	 samples.	 Experimental	 groups	 abbreviated	 as	
follows;	control	maturation	media	[C;	BLUE,	COCs	that	depleted	all	available	glucose	
during	IVM	are	highlighted	in	light	blue],	high	glucose	maturation	media	[HG;	RED],	
high	glucose	high	pyruvate	maturation	media	 [HG-HP;	GREEN]	and	DMEM	media;	
PINK.	Mean	±	SEM	are	presented.	
	
	
	
Figure	6.4:	Relative	gene	expression	(normalised	against	RPL32)	of	genes	related	to	
substrate	transport	in	the	cumulus	cell	samples.	Experimental	groups	abbreviated	as	
follows;	control	maturation	media	[C;	BLUE,	COCs	that	depleted	all	available	glucose	
during	IVM	are	highlighted	in	light	blue],	high	glucose	maturation	media	[HG;	RED],	
high	glucose	high	pyruvate	maturation	media	 [HG-HP;	GREEN]	and	DMEM	media;	
PINK.	Mean	±	SEM	are	presented.	
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Oocytes	
Thirty-seven	 individual	 oocytes	 (11	 immature	 and	 26	MII)	 were	 analysed	 in	 total	
across	 the	 experimental	 groups.	One	oocyte	 (Group	HG-HP)	was	 excluded	due	 to	
lack	of	expression	of	all	target	genes	and	reference	genes.		The	inter-plate	variation	
was	≤	1%.	 	Reference	genes	UBC	 and	RPL32	were	 further	examined	 for	 suitability	
for	 normalisation,	 and	 as	UBC	 showed	 higher	 expression	 in	 all	 samples	 (mean	 Ct	
20.8	vs.	23.9	for	RPL32)	and	also	less	variation	(SD	3.6	and	CV	17%	vs.	45.3	and	22%	
for	RPL32),	UBC	was	used	to	calculate	ΔCt	values.	Across	all	groups,	as	for	cumulus	
cells,	GPX1,	 LDHA	 and	 G6PD	 showed	 the	 highest	 relative	 expression	 (Figure	 6.5).	
Only	GPX1	 was	 universally	 expressed;	 92%,	 94%,	 25%,	 11%	 and	 28%	 of	 samples	
showed	 expression	 of	 LDHA,	G6PD,	 PFKM,	 TFAM	and	 SLC2A1	 respectively.	CPT1A	
was	not	detected	in	any	sample.	TFAM	had	higher	relative	expression	in	immature	
oocytes	 than	 in	MII	 oocytes	 (p	 <	 0.05)	 and	 LDHA	 tended	 to	 have	 higher	 relative	
expression	in	immature	oocytes	than	in	MII	oocytes	(p	=	0.06).	
	
Figure	6.5:	Summary	of	relative	expression	(normalised	against	UBC)	of	each	gene	in	
oocytes	across	all	experimental	groups.	N	=	37.	 	Mean	±	SEM	are	presented.	Black	
asterisk	represents	significant	difference	(p	<	0.05)	and	grey	asterisk	p=0.06.	
	
*	
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As	 each	 group	 contained	 a	 similar	 number	 of	 Ex	 and	 Cp	 oocytes,	 relative	 gene	
expression	data	for	each	gene	of	 interest	were	first	compared	between	Ex	and	Cp	
within	each	condition.		GPX1	showed	higher	relative	expression	in	Cp	compared	to	
Ex	in	Group	HG	(p	<	0.05).	There	were	no	other	differences	attributable	to	cumulus	
classification	so	for	further	analysis	they	were	treated	as	one	group.	
	
Biological	 variation	 was	 large	 within	 experimental	 groups	 and	 no	 significant	
differences	were	detected	in	relative	gene	expression	attributable	to	experimental	
condition	(p	>	0.05;Figure	6.6).	Two	of	the	four	COCs	in	the	control	group	depleted	
all	available	glucose	during	IVM	and	are	highlighted	separately.	
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Figure	6.6:	Relative	gene	expression	(normalised	against	UBC)	of	genes	investigated	
in	 the	 oocyte	 samples.	 Experimental	 groups	 abbreviated	 as	 follows;	 control	
maturation	media	[C;	BLUE,	COCs	that	depleted	all	available	glucose	during	IVM	are	
highlighted	 in	 light	 blue],	 high	 glucose	maturation	media	 [HG;	 RED],	 high	 glucose	
high	pyruvate	maturation	media	[HG-HP;	GREEN]	and	DMEM	media;	PINK.	Mean	±	
SEM	are	presented	where	appropriate.	
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6.4.2	 Experiment	 6.1,	 Study	 2:	 Effect	 of	 increased	 glucose	 and	 pyruvate	
concentration	during	IVM	on	COC	metabolism.	
	
Numbers	 available	 for	 metabolic	 analysis	 were	 low.	 For	 5/26	 COCs	 there	 were	
insufficient	 numbers	 of	 cumulus	 cells	 for	 both	 DNA	 quantification	 and	 mRNA	
extraction;	 in	 these	 cases	 (where	 there	were	 enough	 cells)	mRNA	 extraction	was	
prioritised	and	 spent	media	 analyses	were	not	performed	 (Table	6.5).	 Two	of	 the	
four	COCs	 in	Group	C	depleted	all	available	glucose	and	were	not	 included	 in	GPL	
analysis.		
	
	 Control	
(C)	
(5.6	mM	G/	
0	mM	P)	
High	Glucose	
(HG)	
(17	mM	G/		
0	mM	P)	
High	Glucose	
High	Pyruvate	
(HG-HP)	
(17mM	G/	
0.5mM	P)	
DMEM	
(17	mM	G/	
0.5	mM	P)	
Total	
MII	oocytes	 6	 7	 4	 9	 26	
GPL	 4		 7	 3	 7	 21	
	
Table	 6.4:	 Number	 of	 oocytes	 that	 reached	MII	 in	 each	 condition	 and	 number	 of	
COCs	 for	 which	 glucose,	 pyruvate,	 lactate	 (GPL)	 analysis	 of	 spent	 media	 was	
performed.	
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There	were	no	significant	differences	in	glucose	consumption	or	lactate	production	
rates	 between	 groups.	 Pyruvate	was	 consumed	 in	 both	HG-HP	media	 and	DMEM	
media	(both	containing	0.5	mM	pyruvate)	whereas	it	was	produced	in	the	other	two	
conditions	in	which	pyruvate	was	not	present		(p	<	0.05;	Figure	6.7).	
	
	
	
	
Figure	 6.7:	 Effect	 of	 media	 on	 glucose	 consumption	 (A),	 lactate	 production	 (B),	
lactate:	 glucose	 ratio	 (C)	 and	 Pyruvate	 production/consumption	 (D).	 Experimental	
groups	 abbreviated	 as	 follows;	 control	 maturation	media	 [C;	 BLUE],	 high	 glucose	
maturation	media	[HG;	RED],	high	glucose	high	pyruvate	maturation	media	[HG-HP;	
GREEN]	 and	 DMEM	 media;	 PINK.	 Mean	 ±	 SEM	 are	 presented	 and	 different	
superscripts	represent	significance	difference	between	groups.	
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6.4.3	 Experiment	 6.1,	 Study	 3A:	 Association	 between	 gene	 expression	 in	 oocytes	
and	corresponding	cumulus	cells	
	
Relative	 gene	 expression	 of	 all	 six	 genes	was	 compared	 between	 the	 oocyte	 and	
corresponding	cumulus	cells	for	the	32	COCs	for	which	both	expression	data	existed	
(data	 not	 shown).	 Only	 GPX1	 expression	 showed	 a	 weak	 association	 (p	 =	 0.16;	
Figure	6.8).	There	were	no	further	associations	between	the	relative	expression	of	
any	gene	in	oocytes	and	their	corresponding	cumulus	cells	(p	>	0.05)	
	
	
	
Figure	 6.8:	 Correlation	 between	 relative	 GPX1	 expression	 in	 oocytes	 and	 their	
corresponding	cumulus	cells		(p	=	0.16;	r2	=	0.06).	
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6.4.4	 Experiment	 6.1,	 Study	 3B:	 Association	 between	 relative	 expression	 of	
individual	genes	
	
Cumulus	cells	
Forty-two	 pairwise	 linear	 regressions	 were	 performed	 to	 explore	 associations	
between	relative	expression	of	individual	genes	(data	not	shown).		G6PD	expression	
was	positively	correlated	to	GPX1	expression	(p	<	0.001;	r2	=	0.3;	Figure	6.9A)	and	
both	G6PD	and	GPX1	were	positively	correlated	to	TFAM	(p	<	0.001;	r2	=	0.4;	Figure	
6.9B	and	6.9C).	LDHA	was	also	positively	correlated	to	PFKM	expression	(p	=	0.03;	r2	
=	0.15;	Figure	6.9D).	
	
	
Figure	6.9:	Correlation	between	G6PD	expression	and	GPX1	(A;	p	<	0.001;	r2	=	0.3),	
G6PD	and	TFAM	(B;	p	<	0.001;	r2	=	0.4),	GPX1	and	TFAM	(C;	p	<	0.001;	r2	=	0.4),	and	
between	LDHA	and	PFKM	(p	=	0.03;	r2	=	0.15)	expression	in	cumulus	cells.	
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Oocytes	
Thirty-six	 pairwise	 linear	 regressions	 were	 performed	 to	 explore	 associations	
between	relative	expression	of	individual	genes	(data	not	shown).		PFKM	expression	
was	positively	correlated	to	both	GPX1	expression	(p	=	0.01;	r2	=	0.15)	and	SLC2A1	
expression	(p	<	0.001;	r2	=	0.4),	however	these	relationships	were	driven	by	a	single	
oocyte.	
	
6.4.5	Experiment	6.1,	Study	3C:	Associations	between	relative	gene	expression	and	
COC	metabolism	during	IVM	
	
In	 cumulus	 cells,	 increased	 expression	 of	 GPX1	 was	 positively	 correlated	 with	
glucose	consumption	(Figure	6.10A;	p	=	0.04;	r2	=	0.2)	and	tended	to	be	positively	
correlated	to	pyruvate	production	(Figure	6.10B;	p	=	0.1;	r2	=	0.2).	In	addition,	TFAM	
expression	was	positively	correlated	to	pyruvate	production	(Figure	6.11B;	p	=0.04;	
r2	 =	 0.3)	 and	 tended	 to	 be	 negatively	 correlated	 to	 lactate:	 glucose	 ratio	 (Figure	
6.11A;	p	=	0.09;	r2	=	0.13).	In	oocytes,	there	were	no	associations	between	relative	
gene	expression	and	any	metabolic	parameter	measured	(p	>	0.05).	
	
	
Figure	 6.10:	 Correlation	 between	 relative	 GPX1	 expression	 in	 cumulus	 cells	 and	
glucose	consumption	(A;	p	=	0.01;	r2	=	0.3)	and	pyruvate	production	(B;	p	=	0.1;	r2	=	
0.2).	
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Figure	6.11:	Correlation	between	relative	TFAM	expression	and	lactate:	glucose	
ratio	(A;	p	=	0.09;	r2	=	0.13)	and	pyruvate	production	(B;	p	=	0.04;	r2	=	0.3).	
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6.5	Discussion	
	
This	chapter	reports	the	successful	application	of	PolyA	PCR	to	equine	cumulus	cells	
and	single	oocytes.	The	relative	expression	of	seven	genes	is	described.	In	cumulus	
cells,	one	of	the	seven	genes,	G6PD,	was	differentially	expressed:	this	was	higher	in	
HG-HP	 (17	mM	glucose	and	0.5	mM	pyruvate)	 than	 in	HG	 (17	mM	glucose	and	0	
mM	 pyruvate).	 Biological	 variation	 was	 large	 and	 as	 such	 no	 differences	 were	
detected	in	gene	expression	attributable	to	experimental	condition	in	oocytes.		
	
G6PD	 is	a	 regulatory	enzyme	of	 the	pentose	phosphate	pathway	 (PPP),	 important	
for	redox	balance	through	the	production	of	NADPH,	involved	in	redox	status,	and	
production	 of	 PRPP,	 an	 essential	 substrate	 for	 de	 novo	 purine	 synthesis.	 The	
difference	 observed	 in	 G6PD	 expression	 suggests	 higher	 flux	 though	 the	 PPP	 in	
group	HG-HP.	 It	 is	possible	that	the	presence	of	pyruvate	 in	the	medium	could	be	
sparing	glucose	and	increasing	availability	for	the	PPP.	Consistent	with	this	notion,	
in	the	presence	of	pyruvate,	COCs	shifted	from	pyruvate	production	and	secretion	
to	pyruvate	consumption.	As	discussed	 in	previous	chapters,	pyruvate	secretion	 is	
often	prioritised	as	an	antioxidant	defence	strategy	(O’Donnel	Turmey	et	al.,	1987).	
Interestingly,	 at	 0.15	 mM	 pyruvate,	 as	 used	 in	 previous	 experiments,	 pyruvate	
production	was	maintained	suggesting	there	is	a	threshold	between	0.15-	0.5	mM	
at	which	the	shift	to	consumption	occurs.	Based	on	research	in	the	preimplantation	
mouse	 embryo,	 which	 reported	 a	 requirement	 for	 an	 absolute	 medium	
concentration	 of	 0.3	 mM	 pyruvate	 (O’Fallon	 and	 Wright	 1996),	 it	 would	 be	
interesting	to	test	that	concentration	in	future	studies.	It	would	also	be	interesting	
to	 investigate	 if	 0.5	mM	pyruvate	would	 have	 a	 similar	 effect	 in	 5.6	mM	glucose	
medium	or	if	the	increase	in	PPP	is	only	due	to	a	synergism	with	high	glucose.	
	
G6PD	 was	 the	 third	most	 abundant	 transcript	 in	 the	 current	 study,	 expressed	 in	
100%	 of	 cumulus	 samples	 and	 94%	 of	 oocytes.	 G6PD	 activity	 has	 received	much	
attention	in	immature	oocytes	due	to	the	use	of	the	Brilliant	cresyl	blue	stain	(BCB).	
BCB	is	degraded	by	G6PD	and	as	such,	stained	COCs	become	colourless	when	G6PD	
activity	is	high	but	stay	blue	when	activity	is	low	(Mohammadi-Sangcheshmeh	et	al.,	
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2011;	 Torner	 et	 al.,	 2008).	 The	 studies	 by	Mohammadi-Sangcheshmeh	 et	 al.	 and	
Torner	 et	 al.	 reported	 that	 in	 immature	 equine	 and	 bovine	 oocytes	 low	 G6PD	
activity	was	correlated	with	expanded	cumulus	morphology	(Ex)	and	higher	meiotic	
and	 developmental	 competence.	 However,	 no	 correlation	 was	 found	 between	
G6PD	activity	and	 follicular	status	 in	another	equine	study	 (Vernunft	et	al.,	2013).	
There	is	dynamic	regulation	of	G6PD	due	to	the	role	of	the	PPP	in	redox	balance.	A	
study	in	mice	demonstrated	that	inhibiting	the	PPP	not	only	resulted	in	a	decreased	
blastocyst	development	rate	but	also	a	decrease	in	glutathione	and	NADPH	content,	
and	 increased	ROS	 (Xie	et	al.,	2016).	 	As	described	 in	Chapter	5,	 there	 is	negative	
feedback	 on	 G6PD	 as	 a	 result	 of	 increased	 HBP	 and	 Poly-o-L	 flux	 in	 the	 face	 of	
hyperglycaemia.	In	this	regard,	Colton	et	al.	(2003)	reported	decreased	flux	through	
the	 PPP	 in	 COCs	 from	 diabetic	 mice	 using	 radiolabelled	 glucose,	 and	 a	 study	 in	
buffalo,	 demonstrated	 a	 decrease	 in	G6PD	 expression	 in	 oocytes	 in	 response	 to	
increased	 glucose	 concentration	during	 IVM	 (10	mM	glucose	 vs.	 5.6	mM	glucose;	
Kumar	et	al.,	2013).	Interestingly,	in	the	buffalo	study,	low	glucose	concentration	(0	
and	 1.5	 mM)	 also	 resulted	 in	 decreased	 G6PD	 expression.	 There	 were	 no	
differences	 in	 transcript	 abundance	 in	 the	 current	 study	 in	 either	 oocytes	 or	
cumulus	cells	attributable	to	glucose	concentration	alone.	This	could	be	due	to	lack	
of	correlation	between	transcript	 levels	and	enzyme	activity,	medium	composition	
or	high	biological	variation.			
	
GPX1	was	the	only	gene	to	be	universally	expressed	in	both	sample	types	and	also	
showed	 the	 highest	 relative	 expression	 in	 all	 samples.	 In	 cumulus	 cells	 GPX1	
expression	was	positively	associated	with	G6PD	and	TFAM	expression.	Glutathione	
peroxidases	 are	 potent	 antioxidant	 enzymes,	 GPX1	 being	 the	 most	 abundant	
cytosolic	isoform.	The	enzymes	break	down	H2O2	to	oxygen	and	water	and	thus	are	
central	 in	 antioxidant	defence	 and	abundant	 in	oocytes	 and	embryos	 (Agarwal	 et	
al.,	 2012).	 Increased	 GPX1	 expression	 in	 oocytes	 has	 been	 correlated	 with	
decreased	DNA	 fragmentation	 in	pigs	and	 large	healthy	 follicles	 in	 cattle	 (Ceko	et	
al.,	 2015;	 Whitaker	 and	 Knight,	 2008).	 In	 human	 cumulus	 cells,	 increased	 GPX1	
expression	was	associated	with	positive	pregnancy	outcome	after	ICSI	(Ceko	et	al.,	
2015).	In	the	horse,	GPX1	expression	has	been	measured	in	oocytes	and	cumulus	by	
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Luciano	et	al.,	(2006)	who	found	that	while	expression	increased	over	the	course	of	
IVM	 in	 cumulus	 cells,	GPX1	mRNA	was	not	 detected	 in	 either	GV	or	MII	 oocytes.	
Similarly,	 Hendriks	 et	 al.,	 (2015)	 could	 not	 detect	 GPX3	 mRNA	 in	 30/48	 pooled	
equine	 oocyte	 samples.	 Interestingly,	 in	 a	 human	 study	 by	 El	 Mouatassim	 et	 al.	
(1999),	GPX1	mRNA	was	detected	only	in	MII	oocytes,	however	when	a	3’	directed	
primer	 was	 used	 instead	 of	 an	 Oligo	 based	 primer	 during	 reverse	 transcription	
(which	recognizes	the	polyA	tail	of	mRNA),	GPX1	mRNA	was	also	detected	at	the	GV	
stage.	While	this	suggests	GPX1	mRNA	is	polyadenylated	during	maturation,	in	the	
present	study,	an	Oligo	based	primer	was	used	and	as	such	confirms	polyadenylated	
mRNA	(of	at	least	24	bp)	in	both	GV	and	MII	equine	oocytes.	This	could	be	a	species	
difference	but	it	is	also	possible	that	environmental	factors	could	be	responsible	for	
such	differences.	For	example,	hyperglycaemia	and	subsequent	increased	oxidative	
state	 in	 humans	 can	 influence	 GPX1	 expression,	 since	 decreased	 GPX1	 in	
endothelium	is	correlated	with	diabetes	(Hamanishi	et	al.,	2004).	
	
Since	 individual	 oocytes	 were	 tracked	 throughout	 IVM	 and	 mRNA	 extraction,	
associations	 between	 relative	 gene	 expression	 and	 COC	 glucose,	 lactate	 and	
pyruvate	metabolism	could	be	explored	for	the	first	time.	While	the	coefficients	of	
determination	 (r2)	 were	 low	 in	many	 of	 the	models,	 the	 low	 p	 values	 show	 that	
there	 is	 still	 predictive	 value	 in	 the	 variables	 tested	 and	 as	 such	 findings	 will	 be	
discussed	 below	 in	 context	 of	 the	 existing	 literature.	 In	 cumulus	 cells,	 the	
expression	 of	 GPX1	 was	 positively	 correlated	 with	 glucose	 consumption	 and	
pyruvate	production.	It	was	shown	in	Chapter	3	that	increased	glucose	consumption	
in	COCs	was	 associated	with	 increased	oxidative	phosphorylation.	 Taken	 together	
these	 findings	 suggest	 that	 COCs	 that	 are	 more	 metabolically	 active	 also	 have	 a	
higher	 anti-	 oxidant	 capacity.	Which	 of	 these	 is	 the	main	 determinant	 cannot	 be	
ascertained	 from	 the	 present	 data,	 though	 it	 is	 interesting	 to	 speculate	 that	 the	
increased	metabolic	activity	resulted	in	increased	GPX	transcription	to	protect	from	
the	 inevitable	 increase	 in	ROS.	This	 is	 supported	by	 the	 correlation	with	pyruvate	
production,	 also	 potentially	 as	 a	 protective	 mechanism	 against	 ROS.	 Conversely,	
COCs	with	 increased	 antioxidant	 capacity	 could	 be	 those	 in	which	 a	 high	 level	 of	
glucose	and	oxidative	metabolism	can	be	sustained.	
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TFAM	was	the	only	other	gene	in	which	the	relative	expression	in	cumulus	cells	was	
associated	with	COC	metabolism.	TFAM	is	involved	in	mitochondrial	biogenesis	and	
mtDNA	transcription	and	translation	(Itami	et	al.,	2015)	and	expression	of	the	gene	
is	 increased	 when	 mitochondrial	 regeneration	 or	 synthesis	 is	 occurring.	 In	 the	
present	study,	TFAM	was	expressed	in	75%	of	cumulus	cell	samples	but	only	11%	of		
oocytes.	 TFAM	 expression	 has	 previously	 been	 described	 in	 immature	 equine	
oocytes	 by	Mohammadi-Sangcheshmeh	 et	 al.,	 (2014,	 2011)	 who	 reported	 higher	
TFAM	 expression	 in	 Ex	 oocytes	 (compared	 to	 Cp)	 and	 in	 those	 with	 low	 G6PD	
activity	 (BCB+)	 and	higher	 developmental	 competence.	TFAM	 expression	 can	 also	
be	 regulated	 by	 environmental	 glucose	 concentration.	 Specifically,	 in	 humans,	
TFAM	 expression	 is	 decreased	 in	 both	 hepatocytes	 and	 cardiomyocytes	 in	
hyperglycaemic	 conditions	 such	 as	 diabetes	 (Palmeira	 et	 al.,	 2007;	 Suarez	 et	 al.,	
2008).	The	study	by	Suarez	et	al.,	(2008)	also	demonstrated	that	by	overexpressing	
TFAM	 using	 plasmid	 transfection,	 mitochondrial	 function	 was	 restored	 in	
cardiomyocytes.	 In	 the	 oocyte,	 the	 mechanisms	 surrounding	 mitochondrial	
biogenesis	 and	 repair	 are	 poorly	 understood;	 however	 Itami	 et	 al.,	 (2015)	
demonstrated	that	porcine	oocytes	had	the	capacity	for	mitochondrial	regeneration	
following	 FCCP-induced	 damage,	 as	 indicated	 by	 rising	 TFAM	 mRNA	 levels	 after	
prolonged	 culture.	 This	 mechanism	 was	 subsequently	 shown	 to	 be	 affected	 by	
advance	age	in	the	cow:	recuperation	was	not	as	pronounced	in	oocytes	from	aged	
animals	 after	 FCCP	 treatment	 than	 in	 those	 from	 young	 animals	 (Kansaku	 et	 al.,	
2017).	 In	a	murine	study,	an	unexpected	 finding	was	 that	TFAM	mRNA	 levels	and	
mtDNA	copy	number	were	increased	in	cumulus	cells	from	diabetic	mice	(Wang	et	
al.,	 2010).	 As	 suggested	 above,	 the	 authors	 speculated	 that	 this	 was	 a	
compensatory	 mechanism	 in	 response	 to	 the	 decreased	 efficiency	 of	 individual	
mitochondria.		It	 is	interesting	that	both	cumulus	cell	samples	from	COCs	that	had	
depleted	all	available	glucose	during	IVM	(2/6	depleted	in	Group	C)	expressed	TFAM	
outside	the	mean	and	higher	than	all	other	samples.		
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TFAM	expression	 in	cumulus	cells	was	negatively	associated	with	 lactate	 :	glucose	
ratio	 and	 positively	 associated	with	 pyruvate	 production.	 As	 the	 lactate	 :	 glucose	
ratio	allows	an	estimate	of	the	proportion	of	glucose	consumed	by	glycolysis	rather	
than	 other	 pathways,	 the	 current	 data	 suggest	 that	 as	 glycolysis	 proportionately	
decreased,	 TFAM	 expression	 increased.	 Again,	 the	 mechanisms	 involved	 are	 not	
clear	 however	 if	 more	 OXPHOS	 was	 occurring	 it	 could	 feed	 back	 to	 initiate	
mitochondrial	 transcription	 especially	 if	 OXPHOS	 was	 inefficient	 as	 suggested	 by	
Wang	et	al.,	(2010),	or	alternatively	the	presence	of	more	mitochondria	may	be	able	
to	 sustain	 a	 higher	 rate	 of	 OXPHOS.	 The	mechanism	 behind	 the	 association	with	
pyruvate	production	 is	unclear,	 especially	 as	pyruvate	production	was	 linked	with	
the	absence	of	pyruvate	in	the	medium.	
	
Given	 the	 associations	 between	GPX1	 and	TFAM	 expression	 in	 cumulus	 cells	 and	
metabolic	activity	of	the	COC,	it	 is	notable	that	there	were	no	such	associations	in	
oocytes.	 This	 supports	 the	 theory	 that	 transcript	 abundance	 is	 under	 post-
transcriptional	control	and	as	such,	the	amount	of	mRNA	is	not	closely	linked	with	
enzyme	 activity.	 The	 other	 explanation	 is	 that	 the	 oocyte	 itself	 and	 its	metabolic	
enzymes	 contribute	 very	 little	 to	 the	metabolic	 activity	 of	 the	 COC.	 It	 is	 likely	 to	
comprise	 a	 combination	 of	 both	 explanations,	 however	 as	 >70%	 samples	 had	 no	
expression	PFK,	TFAM,	SLC2A1	 and	none	had	CPT1A,	more	experiments	would	be	
required	 to	 uncover	 the	 mechanisms	 involved.	 The	 low	 expression	 of	 PFK	 and	
SLC2A1	 is	 in	 agreement	with	 the	 current	 accepted	understanding	 that	 the	oocyte	
itself	has	little	capacity	to	metabolise	glucose;	cumulus	cells	provide	the	oocyte	with	
pyruvate	 through	 glycolysis	 (Cetica	 et	 al.,	 2002;	 Downs	 and	 Utecht,	 1999;Figure	
1.9).	 The	 finding	 that	 glycolytic	 enzyme	 genes	 LDHA	 and	 PFK	 expression	 were	
correlated	in	cumulus	cells	is	therefore	not	surprising.		
	
Murine	 studies	 investigating	 the	 effects	 of	 hyperglycaemia	 have	 reported	 a	 clear	
and	 consistent	 decrease	 in	 glucose	 uptake	 by	 cumulus	 cells	 concurrent	 with	
decreased	 expression	 of	 glucose	 transporters	 (Wang	 et	 al.,	 2012,	 2010).	 In	 the	
present	study,	while	the	numbers	for	comparison	were	small,	equine	COCs	did	not	
appear	to	respond	to	hyperglycaemia	(17	mM)	by	decreasing	expression	of	SLC2A1.	
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While	a	decrease	 in	transcription	 is	only	one	of	the	mechanisms	by	which	glucose	
transport	 can	 be	 reduced,	 this	 is	 in	 agreement	 with	 the	 unchanged	 glucose	
consumption	 reported	 herein	 and	 in	 Chapter	 5.	 The	 reason	 for	 this	 is	 unclear,	
however	 perhaps	 examining	 the	 expression	 of	 other	 glucose	 transporters	 and	
exposing	 equine	 COCs	 to	 even	 higher	 glucose	 concentrations	 would	 aid	 in	
deciphering	 the	underlying	physiology.	 It	 is	 interesting	 to	 speculate	 that	 a	 lack	of	
downregulation	of	glucose	 transport	could	be	central	 to	 the	mechanism	by	which	
equine	COCs	tolerate	high	glucose	concentrations.	In	mice,	it	has	been	proposed	by	
Wang	 and	 Moley,	 (2010)	 that	 the	 deficiency	 in	 cumulus	 cell	 glucose	 transport	
initiates	the	series	of	events	leading	to	a	decline	in	oocyte	quality.	As	cumulus	cells	
are	 central	 to	 providing	 pyruvate	 and	 ATP	 to	 the	 oocyte,	 decreased	 glucose	
transport	results	 in	decreased	pyruvate	and	ATP	transfer,	since	such	oocytes	from	
diabetic	mice	 contain	 less	 ATP.	 Additionally,	 lack	 of	 glucose	 transport	 can	 trigger	
BAX	dependent	apoptotic	pathways	(Chi	et	al.,	2000).	It	has	been	postulated	by	the	
same	 authors	 (Wang	 and	 Moley)	 that	 toxic	 factors	 related	 to	 apoptosis	 such	 as	
cytochrome	 C	 and	 excess	 calcium,	 could	 then	 be	 transferred	 to	 the	 oocyte	 and	
disrupt	 a	 myriad	 of	 cytoplasmic	 functions.	 None	 of	 these	 events	 would	 occur	 if	
glucose	transport	were	maintained.	
	
The	lack	of	CPT1A	mRNA	in	equine	oocytes	is	interesting	as	it	has	been	detected	in	
bovine	oocytes	by	Van	Hoeck	et	al.,	(2013).	Carnitine	palmitoyl	transferase	1	(CPT1)	
is	 the	 enzyme	 responsible	 for	 the	 transfer	 of	 fatty	 acids	 across	 the	 outer	
mitochondrial	 membrane	 and	 is	 the	 rate-limiting	 step	 of	 β-oxidation.	 CPT1	 has	
three	isoforms	1A,	1B	and	1C.	Both	CPT1B	and	1A	mRNA	have	been	detected	in	the	
mouse	however	whole	COCs	were	analysed	rather	than	denuded	oocytes	(Dunning	
et	al.,	2014a,	2010).	As	β-oxidation	of	fatty	acids	likely	plays	a	role	in	equine	oocyte	
maturation,	this	result	highlights	the	need	for	caution	in	interpretation,	as	detected	
transcripts	 levels	 often	 do	 not	 correlate	 well	 with	 enzyme	 activity.	 This	 was	
demonstrated	 in	 a	 study	 by	 Forsey	 et	 al.,	 (2013)	 when	 investigating	 the	 role	 of	
creatine	 kinase	 (CK)	 in	 the	 murine	 preimplantation	 embryo.	 In	 that	 study,	 no	
correlation	existed	between	CK	mRNA	levels	and	measured	CK	enzyme	activity.	
	
	 209	
In	 the	 present	 study,	 there	 was	 higher	 relative	 abundance	 of	 TFAM	 mRNA	 in	
immature	 oocytes	 compared	 to	 MII	 oocytes.	 In	 agreement	 with	 this	 finding,	
Hendriks	 et	 al.,	 (2015)	 found	 that	TFAM	 expression	was	 decreased	 in	MII	 equine	
oocytes	 compared	 to	 immature	 oocytes.	 As	 TFAM	 expression	 is	 closely	 linked	 to	
mtDNA	copy	number,	it	is	notable	that	Rambags	et	al.,	(2014)	reported	a	decrease	
in	 equine	 mtDNA	 copy	 number	 after	 IVM	 but	 only	 in	 aged	 mares.	 This	 was	
associated	with	 loss	 of	 normal	mitochondrial	 architecture.	 It	 is	 accepted	 in	 other	
species	 and	 recently	 demonstrated	 in	 the	 horse	 by	 Hendriks	 et	 al.,	 (2018)	 that	
mitochondrial	 replication	 ceases	 as	 MII	 is	 reached	 and	 that	 the	 resulting	
mitochondrial	 complement	 is	 relied	 on	 through	 early	 development	 until	 the	
blastocyst	stage	(Review;	St.	John,	2012).	The	decrease	in	TFAM	mRNA	levels	after	
IVM	is	in	keeping	with	these	findings.	
	
Conclusions	
The	aim	of	this	chapter	was	to	use	transcriptomics	of	oocytes	and	cumulus	cells	to	
provide	further	insight	into	the	effect	of	high	glucose	during	IVM.	Our	main	finding	
was	that	presence	of	0.5	mM	pyruvate	in	high	glucose	medium	was	associated	with	
a	switch	 to	pyruvate	consumption	rather	 than	production	and	with	an	 increase	 in	
G6PD	expression,	an	enzyme	of	the	PPP	pathway.	Decreased	TFAM	expression	was	
also	demonstrated	in	MII	oocytes	compared	to	immature	oocytes.	 In	addition,	the	
necessary	 methods	 were	 refined	 and	 validated	 by	 proof	 of	 principle	 in	 single	
oocyte/COC	 analysis,	 creating	 a	 platform	 for	 further	 research	 to	 be	 performed.	
Findings	were	 consistent	with	 independent	 regulatory	mechanisms	 of	 the	 oocyte	
and	 cumulus	 cell	 transcriptome	 and	 lack	 of	 association	 between	 the	 oocyte	
transcriptome	 and	 COC	 metabolism,	 adding	 to	 current	 understanding	 of	 the	
physiology	of	oocyte	cumulus	cell	interactions.	
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7.	General	discussion		
	
Assisted	reproduction	technologies	aim	to	mimic	the	periconceptual	environment.	
As	 such,	 it	 is	 important	 to	 make	 sure	 they	 are	 optimised	 to	 the	 best	 of	 our	
knowledge.	In	the	horse,	there	is	a	paucity	of	species-specific	IVM	optimisation.	As	
for	all	inter-species	comparisons,	caution	should	be	exercised	in	extrapolating	from	
data	from	other	species,	such	as	the	mouse	or	cow,	for	which	there	exists	a	wealth	
of	knowledge	on	the	subject	 (Leese,	2012).	 	 In	 this	 regard,	 the	general	aim	of	 the	
work	 contained	 in	 this	 thesis	 was	 to	 characterise	 carbohydrate	 and	 oxidative	
metabolism	 in	 equine	 COCs	 during	 IVM,	 investigate	 it	 under	 varying	 clinical	
conditions,	and	ascertain	their	physiological	relevance.		
	
7.1	Summary	findings	
	
Below	is	a	summary	of	the	key	findings	from	each	chapter	 in	context	of	the	 initial	
study	aims	and	how	the	findings	relate	to	current	published	literature.		
	
Carbohydrate	metabolism	in	equine	COCs		
	
The	 initial	 aim	of	 these	 studies	was	 to	 characterise	 the	 glucose,	 lactate,	 pyruvate	
and	oxidative	metabolism	of	equine	COCs	during	IVM	under	commonly-used	clinical	
conditions.	It	was	demonstrated	that	COCs	incubated	in	M199	based	medium	at	10-	
µl	 medium	 per	 oocyte	 have	 high	 glucose	 consumption	 rates,	 utilise	 this	 glucose	
mainly	 for	 glycolysis,	 and	 also	 produce	 and	 secrete	 pyruvate	 into	 the	 medium	
(Figure	7.1).	It	was	further	shown	that	glucose	consumption	and	lactate	production	
were	 positively	 correlated	 to	 DNA	 content	 of	 the	 COC	 (and	 thus	 to	 number	 of	
cumulus	 cells	 present)	 but	 pyruvate	 production	 was	 not.	 COCs	 with	 compact	
cumulus	 (Cp)	 contained	 more	 DNA	 (more	 cumulus	 cells)	 and	 as	 such	 consumed	
more	glucose	 than	did	COCs	with	expanded	 cumulus	 (Ex),	 however	when	glucose	
consumption	 was	 corrected	 for	 DNA	 content	 the	 difference	 disappeared.	
Additionally,	glucose	and	lactate	metabolism	did	not	differ	between	COCs	that	were	
meiotically	 competent	 (matured	 to	 Metaphase	 II	 during	 IVM)	 or	 those	 that	
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degenerated	 during	 IVM,	 again	 suggesting	 that	 the	main	metabolic	 player	 in	 the	
COC	 is	 the	 cumulus,	 and	 indicating	 that	 cumulus	 function	 in	 these	 two	 cases	was	
similar.	 These	 findings	 are	 in	 agreement	with	 previous	 studies	 in	 the	mouse,	 pig,	
cow	and	horse	(Biggers	et	al.,	1967;	Downs	et	al.,	2002;	Gonzalez-Fernandez	et	al.,	
2018;	Sutton	et	al.,	2003).	It	 is	the	first	time	however	that	data	corrected	for	DNA	
(proxy	for	cumulus	cell	number)	are	reported	for	the	horse.	
	
Up	to	24%	of	the	COCs	depleted	all	available	glucose	during	the	30-hour	IVM	period	
in	 clinical	 conditions	 (10-μl	 droplets	 of	 M199	 based	 medium	 [5.6mM	 glucose]).	
Surprisingly,	this	did	not	appear	to	affect	maturation,	cleavage	or	blastocyst	rates.	
Those	COCs	that	had	depleted	all	available	glucose	had	a	decreased	glycolytic	index	
(decreased	 lactate	 :	 glucose	 ratio)	 and	 decreased	 pyruvate	 production.	 This	 total	
glucose	 depletion	 has	 not	 been	 previously	 reported	 with	 regard	 to	 equine	 IVM.	
Adjustments	of	trimming	excess	granulosa	and	increasing	the	droplet	size	to	15	μl	
(Chapter	 4)	 reduced	 the	 proportion	 of	 COCs	 depleting	 all	 available	 glucose	 from	
24%	to	2.9%.	
	
The	 studies	 in	 this	 thesis	 represent	 the	 first	 characterisation	 of	 COC	 oxidative	
metabolism	together	with	mitochondrial	function	in	any	species.	This	was	analysed	
in	 equine	 COCs	 using	 the	 Seahorse	 XFp	 analyser.	 Mitochondrial	 efficiency	 was	
evaluated	at	both	the	beginning	and	conclusion	of	 IVM.	There	was	a	tendency	for	
basal	OCR	 to	 rise	 over	 the	 course	 of	 IVM	but	 this	was	 not	 statistically	 significant	
(mean	 42.5	 and	 60.6	 pmol	 O2/ng	 DNA/	 hour	 at	 the	 beginning	 and	 end	 of	 IVM	
respectively).	 The	 proportion	 of	 basal	 OCR	 coupled	 to	 ATP	 production	 (47-58%),	
non-mitochondrial	 processes	 (38-31%)	 and	 proton	 leak	 (17%)	 did	 not	 differ	
between	 the	beginning	 and	 the	end	of	 IVM	 (Figure	7.1).	 Spare	 capacity	however,	
changed	significantly	during	IVM,	starting	at	85%	and	falling	to	5%	at	the	end.	Basal	
OCR	in	the	present	study	was	~20	times	higher	than	that	reported	for	bovine	COCs	
under	 similar	 conditions	 (Sutton	 et	 al.,	 2003)	 demonstrating	 that	 OXPHOS	 has	 a	
more	 significant	 role	 in	 energy	 metabolism	 in	 the	 equine	 COC.	 There	 are	 no	
previous	studies	on	mitochondrial	function	testing	in	COCs	of	any	species	to	which	
to	compare	the	present	data,	only	a	single	bovine	study	and	a	single	equine	study	
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exist,	both	performed	on	denuded	oocytes	and	showed	that	even	at	the	denuded	
oocyte	level,	equine	oocytes	have	a	higher	OCR	than	bovine	oocytes	(Obeidat	et	al.,	
2018;	Sugimura	et	al.,	2012).		
	
Temporal	differences	in	glucose,	lactate	and	pyruvate	metabolism	in	COCs	during	in	
vitro	 maturation	 were	 also	 evaluated	 for	 the	 first	 time.	 Glucose	 consumption	
increased	during	the	middle	period	of	 IVM	(10-20	hours)	and	fell	again	at	the	end	
(20-30	hours).	Lactate	production	followed	the	same	pattern.	Pyruvate	production	
however,	was	 constant	during	 the	 first	20	hours	but	 increased	 sharply	during	 the	
final	period	(Figure	7.1).	Mural	granulosa	cells	alone	 in	culture	did	not	exhibit	 this	
pattern,	with	constant	glucose	consumption	and	lactate	production	throughout	the	
30-hour	period.	Interestingly,	isolated	granulosa	cells	produced	more	pyruvate	than	
did	 COCs	 at	 the	 outset	 of	 IVM	 but	 this	 subsequently	 decreased,	 and	 pyruvate	
production	did	not	rise	at	the	end	of	IVM	as	it	did	for	COCs.	The	temporal	pattern	of	
glucose	and	lactate	metabolism	for	equine	COCs	reported	here	differed	from	that	in	
murine	and	bovine	COCs.	In	these	two	species,	glucose	consumption	increased	over	
time	but	 no	 corresponding	 increase	 in	 lactate	production	was	detected	 such	 that	
the	glycolytic	 index	decreased	 (Preis	et	al.,	2005;	Sutton	et	al.,	2003).	 In	contrast,	
the	equine	COCs	in	the	current	studies	maintained	a	constant	lactate	:	glucose	ratio	
throughout	the	culture	period.	
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Figure	 7.1:	 Summary	 figure	 of	 characterisation	 data	 from	Chapters	 3,	 4,	 5	 and	 6.	
Changes	in	glucose,	lactate	and	pyruvate	metabolism	are	depicted	by	arrows	at	the	
top.	 The	middle	 section	 contains	mitochondrial	 function	 data	 from	 the	 beginning	
and	 conclusion	 of	 IVM	 and	 the	 bottom	 section	 contains	 gene	 expression	 data	 of	
transcripts	 that	 differed	 between	 immature	 oocytes	 and	 metaphase	 II	 oocytes,	
arrows	denote	up	or	down	regulation	in	either	the	oocyte	or	cumulus	cell.		
	
	 214	
Pyruvate	and	oxygen	concentration	during	equine	IVM	affect	COC	metabolism		
	
In	an	attempt	to	address	the	glucose	depletion	and	loss	of	spare	capacity	at	the	end	
of	IVM	and	explore	potentially	more	physiological	IVM	conditions	for	the	horse,	the	
addition	of	0.15	mM	pyruvate	(similar	to	the	concentration	in	equine	follicular	fluid)	
and	 a	 decrease	 in	 oxygen	 concentration	 (21%	 to	 5%)	 was	 investigated.	
Paradoxically,	there	was	an	increase	in	glucose	consumption	in	pyruvate-containing	
medium,	 independent	 of	 oxygen	 concentration,	 and	 at	 5%	 oxygen	 in	 pyruvate-
containing	media,	 there	was	 a	 reduction	 in	 pyruvate	 production	 and	 in	 glycolytic	
index	 compared	 to	 the	 other	 conditions	 (Figure	 7.2).	 The	 effect	 of	 pyruvate	
concentration		(up	to	0.5	mM)	on	basal	OCR	and	mitochondrial	efficiency	was	also	
evaluated.	 There	 was	 a	 tendency	 for	 increased	 basal	 OCR	 at	 0.5	 mM	 pyruvate	
compared	 to	 0	 mM,	 however	 this	 was	 not	 statistically	 significant	 and	 pyruvate	
addition	did	not	affect	mitochondrial	efficiency	measures.	The	 increase	 in	glucose	
consumption	in	the	presence	of	pyruvate	and	lack	of	response	to	decreased	oxygen	
was	unexpected.	In	Chapter	6,	GPL	measurements	during	IVM	in	medium	with	0.5	
mM	pyruvate	(M199	in	the	presence	of	17mM	and	DMEM/F12)	showed	that	COCs	
switched	to	net	pyruvate	consumption	rather	than	production	(Figure	7.2).	To	the	
best	of	my	knowledge	 there	are	no	other	 studies	on	direct	evaluation	of	glucose,	
lactate	 and	 pyruvate	 metabolism	 in	 response	 to	 varying	 oxygen	 concentration	
during	IVM;	however	COC	gene	expression	data	from	other	species	suggest	that,	in	
contrast	 to	 our	 findings,	 glycolytic	 pathways	 are	 up	 regulated	 in	 the	 face	 of	 low	
oxygen	 (Bermejo-Álvarez	 et	 al.,	 2010,	 Hashimoto	 et	 al.,	 2000,	 Kang	 et	 al.,	 2011,	
Kumar	et	al.,	2015).	
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Glucose	concentration	during	IVM	influences	mitochondrial	efficiency	
	
In	other	species,	IVM	medium	glucose	concentration	affects	oocyte	developmental	
competence	 (Frank	 et	 al.,	 2013,	 Hashimoto	 et	 al.,	 2000).	 In	 the	 horse,	 successful	
IVM	and	foal	production	is	commonly	reported	using	DMEM/F12,	which,	at	17	mM,	
is	hyperglycaemic	for	the	horse.	The	aim	of	these	studies	was	to	evaluate	the	effect	
of	 medium	 glucose	 concentration	 during	 IVM	 (5.6	 mM	 vs.	 17	 mM)	 on	 oocyte	
developmental	 parameters	 and	 COC	 glucose,	 lactate,	 pyruvate	 and	 oxidative	
metabolism	in	an	attempt	to	ascertain	the	consequences	of	hyperglycaemia	during	
IVM	at	the	metabolic	level	and	understand	the	mechanisms	by	which	equine	COCs	
maintain	their	developmental	potential	in	the	face	of	hyperglycaemia.		
	
Glucose	 concentration	 during	 IVM	 (5.6	 vs.	 17	mM)	 did	 not	 affect	 developmental	
parameters,	morphokinetics	 of	 early	 embryo	 development,	 glucose	 consumption,	
and	 lactate/pyruvate	 production,	 or	 basal	 OCR.	 However,	 when	 evaluating	
mitochondrial	 function,	 it	 was	 found	 that	 IVM	 in	 17	 mM	 glucose	 resulted	 in	 a	
decrease	 in	 ATP-coupled	 respiration	 and	 an	 increase	 in	 non-mitochondrial	
respiration	 compared	 to	 that	 in	 5.6	 mM	 glucose	 (Figure	 7.2).	 In	 other	 species	
studied,	hyperglycaemia	during	oocyte	maturation	results	 in	a	decrease	 in	glucose	
consumption	attributed	 to	 inhibition	of	 glucose	 transporters;	 thus	 the	absence	of	
an	effect	in	equine	COCs	was	surprising	(Frank	et	al.,	2014,	Sutton-McDowall	et	al.,	
2010,	 Wang	 et	 al.,	 2010,	 2012).	 While	 COC	 mitochondrial	 efficiency	 parameters	
have	 not	 been	 specifically	 investigated	 in	 other	 species	 in	 response	 to	
hyperglycaemia	 during	 IVM,	 other	 markers	 of	 mitochondrial	 function	 have	 been	
shown	 to	be	detrimentally	 affected.	Namely,	decreased	 cumulus	 cell	ATP	 content	
and	 increased	oocyte	ROS	production	have	been	demonstrated	 in	mice	and	cattle	
respectively,	indicating	mitochondrial	effects	of	hyperglycaemia,	in	agreement	with	
the	current	data	(Hashimoto	et	al.,	2000,	Wang	et	al.,	2010).	
	
	
	
	
	 216	
Glucose	concentration	during	IVM	and	its	effect	on	blastocyst	gene	expression	
	
In	order	 to	 investigate	 the	potential	downstream	effects	of	glucose	concentration	
during	 IVM	(5.6	mM	vs.	17	mM)	on	developmental	potential,	expression	of	genes	
coding	 carbohydrate-metabolism	 enzymes	 involved	 in	 key	 metabolic	 pathways	
known	 to	 be	 targets	 of	 hyperglycaemia	 were	 evaluated	 in	 resulting	 blastocysts.	
Developmental	marker	genes	for	pluripotency	and	cell	lineage	were	also	evaluated.	
Regrettably,	blastocyst	rates	were	too	low	(8.2	and	2.9%	per	injected	oocyte	for	5.6	
mM	and	 17	mM,	 respectively)	 to	 satisfy	 the	 original	 experimental	 aim.	However,	
the	expression	of	glucose	metabolism	genes	SLC2A1,	LDHA,	G6PD,	PFKM	and	the	TE	
marker	 TEAD4	 was	 described	 for	 the	 first	 time	 in	 equine	 blastocysts	 and	 further	
description	of	POU5F1,	SOX2	and	CDX2	added	to	limited	knowledge	of	cell	 lineage	
allocation	 dynamics	 in	 the	 horse.	 To	 the	 best	 of	my	 knowledge	 this	was	 the	 first	
study	to	examine	the	downstream	effects	of	glucose	concentration	during	 IVM	on	
blastocyst	gene	expression	in	any	species.	
	
A	secondary	aim	possible	through	the	experimental	design	of	single-oocyte	tracking	
through	maturation	followed	by	mRNA	extraction	from	blastocysts,	was	to	explore	
associations	between	the	relative	expression	of	the	above	genes	in	the	blastocysts	
and	 the	 corresponding	 COC	 metabolism	 during	 IVM.	 Use	 of	 time-lapse	 imaging	
during	embryo	culture	allowed	associations	between	the	relative	expression	of	the	
genes	 and	 blastocyst	 morphokinetics	 during	 embryo	 development	 to	 also	 be	
explored.	Again,	while	some	relationships	were	suggested,	such	as	decreasing	LDHA	
being	 associated	 with	 increasing	 POU5F1	 and	 GPX1,	 and	 increasing	 GPX1	 being	
associated	with	 increasing	POU5F1	 and	 TEAD4,	 overall	 blastocyst	 production	was	
too	low	to	satisfy	the	original	aim	and	draw	conclusions.			
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Glucose	concentration	during	equine	IVM	and	its	effect	on	oocyte	and	cumulus	cell	
gene	expression	
	
As	 noted	 above,	 increased	 glucose	 concentration	 during	 IVM	 resulted	 in	 altered	
mitochondrial	 function	 in	 the	 equine	COC;	 however,	 an	 effect	 on	blastocyst	 gene	
expression	could	not	be	determined.	To	give	further	 insight	 into	the	effect	of	high	
glucose	 during	 IVM,	 cumulus	 cell	 and	 oocyte	 expression	 of	 metabolic	 genes	 was	
examined.	 DMEM/F12,	 one	 of	 the	 media	 used	 clinically	 for	 IVM	 in	 the	 horse,	
combines	high	glucose	(17	mM)	and	pyruvate	(0.5	mM).	Due	to	the	possibility	that	
the	 pyruvate	 in	DMEM/F12	 ameliorates	 the	 effect	 of	 the	 high	 glucose,	metabolic	
parameters	 in	 DMEM/F12	 were	 compared	 not	 only	 to	 those	 for	 the	 other	
commonly-used	 IVM	base	medium,	M199,	but	also	those	 for:	M199	medium	with	
added	glucose	 (17	mM)	and	M199	medium	with	added	glucose	and	pyruvate	 (0.5	
mM).	 In	this	way,	 it	could	be	determined	whether	A)	the	 increased	glucose	would	
alter	metabolic	parameters	and	B)	the	presence	of	pyruvate	would	ameliorate	this	
effect.	 	 A	 significant	 effect	 of	 pyruvate	 was	 found:	 in	 cumulus	 cells,	 G6PD,	 an	
enzyme	of	the	PPP	pathway,	was	upregulated	in	M199	with	17	mM	glucose	and	0.5	
mM	 pyruvate	 compared	 to	 M199	 with	 17	 mM	 glucose	 alone.	 Unfortunately,	
biological	variation	was	large	and	no	differences	were	detected	in	gene	expression	
attributable	to	experimental	condition	in	oocytes.		
	
Uniquely,	 the	 combination	 of	 metabolic	 evaluation	 and	 gene	 expression	 analysis	
allowed	associations	between	 relative	gene	expression	 in	 the	oocyte/cumulus	cell	
and	COC	glucose,	lactate	and	pyruvate	metabolism	to	be	explored.	In	cumulus	cells,	
expression	 of	GPX1,	 was	 positively	 correlated	 to	 glucose	 consumption	 suggesting	
those	 COCs	 which	 were	 more	 metabolically	 active	 required	 a	 higher	 antioxidant	
capacity.	 In	 addition,	 expression	 of	 TFAM,	 was	 negatively	 correlated	 to	 lactate	 :	
glucose	 ratio	 (it	 increased	as	 glycolysis	 proportionately	decreased)	 	 and	positively	
correlated	 to	 pyruvate	 production.	 Notably	 no	 relationship	 existed	 between	 the	
expression	of	genes	in	oocytes	and	COC	metabolism,	or	between	cumulus	cell	gene	
expression	and	oocyte	gene	expression.	
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Figure	 7.2:	 Summary	 diagram	 of	 significant	 findings	 from	 Chapters	 4,	 5	 and	 6	
pertaining	 to	 medium	 adaptation.	 Glucose,	 lactate	 and	 pyruvate	 metabolism	 is	
depicted	 by	 arrows	 as	 increasing	 or	 decreasing	 compared	 to	 control	 conditions.	
Presence	 of	 17	 mM	 glucose	 resulted	 in	 changes	 in	 mitochondrial	 efficiency;	
decreased	 proportion	 of	 OCR	 coupled	 to	 ATP	 production	 and	 increase	 in	 the	 OCR	
attributable	to	non-mitochondrial	processes.		
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7.2	Interpretive	caution	
	
The	major	 caveat	 to	 interpreting	 data	 originating	 from	 abattoir-derived	 tissues	 is	
that	 of	 heterogeneity	 of	 animal	 age,	 breed	 and	 health	 status.	 In	 addition,	 as	 all	
follicles	 present	 on	 the	 ovary	 were	 used	 for	 oocyte	 recovery,	 there	 is	 great	
heterogeneity	 in	the	ovarian	follicle	population,	even	within	the	same	animal.	The	
scarcity	of	equine	abattoirs	and	the	difficulty	in	recovering	meaningful	numbers	of	
oocytes	 from	 live	 animals	 in	 this	 species	 necessitates	 that	 inclusion	 criteria	 are	
lenient	 and	 as	 such	 a	 high	 biological	 variation	 is	 expected.	 Optimally,	 stringent	
inclusion	criteria	such	as	age	and	health	status	of	mare,	stage	of	follicle	in	relation	
to	the	follicular	wave	(i.e.	status	in	terms	of	viability/atresia)	and	follicle	size	could	
reduce	variation	in	results.		
	
While	 this	 research	 represents	 pioneering	work	 in	 evaluation	 of	 COC	metabolism	
during	 IVM,	 some	 technical	 aspects	 of	 the	 experiments,	 such	 as	 performing	 OCR	
measurements	 on	 groups	 of	 COCs	 leave	 room	 for	 improvement.	 	 While	 the	
Seahorse	XFp	analyser	had	many	benefits	over	existing	methods	to	measure	OCR,	
the	 relative	 low	 sensitivity	necessitated	equine	COCs	 to	be	 cultured	 in	 groups.	As	
such,	 information	 pertaining	 to	meiotic	 status	 or	 future	 developmental	 potential	
could	not	be	assigned	to	individual	oocytes.	
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7.3	Common	themes,	clinical	implications	and	future	work		
	
What	substrates	are	responsible	for	ATP	production	in	the	equine	COC?	
	
An	 estimate	 can	 be	made	 of	 total	 ATP	 production	 by	 equine	 COCs	 by	 combining	
data	from	different	experiments.	Appearance	and	depletion	of	substrates	can	allow	
meaningful	deductions.	The	production	of	one	mole	of	 lactate	produces	one	mole	
ATP	whereas	 approximately	 five	moles	 of	 ATP	 are	 produced	 per	mole	 of	 oxygen	
consumed	 (2	 x	 P/O	 max	 [O]	 of	 2.5;	 (Mookerjee	 et	 al.,	 2017).	 Across	 all	 current	
experiments	 lactate	 production	 was	 approximately	 18	 pmol/ng	 DNA/hour;	 this	
represents	 18	 pmol	 ATP.	 Considering	 OXPHOS,	 mean	 OCR	 was	 46	 pmol/ng	 DNA	
/hour	 of	 which	 50%	was	 coupled	 to	 ATP	 production,	 equating	 to	 115	 pmol	 ATP.	
Taken	together	it	can	be	estimated	that	13.5%	of	ATP	production	can	be	accounted	
for	by	glycolysis	and	86.5%	from	OXPHOS	i.e.	the	majority	of	ATP	is	being	produced	
by	OXPHOS	which	is	in	contrast	to	at	least	the	bovine	COC	(Sutton	et	al.,	2003).	It	is	
interesting	 to	note,	 that	at	 least	 from	a	 functional	perspective,	 stallion	 sperm	are	
also	different	 to	other	 species	 in	 that	 they	 rely	on	OXPHOS	and	not	glycolysis	 for	
both	motility	and	membrane	integrity	(Davilla	et	al.,	2016).	
	
Now	 considering	 substrate	 use,	 the	 glycolytic	 index	 across	 all	 experiments	 (when	
glucose	was	 not	 limiting)	was	 close	 to	 100	%.	 This	 suggests	 that	 glucose	was	 not	
being	directly	oxidised	and	that	another	substrate(s)	 is	 involved	in	ATP	production	
in	 the	 equine	 COC	 under	 clinical	 IVM	 conditions.	 The	 preferential	 conversion	 of	
glucose	 to	 lactate	 (i.e.	 favouring	 glycolysis),	 despite	 the	 presence	 of	 plentiful	
oxygen,	is	also	a	characteristic	of	cancer	and	other	rapidly	proliferating	cells	and	is	
known	as	the	Warburg	effect	(reviewed	by	Smith	and	Sturmey,	2013).		Developing	
embryos,	particularly	at	the	early	blastocyst	stage,	are	also	known	to	convert	most	
glucose	consumed	to	lactate	in	the	rat	(Brison	and	Leese,	1994),	mouse	(Houghton	
et	al.,	1996)	and	cow	(Thompson	et	al.,	1996).	Even	at	the	lowest	range	of	glycolytic	
index	found	in	COCs	in	the	presence	of	excess	glucose	in	the	current	studies	(lactate	
:	glucose	ratio	1.8),	a	maximum	of	10	%	of	the	glucose	consumed	would	be	available	
for	oxidation.	Since	mean	glucose	consumption	was	10	pmol/ng	DNA/hour,	10%	of	
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this	would	be	1	pmol	of	glucose	oxidised.	This	would	still	only	account	for	30	pmol	
ATP	 representing	 only	 26%	 of	 the	 total	 ATP	 from	 OXPHOS	 and	 indicating	 that	 a	
source	other	 than	glucose	was	 responsible	 for	 the	 remaining	74%	of	 the	OXPHOS	
generated	ATP.		
	
The	 large	proportion	of	OXPHOS	derived	ATP	observed	 in	 the	 current	 study,	 is	 in	
stark	contrast	to	data	derived	from	bovine	COCs	under	the	same	conditions	(Sutton	
et	 al.,	 2003).	 In	 that	 study	 approx.	 30-60	 pmol	 ATP/ng	 DNA/hour	 could	 be	
attributed	to	lactate	production	and	only	~5-17	pmol	ATP/ng	DNA/hour	to	OXPHOS	
representing	just	~22%	of	overall	ATP	(vs.	86.5%	in	the	equine	COCs)	and	all	of	the	
OCR	 could	 be	 accounted	 for	 by	 pyruvate	 consumption.	 This	 finding,	 however,	
highlights	 the	 need	 to	 examine	 the	 composition	 of	 the	 experimental	 medium	
utilised;	 the	study	by	Sutton	et	al	was	carried	out	 in	medium	containing	0.23	mM	
pyruvate.	In	contrast,	there	was	no	added	pyruvate	in	the	basic	equine	maturation	
medium	 used	 in	 the	 present	 work.	 In	 this	 medium,	 the	 COCs	 preferentially	
produced	and	secreted	pyruvate	into	the	medium.	Hence,	the	OCR	in	equine	COCs	
in	 this	 medium	 cannot	 all	 be	 attributed	 to	 pyruvate.	 Speculating	 further,	 it	 is	
interesting	that	 in	M199	medium	containing	0.5	mM	pyruvate	 (in	 the	presence	of	
high	 glucose;	 17mM-	 the	 amount	 present	 in	 DMEM/F12)	 COCs	 switched	 to	 net	
pyruvate	consumption	and	the	presence	of	pyruvate	alone	at	0.5	mM	resulted	in	a	
non-significant	increase	in	basal	OCR.	However,	even	with	this	amount	of	pyruvate	
consumption	(~1	pmol/ng	DNA/hour,	equating	to	a	maximum	of	15	pmol	ATP)	total	
ATP	 production	 is	 still	 not	 accounted	 for.	 Therefore,	 the	 question	 remains-	 what	
substrates	are	equine	COCs	oxidising	during	 IVM	 to	produce	 the	majority	of	 their	
ATP?	Furthermore,	are	these	findings	physiological	in	relation	to	what	would	occur	
in	vivo?		
	
The	candidates	for	oxidation	other	than	sugars	are	fatty	acids,	glycogen	and	amino	
acids.		Glycogen	stores	have	received	little	attention	in	the	oocyte	but	are	known	to	
accumulate	 throughout	 the	 cleavage	 stages	 of	 embryo	 development,	 perhaps	
playing	a	more	 important	 role	at	 the	blastocyst	 stage	 (Ferguson	and	Leese,	1999,	
Houghton	et	al.,	1996).	Amino	acid	metabolism	as	a	means	of	ATP	generation	has	
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not	 been	 widely	 studied,	 though	 it	 has	 been	 shown	 in	 COCs,	 oocytes	 and	 early	
embryos	that	there	is	significant	turnover	of	amino	acids	from	the	culture	medium	
and	that	the	absence	of	certain	amino	acids	can	perturb	development	(Cetica	et	al.,	
2003;	 Gardner	 and	 Lane,	 1993).	 Amino	 acid	 turnover	 in	 COCs	 and	 embryos	 is	 of	
interest	as	a	potential	bio-assay	related	to	developmental	potential	 (Hemmings	et	
al.,	2012;	Picton	et	al.,	2010).	In	support	of	their	use	as	an	oxidative	substrate,	it	has	
been	 demonstrated	 that	 mouse	 oocytes	 promote	 amino	 acid	 transport	 by	 the	
cumulus	 cell	 (Eppig	 et	 al.,	 2005)	 and	 that	 transaminases,	 aspartate	
aminotransferase	in	particular,	are	highly	active	in	the	bovine	oocyte	suggestive	of	
use	of	amino	acids	 in	 the	TCA	cycle	 (Cetica	et	al.,	2003).	M199,	being	a	complete	
culture	medium	provides	all	amino	acids	and	investigating	amino	acid	flux	would	be	
an	interesting	area	of	further	study.		
	
Despite	 amino	 acid	 and	 glycogen	 oxidation	 potentially	 contributing	 to	 ATP	
production,	 it	 is	unlikely	they	could	sustain	such	a	high	 level	of	ATP	production	as	
reported	here	(Ferguson	and	Leese,	1999).	Given	the	dark	colour	of	the	cytoplasm	
in	 the	 equine	 oocyte,	 similar	 to	 the	 pig,	 and	 the	 appearance	 of	 apparent	 lipid	
droplets	 on	 electron	 microscopy,	 it	 is	 assumed	 that	 the	 equine	 oocyte	 contains	
large	 amounts	of	 lipid	 and	by	 extrapolation,	 that	 fatty	 acid	oxidation	 (FAO)	has	 a	
major	role	in	ATP	generation	in	either	the	oocyte,	the	embryo	or	both.	β-oxidation	
of	 fatty	acids	 is	 known	 to	be	essential	 for	nuclear	maturation	and	optimal	oocyte	
developmental	 competence	 in	 the	 mouse,	 cow	 and	 pig	 (Dunning	 et	 al.,	 2010;	
Paczkowski	 et	 al.,	 2013).	Additionally,	 FAO	provides	 greater	 amounts	of	ATP	 than	
does	oxidation	of	an	equivalent	amount	of	glucose;	as	an	example	one	mole	of	the	
fatty	acid	palmitate	can	produce	106	moles	of	ATP	in	contrast	to	the	30	that	can	be	
produced	from	one	mole	of	glucose	(Dunning	and	Robker,	2012).	In	the	pig	oocyte	
(incubated	in	TCM-199;	5.6	mM	glucose),	it	was	shown	that	intracellular	triglyceride	
content	 reduced	 by	 13	 ng	 during	 the	 44-hour	 maturation	 period	 confirming	 its	
utilisation	as	a	metabolic	substrate	(Sturmey	and	Leese,	2003).	IVM	of	bovine	COCs	
in	TCM-199	in	the	presence	of	methyl	palmoxirate,	an	inhibitor	of	FAO,	resulted	in	a	
45%	decrease	in	OCR	of	MII	denuded	oocytes	further	highlighting	the	relevance	of	
FAO	during	IVM	(	Ferguson	and	Leese,	2006).	
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Taken	 together,	 the	 findings	 of	 these	 studies	 demonstrate	 the	 versatility	 in	
substrate	 use	 for	 ATP	 generation	 which	 characterises	 COCs,	 and	 appears	 to	 be	
influenced	 further	 by	 medium	 composition	 (Cetica	 et	 al.,	 2003).	 This	 is	 well-
illustrated	 by	 the	 issue	 of	 pyruvate	 availability,	 consumption,	 and	 production.	 It	
would,	for	example,	be	very	interesting	to	repeat	the	GPL	and	OCR	measurements	
in	COCs	incubated	in	a	wider	range	of	pyruvate	concentrations	to	identify	if	there	is	
a	preference	for	pyruvate	oxidation	if	and	when	pyruvate	is	available	and	if	so,	the	
threshold	pyruvate	concentration	at	which	this	occurs.	It	would	also	be	interesting	
to	monitor	 triglyceride	content,	manipulate	β-oxidation	and	observe	 the	response	
in	OCR.		
	
In	the	murine	embryo,	there	is	some	evidence	to	suggest	that	promoting	the	use	of	
pyruvate	 as	 an	 oxidative	 substrate,	 through	 stimulating	 pyruvate	 dehydrogenase	
(PDH)	 activity	 with	 dichloroacetic	 acid	 (DCA),	 is	 beneficial	 in	 terms	 of	 embryo	
development	 (Mcpherson	 et	 al.,	 2014).	 PDH	 is	 also	 a	 therapeutic	 drug	 target	 in	
diabetic	 cardiomyopathy	 in	 which	 overutilisation	 of	 FA	 for	 oxidation	 leads	 to	 a	
decrease	in	myocardial	function	(Page	et	al.,	2015)	-demonstrating	that	versatility	in	
substrate	use	is	not	always	beneficial.		
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Is	depletion	of	all	available	glucose	during	IVM	unfavourable?	
	
In	 the	 initial	 study	 (Chapter	 3)	 it	was	 discovered	 that	 a	 large	 proportion	 of	 COCs	
depleted	 all	 available	 glucose	 from	 10-μl	 droplets	 of	 M199	 based	 medium	
containing	 5.6	mM	glucose.	 It	was	 assumed	 that	 this	 suggested	 an	 inadequacy	 in	
the	 current	 clinical	 conditions	 and,	 importantly,	 it	 rendered	 the	 data	 from	 those	
COCs	 unusable	 for	 data	 collection,	 as	 they	 could	 not	 be	 analysed	 in	 terms	 of	
glycolytic	 index	 when	 glucose	 was	 a	 limiting	 factor.	 COCs	 which	 depleted	 all	
available	 glucose	 had,	 as	 would	 be	 expected,	 decreased	 lactate	 and	 pyruvate	
production	 (Figure	 7.3).	 As	 the	 experimental	 design	 measured	 total	 flux,	 it	 is	
possible	 that	 production	 did	 not	 change	 during	 the	 period	 in	 which	 glucose	 was	
available	 for	 glycolysis,	 but	 that	 lactate	 and	 pyruvate	were	 taken	 back	 up	 by	 the	
COC	 to	 act	 as	 oxidative	 substrates	 in	 the	 absence	 of	 glucose	 at	 the	 end	 of	
maturation.	That	presented	a	question-	what	was	the	impact	of	glucose	depletion?	
If	 the	 COCs	 can	 compensate	 adequately	 by	 re-consuming	 secreted	 lactate	 and	
pyruvate	 perhaps	 there	 is	 no	 negative	 effect	 and	 rather	 the	 avid	 consumption	 of	
glucose	shown	by	these	COCs	was	a	sentinel	 for	quality?	This	hypothesis	could	be	
tested	 by	 comparing	 developmental	 competence,	 maturation,	 cleavage	 and	
blastocyst	 rates,	 which	 I	 did	 in	 Chapter	 3.	 These	 parameters	 were	 seemingly	
unaffected	 by	 depletion	 of	 glucose	 by	 the	 COC	 during	 IVM;	 as	 1/9	 oocytes	 that	
depleted	all	glucose	developed	 into	a	blastocyst	 (11%),	an	equivalent	 (numerically	
higher)	 rate	 to	 that	 for	 non-depleting	 oocytes	 (3/40,	 7.5%).	 	 In	 Chapter	 5,	
unfortunately	blastocyst	 rates	were	 too	 low	 to	explore	 the	effect	of	depletion	on	
blastocyst	gene	expression.	However	analysis	of	the	single	blastocyst	to	form	from	a	
COC	that	had	depleted	all	available	glucose	during	IVM	revealed	it	had	the	highest	
relative	expression	of	PFKM	and	LDHA,	was	the	only	embryo	to	express	TFAM	and	
had	 the	 lowest	GPX1	 expression.	 If	 confirmed	 in	a	 larger	 sample	 size,	 it	would	be	
interesting	to	speculate	that	high	rates	of	COC	glucose	metabolism	programmed	a	
high	 rate	of	 glycolysis	 in	 the	blastocyst	 as	demonstrated	by	high	PFKM	 and	 LDHA	
expression.	Also	interesting	is	the	low	GPX1	expression	given	that	high	expression	is	
associated	 with	 blastocyst	 quality	 in	 other	 species	 (Castillo-martín	 et	 al.,	 2014;	
Cebrian-Serrano	 et	 al.,	 2013).	 Furthermore,	 identical	 conditions	 in	 Chapter	 6	
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allowed	 the	 effect	 of	 depletion	 on	 oocyte	 and	 cumulus	 gene	 expression	 to	 be	
explored.	 Two	 COCs	 in	 the	 control	 conditions	 (5.6	mM	 glucose,	 0	mM	 pyruvate)	
depleted	all	available	glucose.	While	the	low	numbers	resulted	in	lack	of	significant	
differences,	it	was	interesting	that	of	the	seven	genes	examined,	TFAM	was	the	only	
one	for	which	both	cumulus	cell	samples	from	depleting	COCs	expressed	the	gene	
above	 the	 mean	 and	 higher	 than	 all	 other	 samples.	 The	 implication	 of	 high	
expression	of	TFAM	in	both	cumulus	and	the	blastocyst	in	those	COCs	depleting	all	
glucose	is	not	clear.	In	most	cell	types	high	TFAM	expression	represents	high	quality	
but	 in	 cumulus	 cells	 from	 diabetic	 mice,	 TFAM	 expression	 is	 also	 elevated,	
presumably	as	a	compensatory	mechanism	(Wang	et	al.,	2010).	TFAM	expression	in	
oocytes	did	not	appear	to	differ	between	the	two	COCs	that	depleted	glucose	and	
those	COCs	that	did	not.	In	summary,	while	it	seems	that	those	COCs	that	deplete	
all	 available	 glucose	 have	 unique	 characteristics,	 it	 remains	 unclear	 if	 this	 is	
beneficial	or	not.	
	
In	considering	the	clinical	equine	IVM	scenario,	the	ratio	of	maturation	medium	per	
COC	varies	and	is	often	not	stated;	however,	10	μl/COC	is	commonly	used	(Choi	et	
al.,	2016).	One	difference	in	clinical	ICSI,	is	that	oocytes	are	aspirated	from	follicles	
in	 live	mares	 rather	 than	 scraped	 from	 follicles	post	mortem	and	as	 such	 contain	
many	 fewer	 cumulus	 cells	 than	 the	 full	 COCs	 in	 this	 experiment.	 However,	 work	
with	slaughterhouse-derived	COCs	matured	at	10	µl	medium	per	COC	has	resulted	
in	high	blastocyst	rates	 (37-42%;	Choi	et	al.,	2007,	Hinrichs	et	al.,	2005,	Ribeiro	et	
al.,	2008).	A	notable	difference	between	these	data	and	that	of	the	current	studies	
is	 that	 COCs	 are	 normally	 cultured	 in	 groups	 in	 research	 and	 clinical	 settings,	 in	
contrast	to	single	culture	in	the	present	experiments.	In	this	scenario,	as	only	~24%	
of	COCs	consume	enough	glucose	to	deplete	it,	the	fact	that	the	other	76%	of	COCs	
do	 not,	 may	 provide	 sufficient	 “spare”	 glucose	 that	 the	 group	 droplet	 is	 rarely	
depleted	 in	 practice.	 It	 is	 also	 possible	 that	 glucose	 metabolism	 differs	 between	
single	 and	 group	 maturation	 culture,	 meaning	 results	 cannot	 be	 directly	
extrapolated.	 However	 the	 results	 of	 Study	 3.2	 suggest	 that	 at	 least	 in	 groups	 of	
three	COCs,	glucose	uptake	per	COC	is	similar	to	that	for	 individual	COCs.	As	total	
glucose	 depletion	 negated	 data	 use	 from	 that	 COC,	 adjustments	 were	 made	 in	
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Chapter	4	to	prevent	this.	Excess	granulosa	trimming	and	increasing	the	droplet	size	
to	 15	 μl	 were	 effective	 in	 reducing	 the	 incidence	 of	 glucose	 depletion.	 I	
hypothesised	 that	 addition	 of	 pyruvate	 (0.15	 mM)	 and	 lowering	 the	 oxygen	
concentration	 (5%)	 would	 further	 decrease	 glucose	 consumption,	 however	
unexpectedly,	glucose	consumption	increased.	Two	further	options	to	prevent	total	
glucose	depletion	would	be	to	refresh	the	media	half	way	through	IVM	or	provide	
more	glucose.	From	a	clinical	standpoint,	17	mM	glucose	prevented	the	depletion	
of	glucose,	however,	perhaps	other	strategies	such	as	increasing	the	volume	of	the	
drop,	 trimming	 excess	 granulosa	 or	 refreshing	 the	 media	 are	 more	 physiological	
methods	until	the	consequences	of	high	glucose	concentration	are	determined.		
	
While	 I	 sought	 to	 examine	 the	 independent	 effect	 of	 17	 mM	 glucose	 in	 M199	
medium	based	on	the	fact	that	clinical	success	has	been	reported	using	DMEM/F12	
(17	mM),	 it	cannot	be	 ignored	that	DMEM/F12	differs	markedly	 to	M199	 in	more	
than	just	glucose	concentration.	It	is	possible	that	other	differences	in	composition	
mean	 that	 glucose	 metabolism	 results	 obtained	 herein	 cannot	 be	 directly	
extrapolated.	Importantly,	DMEM/F12	also	contains	pyruvate	(0.5	mM),	a	substrate	
not	found	in	M199,	which	as	shown	in	Chapter	6	resulted	in	pyruvate	consumption	
rather	 than	 production.	 While	 glucose	 consumption	 and	 lactate/pyruvate	
production	 and	 gene	 expression	 was	 evaluated	 in	 COCs	 matured	 in	 DMEM/F12,	
OCR	and	mitochondrial	efficiency	was	not.	It	would	be	interesting	to	examine	basal	
OCR	 and	 mitochondrial	 efficiency	 in	 DMEM/F12	 to	 determine	 if	 the	 additional	
components	 of	 this	 medium	 cause	 these	 parameters	 to	 differ	 from	 that	 seen	 in	
M199	with	added	glucose	and	pyruvate.		
	
Based	 on	 the	 experimental	 data	 obtained	 in	 the	 current	 studies,	 my	 clinical	
recommendation	 would	 be	 to	 ensure	 tight	 trimming	 of	 excess	 granulosa	 and	 to	
increase	the	COC:	medium	ratio	to	at	least	15	μl	to	ensure	depletion	doesn’t	occur.	
This	would	prevent	the	COC	from	compensating	at	an	as	yet	unknown	cost.		
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Figure	7.3:	Schematic	diagram	summarising	the	effects	of	total	glucose	depletion	by	
equine	COCs	during	IVM	on	COC	metabolic	parameters,	developmental	markers	and	
gene	expression	 in	cumulus	cells	and	the	resulting	blastocyst.	?	denotes	suggested	
but	unconfirmed	observations.	
	
	
Are	the	mitochondria	of	the	COC	compromised	under	current	conditions?	
	
Investigations	 into	 oocyte	 mitochondrial	 function	 and	 efficiency	 are	 very	 much	
centre	 stage	 in	 the	 assisted	 reproduction	 field,	 given	 the	 strong	 association	
between	mitochondrial	health	and	oocyte	developmental	competence	(review;	Van	
Blerkom,	 2011).	 In	 fact,	 while	 somewhat	 controversial,	 procedures	 such	 as	
mitochondrial	 supplementation	 and	 nuclear	 spindle	 transfer	 are	 under	
development	 in	 human	 age-related	 infertility	 research	 and	 avoidance	 of	
mitochondrial	disease	transmission	(Cagnone	et	al.,	2016;	Hyslop	et	al.,	2016;	Zhang	
et	 al.,	 2017).	 Examining	mitochondrial	 efficiency	 in	 the	 experiments	 contained	 in	
this	thesis	consistently	revealed	a	 lack	of	spare	capacity	by	the	conclusion	of	 IVM,	
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independent	 of	 medium.	 As	 experiments	 were	 performed	 on	 whole	 COCs,	 it	 is	
unclear	what	proportion	can	be	attributed	to	cumulus	cells	and	what	to	the	oocyte.	
While	of	course	there	are	many	more	cumulus	cells,	the	oocyte	contains	up	to	100-
fold	 the	number	of	mitochondria	 than	does	one	cumulus	cell.	 If	 cumulus	cells	are	
mostly	represented,	as	speculated	in	Chapter	3	(equine	denuded	oocyte	OCR	data	
represented	10%	of	that	measured	in	whole	COCs	in	the	present	study	[Obeidat	et	
al.,	 2018]),	 it	 is	 possible	 that	 the	 lack	 of	 spare	 capacity	 is	 evolutionary	 in	 that	
cumulus	cells	are	nearing	the	end	of	their	physiological	role	and	lifespan.	However,	
the	 relative	 quiescence	 of	 each	 mitochondrial	 vestment	 is	 unknown	 and	 if	 a	
significant	 proportion	 of	 the	 oocyte	 mitochondria	 are	 represented,	 then	 lack	 of	
spare	 capacity	 and	 a	 high	 non-	 mitochondrial	 component	 suggests	 inefficiency.	
Given	 the	 role	 of	 oocyte	 mitochondrial	 dysfunction	 in	 aneuploidy	 and	 also	 the	
absolute	 requirement	 for	 a	 highly	 polarised	 mitochondrial	 membrane	 to	 sustain	
calcium	oscillations	during	fertilisation	(Dumollard	et	al.,	2004)	it	is	of	great	clinical	
importance	 to	 discover	 if	 oocyte	 mitochondria	 are	 indeed	 compromised	 in	 the	
current	IVM	conditions.	
	
The	 high	 non-mitochondrial	 component	 of	 OCR,	 particularly	 in	 high	 glucose	
medium,	 suggests	excess	ROS	production,	as	 summarised	 in	Chapter	5.	As	 such	 it	
was	 notable	 that	 GPX1,	 an	 anti-oxidizing	 agent,	 was	 the	 gene	 with	 the	 highest	
expression	 in	 all	 three	 sample	 types	 (cumulus	 cells,	 oocytes	 and	 blastocysts).	 It	
could	be	speculated	that	this	was	in	response	to	oxidative	stress	and	further	work	
should	 include	direct	measurement	of	ROS.	 It	 is	worthy	of	mention	that	the	three	
studies	 available	 examining	 the	 effect	 of	 antioxidant	 addition	 to	 equine	 IVM	
medium	did	not	report	a	positive	effect	on	developmental	parameters	or	measures	
of	oxidative	 stress	 (Deleuze	et	 al.,	 2010;	 Luciano	et	 al.,	 2006;	Merlo	et	 al.,	 2016).	
However,	 these	 results	 require	 interpretation	 in	 context	 of	 the	medium	 in	which	
the	 experiments	were	 performed.	 The	 two	 studies	 investigating	 cysteine	 addition	
were	carried	out	in	M199	(5.6	mM	glucose)	and	the	third,	using	β-mercaptoethanol	
was	carried	out	 in	DMEM/F12	 (17	mM).	The	addition	of	antioxidants	 is	worthy	of	
further	investigation.		
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COC	metabolism	and	developmental	markers	
	
At	the	outset	of	these	studies	it	was	expected	that	a	higher	blastocyst	rate	would	be	
obtained,	based	on	success	with	this	technique	experienced	during	the	preliminary	
studies	(14%	blastocyst	rate).	This	would	enable	evaluation	of	associations	between	
glucose,	 lactate	 and	 pyruvate	 metabolism	 and	 developmental	 competence.	 This	
was	 not	 fully	 possible,	 due	 the	 low	 blastocyst	 rate	 achieved	 during	 the	 studies.		
Unfortunately,	the	factors	affecting	variation	 in	blastocyst	production	 in	the	horse	
have	 not	 yet	 been	 elucidated,	 and	 such	 fluctuation	 appears	 to	 be	 a	 common	
problem,	as	can	be	seen	by	varying	rates	reported	even	within	established	equine	
ICSI	 laboratories.	 However	 it	 was	 interesting	 to	 note	 that	 the	 COC	 glucose	
consumption	 and	 lactate	 production	 during	 IVM	 of	 those	 oocytes	 that	 became	
blastocysts	was	close	to	the	exact	mean	of	all	COCs.	While	numbers	are	obviously	
low,	 this	 pattern	 is	 in	 agreement	 with	 the	 ‘Dynamic	 Energy	 Budget	 Theory’	
proposed	by	Professor	Bas	Kooijman	(2010)	and	demonstrated	 in	bovine	embryos	
by	Guerif	et	al.,	 (2013).	A	recent	review	has	termed	this	the	“Goldilocks	principle”	
whereby	embryos	with	maximal	developmental	potential	have	a	metabolic	rate	at	
“just	 the	right	amount”	 (Leese	et	al.,	2016).	 In	contrast,	 in	studies	examining	COC	
metabolism	in	relation	to	blastocyst	development	in	the	cow,	mouse	and	cat,	high	
glucose	 consumption	 was	 associated	 with	 improved	 blastocyst	 development	
(Krisher	and	Bavister,	1999;	Preis	et	al.,	2005;	Spindler	et	al.,	2000).		
	
In	 considering	 possible	 developmental	markers	 from	 the	 gene	 expression	 data	 in	
Chapter	5,	POU5F1	 tended	to	be	associated	with	both	speed	of	development	and	
GPX1	 expression.	 Given	 that	 both	 POU5F1	 and	 GPX1	 have	 been	 suggested	 as	
developmental	markers	of	competence	in	other	species	(Castillo-martín	et	al.,	2014;	
Cebrian-Serrano	et	al.,	2013;	Filliers	et	al.,	2012),	they	warrant	further	study	in	the	
horse.	
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Investigation	of	the	legacy	effect	of	equine	IVM	culture	conditions	is	required	
	
The	downstream	consequences	of	suboptimal	 IVM	conditions	are	as	yet	 relatively	
undefined,	particularly	in	the	horse.	While	I	attempted	to	address	this	by	evaluating	
blastocyst	 gene	expression,	 the	aim	 could	not	be	 fulfilled.	However,	 I	 still	 believe	
this	is	a	crucial	aspect	of	determining	IVM	condition	suitability.	It	is	clear	that	good	
blastocyst	 rates	 and	 foal	 production	 can	 occur	 under	 the	 current	 conditions	 and	
anecdotal	 evidence	 exists	 of	 excellent	 performance	 in	 the	 resulting	 adult	 horses.	
This	indicates	that	the	equine	COC	is	able	to	adapt	to	culture	conditions,	however,	
as	 reviewed	 by	 Roseboom,	 (2018)	 this	 adaptation	 can	 occur	 at	 the	 detriment	 of	
long-term	 health	 outcomes,	 indices	 which	 have	 not	 yet	 been	 examined	 for	 foals	
produced	 by	 equine	 ART.	 Ideally,	 this	 would	 involve	 phenotyping	 foals	 produced	
from	varying	conditions.	A	recent	study	by	Valenzuela	et	al.,	(2017)	investigating	the	
effects	 of	 equine	 assisted	 reproduction	 techniques	 (embryo	 transfer	 and	 ICSI)	 on	
foal	 and	 placenta	 morphometry	 and	 expression	 of	 selected	 placental	 genes,	
interestingly	found	no	significant	differences.	However,	a	study	exploring	the	effect	
of	 mare	 breed	 and	 uterine	 environment	 demonstrated	 an	 influence	 at	 the	
metabolic	level	in	foals	(Peugnet	et	al.,	2014).		
	
The	mechanism	by	which	 gamete	 or	 embryo	 environmental	 variation	 results	 in	 a	
heritable	 change	 of	 phenotype	 is	 epigenetics,	 that	 is,	 the	 intracellular	 control	 of	
gene	 expression.	 	 Epigenetics	 is	 at	 the	 centre	 of	 the	 Developmental	 Origins	 of	
Health	 and	Disease	 (DOHAD)	 concept,	which	was	 first	 described	by	David	Barker.	
The	DOHAD	concept	is	currently	considered	to	be	of	immense	importance	given	the	
worldwide	epidemic	of	non-communicable	diseases	in	humans,	the	risk	for	many	of	
which	has	now	been	 linked	to	the	periconception	and	gestational	period	(recently	
reviewed	by	Fleming	et	al.,	2018).	Thus,	evaluating	the	epigenetic	effects	of	varying	
IVM	conditions	is	a	further	approach	that	could	be	employed	to	decipher	suitability.	
In	 this	 regard,	 aberrations	 in	 gene	 methylation,	 decreased	 expression	 of	 DNA	
methyl	 transferases	 (DNMTs)	 and	 altered	 histone	 acetylation	 have	 been	
demonstrated	 in	 oocytes	 derived	 from	diabetic	mice	 (Ding	 et	 al.,	 2012;	Ge	 et	 al.,	
2014,	 2013;	 Ma	 et	 al.,	 2012).	 To	 the	 best	 of	 my	 knowledge	 there	 are	 only	 two	
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studies	 (performed	 by	 the	 same	 group)	 investigating	 epigenetic	 effects	 in	 equine	
oocytes.	 The	 first	 study	 performed	 by	 Franciosi	 et	 al.,	 (2012)	 identified	 global	
histone	 4	 deacetylation	 on	 lysine	 residue	 16	 (H4K16)	 in	 IVM	 oocytes	 where	 as	
H4K16	was	acetylated	in	in	vivo	matured	oocytes.	As	histone	acetylation	is	a	critical	
epigenetic	 regulator	 of	 processes	 such	 as	 chromatin	 condensation,	 these	 authors	
hypothesised	 that	 the	 observed	 deacetylation	 was	 responsible	 for	 the	 increased	
aneuploidy	rates	and	spindle	defects	they	observed	in	the	IVM	oocytes	compared	to	
in	 vivo	 matured	 oocytes	 (Franciosi	 et	 al.,	 2015).	 While	 this	 association	 remains	
unconfirmed,	 this	and	other	epigenetic	mechanisms	are	certainly	areas	 that	could	
be	explored	further	in	the	context	of	the	experiments	described	in	this	thesis.	
	
Novel	experimental	designs	and	proof	of	concept	
	
A	 notable	 feature	 of	 the	 work	 described	 in	 this	 thesis	 is	 that	 for	 many	 of	 the	
metabolic	methods	utilised,	this	is	the	first	time	they	have	been	applied	to	COCs	of	
any	 species.	 Enzyme-linked	 assays,	 oxygen	 consumption	measurements	 using	 the	
Seahorse	XFp	analyser,	and	PolyA	PCR	amplification	all	 required	development	and	
optimisation.	 	 Additionally,	 novel	 experimental	 designs	 enabled	 ambitious	 aims	
such	 as	 exploring	 associations	 between	 oocyte,	 cumulus	 and	 blastocyst	 gene	
expression	and	COC	metabolism	and	morphokinetics	of	embryo	development	to	be	
investigated.	Unfortunately,	 inadequate	numbers	resulted	 in	these	aims	not	being	
fully	addressed,	however	proof	of	principle	was	demonstrated	and	the	value	of	the	
experimental	 design	 highlighted.	 Further	 uses	 for	 future	 research	 would	 include	
banking	 media	 from	 clinical	 cases	 in	 which	 blastocysts	 produced	 are	 ultimately	
destined	for	transfer.	GPL	measurements	and	cumulus	gene	expression	could	then	
be	 performed	 without	 sacrifice	 of	 the	 oocyte	 and	 potentially	 allow	 for	 more	
detailed	investigations.	If	the	Seahorse	XFp	analyser	sensitivity	could	be	enhanced,	
measuring	 OCR	 of	 single	 COCs	 and/or	 embryos	 would	 also	 allow	 further	
interpretation	of	current	data.					
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7.4	Concluding	remarks	
	
Data	reported	in	this	thesis	characterised	for	the	first	time	the	carbohydrate	energy	
metabolism	of	the	equine	COC	during	IVM,	and	began	to	explore	the	suitability	of	
commonly	 used	 IVM	 medium	 and	 metabolic	 substrates	 for	 equine	 IVM,	 with	
reference	 to	 both	 mitochondrial	 function	 and	 developmental	 parameters.	
Additionally,	I	have	contributed	to	existing	data	on	cumulus,	oocyte	and	blastocyst	
gene	expression	and	have	validated	exciting	platforms	for	future	studies.	
	
I	 believe	 that	 data	 produced	 and	 literature	 reviewed	 in	 the	 course	 of	 this	 thesis	
demonstrates	not	only	the	scientific	value	of	exploring	the	equine	COC	and	embryo	
to	increase	our	knowledge	of	the	comparative	biology	of	these	fundamental	phases	
of	mammalian	life,	but	also	the	importance	of	continuing	this	work	to	ascertain	the	
suitability	 of	 current	 equine	 IVM	 media	 and	 conditions	 used	 for	 clinical	 foal	
production.	A	recommendation	can	be	made	at	the	very	least	to	exclude	elements	
known	to	be	non-physiological	(e.g.	17-mM	glucose	during	IVM)	until	such	a	point	
that	conclusive	evidence	exists	that	they	do	no	harm.	
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Abstract 
 
The study of early embryo metabolism has 
fascinated researchers in the field for nearly a century. 
Herein, we give a brief account of the general features 
of embryo metabolism and some consideration of the 
research performed to reach such conclusions. It is 
becoming increasingly obvious that metabolism informs 
many fate decisions and outcomes beyond ATP 
generation, such as DNA methylation, Reactive Oxygen 
Species generation and cell signaling. We discuss the 
reasons for studying metabolism in the face of our 
current knowledge of the effect that the culture 
environment on the developing embryo and the 
downstream effects that can cause. The study of in vitro 
embryo metabolism can also give us insight into 
developmental perturbations in vivo.  The strengths and 
limitations of the methods we use to study metabolism 
are reviewed with reference to species-specific 
fundamental biology and plasticity and we discuss what 
the future holds for metabolic studies and the 
unanswered questions that remain. 
 
Keywords: ATP generation, method evaluation, 
preimplantation development. 
 
Introduction 
 
The study of mammalian early embryo 
metabolism has a rich history (Leese, 2012). Whilst 
work in the period of the 1940s-1960s focused on the 
effect of adding energy substrates to embryos in culture, 
real progress in understanding embryo metabolism was 
made in the 1970s by the likes of Biggers and Stern 
(1973), Brinster (1973) and Gwatkin and Haidri (1974) 
who examined the fate of radiolabeled compounds 
added to the medium. From experiments such as these, a 
picture of early embryo metabolism began to emerge. 
Like so much of our knowledge of early mammalian 
embryo development, the first data came from the 
classical laboratory model species; mouse and rabbit, as 
well as the hamster. Interest grew, and embryo 
metabolism was soon examined in the large domestic 
animals; pigs, cattle, sheep and, to a lesser extent, the 
horse, dog and cat. Underpinning research were studies 
on early human development with the aim of clinical 
translation for the treatment of infertility; a feat first 
achieved in 1978 by Steptoe and Edwards. Alongside 
this feat was the development of assisted conception 
techniques for use in farm animals. It is not the intention 
of this article to re-describe the history of the research 
that lead to successful embryo culture or the 
contribution that studies on metabolism made. For 
expert insight, the reader is encouraged to read (Leese, 
2012; Chronopoulou and Harper, 2014). 
 
Embryo metabolism: what do we know? 
 
The description of carbohydrate metabolism 
during preimplantation development is largely accepted 
and will be familiar to anyone who has an interest in the 
early embryo. In almost all species studied, the cleavage 
stage embryo, from fertilisation through to formation of 
the morula, is relatively metabolically quiescent. 
Oxygen consumption at this time remains comparatively 
low, and the dominant substrate depleted from the 
culture environment is pyruvate. Pyruvate is consumed 
at an almost steady rate during cleavage, with a 
proportion of the carbon (depending on the species) 
appearing in the medium as lactate with the generation 
of metabolic energy. The source of the pyruvate 
involved in such reactions is generally either glycolytic 
conversion of glucose or that taken up directly from the 
external environment. Pyruvate may also enter the 
Tricarboxylic Acid (TCA; Krebs) cycle, where it can be 
oxidised completely generating electron donors for the 
electron transport chain which occurs in the matrix of 
mitochondria and relies on oxygen acting as the 
terminal electron acceptor. For this reason, oxygen 
consumption provides a good marker of overall 
oxidative metabolic activity (for review, see Smith and 
Sturmey, 2013).  
As the cleavage stage embryo progresses to a 
blastocyst, there is a sharp and characteristic rise in the 
amount of glucose consumed in all species studied, and 
a concomitant rise in lactate release into the medium. 
Coincident with this is a fall in pyruvate consumption. 
This general pattern of “blastocyst glycolysis” appears 
to be conserved across all species studied. There are a 
range of explanations for this, however, as glycolysis is 
a comparatively inefficient means of generating ATP 
therefore energy production is unlikely to be the prime 
reason. Moreover, as the blastocyst forms, oxygen 
consumption also rises (Fridhandler et al., 1957; 
Houghton et al., 1996; Thompson et al., 1996; 
Trimarchi et al., 2000; Sturmey and Leese, 2003) 
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further supporting the notion that glycolytic production 
of lactate is of minor consequence in contributing ATP 
for the blastocyst. It is much more likely that glycolysis 
rises to meet the need for carbon for biosynthetic 
processes. A description of glycolysis in the early 
embryo can be found in Smith and Sturmey (2013). This 
general picture of embryo metabolism was summarized 
with great prescience by Brinster in 1973; in the 
intervening years many laboratories across the world 
have generated evidence to support such a description, 
illustrating the robustness with which these findings can 
be considered. 
While early work focused on carbohydrate 
metabolism, it is now clear that the metabolism of 
amino acids, lipids and vitamins such as folate all also 
act in an interdependent manner to produce a viable 
embryo. Amino acids are crucial components of the 
culture environment in vitro (reviewed by Sturmey et 
al., 2010). Their addition to simple culture medium 
either singly (Rieger et al., 1992a) or in combinations 
(Chatot et al., 1989; Gardner and Lane, 1993) permitted 
mouse embryos to be cultured past the so-called 2-cell 
block (Chatot et al., 1989) and their widespread 
inclusion lead to improved blastocyst rates in almost 
every species studied. The addition of amino acids has 
had such a positive effect on the efficacy of in vitro 
embryo culture, that their inclusion is often described as 
having a primary role in the formulation of “next 
generation medium” (Leese, 2012). The precise 
mechanism for the positive effect of amino acid 
provision is still to be defined, however it is well 
established that addition of amino acids to in vitro 
medium can alleviate culture associated stress in flushed 
murine embryos (Lane and Gardner, 1998). The 
contribution that amino acid metabolism makes to ATP 
production remains unclear, however the turnover of 
amino acids (that is, the sum of their depletion or 
accumulation into the culture droplet) has been linked to 
embryo blastocyst rates (Houghton et al., 2002), human 
embryo live birth rates (Brison et al., 2004), DNA 
damage (Sturmey, 2009), aneuploidy (Picton et al., 
2010) embryo sex (Sturmey et al., 2009a), maternal age 
(Picton et al., 2010) and embryonic stress (Wale and 
Gardner, 2012). 
When considering energy metabolism of early 
embryos, it is vital that the contribution made by 
endogenous triglyceride is not overlooked. Fatty acid β-
oxidation was studied in detail in the 1970s by Kane and 
colleagues (Kane, 1979) but then largely ignored, with 
the notable exception of the work by Downs (see 
Downs, 2015). However, interest in fatty acid 
metabolism has re-awakened, partly in response to the 
report from Dunning et al. (2010) who elegantly 
demonstrated that mouse oocytes require fatty acid 
oxidation in order to develop. A similar conclusion was 
drawn by Sturmey and Leese (2003) in the pig, 
underlining the importance of fatty acid β-oxidation 
during oocyte maturation, development and in the 
preimplantation stages. Species differences in the 
importance of fatty acid oxidation during oocyte and 
embryo development have also been identified. For 
example, where a mouse zygote will arrest after 15 h in 
media lacking nutrients (cited in Leese, 2012) a rabbit 
embryo can complete up to 3 cleavage divisions in the 
absence of energy substrates (Kane, 1987) and sheep 
embryos can also develop to the blastocyst stage in the 
absence of glucose (Thompson et al., 1992). This can be 
explained by the differences in intracellular triglyceride 
content, acting in a buffering capacity by providing an 
alternate energy source (Ferguson and Leese, 2006; 
Sturmey et al., 2009b). Recently, a number of 
laboratories have described altered fatty acid 
metabolism by embryos from overweight and obese 
mice (Pantasri et al., 2015; Reynolds et al., 2015) and 
the human (Leary et al., 2014). After receiving 
comparatively little attention since the work of Kane, 
interest in fatty acid metabolism by oocytes and 
embryos has been intense, and has been widely 
reviewed in recent years (Sturmey et al., 2009b; Leroy 
et al., 2012; McKeegan and Sturmey, 2011; Dunning et 
al., 2014; Downs, 2015). 
This very brief overview is intended to remind 
the reader of the basic features of early embryo energy 
metabolism. However, ‘metabolism’ refers to 
significantly more functions than ATP generation. For 
example, there is an extensive literature describing the 
role of the pentose phosphate pathway (Downs et al., 
1998; Sutton-McDowall et al., 2010) in mammalian 
oocytes and early embryos. Moreover, metabolic 
processes link to signaling mechanisms (Manser and 
Houghton, 2006), generation of Reactive Oxygen 
Species (Agarwal et al., 2005) and gene expression in 
terms of establishment of epigenetic marks such as 
methylation and acetylation and post-translational 
modifications of proteins (DeBerardinis and Thompson, 
2012). For example, defects in folate metabolism have 
been linked to methylation and epigenetic modifications 
affecting developmental competence (Xu and Sinclair, 
2015). However, reviewing all of the literature on 
embryo metabolism in its broadest sense would require 
several articles and so in the remainder of this article, 
we will consider some more fundamental aspects. 
 
Why do we study embryo metabolism? 
 
Understanding the basic physiology and 
metabolism of the early embryo is a noble quest in itself 
that has fascinated researchers over the past decades. 
However, a major gap in our knowledge is the 
metabolism of the in vivo produced embryo, as well as 
the embryo in situ, which remain an elusive goal. We 
aim to gain information that can, and has been, 
translated into clinical practice in many ways; to design 
appropriate species specific culture media with the aim 
of producing viable healthy offspring; to design non-
invasive methods for embryo selection for transfer and
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shed light on metabolic perturbations occurring in vivo. 
Moreover, as our understanding of somatic cell nuclear 
transfer (SCNT; Wilmut et al., 2002) grows and 
becomes linked inextricably to stem cell physiology and 
regenerative medicine, we must also accept that we 
know comparatively little about the impact of such 
techniques may have on embryo physiology. 
Furthermore, we are on the brink of many new and 
exciting developments in Assisted Conception, 
including mitochondrial transfer for the treatment of 
debilitating hereditary conditions as well as the 
replenishment of mitochondria in aged oocytes with the 
aim of improving pregnancy rates in older women 
(Craven et al., 2010; Smeets, 2013). Such techniques 
may be considered ‘beyond experimental’; 
mitochondrial transfer was licensed for treatment in the 
UK in 2014 and autologous mitochondrial transfer for 
infertility is already commercially available in some 
countries. However, since each of the approaches 
described above involve, in some way, altering the 
mitochondrial content of embryos, the need for detailed 
understanding of metabolic regulation of individual 
preimplantation mammalian embryo has never been 
greater. 
A further drive to study embryo metabolism 
comes from the need to identify biomarkers of embryo 
health and viability. This relies on the inherent 
variability in metabolism between different embryos 
and has been used in an attempt to select viable embryos 
for transfer, with the end goal being clinical IVF in 
humans. There have been several observations that have 
yielded promising results. The ‘quiet embryo 
hypothesis’ proposed by Leese in 2002, stated that those 
embryos that are viable have a decreased metabolic rate; 
a proposition that has been supported by several studies 
showing embryos with an upregulated metabolism of 
both carbohydrates and amino acids to have decreased 
viability post transfer (Lane and Gardner, 1996; 
Sturmey et al., 2009a; Guerif et al., 2013). However, 
the notion is contested, and there are recent studies 
suggesting that elevated metabolism, particularly with 
respect to glucose consumption is associated with 
embryo viability (Gardner et al., 2011). Clearly, this is 
an area in which more work is needed. 
Since pioneering observations linking human 
birth weight to cardiovascular events in later life by 
David Barker et al. (1989) it has now been shown 
unequivocally in many species that the periconceptual 
environment can have downstream effects which can 
impact on the viability of the developing embryo and on 
the future health of the resulting offspring (Ceelen et al., 
2008; Watkins et al., 2008; Leroy et al., 2009; Fleming 
et al., 2012; Frank et al., 2014). It is also clear that 
certain embryonic stages are more susceptible to 
damage (Rieger et al., 1992a), such as the early 
cleavage embryo during embryonic genome activation, 
suggesting that progeny may have a ‘memory’ of their 
origins.  
With the rising obesity epidemic both in 
humans and companion animals, in addition to 
metabolic disease in farm animal species due to 
increased production pressures, the study of embryo 
metabolism in vitro can provide insight into the 
mechanisms of resultant suppressed fertility and 
potentially identify therapeutic interventions. 
These are important reasons for studying 
embryo metabolism, and it is clear that metabolic 
processes can directly influence gene expression (Van 
Hoeck et al., 2011, 2013), and patterning of the embryo 
(Leary et al., 2014). However, it is also of fundamental 
importance to be aware of what is measured when 
studying embryo metabolism. In the final part of this 
review, we will describe the strengths and limitations of 
embryo metabolic studies. 
 
What are we actually measuring? 
 
The measurement of embryo metabolism is 
faced with many technical challenges. Critically, the in 
vivo environment is still largely unknown for most 
species, meaning that the extrapolation of knowledge to 
an embryo in vivo is of questionable validity. The data 
available on embryo metabolism inform us of the 
strategy of substrate depletion and appearance in a given 
milieu. In vitro, this milieu is constrained by the 
addition of a limited number of substrates at static 
levels; supply and ratio of substrates varies only in 
response to an embryo’s own activity. This is in stark 
contrast to the situation in vivo, which is dynamic and 
responsive (Leese et al., 2008). Even in species for 
which the in vivo embryo environment has been 
described, the method used to define it should be noted. 
Often post mortem changes and/or inflammatory 
changes due to catheterization can influence results thus 
making samples non-representative (Leese et al., 2008). 
Moreover, the embryo in situ likely exists in a 
microenvironment within the oviduct, thus any subtle, 
specific composition features will be lost in flushing of 
the tube. 
Given the heterogeneity in developmental 
potential, measures pertaining to single embryos are key 
and thus highly sensitive assays are needed. Both the 
use of radiolabelled substrates (Rieger et al., 1992b) and 
enzyme-linked fluorescence assays to detect the 
appearance and disappearance of a substrate from 
culture media have been described (Leese and Barton, 
1984; Guerif et al., 2013). The relative metabolic 
quiescence of single embryos means that ‘analysis 
media’ (that is a medium in which the concentrations of 
substrates is reduced to enable measurement of change) 
is often used in order to permit detection of changes in 
substrate concentration (Hardy et al., 1989; Sturmey 
and Leese, 2003). This ‘analysis medium’ is often 
different to the in vitro culture media known to support 
development for most species, which, in turn differs 
vastly to the in vivo environment. Of course, it also must
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be realized that there are many complex cell transport 
and metabolic pathways involved, and notions of influx 
and efflux leads’ us to make what are essentially 
educated guesses about what occurs in the cell. Despite 
these limitations, these assays have greatly advanced 
our knowledge of metabolic pathways involved and 
have yielded highly repeatable results across different 
laboratories. Further methods that have been used to 
detect metabolic activity of embryos include culturing 
individually in micro-droplets or in large groups of 
embryos. However, the resolution of data from group 
culture is reduced since individual embryo 
heterogeneity is lost by ‘averaging’. 
New promising studies using NMR 
metabolomic technology, where substrate flux can be 
measured in situ have been recently described (Krisher 
et al., 2015), however the subsequent interpretation and 
analysis of the complex data acquired presents new 
challenges. 
Inferences about the contribution of oxidative 
metabolism are usually derived from measuring oxygen 
consumption. Methods vary, the most widely used being 
pyrene fluorescence (Houghton et al., 1996) and 
nanorespirometry (Lopes et al., 2010). Again while 
allowing accurate measurement of oxygen depletion in 
single embryos and seemingly not affecting 
development (Lopes et al., 2005), the methods 
represents a significant ‘alien’ environment for the 
embryo. 
Studies involving metabolic inhibitors and 
enzymatic co-factors have also added to our knowledge 
of embryo metabolism and in some cases provided the 
initial proof of certain pathways occurring and either 
being essential or non-essential for development. 
Among these, Brison and Leese (1994) showed that 
oxidative phosphorylation was not an absolute 
requirement for blastocoele formation in the rat by 
culturing embryos in the presence of cyanide, while 
Macháty et al. (2001) indicated that suppression of 
oxidative phosphorylation at the morula stage improved 
development to the blastocyst in the pig. Moreover, 
Dunning et al. (2010) have shown that β-oxidation is 
essential for optimal development in the mouse by 
culturing in the presence of etomoxir. In some cases, 
inhibition of certain metabolic pathways has been 
shown to improve developmental potential; for example 
the addition of EDTA to embryo culture medium 
(Gardner et al., 2000). Although the mechanism is not 
confirmed, one possible role of EDTA in embryo 
culture medium is the suppression of glycolysis 
(Gardner et al., 2000). However, it is equally likely that 
EDTA acts as an antioxidant by sequesteration of metal 
ions which would otherwise catalyse the formation of 
Reactive Oxygen Species (Orsi and Leese, 2001). 
Studies such as these illustrate the importance of 
appropriate regulation of metabolic pathways during 
development and also indicate why it is necessary for 
pathways to be correctly orchestrated to match needs at 
a given stage of development. 
 
It all depends on the environment 
 
It could be argued that measuring embryo 
metabolism in vitro (by necessity) amounts to 
measuring a stress response. This issue must be 
considered given the extremely adaptable nature of 
embryos of all species. Metabolism is necessarily 
dynamic, enabling rapid changes in needs to be met to 
maintain development. However, such dynamism means 
that the metabolic profile of an embryo can respond 
quickly in response to a change in external environment, 
shown clearly in mice, where perturbations occur within 
3 h of in vitro culture in flushed in vivo blastocysts 
(Lane and Gardner, 1998). Both the presence and 
relative quantities of metabolic substrates in the 
environment in which experiments are conducted will 
significantly affect the results. While not attempting to 
provide a detailed discussion on the controversial 
aspects of in vitro culture systems, which still vary 
widely across laboratories, this point can be further 
illustrated by the differential metabolism that results 
from the presence or absence of serum and the 
atmospheric oxygen concentration (Wale and Gardner, 
2010). 
While the human IVF industry has moved 
towards defined culture media using macromolecular 
sources such as recombinant albumin, serum is still used 
in many production animal systems. Culture with serum 
has been shown to increase blastocyst development 
rates in the horse (Choi et al., 2004) and the kinetics of 
blastocyst development in the cow (Rizos et al., 2003). 
However, its presence has also been associated with 
increased intracellular lipid content (Ferguson and 
Leese, 2006) and altered metabolism (Reis et al., 2003), 
up-regulation of oxidative stress and inflammatory 
pathways (Cagnone and Sirard, 2014) and decreased 
survival after vitrification (Gómez et al., 2008). In 
addition, the oxygen tension of the reproductive tract in 
all species studied has been found to be below 10% 
(Fischer and Bavister, 1993). In terms of the 
environmental gas profile, there is now unequivocal 
evidence to support the notion that 20% oxygen reduces 
embryo development (Thompson et al., 1990; Wale and 
Gardner, 2010) and that culture in low oxygen (5%) 
results in metabolic and proteomic profiles more closely 
matching in vivo counterparts (Thompson et al., 1990; 
Katz-Jaffe et al., 2005). Clearly, these factors will 
influence the results of any metabolic study and must be 
kept in mind when comparing studies. 
In addition to the embryo adapting to its 
environment, the culture environment itself is not static. 
Depletion and accumulation of excreted of substrates 
such as lactate and amino acids will change the local 
environment. Spontaneous de-amination will occur at 
37°C, especially of glutamine, resulting in ammonium 
build up (Gardner and Lane, 1993), lactate build up may
 Lewis and Sturmey. The meaning of embryo metabolism. 
 
Anim. Reprod., v.12, n.3, p.521-528, Jul./Sept. 2015 525 
overwhelm pH buffering system of the media and 
depletion of energy substrates can lead to alternative 
ATP generating pathways being used (Kane, 1987). 
It is also important to note that the manner in 
which an embryo responds to its environment is species 
specific. This can be seen in differences in response to 
hyperglycaemia. While species such as rodents and 
humans, will have significant diminished development 
in the presence of high glucose (Moley et al., 1998; 
Frank et al., 2014), others such as the horse and pig are 
apparently unaffected (Sturmey and Leese, 2003; Choi 
et al., 2015). Qualitative testing of equine embryos 
produced in hyperglycaemic conditions however, 
highlights subtle differences not reflected in the 
blastocyst development rate such as a decrease in ICM 
cell number allocation (also observed in the rat) and 
known to be mediated through apoptosis (Moley et al., 
1998; Choi et al., 2015). 
It is thus vital to consider that studies on 
embryo metabolism provide us a snapshot of physiology 
in a given set of conditions. Whilst such data are of 
fundamental importance, care must be taken when 
extrapolating and comparing such information. It is thus 
much more desirable that studies on the depletion and 
appearance of embryo metabolism are reinforced by 
consideration of mechanisms of metabolic regulation of 
early development. 
 
Embryo metabolism: some unanswered questions 
 
As the emphasis in human IVF is increasingly 
on single embryo transfer, the identification of reliable 
non-invasive methods of determining embryo quality to 
maximize pregnancy rate per transfer remains the Holy 
Grail. Moreover, in species such as the horse where in 
vitro embryo production is rapidly generating interest, a 
specific tailored culture media has yet to be formulated. 
Whilst acceptable blastocyst rates (41%) and pregnancy 
rates after transfer (66%) can be achieved by some 
laboratories in the horse using cell culture media such as 
DMEM-F12, (Jacobson et al., 2010; Hinrichs et al., 
2014) the more subtle effects of potentially 
inappropriate culture conditions leading to decreased 
viability remain to be seen. Identifying optimal species-
specific culture systems presents an exciting challenge 
for those involved in studying embryo metabolism. 
Sex selection is another lively area of embryo 
metabolism. Ethical considerations preclude the 
implementation of sex selection in the human, but in the 
production animal industry, and in dairy cattle in 
particular, appropriate non-invasive identification of sex 
before transfer would be an application with many uses. 
Promising results have been presented so far showing that 
both glucose metabolism and amino acid metabolism 
varies with sex (Sturmey et al., 2010; for review see 
Gardner et al., 2010), however more work will need 
performed to increase specificity in order for the 
technology to make the transition to commercial practice. 
New information is emerging all the time on 
the far-reaching downstream effects of aberrations in 
early embryo metabolism (Harrison and Langley-Evans, 
2009). Given the clear links between the periconceptual 
environment and sub-optimal health outcomes in the 
human (Barker et al., 2002) and production species such 
as the bovine (for example, the so-called Large 
Offspring Syndrome; Young et al., 1998), 
understanding and attempting to mitigate the negative 
effects on suboptimal embryo development and life-
long health of the offspring is an important area for 
future study (Leese, 2014). 
 
Conclusions 
 
It is acknowledged“that metabolism pervades 
every aspect of cell physiology” (DeBerardinis and 
Thompson, 2012) and this is especially pertinent to the 
developmentally plastic early mammalian embryo. As 
genomic, transcriptomic and imaging techniques 
advance we will be able to expand our understanding of 
embryo metabolism and how it links inextricably with 
developmental pathways through subsequent stages of 
gestation leading to the birth of a healthy offspring. It is 
the responsibility of us all working in the earliest stages 
of this process to understand the periconceptual 
environmental challenges faced by the embryo and to 
optimize the conditions under which it is grown to 
ensure the best start in life. Metabolic studies allow us 
to gain vital information on the requirements of a 
competent embryo and identify when things go wrong, 
but the reader is cautioned towards careful interpretation 
of measures of metabolism especially between 
laboratories and to consider the environment as a whole 
under which they have been taken.  
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Effect of oocyte source and transport time on rates of equine oocyte maturation and cleavage 
after fertilization by ICSI, with a note on the validation of equine embryo morphological 
classification 
N. Lewis, K. Hinrichs, K. Schnauffer, M. Morganti, C. McG. Argo
School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, UK 
Abstract 
Production of equine embryos using intracytoplasmic sperm injection (ICSI) is rapidly 
gaining interest in the horse industry.  Due to increasing client demand, equine practitioners with 
limited experience in embryology are attempting to set up clinical ICSI programs, with little success.  
We report here studies performed with the purpose of establishing an equine in vitro maturation 
(IVM)/ICSI program.  We addressed three objectives: to determine (1) the effect of oocyte source 
(transvaginal follicle aspiration [TVA] vs. abattoir) on maturation, cleavage and blastocyst rates; (2) 
the impact of time of oocyte recovery (soon after death vs. delayed [median time 7.5 h]) on these 
parameters in abattoir-derived ovaries; and (3) the correlation of post-ICSI embryo morphology with 
histologically-confirmed nuclear status.  Maturation rates were greater for TVA-derived than for 
abattoir-derived oocytes (67% vs. 32%, respectively; P <0.01).  Duration of ovary transport did not 
affect oocyte maturation (34-48%) or cleavage rates (70-73%).  Chromatin staining revealed that 
light-microscopic evaluation was accurate in determining oocyte maturation to metaphase II (14/15, 
93%), but was not accurate in classification of either normal embryo cleavage (8/31 cleaved embryos 
possessed normal nuclei) or blastocyst formation (7/15 embryos classified as blastocysts were verified 
on staining).  Early embryo and blastocyst viability was confirmed by transfer of some embryos into 
recipient mares.  These findings indicate that oocyte source (TVA vs. abattoir) can affect results in an 
equine IVM/ICSI system, and suggest that new laboratories should use a systematic approach of 
comparison of nuclear chromatin staining with morphological classification to validate embryo 
development after ICSI. 
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Introduction 
The ability to produce foals using ICSI has the potential to improve our understanding of 
early embryo development and has clinical applications in the salvage of valuable equine genetics.1  
In mares, this is either following post-mortem oocyte recovery or by collecting oocytes from living 
sub-fertile mares that cannot provide an embryo for transfer2,3 and in stallions, by offering a 
mechanism to produce embryos and foals when only limited reserves of semen are available. 
 The in vitro production of viable blastocysts and subsequent pregnancies, encompasses many 
complex and interdependent procedures, as well as requiring knowledge of cell culture and 
embryological techniques, such that the development of a successful equine ICSI program has been 
described as “practically unattainable in most situations”.4  Interest in the use of equine ICSI in both 
commercial and research applications has rapidly increased worldwide, and client demand has 
resulted in an increasing number of equine practitioners and equine laboratories with limited 
experience in in vitro embryo production embarking on the establishment of commercial equine ICSI 
laboratories.  Given the challenges, successes have been limited.  Groups that report blastocyst 
development after equine ICSI typically achieve a < 10% blastocyst rate per injected in vitro-matured 
(IVM) oocyte.5-8  Although it is generally understood that equine ICSI is feasible, in reality, only a 
few laboratories have reported high blastocyst rates (>20%) using IVM oocytes9-12 and only two of 
these have reported >20% blastocyst rates for this procedure more than once (~25-43%).3,11-15 
The rate of oocyte maturation is another major determinant of commercial success.  If 
blastocyst rates are low (<10%), production of one blastocyst would take over ten mature (metaphase 
II [MII]) oocytes.  For many laboratories, oocyte recovery and in vitro maturation rates currently 
conspire against this.  Rates of in vitro maturation are variable (44 to 61%), particularly when 
collecting oocytes post-mortem, as in genetic salvage cases.11,16 
Clinically, in the case of genetic salvage, a mare often dies or is euthanized at a location 
distant from the ICSI facility.  Under these circumstances ovaries/oocytes must be optimally retrieved 
and transported to the ICSI facility.  Despite anecdotal reports, currently, only a single report has 
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 detailed the clinical production of foals by ICSI under these conditions.  In that report, pregnancies 
were obtained following ovary removal at the location of death and transport of both whole ovaries or 
recovered oocytes.2 
 Another aspect affecting development of an ICSI program is the ability of the practitioner to 
appropriately identify viable embryos.  While some laboratories have validated their classification of 
embryos as blastocysts by chromatin staining for nuclear status or by achieving high pregnancy rates 
(>50%) after transfer, some laboratories have assessed blastocyst development based only on 
morphological appearance.3,6,12,17,18  The morphology of in vitro produced (IVP) equine blastocysts 
differs from both the morphology of IVP blastocysts in other species and from that of equine in vivo-
derived blastocysts, thus identification of viable embryos may be problematic for the inexperienced 
eye.  However, to the best of our knowledge, other than early reports from the laboratory in Texas 
which reported both morphological cleavage and cleavage with normal nuclei (41% to 88% of 
morphologically cleaved embryos had normal cleavage on nuclear evaluation),19-21 essentially no 
information is available on the relationship of light-microscopic morphological classification to actual 
embryo status as shown by evaluation after nuclear staining.  
 In this study, we performed three evaluations to establish basic parameters for the development of an 
equine ICSI program.  We determined (1) the effect of oocyte source (TVA from live mares vs. 
abattoir-derived) on maturation, cleavage and blastocyst rates after ICSI; (2) the relative impact of 
oocyte recovery soon after death as opposed to a delay following the transport of entire ovaries and 
(3) the correlation of post-ICSI embryo morphology on light microscopy with histologically-
confirmed nuclear status. 
 
Materials and methods 
 All procedures were conducted in agreement with the principals of the University of 
Liverpool Veterinary Ethics Committee and with the approval of the Royal College of Veterinary 
Surgeons. 
 
Oocyte recovery from abattoir-derived ovaries 
 Ovaries were obtained from mares, of unknown age and breed, slaughtered at a UK abattoir 
for purposes unrelated to the study.  Slaughter was conducted in accordance with EU legislations EC 
852/2004, 853/2004 and 854/2004.  Ovaries were obtained within 15 min post-mortem, placed in a 
polythene bag within a polystyrene foam container and maintained at ambient temperature (18-20°C) 
until all tissues had been processed.  Ovaries were either transported to the ICSI laboratory (transport 
time 4 hr) or to a local facility as dictated by the study protocols detailed below.  On arrival, all visible 
follicles were aspirated using a 14 G needle and vacuum pump  (Rocket Medical PLC., Watford, 
Herts, UK) set at approximately 200 mmHg.  All plastics (MILA international, Erlanger, Kentucky) 
were sterilized in ethylene oxide with a minimum gas-off time of 4 wk.  A syringe and needle were 
used to flush each follicle one to two times with flush medium (M199 with Hanks salts, 0.4% Fetal 
Bovine Serum (FBS) (Life Technologies Ltd, Paisley, UK), 25 μg/ml gentamicin, 8 IU/ml heparin 
(Sigma-Aldrich Ltd, Gillingham, Dorset, UK).  Ovaries were then sliced at 5-10 mm thickness and 
additional visible follicles were aspirated and scraped using the 14 G needle with vacuum.  Aspirated 
fluid was collected into sterile 500-ml bottles and passed through an embryo filter (Emcare ICPbio 
Reproduction, Auckland, NZ).  The filter was rinsed with flush medium and cumulus-oocyte 
complexes (COCs) were located in the recovered tissue under a dissection microscope at 60-120X.  
Identified COCs were moved to manipulation medium (M199 with Hanks salts, 10% FBS, 25 μg/ml 
gentamicin).  All manipulations were conducted at ambient temperature (approximately 18-20°C). 
 
Oocyte collection from live mares 
 Oocytes were recovered by TVA from six sport-horse type mares aged 7-14 years.  The TVA 
procedures were conducted as previously described.10  All visible follicles > 0.5 cm were aspirated; 
each follicle was flushed up to six times with flush medium.  The aspirated fluid was processed within 
1-2 hr of aspiration, as described above for fluid aspirated from follicles in abattoir-derived ovaries. 
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 Oocyte holding 
 Recovered COCs were divided into groups of eight to 14 and placed in individual 1-ml glass 
vials (Thermoscientific Inc., Waltham, MA) in EH Medium (40% M199 with Hanks salts, 40% M199 
with Earle’s salts, 20% FBS and 25 μg/ml gentamicin).22  Vials were sealed and held overnight (12-18 
hr) at room temperature (20°C) protected from light. 
 
Oocyte maturation 
 Maturation dishes (pre-prepared with medium and oil) were pre-equilibrated for 12 hr before 
use.  Cumulus-oocyte complexes were removed from the EH holding vial, washed in maturation 
medium (M199 with Earle’s salts, 10% FBS, 25 μg/ml gentamicin with 5 mU/ml FSH [Sioux 
Biochemical Inc., Sioux Center, IA]) and incubated in groups of 9-12 at a ratio of 10 μl medium per 
COC in a 4-well dish (Thermoscientific), under mineral oil  (Vitrolife Ltd., Warwick, UK) for 30 hr at 
38.3°C in 5% CO2 in air.  Oocytes were then denuded of cumulus cells by repeated pipetting in 
manipulation medium containing 80 IU/ml hyaluronidase (Vitrolife).  Oocytes were evaluated by light 
microscopy using a dissection microscope at 500X.  Those with a visible polar body were classified 
as metaphase II (MII), oocytes with an intact oolemma without a polar body were classified as intact 
and those with an irregular oolemma or shrunken cytoplasm were classed as degenerating (DEG).  
Confirmation of correlation of oocyte morphological classification with chromatin status was 
performed in experiment 3. 
 
ICSI and Embryo Culture 
 Frozen-thawed sperm from one fertile stallion was used for ICSI.  For each ICSI session, a 
single 0.5-ml straw of semen was thawed at 37°C for 30 sec.  To perform swim-up, 200 μl of thawed 
semen was placed under 3 ml of frozen-thawed Sp-Talp23 and incubated at 37°C for 30 min.  Sperm 
suspension from the top of the Sp-Talp layer was used for ICSI. 
 Conventional ICSI was performed using an Integra micromanipulator (Research Instruments, 
Falmouth, UK) by an embryologist (KS) with extensive experience in human clinical ICSI.  A 
standard sharpened ICSI needle (5 μm inner diameter; Research Instruments) was used.  Denuded MII 
oocytes were placed in individual 10-μl droplets of manipulation medium and 1-2 μl of sperm 
suspension was placed in a separate 5-μl droplet of a commercial 9% PVP solution (ICSITM; 
Vitrolife).  Motile spermatozoa were immobilized by crushing of the flagellum with the ICSI needle 
until kinking was observed and aspirated into the ICSI needle flagellum first.  The oocyte was 
positioned with the polar body at 6 o’clock and the ICSI needle was advanced through the zona 
pellucida and into the oocyte cytoplasm, essentially to the opposite side of the oocyte.  Puncture of the 
oolema was confirmed by visualization of cytoplasmic contents in the ICSI needle after suction and 
the spermatozoon was then deposited in the cytoplasm with a minimum of medium. 
Micromanipulator platform temperature was controlled in relation to ambient temperature in an 
attempt to perform all ICSI manipulations at 37°C. 
 Injected oocytes were washed twice in pre-equilibrated culture medium (DMEM-F12 [Sigma 
Aldrich] with 10% FBS and 25 μg/ml gentamicin)12 to remove manipulation medium and were placed 
in 20-μl droplets of culture medium under oil (four to ten injected oocytes/droplet, i.e. 2-5μl per 
injected oocyte) in a 4-well dish, (Thermoscientific) at 38.3°C in 5% CO2, 5% O2 and 90% N2.  
Except when noted below, embryos were assessed for cleavage on Day 3 (Day 0 = Day of ICSI), at 
which point uncleaved oocytes were moved to a different droplet within the same dish.  Medium in 
the original droplet was refreshed by adding 20 μl of fresh culture medium and then removing 20 μl.  
From Day 7 to Day 11, embryos were assessed for blastocyst development daily by visualization 
under an inverted microscope at 200X.  Embryos were classified as blastocysts morphologically based 
on an increase in diameter from the previous day and a multicellular appearance with presence of an 
apparent uniform outer cell layer. 
 
Transcervical embryo transfer 
 Embryos were loaded into 0.25 ml straws using pre-equilibrated culture medium, warmed to 
38.3°C.  A stainless steel gun with a disposable sheath  (both IMV Technologies, France) was used for 
the transfer.  Altrenogest (Regumate, MSD Animal health, Buckinghamshire, UK; 0.044 mg/kg bwt 
PO q 24 hr) was administered to each recipient mare beginning on the day of transfer.  Pregnancy 
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 diagnosis was first performed via transrectal ultrasonography on Day 14 (Day 0= Day of ICSI).  If an 
embryonic vesicle was not present, examinations were repeated every 2-3 days until Day 20 at which 
point the mare was declared non- pregnant and altrenogest treatment was discontinued.  If an 
embryonic vesicle was visualized on one of these examinations, examination was repeated on days 
21, 28, 45, 60 and 90.  Altrenogest treatment was continued until Day 120. 
 
Oviductal  embryo transfer 
 Transfer of embryos to the oviduct was performed by flank laparotomy under standing 
sedation as described previously,24 with the following major modifications: 1) a 15-cm oblique 
incision was made in the paralumbar fossa contralateral to the site of ovulation, beginning just ventral 
to the cranioventral aspect of the tuber coxae and extending cranially and ventrally perpendicular to 
the last rib; 2) injected oocytes/embryos were loaded into a modified 6 F dog urinary catheter attached 
to a 1 ml all-plastic syringe with < 0.5 ml of culture medium for transfer.  
 
Evaluation of oocytes and embryos for chromatin status 
 Oocytes or presumptive embryos were briefly fixed in buffered formal saline and mounted on 
a slide with 7 μl mounting medium (9:1 glycerol:PBS) containing 5 μg/ml Hoechst 33258 and 
examined by fluorescent microscopy (range 350-461nm) at 400X.  Oocytes were classified as MII, 
MI, GV (having an intact nucleus) or degenerating (no chromatin or abnormal chromatin).  Zygotes 
were evaluated for presence of two pronuclei and two polar bodies.  Cleaved embryos were evaluated 
to determine the number and status of nuclei.  Only nuclei that appeared to be normal were included 
in the number of nuclei recorded; nuclei with signs of degeneration (vacuolization, condensation or 
fragmentation) were disregarded.  Embryos were confirmed to be blastocysts if they contained more 
than 64 normal nuclei and showed arrangement of an outer rim of nuclei in a presumptive trophoblast 
layer. 
 
 Preliminary study.  To establish oocyte collection and maturation procedures, ovaries were 
obtained from the abattoir and transported to the main laboratory for processing.  After EH holding, 
oocytes were placed in culture in maturation medium as described above, then evaluated 
morphologically for presence of a polar body after 30 hr culture. 
 
 Experiment one: the effect of oocyte source (abattoir vs. in vivo) on maturation, cleavage and 
blastocyst rates after ICSI.  Oocyte maturation rates recorded in the preliminary study were low.  This 
study was conducted to determine whether the oocyte source affected maturation rates.  Oocytes were 
obtained from abattoir-derived ovaries as described above, or from live mares via TVA.  After IVM, 
the proportion of oocytes having polar bodies was recorded for each treatment, and these oocytes 
were then subjected to ICSI.  Injected oocytes were cultured, and evaluated for blastocyst 
development from Day 7 to Day 11.  Embryos classified morphologically as having developed to 
blastocyst were either transferred transcervically to the uterus of a recipient mare, or were stained for 
evaluation of chromatin status. 
 
 Experiment two: effect of ovary transport time on maturation, cleavage and blastocyst rate 
after ICSI.  The maturation rate was higher with in vivo-derived oocytes in Experiment 1.  It was 
hypothesized that the low maturation rates found in abattoir-derived oocytes in Experiments 1 and 2 
might be related to the delay during transport of the ovaries to the laboratory.  To test this hypothesis, 
abattoir-derived ovaries were divided into two treatments.  Group 1: local facility (LOC) ovaries 
collected from mares slaughtered from 7 am to 1 pm were processed at a facility near the abattoir.  
Recovered oocytes were placed into EH medium as described for overnight holding above, then 
transported to the laboratory.  Group 2: LAB, ovaries from mares slaughtered from 1-5 pm were 
collected and transported to the main laboratory for processing.  Recovered oocytes were placed into 
EH medium for overnight holding. 
 After IVM and ICSI, injected oocytes were examined from Day 7 to 11 of culture for 
development to blastocyst, at which time all presumptive embryos were stained for evaluation of 
nuclear status.  In one replicate, for the purpose of evaluating embryo viability, at 66 hr after ICSI, the 
embryos showing the greatest degree of development (uniform morphological cleavage and > six 
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cells) as assessed under light microscopy were transferred to the oviduct of a recipient mare on Day 1 
after ovulation. 
Experiment three: correlation of embryo morphology with nuclear status.  Staining of 
embryos at Days 7 to 11 in Experiments 2 and 3 suggested that morphological classification was not 
accurately reflecting the nuclear status of embryos.  To improve our understanding of the association 
between equine embryo morphology and nuclear status, a systematic, sequential embryo staining 
study was performed. 
Oocytes recovered from abattoir-derived ovaries and processed at the main laboratory were 
matured in vitro, then subjected to ICSI and embryo culture as described above, with the 
modifications that 0.27mM pyruvate was added to the oocyte injection medium and the sperm 
preparation method was changed to direct swim up.10 
Staining and assessment of chromatin status was performed at the following times: A) 
immediately after IVM in oocytes classified as MII on the basis of presence of a polar body; B) at 20 
hours post-ICSI to evaluate pronuclear status; C) at Day 2, 3, 4, or 7 after ICSI to determine nucleus 
number and correlation of morphological cleavage classification with nucleus number; and D) after 
seven to 11 days of culture.  In group D, embryos classified morphologically as blastocysts were 
stained and evaluated on the day they were identified, then all remaining presumptive embryos were 
stained and evaluated on Day 11 of culture.  Two Day-9 presumptive blastocysts from this group were 
not stained but were transferred to the uterus of a recipient mare five days after ovulation to evaluate 
viability. 
Statistical analyses 
Differences in rates of oocyte maturation, cleavage, and blastocyst development were 
compared among groups by Chi-square analysis, with Fisher’s Exact Test used between treatments 
when a value of less than ten was anticipated for any parameter. 
Results 
Preliminary study 
Five replicates were performed, and 49 oocytes were recovered and subjected to IVM.  The 
rate of maturation to MII was 39%. 
Experiment one: effect of oocyte source (abattoir vs. in vivo) on maturation, cleavage and blastocyst 
rates after ICSI 
Fifteen TVA procedures were performed, and 99 oocytes were recovered (Table 1).  Three 
replicates were performed with abattoir-derived ovaries.  Overall maturation rates were greater for 
oocytes obtained by TVA than for oocytes from abattoir-derived ovaries (67 % vs. 32%, respectively; 
P <0.01).  There was no significant difference between groups in morphological cleavage rate after 
ICSI (50 -53 %). 
On Day 8 after ICSI, on visual appraisal, based on increased diameter and the apparent 
presence of a uniform outer cell layer, four embryos (two TVA and two abattoir), were considered to 
have developed to the blastocyst stage.  Three of these were transferred transcervically (one single 
[abattoir]; one double [TVA]) to the uteri of two recipient mares six days after ovulation.  No 
pregnancies resulted.  The fourth presumed blastocyst was stained with Hoechst 33258; on evaluation, 
this proved to be a degenerated embryo. 
Experiment two: effect of ovary transport time on maturation, cleavage and blastocyst rates after ICSI 
Three replicates were performed (264 oocytes).  The time from mare death to placement of 
oocytes in EH media for the LOC treatment ranged from 0.5- 4 hr (median 2.25 hr); in the LAB 
treatment this ranged from 5-10 hr (median 7.5 hr).  Three metaphase II oocytes were lost during 
manipulation and not injected.  There was no significant difference in oocyte maturation or cleavage 
rates between LOC and LAB treatments (Table 2). 
Transfer of the four most advanced embryos at 66 hr culture in one replicate resulted in two 
embryonic vesicles (4 mm and 5 mm in diameter) detected by transrectal ultrasonography of the 
recipient mare on Day 17 after ICSI.  These vesicles were lost by Day 24.  None of the 61 cleaved 
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 embryos cultured to Day 11 were classified as blastocysts morphologically.  However, on evaluation 
after staining, one blastocyst was identified in this group based on the presence of > 64 cells and an 
organized outer layer of nuclei. 
 
Experiment three:  correlation of embryo morphology and nuclear status 
 Staining and evaluation of chromatin status was performed at sequential steps to validate 
morphological classification of oocyte and embryo status.  In one replicate, 18 oocytes presumed to 
be in MII based on presence of a polar body were stained to confirm meiotic status; three were lost 
during manipulation and 14/15 (93%) were confirmed in MII (Fig. 1A). A total of 109 oocytes were 
subjected to ICSI. Over four replicates, the rate of pronuclear (PN) formation at 20 hr after ICSI was 
43% (10/23 oocytes; Fig. 1B); a further eight injected oocytes were lost during processing. Over six 
replicates, 46 presumptive embryos were stained on Day 2, 3, 4, or 7 after ICSI.  Of these, 31 (64%) 
demonstrated apparent morphological cleavage, but only eight of these (17%) had two or more 
normal nuclei on staining.  In 3/46 embryos (6.5%), the number of nuclei matched the number of 
visible blastomeres and were appropriate for age (Fig. 2A); five embryos possessed two to six normal 
nuclei, but nucleus number was lower than expected for day.16  The other 23 stained embryos that 
appeared cleaved morphologically possessed only degenerated nuclei or were completely anuclear 
(Fig. 2B). 
 In five replicates, presumptive embryos were cultured to determine blastocyst development 
(Table 3).  Seven metaphase II oocytes were used in other studies and not injected.  After culture for 7 
to 11 days, 17 presumptive embryos were classified as having developed to the blastocyst stage based 
on morphological criteria.  Of these, 15 were stained for nuclear evaluation and two were transferred 
to the uterus of a recipient mare (results below).  Evaluation of the 15 presumptive blastocysts after 
staining revealed seven confirmed blastocysts (e.g. Fig. 3A1-3, Fig, 4) and eight degenerating 
embryos (e.g. Fig, 3C1-2).  In these replicates, at Day 11 all remaining structures (not classified as 
blastocysts) were stained, and one of these was also revealed to be a blastocyst (Fig, 3D1-2).  
Notably, as uncleaved oocytes were placed in a separate droplet at Day 4 but were kept in culture, we 
could evaluate changes in these oocytes over time.  Several known uncleaved oocytes increased in 
diameter on Day 9 (e.g. Fig. 3B1), which, on simple morphological evaluation, could have led to 
mistaken classification of these structures as blastocysts (Fig. 3B2-3). 
 Transcervical transfer of two Day-9 presumptive blastocysts in the final replicate, to the 
uterus of a recipient mare five days after ovulation resulted in two embryonic vesicles (3 mm and 10 
mm in diameter) detected by transrectal ultrasonography on Day 14 after ICSI.  The smaller vesicle 
was manually reduced at Day 16 and the remaining vesicle developed normally.  A healthy colt foal 
was born at 345 days gestation (Fig. 5).  Overall, in these five replicates, including the two transferred 
embryos, the rate of “blastocyst” development based on morphological assessment was 17/138 
(12.3%); however, the confirmed blastocyst development per injected oocyte was 10/138 (7.2%). 
 
Discussion 
 This study highlights factors that may affect the development of an effective equine ICSI 
program.  We found an increased rate of meiotic maturation in oocytes derived from live mares by 
TVA compared to oocytes recovered post-mortem.  The maturation rate of post-mortem derived 
oocytes was not affected by ovary transport time (up to 10 hr).  Notably, when assessing embryo 
development in the first two experiments, we found discrepancies between our morphological 
classification of the embryos on light microscopy and the findings on staining for nuclear evaluation.  
This led us to evaluate the accuracy of our morphological classifications via step-wise oocyte and 
embryo staining in Exp. 3. 
 The rate of nuclear maturation in our preliminary study with abattoir-derived oocytes was low  
(39%).  To determine if this was related to oocyte source, or to our untested IVM system, we 
compared maturation rates of TVA vs. abattoir-derived oocytes.  This showed that with TVA oocytes 
the IVM system produced acceptable rates of maturation to MII (67%) whereas maturation remained 
low for oocytes from abattoir-derived oocytes, serving to validate the IVM system.  We then 
evaluated whether the long transport time was associated with the low maturation rates in abattoir-
derived oocytes; however, maturation remained low for oocytes collected after a median time of 2.25 
hr or 7.5 hr.  It is possible that changes in oocyte meiotic competence had already occurred within our 
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shortest handling duration (2.25 hr in the LOC group), thus lowering the maturation rates.  A study by 
Guignot et al. also found no difference in maturation rates across transport times (1.5- 4 hr vs. 6-8 
hr);26 while Hinrichs et al. did find a higher maturation rate in oocytes collected < 1 hr of slaughter 
than in oocytes collected 5-9 hr after slaughter.  Due to abattoir location and available processing 
facilities, the LOC group represented the most rapid processing time possible in this study.  Of course, 
transport time is only one factor affecting rates of meiotic maturation and developmental competence 
in abattoir-derived ovaries, others including temperature of transport, mare age and health, and 
exposure of the ovaries to toxic compounds at the abattoir.  Several studies have investigated optimal 
transport temperatures for equine ovaries and it was suggested that for periods < 1 hr, ovaries should 
be kept at 30-37°C but for longer periods, room temperature (22-24°C; as in this study) was more 
appropriate and resulted in the highest developmental competence.27-29 
The final blastocyst rate (number of confirmed blastocysts per injected oocyte) achieved was 
7.2%, which is similar to that reported by some established ICSI laboratories6,8 but lower than optimal 
(20-40%).3,10,30  All embryos in this study were produced by conventional ICSI.  Historically, the first 
equine ICSI pregnancy was produced using conventional injection and surgical transfer of early 
embryos.31  Some laboratories applied chemical oocyte activation due to low cleavage rates after 
ICSI,1 although soon after, workers employing Piezo drill-assisted ICSI indicated that chemical 
activation was unnecessary.19  On the basis of successes with the Piezo drill,12,21,33 it has been 
hypothesized that this technique is an important aid to equine ICSI.  In the only study in which Piezo-
assisted and conventional (laser-assisted) ICSI were directly compared, no significant difference was 
recorded, however, blastocyst rates per injected oocyte were low for both methods (4.8% and. 5.1%, 
respectively).6  The same authors have reported a live foal produced following conventional ICSI.34  
That study, and ours report blastocyst development at a much lower rate (7.4 % and 7.2% 
respectively) than do those that use Piezo-assisted ICSI (> 25%),10,11,14 but clearly there are a myriad 
of other potential differences among these laboratories.  There is a need for a systematic, prospective 
study within the same laboratory to establish whether Piezo-assisted ICSI offers a significant 
advantage over conventional ICSI.  This is important, as the inclusion of the Piezo drill represents a 
significant additional investment for new laboratories and introduces an additional requirement for 
technical expertise. 
Difficulties were experienced in correctly interpreting the morphology of cleaved embryos.  
Initially, we used a human grading system, which was shown not to be appropriate for application to 
equine embryos.  The systematic staining of cleaved embryos revealed that only three of 31 embryos, 
empirically classified as morphologically cleaved, actually possessed the number of nuclei 
appropriate for age, and we found that many embryos contained anuclear blastomeres.25  The 
significance of this latter finding is unclear.  A recent study in humans reported that presence of 
anuclear blastomeres had no significant effect on birth rate.35 
Blastocyst identification was also problematic.  Even when interpretation was based on 
images and information from laboratories working in equine ICSI,10,36 we still encountered 
discrepancies between morphological blastocyst appearance and nuclear status (Figure 3).  It was 
noted that several known uncleaved oocytes increased in diameter between Days 7 and 9 after ICSI, 
and these were shown to have no nuclear chromatin upon staining (Figure 3B1-3).  This phenomenon 
has not to the best of our knowledge been presented previously.  Certain time-dependent cell-cycle 
and development stages can occur independently of nuclear status,37 therefore it could be 
hypothesized that there are cytoplasmic developmental clock mechanisms driving oocyte expansion in 
the absence of cleavage.  Our findings reinforced the importance of removing uncleaved oocytes to 
limit uncertainty in later assessments of blastocyst development, and of staining embryos for DNA to 
definitively establish blastocyst development.  In practical terms, chromatin integrity cannot be 
evaluated in presumed blastocysts designated for transfer.  Here, the benefits gained from coupling 
morphological assessments with definitive evaluations of nuclear status were invaluable.  Morphology 
can be used to reliably select true blastocysts, as shown by the high initial pregnancy rate of IVP 
blastocysts after transfer reported by experienced laboratories (82/101, 82%;30; 9/13, 69%;3).  In our 
case, morphological selection of two blastocysts in the final replicate of the study resulted in two 
embryonic vesicles. 
To the best of our knowledge, this is the first report to document the disparity between 
morphological and histological assessment in equine IVP embryos.  When setting up an ICSI 
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laboratory, it is tempting, as we did in Experiments 1 and 2, to transfer structures presumed to be 
embryos to recipient mares in an attempt to establish pregnancies and thus validate the program.  
However, in retrospect, this was counter-productive as evaluating morphology alone proved to be 
inaccurate and misleading.  Our data and the related figures from Exp. 3 highlight the need for 
objective verification of embryo status.  We hope that by sharing our experience of identifying 
discrepancies between morphological classification and actual embryo developmental stage, we have 
highlighted that morphology must be confirmed by a method such as nuclear staining when 
laboratories are initially evaluating their rate of blastocyst production. 
Figure 1: Photomicrographs of oocytes evaluated after IVM to validate MII status (A) and after ICSI to validate fertilization 
status (B).  A1, B1: bright field microscopy 300X; A2, B2: after staining with Hoechst 33258, under fluorescence 400X.  
A1: MII oocyte with polar body (arrow); A2: metaphase plate (arrow) and polar body (closed arrow); B1: Injected oocyte 22 
hours after ICSI B2:  Fertilization confirmed by visualization of two pronuclei (staining incomplete; arrows) and two polar 
bodies (closed arrows). 
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Figure 2: Photomicrographs of two embryos 96 hours after ICSI.  A1, B1:  bright field 300X; A2, B2 after staining with 
Hoechst 33258 400X.  A1: apparent 10-cell embryo; A2: 9 normal nuclei and one anuclear blastomere (arrow); B1: apparent 
8-cell embryo; B2: no normal nuclei.
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Figure 3: Photomicrographs of presumptive blastocysts at Day 9 after ICSI, showing discrepancies between morphological 
classification and nuclear status.  A1 and B1: bright field images (60X) of presumptive embryos shown in panels A2-A3 and 
B2-B3, respectively, showing relative increase in diameter (arrows).  B1-3; structure arising from uncleaved oocyte.  Left: 
bright field (300X); right, after Hoechst 33258 staining (400X).  A2: Presumed blastocyst shown in A1, with presumptive 
trophoblast layer (outer layer of organized cells) and thinning zona pellucida (ZP).  A3: Status as blastocyst (presence of >64 
cells with organized outer layer of nuclei) confirmed after staining.  B2: structure pictured in B1, having similar morphology 
to blastocyst; B3: structure confirmed as a degenerating uncleaved oocyte, with no visible chromatin.  C1: presumed 
blastocyst (from cleaved embryo) due to increase in size and thinning of ZP.  C2: staining revealed structure to be 
degenerating.  D1: presumed degenerating embryo (from cleaved embryo) due to irregular cytoplasmic outline and lack of 
size increase.  D2: staining revealed structure to be blastocyst (penetration of the stain is incomplete). 
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Figure 4: Photomicrographs (Bright field 300X) showing sequential development of a blastocyst on Days 7 through 9 (A-C) 
after ICSI (blastocyst status was subsequently confirmed by staining).  An increase in diameter and in organization of the 
presumptive trophoblast layer can be seen.
Figure 5: Photograph of ICSI foal at 5 days old. 
Editor’s note:  The photographs in this manuscript are available in color in the online edition of 
Clinical Theriogenology. 
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Appendix	3:	Multivariable	models	to	accompany	results	of	Chapter	4	
	
	
Experiment	4.1:	Effect	of	oxygen	concentration	and	pyruvate	concentration	during	
IVM	on	GPL	metabolism.	
	
	 	
Coef.	 95%	CI	
	
P	
	 	 	 	 	 	Glucose	 Media	 7.17 0.53 13.82 0.04
consumption	 Oxygen	 -1.1	 -7.22	 5	 0.72	
	
Media*oxygen	 0.78	 -7.56	 9.13	 0.85	
	
Trimming	 5.19	 1.16	 9.23	 0.01	
	
Constant	 3.07	 -4.92	 11.06	 0.45	
	 	 	 	 	 	Lactate		 Media	 -1.7 -11.13 7.69 0.72
production	 Oxygen	 -7.07	 -15.71	 1.56	 0.12	
	
Media*oxygen	 6.4	 -5.46	 18.26	 0.29	
	
Constant	 25.76	 18.67	 32.84	 <0.001	
	 	 	 	 	 	Pyruvate		 Media	 -1.47 -2.47 -0.48 0.01
production	 Oxygen	 -0.52	 -1.43	 0.4	 0.27	
	
Media*oxygen	 1.15	 -0.1	 2.39	 0.07	
	
Cumulus	
classification	 0.49	 -0.12	 1.1	 0.11	
	
Trimming	 1.22	 0.62	 1.82	 <0.001	
	
Constant	 0.09	 -1.11	 1.29	 0.88	
	 	 	 	 	 	Lactate:	 Media	 -0.67 -1.19 -0.16 0.01
Glucose	ratio	 Oxygen	 -0.2	 -0.69	 0.3	 0.43	
	
Media*oxygen	 0.37	 -0.28	 1.02	 0.26	
	
Trimming	 -0.47	 -0.78	 -0.16	 <0.001	
	
Constant	 2.77	 2.17	 3.37	 <0.001	
	
Table	 A3.1:Multivariable	 linear	 regression	 model	 for	 effect	 of	 media	 (0	 mM	
pyruvate	vs.	0.15	mM	Pyruvate)	and	oxygen	concentration	(5%	vs.	21%)	during	IVM	
on	 glucose	 consumption,	 lactate	 and	 pyruvate	 production	 and	 lactate	 :	 glucose	
ratio.	*	Indicates	interaction	term.	Constant	represents	a	visually	trimmed	compact	
COC	matured	in	control	maturation	media	(0	mM	pyruvate)	at	21%	Oxygen.	
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Experiment	4.3	
	
Study	 1:	 Temporal	 changes	 in	 GPL	 metabolism	 over	 the	 course	 of	 IVM	 in	 the	
presence	of	pyruvate	
	
	
Variable	
Sub		
Category	 Coef.	 95%	CI	
	
P	
Glucose	
Consumption	 Time	 0-10h	 Ref.	
	 	 	
	 	
10-20	h	 4.31	 0.95 7.66 0.01
	 	
20-30	h	 -5.17	 -8.49	 -1.85	 0.002	
	
Batch		 1	 Ref.	
	 	 	
	 	
2	 -6.8	 -12.48 -1.13 0.02
	 	
3	 5.09	 0.69	 9.5	 0.02	
	 	
4	 -6.43	 -12.12	 -2.75	 0.002	
	 	
5	 -5.81	 -10.76	 -0.85	 0.02	
	 	
6	 2.78	 -1.9	 7.47	 0.24	
	
Constant	
	
17.41	 13.49	 21.32	 <0.001	
Lactate	
production	 Time	 0-10h	 Ref.	
	 	 	
	 	
10-20	h	 3.14	 -0.61 6.88 0.1
	 	
20-30	h	 -8.28	 -12.07	 -4.48	 <0.001	
	
Batch		 1	 Ref.	
	 	 	
	 	
2	 -2.67	 -14.29 8.95 0.65
	 	
3	 -13.05	 -22.08	 -4.02	 0.01	
	 	
4	 -10.52	 -20.16	 -0.9	 0.03	
	 	
5	 2.89	 -7.22	 13.02	 0.58	
	 	
6	 -2.93	 -12.51	 6.63	 0.55	
	
Constant	
	
36.56	 29.28	 43.84	 <0.001	
Pyruvate	
production	 Time	 0-10h	 Ref.	
	 	 	
	 	
10-20	h	 0.73	 -0.44 0.59 0.78
	 	
20-30	h	 1.05	 0.52	 1.58	 <0.001	
	
Batch		 2	 Ref.	
	 	 	
	 	
3	 -0.88	 -1.81 0.05 0.06
	 	
4	 -0.32	 -1.23	 0.6	 0.5	
	 	
5	 0.21	 -0.73	 1.14	 0.67	
	 	
6	 0.35	 -0.55	 1.25	 0.45	
	
Constant	
	
1.52	 0.81	 2.23	 <0.001	
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Table	2	continued		
	
	
Variable	
Sub		
Category	 Coef.	 95%	CI	
	
P	
Lactate:	
Glucose	
ratio	 Time	 0-10h	 Ref	
	 	 	
	 	
10-20	h	 -0.21	 -0.41 0.37 0.92
	 	
20-30	h	 0.29	 -0.11	 0.69	 0.16	
	
Batch		 1	 Ref	
	 	 	
	 	
2	 1.17	 0.38 1.96 0.004
	 	
3	 -0.98	 -1.51	 -0.46	 <0.001	
	 	
4	 0.84	 0.26	 1.42	 0.004	
	 	
5	 1.33	 0.74	 1.93	 <0.001	
	 	
6	 -0.3	 -0.86	 0.26	 0.3	
	
Constant	
	
1.93	 1.45	 2.41	 <0.001	
	
	
Table	A3.2:	Mixed	random	effect	multivariate	 linear	regression	model	 for	effect	of	
time	 during	 IVM	 on	 glucose	 consumption,	 lactate	 and	 pyruvate	 production	 and	
lactate	 :	 glucose	 ratio.	 COC	 ID	 was	 added	 as	 a	 random	 effect	 to	 account	 for	
repeated	measures	over	time.	Constant	represents	COC	in	batch	2		during	0-10	hours	
of	in	vitro	maturation.	
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Study	 2:	 The	 impact	 of	 oocyte	 presence	 on	 GPL	 metabolism	 (intact	 COC	 vs.	
granulosa	only).	
	
	
	
Variable	
Sub-
Category	 Coef.	
95%	
CI	
	
P	
Glucose	
consumption	 Time	 0-10h	 Ref	
	 	 	
	 	
10-20	h	 -2.83	 -7.93 2.27 0.28
	 	
20-30	h	 -3.04	 -8.14	 2.06	 0.24	
	
Intact	COC	 2.34	 -3.35	 8.03	 0.42	
	
Time*COC	 0-10	h*COC	 Ref	
	 	 	
	 	
10-20h*COC	 10.24	 3.65	 16.83	 0.002	
	 	
20-30h*COC	 -1.31	 -7.86	 5.25	 0.7	
	
Constant	
	
13.31	 8.89	 17.73	 <0.001	
Lactate	
production	 Time	 0-10h	 Ref	
	 	 	
	 	
10-20	h	 3.91	 -1.61 9.41 0.17
	 	
20-30	h	 3.82	 -1.69	 9.34	 0.17	
	
Intact	COC	 17.61	 9.64	 25.58	 <0.001	
	
Time*COC	 0-10	h*COC	 Ref	
	 	 	
	 	
10-20h*COC	 1.01	 -6.04 8.07 0.78
	 	
20-30h*COC	 -9.18	 -16.23	 -2.12	 0.01	
	
Constant	
	
12.81	 6.6	 19.04	 <0.001	
Pyruvate	
production	 Time	 0-10h	 Ref	
	 	 	
	 	
10-20	h	 -1.89	 -2.85 -0.94 <0.001
	 	
20-30	h	 -1.78	 -2.72	 -0.84	 <0.001	
	
Intact	COC	 -1.3	 -2.36	 -0.24	 0.02	
	
Time*COC	 0-10	h*COC	 Ref	
	 	 	
	 	
10-20h*COC	 1.84	 0.58 3.1 0.003
	 	
20-30h*COC	 2.75	 1.49	 4	 <0.001	
	
Constant	
	
2.66	 1.87	 3.45	 <0.001	
Lactate:glucose	
ratio	 Time	 0-10h	 Ref	
	 	 	
	 	
10-20	h	 0.74	 0.18 1.31 0.01
	 	
20-30	h	 0.34	 -0.22	 0.9	 0.23	
	
Intact	COC	 0.72	 0.31	 1.42	 0.04	
	
Time*COC	 0-10	h*COC	 Ref	
	 	 	
	 	
10-20h*COC	 -0.95	 -1.68	 -0.23	 0.01	
	 	
20-30h*COC	 0.06	 -0.68	 0.79	 0.88	
	
Constant	
	
1.22	 0.7	 1.75	 <0.001	
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Table	A3.3:	 	Mixed	multivariate	random	effects	 linear	regression	model	for	 impact	
of	oocyte	presence	(intact	COC	vs.	granulosa	only)	on	glucose	consumption,	lactate	
and	 pyruvate	 production	 and	 lactate:	 glucose	 ratio.	 *	 Indicates	 interaction	 term.	
Constant	represents	granulosa	only	during	0-10	hours	of	in	vitro	maturation.	
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Study	3:	The	impact	of	presence/absence	of	FSH	on	GPL	metabolism.	
	
	
	
	
Variable	
Sub-
Category	 Coef.	 95%	CI	
	
P	
	 	 	 	 	 	 	Glucose		 Time	 0-10h Ref
	 	 	consumption	
	
10-20	h	 -1.24	 -5.94	 3.45	 0.6	
	 	
20-30	h	 -8.16	 -12.86	 -3.46	 0.001	
	
FSH	present	 -0.76	 -6.44	 4.91	 0.79	
	
Time*FSH		 0-10	h*FSH		 Ref	
	 	 	
	 	
10-20h*FSH		 5.83	 -0.37	 12.02	 0.07	
	 	
20-30h*FSH		 2.68	 -3.5	 8.84	 0.4	
	
Constant	
	
16.98	 12.65	 21.3	 <0.001	
	 	 	 	 	 	 	Lactate		 Time	 0-10h Ref
	 	 	production	
	
10-20	h	 -4.6	 -9.54	 0.33	 0.07
	 	
20-30	h	 -15.68	 -20.68	
-
10.69	 <0.001	
	
FSH	present	 1.6	 -5.11	 8.31	 0.64	
	
Time*FSH		 0-10	h*FSH		 Ref	
	 	 	
	 	
10-20h*FSH		 8.72	 2.23	 15.2	 0.008
	 	
20-30h*FSH		 9.59	 3	 16.18	 0.004	
	
Constant	
	
26.16	 21.07	 31.26	 <0.001	
	 	 	 	 	 	 	Pyruvate		 Time	 0-10h Ref
	 	 	production	
	
10-20	h	 -0.81	 -1.36	 -0.27	 0.004	
	 	
20-30	h	 -0.39	 -0.95	 0.16	 0.17	
	
FSH	present	 0.11	 -0.65	 0.86	 0.79	
	
Time*FSH	 0-10	h*FSH		 Ref	
	 	 	
	 	
10-20h*FSH	 1.05	 0.32	 1.77	 0.005	
	 	 	
1.38	 0.64	 2.11	 <0.001	
	
Constant	
	
0.99	 0.43	 1.55	 0.001	
	 	 	 	 	 	 	Lactate:glucose	 Time	 0-10h Ref
	 	 	ratio	
	
10-20	h	 0.79	 0.07	 1.52	 0.03	
	 	
20-30	h	 -0.004	 -0.78	 0.77	 0.99	
	
FSH	present	 0.01	 -0.76	 0.79	 0.97	
	
Time*FSH		 0-10	h*FSH		 Ref	
	 	 	
	 	
10-20h*FSH		 -0.59	 -1.56	 0.37	 0.23	
	 	
20-30h*FSH			 0.58	 -0.45	 1.61	 0.27	
	
Constant	
	
1.66	 1.08	 2.23	 <0.001	
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Table	A3.4:	Mixed	multivariate	random	effects	linear	regression	model	for	impact	of	
FSH	presence	(5mU/ml	vs.	0mU/ml)	on	glucose	consumption,	 lactate	and	pyruvate	
production	 and	 lactate:glucose	 ratio.	 *	 Indicates	 interaction	 term.	 Constant	
represents	COC	matured	without	FSH	during	0-10	hours	of	in	vitro	maturation.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
		
